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The protein RP2 is a tubulin cofactor C-domain containing protein with important roles 
in ciliogenesis. In humans, mutations in the RP2 gene are associated with 10-15% of 
cases of X-linked retinitis pigmentosa; a devastating disease characterised by 
progressive degeneration of retinal photoreceptors. Although XRP2 was initially 
proposed to function as a GTPase-activating protein (GAP) for tubulin, evidence now 
suggests that it acts as a GAP for Arl3 (a small GTPase) and together with Arl3 is 
involved in trafficking proteins to the cilium. I have been studying RP2 function in the 
flagellated protist Trypanosoma brucei, a tractable model to study eukaryotic 
flagellum assembly but also a parasite of medical and veterinary importance in sub-
Saharan Africa. Thus, the study of RP2 in trypanosomes has relevance for parasitology, 
but also the human inherited disease retinitis pigmentosa. However, important 
differences exist between XRP2 and TbRP2, for instance TbRP2 lacks the consensus 
sequence specifying N terminal myristoylation (a modification that targets XRP2 to the 
basal body in mammalian cells) but rather utilises twinned TOF-LisH motifs at the N-
terminus of the protein to direct basal body targeting. To further interrogate the 
targeting and function of TbRP2, I employed proximity-dependent biotin identification 
(BioID), in combination with quantitative proteomic (SILAC) techniques, to identify 
putative TbRP2-interacting proteins in vivo. A selected cohort of these proteins were 
subsequently interrogated by bioinformatics, localised within the cell using a PCR only 
(pPOT) YFP-tagging strategy and their potential roles in flagellum formation 
interrogated using inducible RNA interference (RNAi). My studies identified: (i) an 
Arl3-related protein as the likely molecular client of TbRP2 GAP activity; (ii) the 
trypanosome mature basal body as a hub for molecular chaperone activity associated 
with eukaryotic flagellum assembly; and (iii) insight into lineage-specific aspects of 
basal body biogenesis, as illustrated by the unusual spatial and temporal inheritance 
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Chapter 1 Introduction  
 
 1.1 Cilium/Flagellum  
 
1.1.1 General background 
 
Eukaryotic cilia/flagella (terms which will be used interchangeably in this chapter) are 
finger-like, microtubule-based structures, which protrude from the surface of many 
eukaryotic cells (Fig 1.1). The distinction between cilia and flagella is not always very 
clear. Historically, they have been distinguished by (1) their number - if there are 
many, (more than 100) they are normally called cilia, whereas if there are fewer than 
8, they are usually called flagella, (2) their length - flagella are typically longer than cilia 
(Moran et al., 2014). Despite these differences, the basic organisation and mechanism 
of flagellum/cilium assembly are evolutionarily conserved and remarkably similar in 
phylogenetically diverse species. Both cilia/flagella have extremely important 
biological functions, ranging from motility to sensory perception and are vital to 
human health. Defects in cilium/flagellum functions can lead to a wide range of 
inherited human disorders called ciliopathies, which can affect respiratory system, 
retinal cells, kidney etc. (Tobin and Beales, 2009; Waters and Beales, 2011). Moreover, 
defects in cilia are also associated with other pathologies such as diabetes and cancer 
(Han and Alvarez-Buylla, 2010). In the following sections, I will provide details on 
cilium/flagellum structure and function as well as the mechanism(s) by which a 




























Figure 1.1 A diversity of cilia and flagella can be found in eukaryotic organisms.  Motile cilia 
in the human respiratory tract can move mucus and dirt out of human body. Trypanosoma 
brucei - the flagellum plays multiple roles (motility, host-parasite interaction, organelle 
positioning). Giardia spp - flagella are essential for motility, cell division and attachment to 
intestinal villi in the host body. Paramecium (a unicellular protozoa) is covered with many cilia 
whose main purpose is movement and the gathering of food particles. Leishmania is closely 
related to trypanosomes, and flagella can serve various roles, including sensory perception, 
cellular organisation and movement. Trichomonas vaginalis causes a sexually transmitted 
infection called Trichomoniasis, and flagella play an important role in motility. Source: All 
images reprinted with permission from Encyclopaedia Britannica ImageQuest. 
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1.1.2 Cilium/Flagellum structure  
 
From a structural viewpoint, the cilium can be divided into sub-compartments that 
include the basal body, from where the microtubule axoneme is nucleated, the 
transition zone (TZ), and the core axoneme structure (Fig 1.2.A). At the basal body, 
there are nine radially organised microtubule triplets (designated the A, B and C 
tubules) (Fig 1.2.A-(1)). The A-tubule of each doublet is a complete MT, which consists 
of 13 protofilaments (pf), whereas the B and C-tubule is an incomplete MT often 
consisting of only 10 pfs (Nicastro et al., 2011; Sui and Downing, 2006). Because the 
cilium is a ‘ribosome-free zone’, in most flagellated eukaryotes proteins need to be 
delivered into the cilia by a process called intraflagellar transport (IFT); a motor driven 
process that transports proteins along axonemal microtubules. There are some 
species that do not require IFT for axoneme assembly, such as Plasmodium falciparum, 
which assemble the axoneme within the cytoplasm (Briggs et al., 2004a; Sinden and 
Smalley, 1976).  
 
As the cilium extends to create a transition zone, the triplet microtubule structure of 
the basal body converts into doublet structure i.e. only the A and B tubules continue 
to extend to form the nine outer doublet microtubules of the axoneme shaft; the C 
tubules terminate within the transition zone between the basal body and the shaft. 
The proximal end of transitional fibres (Fig 1.2.A-(2)) connect the microtubule 
doublets to the membrane and mark the compartment border at which IFT proteins 
accumulate (Ishikawa and Marshall, 2011).   The transition zone (TZ) is characterised 
by the Y-shaped linkers, which bridge from microtubule doublets to the ciliary 
membrane and distal appendages. Together the transitional fibres and the so-called 
ciliary necklace are proposed to form a physical and selective barrier (i.e. the ciliary 
gate) at the base of the cilium, which regulates the movement of ciliary proteins 
between the cytoplasm and ciliary compartment (Fig 1.2.A-(3)) (Gilula and Satir, 1972; 
Nachury et al., 2010). In the ciliary gate area, there are several multiprotein 
complexes, mutations in the genes that encode some of the proteins can lead to many 




Generally, cilia can be classified into either motile or immotile (often called primary 
cilium).  In motile cilia, the axoneme in (most) motile cilia has a canonical 9 + 2 
microtubule organisation i.e. nine doublet MTs arranged symmetrically around a pair 
of single MTs called the central pair (Fig 1.1.B) (Satir and Christensen, 2007). The nexin 
links link MT doublets together, and the central pair is connected to the MT outer 
doublets by radial spokes (Pigino and Ishikawa, 2012).  Both inner and outer dynein 
arms are located on the A tubules of the MT outer doublets, which allow the dynein 
motor domains to contact the neighbouring B-tubule to generate ciliary movement 
(King, 2016).  
 
In contrast, primary cilia have a 9+0 arrangement, in which the axoneme lacks central 
pair microtubules as well as radial spokes, nexin links and inner- and outer-arm dynein 
complexes. Although the 9+2 and the 9+0 arrangement are the two most commonly 
found MT structures, a wide variety of other arrangements exist for both motile and 
non-motile cilia. For example, the cilia on the notochordal plate of the rabbit embryo 
have 9+4 MTs arrangement (Feistel and Blum, 2006), and more extreme case such as 
gregarine apicomplexan parasites Lecudina tuzetae, which have 6+0 arrangement of 
their male gametes (Kuriyama et al., 2005). Although, the majority of motile cilia 
consist of a 9+2 arrangement, and primary cilia have 9+0 configurations, motile cilia 
can also be 9+0, or primary cilia can have a 9+2 arrangement; such as monocilia at 
embryonic node that generate fluid flow for left-right asymmetry (Nonaka et al., 
1998), and immotile cilia in frog olfactory epithelium with 9+2 arrangement (Reese, 
1965).    
 
For many years, primary cilia were considered vestigial organelles without any real 
function. However, it is now recognised that primary cilia serve crucial roles, acting as 
a sensory antenna to allow cells to sense their environments, coordinate signalling 
pathways, and (in multicellular organisms) maintain tissue homeostasis (Fliegauf et 
al., 2007). Indeed, it is now evident that ciliary dysfunction underpins many 
devastating human genetic diseases, collectively termed ciliopathies (Adams et al., 

















Figure 1.2. (A) The general structure and the cross section of a cilium at the level of the basal 
body, transition fibres, transition zone. (B) The cross section axoneme microtubule in a typical 
motile cilium with major structures. Adapted from (Ginger et al., 2008; Szymanska and 
















1.1.3   Cilium biogenesis  
 
Early studies in mammalian cells indicated that ciliary/flagellar assembly proceeds 
through distinct and ordered steps (Sorokin, 1962; Sorokin, 1968) (see Fig 1.3), which 
were later confirmed using time-lapse microscopy (Westlake et al., 2011). The initial 
stage requires Golgi derived cytoplasmic vesicles, called distal appendage vesicles 
(DAVs), which accumulate at the distal end of the mother centriole (Kobayashi et al., 
2014; Lu et al., 2015; Schmidt et al., 2012).  Vesicular fusion then produces a 
membranous cap (also called ciliary vesicle) on the distal tip of the mother centriole 
(primary ciliary vesicle) (Sorokin, 1962), the microtubules of the centriole continue to 
grow underneath the cap, and subsequent vesicular trafficking keeps expanding the 
cap concomitant with microtubule extension. In this complex, the time of the 
sequence of events are still poorly understood. However, some evidence suggests the 
transition zone MT doublets, which are linked to the overlying membrane by Y-shaped 
linkers have already formed at this stage (Dean et al., 2016; Reiter et al., 2012; Wei et 
al., 2015).  Later the ciliary membrane starts to form and the axoneme MTs are 
growing unsheathed in a double membrane. The newly formed cilium then docks to 
the plasma membrane by fusion with the ciliary sheath, establishing other ciliary 










Fig 1.3 Ciliogenesis; how cilium/flagellum assembled. The process starts when a mother 
centriole contacts a ciliary vesicle. Axoneme elongates at the tip and is constructed from 
proximal to distal, with the most proximal region giving rise to the transition zone. The ciliary 
vesicle continues to grow with the axoneme and gives rise to the ciliary sheath, finally the 
axoneme within the ciliary membrane project out from the surface and the outer sheath 
transforms into the periciliary membrane and fuse with the plasma membrane. Taken from 






1.1.4 Ciliary signalling 
 
Cilia and flagella not only function as organelles of motility, but also detect 
environmental or intercellular stimuli. The signalling functions of cilia require 
regulated import and export of ciliary components, which allows those signalling 
molecules into and out of cilia in a semi-closed system. In recent years, a number of 
core signalling pathways have been described that depend on intact cilia including 
Hedgehog (Hh) and Wnt signalling pathways which are important cilium-associated 










1.1.5 IFT machinery  
 
1.1.5.1 IFT motors 
As mentioned earlier, ciliary assembly and maintenance relies on an evolutionary 
conserved mechanism known as IFT.  The first description of IFT was over two decades 
ago in the green algae Chlamydomonas reinhardtii, where IFT particles were observed 
to move bi-directionally along the flagellum (Kozminski et al., 1993) (Fig 1.4). There 
are two distinct motor protein superfamilies — kinesins and dyneins that power the 
IFT-trains and transport IFT complex particles A and B.  Each of the motor proteins only 
travels in one direction; anterograde IFT (base to tip) movement is facilitated by 
kinesin-2, and retrograde IFT (tip to base) is driven by cytoplasmic dynein 2 (Pedersen 
and Rosenbaum, 2008; Rosenbaum and Witman, 2002).  It has been suggested that in 
mammals, the stage at which IFT engages and begins to assemble is shortly after the 
ciliary necklace has formed, and when the distal appendages bind to the membrane 
before axoneme assembly (Rohatgi and Snell, 2010; Sorokin, 1962). There are two 
types of kinesin-2 motors; heterotrimeric (consisting of two heterotrimeric kinesin-1 
motor subunits and KAP (kinesin-associated protein)) and a homodimeric kinesin that 
together contributes to anterograde IFT.  Both  types of kinesin-2 motors are essential 
for assembly and maintenance of cilia/flagella in most of ciliated organisms (Ishikawa 
and Marshall, 2011). For example, C. reinhardtii (fla10) null mutants (one of the 
Kinesin-2motor subunits), results in defective flagellum assembly. Moreover, fla10 
mutants appeared to be temperature-sensitive, as they failed to form flagella at the 
restrictive temperature (32°C), but retained flagella at a lower (21°C) temperature 
(Kozminski et al., 1995; Walther et al., 1994).  In C. elegans cilia, loss of KAP subunit 
function on an osm-3 (homodimeric kinesin-2 motor) mutant background resulted in 
the axoneme being completely absent (Evans et al., 2006a; Snow et al., 2004).  The 
results suggest that KAP stabilises the heterodimeric coiled-coil structure formed 
between motor subunits in order to target the motors to the cilia and along the 




Cytoplasmic Dynein 2 is part of a multiprotein complex that drives retrograde 
transport, returning the IFT train from the ciliary tip back to the cell body; the complex 
consists of cytoplasmic dynein-2 heavy chains, intermediate chain, light intermediate 
chain and light chain (Ishikawa and Marshall, 2011).  Early studies in C. reinhardtii, 
showed that deletion of the dynein light chain (LC8) gene resulted in cells producing 
short and paralysed flagella that progressively shortened (Pazour et al., 1998).  In 
these cells, anterograde IFT appeared to be normal, but retrograde IFT was decreased 
or absent. Large numbers of IFT particles accumulated at the tip of the flagella, 
suggesting that loss of cytoplasmic dynein (LC8) affected retrograde transport (Pazour 
et al., 1998).  Later work by Yang and co-workers, indicated that LC8 is a component 
of inner and outer dynein arms, and is involved in stabilising outer and inner dynein 
arms (Yang et al., 2009). Therefore, it was not clear which motor actually causes 
defective retrograde IFT. Deletion of the gene encoding cytoplasmic dynein 1b heavy 
chain (DHC1) in C. reinhardtii also resulted in very short flagella and the redistribution 
of raft proteins from their original peri-basal body region to the flagella.  However, 
there was no evidence of any effect on the growth and Golgi apparatus (Pazour et al., 
1999). The role of the dynein light intermediate chain (D1bLIC) was also studied in 
Chlamydomonas (Reck et al., 2016), their data illustrated that  knockdown of D1bLIC 
de-stabilised the DHC1b complex, as well as reduced both the frequency and velocity 
of retrograde IFT, but not completed abolishing transport. Flagellar assembly 
phenotypes depend on their sensitivity to the amount of active dynein 1b motor in 
the cell (Reck et al., 2016). In C. elegans, mutations in the CHE-3 gene (homologues of 
DHC1b) gave similar phenotypes seen in DHC1b mutant (Wicks et al., 2000). In mice 
model, null mutations also result in short, stumpy (<1 μm) cilia and the IFT particles 




















Fig 1.4 The assembly and trafficking of the primary cilium by intraflagellar transport (IFT).   
(1) Golgi-derived centriolar vesicle (CV) localises to the distal end of the centrosomal mother 
centriole, and migrate toward the plasma membrane. (2) A complete formation of IFT 
anterograde particles (IFT complex A and complex B, BBSome and the kinesin motors) near or 
at the basal body transition fibre. (3) Ciliary cargo proteins are loaded onto the IFT particles. 
(4) Cargo is transported from the base to the tip of the cilium by anterograde motor(s). (5) 
When cilium grows at certain length, IFT particle remodelling occurs. (6) The retrograde 
dynein motors will transport ciliary cargo from tip to the base to complete the IFT cycle. (7) 
And the whole process will start again. The question marks indicate that unknown questions 
of how dynein and kinesin machineries move in the cilium. Adapted from (Sung and Leroux, 




1.1.5.2 IFT particles  
IFT particles were first isolated in C. reinhardtii and can be divided into two large 
biochemically distinct protein complexes; named IFT complex A and complex B (Cole 
et al., 1998; Piperno and Mead, 1997).  To date, there are at least 22 proteins that 
have been identified. IFT complex A consists of six proteins; and complex B sixteen 
proteins; most of which are conserved across ciliated/flagellated organisms (see table 
1.1) (Fan et al., 2010; Ishikawa and Marshall, 2011; Piperno et al., 1998; Wang et al., 
2009). During anterograde IFT, both inactive dynein-IFT complex A and active kinesin2-
IFT B complex travel together along the cilium. Dynein-IFT complex A remains inactive 
until anterograde movement is complete, i.e. at the distal tip of the elongating 
axoneme. At this point motor activity swaps, with the dynein motor becoming active 
to drive retrograde movement of IFT particles (Ishikawa and Marshall, 2011). There 
are phenotypic differences in mutants lacking IFT complex A and B components.  Null 
mutants of most of the IFT complex B proteins result in a more severe ciliogenesis 
defect. For example, IFT52 along with other 5 proteins (IFT 88, 81, 74, 46 and 27) 
together were originally identified as core IFT complex B protein in the green algae 
(Cole, 2003), and interaction organisation was characterised by Lucker et al. (Lucker 
et al., 2005).  Their data indicated that IFT52 locates at the centre of the IFT complex 
B and interacts with at least five other proteins.  Depletion of IFT52 leads to C. 
reinhardtii being unable to form flagella (Brazelton et al., 2001; Deane et al., 2001), 
and also strong destabilisation of IFT complex B subunits (except IFT27/25) (Richey 
and Qin, 2012). Other studies on a C. reinhardtii IFT complex B mutant (ift74-2) also 
showed similar destabilisation of complex B proteins (IFT20, 57, 46 and 81). 
Interestingly, the level of IFT139 (complex A protein) also showed a slight increase 
(Brown et al., 2015). Moreover, similarly increased level of IFT complex A proteins 
have been observed in a IFT70 knockdown background (Fan et al., 2010).  Members of 
IFT complex B have also been shown to be involved in transport and regulating 
signalling pathways. For instance, IFT25 knockout mice did not show any defects in 
ciliogenesis or structural development, however without IFT25, membrane proteins 
includes Protein patched homolog 1 (Ptch1),  GLI family zinc finger protein 2 (Gli2) and 
Smoothened (Smo) fail to active Hedgehog pathway upon stimulation (Keady et al., 
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2012), and similar defective Hh signalling also seen in null mutant of IFT27 background, 
despite IFT25 presence (Eguether et al., 2014).  
 
In contrast, analysis of IFT complex A mutants showed the complex is not essential for 
the assembly of cilia. For example, C. reinhardtii fla15 (IFT144) mutants and fla17 
(IFT139) mutants were still able to produce flagella, but were swollen and 
accumulated IFT particles (Iomini et al., 2001; Iomini et al., 2009; Piperno et al., 1998). 
In the mouse model, similar phenotypes have been observed in null mutants for 
Ift139a/Ttc21b and Ift122, where normal length cilia can be formed but the rate of 
retrograde IFT was reduced and cilia tips were distended (Cortellino et al., 2009; Tran 
et al., 2008). However, null mutations in Ift121/Wdr35 result in a failure to produce 
cilia (or production of short cilia) in both humans and mice (Mill et al., 2011).  
 
Mass spectrometry based analysis by Boldt and co-workers did not detect specific 
direct interaction between IFT complexes A and B (Boldt et al., 2016). However, a 
study in C. reinhardtii suggested that IFT74 (a complex B component) could be a linker 
between the two complexes, as truncated IFT74 (lacking 1–196 aa, including a region 
of coiled-coil) disturbed the interaction of IFT A and B at the base of the flagellum. This 
resulted in IFT complex A particles accumulating at the base of the flagellum , and IFT 
complex B proteins were stuck at the tip (Brown et al., 2015).   
 
In addition to IFT complexes, there is another important protein complex called the 
BBSome, which contains eight conserved Bardet–Biedl syndrome proteins; BBS1, 
BBS2, BBS4, BBS5, BBS7, BBS8, BBS9 and BBS10 (Loktev et al., 2008; Nachury et al., 
2007). These proteins move along the ciliary axoneme at the same rate as IFT particles, 
which have given rise to the idea of that the BBSome may act as an adaptor between 
the IFT complexes and IFT cargo (Mykytyn et al., 2004; Nachury et al., 2007; Ou et al., 
2005). Work carried out using C. elegans, C. reinhardtii and human cells has suggested 
that some BBS proteins are also involved in vesicle transport from the Golgi to the 
basal body and cilia. A study in mice indicated that the WDR19/IFT144 (the homologue 
of DYF-2) and BBS1 (the homologue of BBS-1) show strong interaction, and normal 
cilia form in hypomorphic mutations of dyf-2 and bbs-1, but  
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 IFT complex B proteins turnaround at the ciliary tip is severely abrogated (i.e an 
accumulation of IFT-B components at the ciliary tip) (Liem et al., 2012; Wei et al., 
2012). It remains unclear why separation of IFT complexes leads to ciliary defects.  This 
might be due to that the fact that BBSome proteins are somehow associated with the 
interaction between both IFT complexes and cargo transport (Blacque et al., 2004; Ou 
et al., 2005; Sung and Leroux, 2013).  In general, BBSome proteins are not required for 
ciliogenesis (except BBS1 and BBS5, which fail to form cilia in siRNA treated cells) 
(Loktev et al., 2008; Mykytyn et al., 2004; Nachury et al., 2007; Williams et al., 2014). 
However, IFT machinery is required in almost all organisms for cilium/flagellum 
formation.  This could indicate that the BBSome only transports a specific set of 
transmembrane proteins to cilia while the IFT complexes are likely to be required for 






































IFT144 IFT144 DYF-2 WDR19 IFT144 
IFT140 IFT140 CHE-11 IFT140 IFT140 
IFT139 IFT139 ZK328.7 THM1 
TTC21B 
IFT139 
IFT122 IFT122/FAP80 DAF-10 IFT122 
WDR10 
IFT122 
IFT121 IFT121 IFTA-1 WDR35 PIFTD4 
















IFT88 IFT88 OSM-5 IFT88 IFT88 
IFT81 IFT81 IFT-81 IFT81 IFT81 
IFT74/IFT72 IFT74/IFT72 IFT-74 IFT74/IFT72 IFT74/IFT72 
IFT70 IFT70/FAP259 DYF-1 TCC30A 
TTC30B 
PIFTB2 
IFT56 IFT56/DYF-13 DYF-13 - PIFTB3 
IFT52 IFT52/BLD1 OSM-6 IFT52 
NGD5 
IFT52 
IFT46 IFT46 DYF-6 IFT46 
C11orf60 
IFT46 
IFT27 IFT27 Absent IFT27 
RABL4 
IFT27 
IFT25 IFT25/FAP232 Absent IFT25 
HSPB11 
IFT25 
IFT22 IFT22/FAP9 IFTA-2 RABL5 IFT22 
IFT172 IFT172 OSM-1 IFT172 IFT172 
IFT80 IFT80 CHE-2 IFT80 
WDR56 
IFT80 
IFT57 IFT57 CHE-13 IFT57 IFT57 




IFT38 IFT38/FAP22 DYF-3 IFT38 PIFTA1 
IFT20 IFT20 IFT-20 IFT20 IFT20 
Table 1.1 Components of the IFT proteins in different organisms. CHE, chemotaxis abnormal; 
DYF, abnormal dye-filling; WDR, WD repeat-containing; TTC, tetratricopeptide repeat; THM1, 
TTC-containing Hedgehog modulator; DAF, abnormal dauer formation; OSM, osmotic 
avoidance abnormal; PIFT, putative involved in IFT; ZK328.7, Tetratricopeptide repeat protein 
21 homolog; FAP, flagellar-associated protein; TRAF3IP1, TRAF3-interacting protein 1; IFT, 
intraflagellar transport; MIPT3, microtubule-interacting protein associated with TRAF3; IFTA, 
IFT-associated; KAP, kinesin-associated protein; Table is adapted from (Ishikawa and Marshall, 
2011; Taschner and Lorentzen, 2016).  
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1.2 The base of the cilium   
 
 1.2.1 The ciliary gate  
 
In a cilium, the junction between the basal body and the axoneme is called the ciliary 
gate, and can be divided into two structurally distinct sub-regions; (1) the transitional 
fibres (TFs) (also called the alar sheets) (Anderson, 1972), which serve as the docking 
site for both the cargo that requires import into the flagellum and IFT particle proteins. 
There are nine TFs, and each one emerges from the distal end of the C-tubule of the 
basal body, and terminates at an electron dense knob at the most proximal end of 
ciliary membrane (Lu et al., 2015; Sorokin, 1962). TEM studies suggest that the space 
between each TF is less than 60 nm in diameter, which might allow a ribosome to pass 
through but not a vesicle (Nachury et al., 2010). So far, at least five proteins have been 
identified that localise to the TFs.  Centrosomal protein of 164 kDa (Cep164) is a key 
component of the TFs, and has an important role in ciliogenesis, as depletion of 
Cep164 can lead to ciliary assembly defects and blocks DAV formation (Graser et al., 
2007). When Cep 164 was absent, IFT88 (IFT B complex component) failed to recruit 
to the basal body and ciliogenesis was prevented (Schmidt et al., 2012; Čajánek and 
Nigg, 2014). By using super resolution microscopy techniques such as PALM and 
STORM analysis, another centrosomal protein, Cep89/Cap123/CCDC123, has also 
been localised to the centriolar appendages, and forms ring-like structures with a 
diameter of 500 nm (Sillibourne et al., 2011). Three other novel DAP proteins 
(Cep83/Ccdc41, SCLT1 and FBF1) were identified by Tanos and colleagues using 
quantitative centrosome proteomics and super resolution microscopy (Tanos et al., 
2013), they revealed a hierarchy of DAP assembly.  Both SCLT1 and Cep89 are required 
Cep83 to the centrioles.  The centriolar localisation of FBF1 and CEP164 are not 
dependent on each other or Cep89, but is mediated by SCLT1. All three proteins have 
been shown to be involved in ciliogenesis and the docking of the basal body to the 
plasma membrane. The consequences of the basal body being unable to dock can lead 
to a failure to recruit Tau-tubulin kinase 2 (TTBK2) or the release of centriolar coiled-
coil protein of 110 kDa (Ccp110). In vitro, TTBK2 is able to phosphorylate microtubule-
associated proteins (Takahashi et al., 1995), and in vivo it acts as a key regulator for 
16 
 
controlling the initiation of ciliogenesis by removing basal body capping protein Cp110 
from the distal end of the mother centriole, permitting initiation of ciliogenesis 
(Bouskila et al., 2011; Goetz et al., 2012). However, TTBK2 is not essential for basal 
body formation (Goetz et al., 2012). TF components also participate in recruiting IFT 
particles and facilitating the passage of assembled IFT particles through the TF. For 
instance, Cep83 and FBL1 both bind IFT complex B protein IFT20 and IFT54 
respectively, null mutation Cep83 and FBL1 failed IFT particles to recruit to the basal 
body and promote to them pass the ciliary gate to entre cilium, which lead to a 
ciliogenesis defect (Wei et al., 2013; Ye et al., 2014) .   
 
TFs serve an important function in recruiting proteins bound for the cilium.  However, 
exactly how TFs actively promote proteins to pass the ciliary gate is unknown. 
Ludington et al. (2013), proposed an avalanche-like behaviour in ciliary import, i.e. 
after an accumulation of IFT proteins at the cilium base for a period of time, a large 
number of IFT particles enter the cilium together. Whether this avalanche-like 
behaviour depends on the amount of IFT accumulating on the TFs is unclear.   
 
 
(2) The transition zone (TZ) is the boundary between the basal body and the axoneme, 
and is an area with high molecular complexity. Within the transition zone, there is a 
distinctive and characteristic structure called the Y-shaped linkers (Y-linkers), which 
connect axonemal microtubule outer doublets  to the ciliary membrane and form a 
unique particle arrangement called the ciliary necklace (Gilula and Satir, 1972). 
Although the protein components of both Y linkers and the necklace are largely 
uncharacterised, it is generally accepted that the TZ functions as a ciliary gatekeeper 
that regulating protein enter and exit the cilium (Reiter et al., 2012).  For many years, 
transmission electron microscopy (TEM) cross-sections were used to investigate the 
TZ, and data suggested that it forms at the very earliest stages of ciliogenesis that 
precedes the recruitment of IFT particles (Omran, 2010; Ringo, 1967; Williams et al., 




1.2.2 The ciliary gate and ciliopathies  
 
For many years, the function of cilium/flagellum was thought to only involve motility 
and primary cilia were long thought to be evolutionary vestigial organs. However, 
increasing evidence recognised that primary cilia act as multi-functional organelles 
associated with a series of important signaling pathways (e.g. Hedgehog (Corbit et al., 
2005) and Wnt signaling pathways (Corbit et al., 2008)) during early vertebrate 
embryonic development and maintain postnatal tissue homeostasis (Chih et al., 2012; 
Gerdes et al., 2009; Goetz and Anderson, 2010; Gonçalves and Pelletier, 2017). 
  
In humans, dysfunction or defects in motile and primary cilia are now understood to 
underlie a number of devastating genetic conditions, which are termed ciliopathies 
(Fliegauf et al., 2007; Novarino et al., 2011; Tobin and Beales, 2009; Veland et al., 
2009). Ciliopathies can affect single organs, such as Polycystic kidney disease (PKD) or 
can develop as multi-system disorders such as Bardet–Biedl syndrome (BBS), 
Nephronophthisis (NPHP), Joubert Syndrome (JBTS) and Meckel-Gruber Syndrome 
(MKS), which have phenotypically variable and overlapping disease manifestations 
(Badano et al., 2006; Cardenas-Rodriguez and Badano, 2009). Common clinical 
features in ciliary dysfunction syndromes include polycystic kidneys, liver fibrosis, 
retinal degeneration, brain/nervous system defects and skeletal deformities (Fliegauf 
et al., 2007; Gerdes et al., 2009). Clinical data also shows that defects in cilia formation 
can be observed in human cancers, as key developmental signalling pathways are 
regulated from the primary cilium (Seeger-Nukpezah et al., 2013). For example, 
Hedgehog signalling activity is required for IFT proteins to be transported to and from 
the tip of primary cilia, when cilia formation is blocked, alteration of signalling activity 
can promote cancer development (Goetz and Anderson, 2010; Huangfu et al., 2003).  
 
Several studies have revealed that there are large number of proteins encoded by 
genes mutated in NPHP, JBTS and MKS that are localised to the basal body/TZ area 
(Sang et al., 2011). This area acts as a barrier to control protein entry into, and exit 
from, the cilium; hence the term “ciliary gate” (Anand and Khanna, 2012; Bachmann-
Gagescu et al., 2011; Chih et al., 2012; Czarnecki and Shah, 2012; Garcia-Gonzalo et 
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al., 2011; Williams et al., 2011; Garcia-Gonzalo and Reiter, 2017). Over the past few 
years, several research groups have investigated the composition of protein 
complexes at the ciliary gate area, and have provided insight into (1) how these 
proteins might interact; (2) how they assemble within the TZ; (3) their specific 
functions within the ciliary compartment; and (4) how these proteins are targeted to 
the ciliary gate (See Table 1.2 and Fig 1.5).  A number of distinct complexes have been 
identified at the region of ciliary gate – these are: 
 
(1) NPHP1-4-8 (NPHP1/JBTS4; NPHP4 and NPHP8/RPGRIP1L) 
 
(2)  NPHP5-6 (NPHP5/IQCB1 and CEP290/NPHP6/MKS4/TBTS5) 
 
(3) MKS/TCTN/B9 (MSK1; MKS2/TMEM216; MKS3/NPHP11/JBTS3; 
CC2D2A/MKS6/JBTS9; MKS8/TCTN3; TCTN1/JBTS13; TCTN2/MKS8; TCTN3; 





















Figure 1.5 Model organization chart of four 
protein complexes and the possible 
connections 
 
The NPHP1-4-8 protein complex consist 
NPHP1, NPHP4 and NPHP 8/RPGRIP1L. 
NPHP8/RPGRIP1L localizes the TZ, but also to 
the BB. Evidences suggested that NPHP4 
directly interact with RPGRIP1L and NPHP1, 
but no direct interaction between NPHP1 and 
NPHP1. The MKS/B9 protein complex, MKS1, 
TMEM216 and TMEM67, is consistently 
associated with severe ciliopathies in human. 
Cep290 was considered as a core candidate of 
NPHP5-6 protein complex (Sang et al., 2011), 
but it may also be part of MKS-like complex in 
another study (Garcia-Gonzalo et al., 2011). 
The inversin compartment protein candidates 
may serve a bridging role and contribute to 
multiple distinct roles. Reproduced from 
(Garcia-Gonzalo and Reiter, 2017; Gonçalves 











Ciliopathy names Localisation Protein  
Domain  
Selected References  
  NPHP MKS JBTS    
 
 
NPHP 1-4-8  
RPGRIPL1 NPHP8 MKS5 JBTS7      TZ, BB CC, C2 (Garcia-Gonzalo et al., 2011; Huang et al., 
2011; Sang et al., 2011; Williams et al., 2011)  
NPHP1 NPHP4   TZ CC, C2, SH3 (Sang et al., 2011; Williams et al., 2011) 
NPHP4 NPHP1  JBTS4 TZ C2, MSP (Garcia-Gonzalo et al., 2011; Huang et al., 
2011; Sang et al., 2011; Williams et al., 2011) 
       
     NPHP 5-6 
CEP290 NPHP6 MKS4 JBTS5 TZ, BB CC (Garcia-Gonzalo et al., 2011; Huang et al., 
2011; Sang et al., 2011; Williams et al., 2011)  
IQCB1 NPHP5   BB IQ (Williams et al., 2011; Garcia-Gonzalo et al. ; 
Sang et al., 2011)    
 





B9D1  MKS9  TZ, BB B9 (Williams et al., 2011; Sang et al., 2011; Chih et 
al., 2012; Dowdle et al., 2011) 
B9D2  MKS10  TZ B9 (Williams et al., 2011; Sang et al., 2011; Dowdle 
et al., 2011)  
TCTN1   JBTS13 TZ TCTN,  (Garcia-Gonzalo et al., 2011) 
TCTN2  MKS8  TZ, AX TCTN, TM (Garcia-Gonzalo et al., 2011; Sang et al., 2011)    
TCTN3    TZ, AX TCTN, TM (Garcia-Gonzalo et al., 2011) 
CC2D2A  MKS6 JBTS9 TZ CC, C2 (Garcia-Gonzalo et al., 2011; Huang et al., 
2011; Sang et al., 2011; Williams et al., 2011) 
MKS1  MKS1  TZ B9 (Williams et al., 2011; Garcia-Gonzalo et 
al.,2011; Sang et al., 2011; Goetz et al., 2017)    
TMEM17    TZ TM (Chih et al., 2012; Li et al., 2016) 
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TMEM107    TZ TM (Lambacher et al., 2016) 
TMEM213  MKS11 JBTS20 TZ TM (Chih et al., 2012) 
TMEM216  MKS2 JBTS2 TZ, BB TM (Garcia-Gonzalo et al., 2011; Huang et al., 
2011; Valente et al., 2010) 
TMEM67  MKS3 JBTS6 TZ, AX TM (Iannicelli et al., 2010; Williams et al., 2011; 
Garcia-Gonzalo et al. 2011) 





Inversin         
Compartment 
IVN NPHP2   TZ, BB, AX Ankyrin, IQ (Yokoyama et al., 1993; Otto et al., 2003; 
Simons et al., 2005; Shiba et al., 2010) 
NPHP3 NPHP3 MKS7  AX ATPase, TPR (Olbrich et al.,2003; Shiba et al., 2010) 
NEK8 NPHP9   AX Ser/Thr, 
RCC1 
(Zhang et al., 2002; Attanasio et al., 2007) 
ANKS3    AX Ankyrin, SAM (Delestré et al., 2015; Leettola et al., 2014; 
Yakulov et al., 2015) 
ANKS6 NPHP16   AX Ankyrin, SAM (Czarnecki et al., 2015; Delestré et al., 2015; 
Hoff et al., 2013; Leettola et al., 2014) 
TZ, Transition zone; BB, basal body; AX, axonemal compartment; CC, coiled coil domain; TM, transmembrane; SH3, Src homology 3; TPR, tetratricopeptide 
repeat; WD40, WD40- or b-transducin domain; RCC1, regulator of chromosome condensation 1-like; C2, B9, membrane-association domain; C2H2, zinc 
finger-like domain; IQ, IQ calmodulin-binding domain. 
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1.2.2.1 NPHP1-4-8 protein complex      
NPHP1-4-8 module was first identified by Sang et al., (Sang et al., 2011) and shown to 
consist of (i) NPHP1/JBTS4 protein - previously suggested to be involved in regulating 
IFT particle entry into the cilium (Jiang et al., 2009); (ii) NPHP4- mutations in the gene 
encoding NPHP4 lead to nephronophthisis and blindness in humans (Hoefele et al., 
2005; Otto et al., 2002), and (iii) NPHP8 (also called RPGRIP1L/MSK5/JBTS7) (Arts et 
al., 2007; Delous et al., 2007).  
 
Several studies have investigated the function of NPHP4 in different models, and 
suggest that when NPHP4 is absent, it can lead to phenotypes indicating a ciliary 
defect. For example, in zebrafish, morpholino-mediated knockdown of NPHP results 
in typical ciliary-defect phenotypes such as abnormal body curvature and pronephric 
cysts (Burcklé et al., 2011).  In mice, NPHP4 is required for formation and maintenance 
of photoreceptor cells and sperm development (Won et al., 2011).  Later studies in C. 
reinhardtii also demonstrated that NPHP4 is involved in regulating both membrane 
and soluble protein composition at the flagellum TZ (Awata et al., 2014).  
 
A study by Sang et al., (Sang et al., 2011) showed that the NPHP1-4-8 complex localises 
to the TZ and in vitro studies revealed that NPHP4 directly binds both NPHP1 and 
NPHP8; acting as a bridge between them, but that NPHP1 and NPHP8 do not bind to 
each other. Based on their in vitro model, cilium formation is not dependent upon 
NPHP1, NPHP4 or NPHP8. However, when a 3D spheroid culture model involving 
IMCD3 cells was analysed (which represents the architecture of the kidney collecting 
duct with a clear lumen, apical cilia, defined tight junctions, and clear basolateral 
structure) the depletion of NPHP1, 4 and 8 resulted in cells developing an irregular 
lumen and there was loss of tight junction formation (Sang et al., 2011). All three 
NPHP1-4-8 proteins contain C2 domains, which could mediate interaction with 
phospholipids at cell-cell junctions or at the ciliary base. In mice, studies have shown 
that both NPHP1 and NPHP4 mutations only lead to mild cilia formation defects, in 
sperm flagella and cilia in photoreceptor cells (Jiang et al., 2009; Jiang et al., 2008).  
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Williams and colleagues (Williams et al., 2011) investigated NPHP1-4-8 and MKS 
protein complexes (for more details see section 1.2.2.2) in ciliated sensory neurons in 
C. elegans, and reported that NPHP8/RPGRIP1L/MKS5 was the key protein linking 
these two protein complexes. They proposed that NPHP8 is at the top of the 
hierarchical network of these protein modules, When NPHP8 gene was deleted it 
resulted in defective cilia formation, and also affected the recruitment of NPHP1 and 
NPHP4 to the TZ; it also leads to all MKS proteins failing to localise to the TZ. In C. 
elegans, disruption of proteins from either the NPHP or MKS complex do not have 
noticeable effects on ciliogenesis, but disruption of proteins from both the MKS and 
NPHP complexes results in severe phenotypes. For example, perturbation of both 
MKS5 and MKS6 (MKS protein complex) and NPHP4 (NPHP complex) can abrogate 
ciliogenesis in most cilia. Transmission electron microscopy reveals that these double 
mutants lack theTZ and Y linkers, which leads to membrane detachment from the 
ciliary axoneme (Huang et al., 2011; Jensen et al., 2015; Williams et al., 2011). 
However, NPHP8 is the exception, as mutations in NPHP8 in mice are embryonic lethal 
which is similar to the consequences of double mutants in the mouse model (affecting 
MKS and NPHP complexes components (Garcia-Gonzalo et al., 2011; Sang et al., 2011). 
This may also explain why mutations in the NPHP8 gene are present in patients with 
NPHP, MKS and JBTS. However, NPHP-1 or NPHP-4 are involved in less severe 
ciliopathies, because they do not directly interact  with proteins in other complexes 
(Czarnecki and Shah, 2012).  
 
Both the MKS and NPHP protein modules are required for the early stage of the 
ciliogenesis pathway, before the IFT-dependent axoneme extension, TZ membrane 
docking and TZ formation, since when single or double mutants of the MKS/NPHP 
complex were generated IFT is unaffected. Additionally, TZ localisation of the 
MKS/NPHP module proteins were unaffected in IFT mutants (osm-5, che-11) and BBS 
mutants (bbs7 and bbs8). The results might indicate that MKS and NPHP protein 
complexes must be established before IFT becomes active. Together, these data 
suggested that NPHP1-4-8 complex is involved in apical and polarized cells 
organizations and participated in cell morphogenesis and architecture (Sang et al., 
2011).   
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 1.2.2.2 The MKS/B9 complex  
The MKS/B9 protein complex identified by several studies contains three membrane-
targeting B9-containing proteins (MKS1; MKS9/B9D1 and MKS10/B9D2), a coiled-coil 
protein MKS6/CC2D2A, transmembrane proteins TMEM67, TMEM216, TMEM17, 
TMEM231, TMEM107 and possibly TMEM237 and TMEM 218, as well as three 
Tectonic proteins (Tctn1-3) (Chih et al., 2012; Garcia-Gonzalo et al., 2011; Sang et al., 
2011; Williams et al., 2011).   
 
As with other TZ protein complexes, studies have revealed that mutations in single 
MKS genes (e.g. MKS6, MKSR-1, MKSR-2, MKS1, MKS3, TMEM107, TMEM237 and 
TMEM218) resulted in mild or no obvious defects in cilia formation; nor did they 
impair IFT. However, mutations in combined MKS genes and NPHP genes appeared 
more severe, and resulted in defective ciliogenesis and ciliary function (Huang et al., 
2011; Li et al., 2016; Williams et al., 2011; Williams et al., 2008).  
 
In mammals, knocking-out different genes coding for different MKS components can 
lead to tissue-specific defect in ciliogenesis. Tectonic 1 (TCTN1), (which is involved in 
modulating Hh signalling pathway) is required for ciliogenesis in a tissue-dependent 
manner, for example in TCTN1 null mutants the majority of the cilia in neural tubes 
appear to be shortened and bulbous, and the number of cilia is significantly reduced 
compared to controls. In TCTN1 null mutants, basal bodies dock at the cellular plasma 
membrane, but the axoneme fails to extend. In contrast, in limb bud mesenchym cells 
(TCTN1−/−), while the number of cilia were reduced, no obvious defects could be 
observed in the cilia that were formed (Garcia-Gonzalo et al., 2011).   
 
Later studies in C. elegans demonstrated TCTN1 interacted with BBS1, and MKS1 
interacts with BBS4 (Goetz et al., 2017; Yee et al., 2015). Deletion of TCTN1 alone, or 
together with other MKS complex components, did not abolish ciliogenesis. However, 
when TCTN1 depletion were combined with either NPHP-1 or NPHP-4 mutants, ciliary 
structure and ciliogenesis was compromised, possibly due to deregulation of the Hh 
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signalling pathway. In addition, when limb bud cells are missing both TCTN1 and BBS1, 
cilia formation is completely blocked (Yee et al., 2015). The study carried out by Goetz 
and co-workers showed strong genetic interactions between MKS1 and IFT72, as well 
as dynein subunit DYNC2H1 (IFT retrograde motor) (Goetz et al., 2017). Double 
mutants of MKS1 and either IFT72 or DYNC2H1 led to a reduced rate of ciliary protein 
trafficking, and a failure of cilium formation. Collectively, this data suggests that the 
MKS complex may cooperate with IFT to mediate axoneme assembly, and that the 
BBSome may have functional overlap with MKS modules in facilitating IFT dependent 
ciliogenesis.  
 
Proteomic analysis of mammalian COS1 cells suggested that TCTN1 strongly interacts 
with TCTN2 and TCTN3; indicating that all three TCTN proteins are within the same 
protein complex.  TCTN1 also interacts with MKS1, CC2D2A/MKS6 and B9D1, but only 
interacts with TMEM67 and TMEM216 under certain circumstances. For example, 
TMEM67 and TMEM216 can only immunoprecipitate with TCTN1-LAP and TCTN1-V5 
respectively in the lysates of COS1 cells. CEP290, a possible component of the Y-
shaped linkers at TZ, has also been identified as an interactor with TCTN1 by mass 
spectrometry and chromatography but not co-immunoprecipitation. It might have 
suggested that CEP290, TMEM67 and TMEM216 are peripheral components of the 
Tectonic complex (Garcia-Gonzalo et al., 2011). TNCT1 is required for the recruitment 
of both MKS1 and TMEM67 proteins to the TZ. Mutations in MKS complex 
components, such as TCNT2, MKS6 and TMEM67, lead to tissue-specific defects in cilia 
formation, protein trafficking and membrane composition (Garcia-Gonzalo et al., 
2011).  
A small G protein – Arl13B has been shown to be important in the trafficking of ciliary 
proteins and structural integrity of the cilium (Li et al., 2012).  A recent study carried 
out by Gotthardt and co-workers identified that Arl13B actually acts as a GEF to 
activate Arl3 in cilia, and the GEF activity relies on its G-protein domain and C-terminal 
helix (Gotthardt et al., 2015). Previous studies have shown that mutations in the gene 
that encodes Arl13B can cause Joubert syndrome in humans (Cantagrel et al., 2008). 
Studies in C. elegans showed that ARL13B is associated with IFT complex B, via 
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interaction with IFT46 and IFT74, and that MKS/NPHP modules regulate the ARL13 
diffusion barrier at the TZ (Cevik et al., 2010; Cevik et al., 2013).  In mammal, ARL13B 
levels was markedly reduced in Tctn1−/−, Tctn2−/− cilia. The role of TCTN1 is more likely 
to involve promoting ciliary translocation of Arl13B and Smo signalling rather than 
limb bud ciliogenesis (Caspary et al., 2007; Corbit et al., 2005; Garcia-Gonzalo et al., 
2011).   
 
Huang et al., 2011 identified TMEM237/JBTS14 and showed that mutations in the 
gene encoding this protein can lead to JBTS related disorders (Huang et al., 2011). 
Studies in three models (mammalian IMCD3 cells, D. rerio and C. elegans) confirmed 
that TMEM237 is a TZ protein. TMEM237 functionally interacts with other ciliary 
proteins, such as B9D1/MKS9 and B9D2/MKS10, NPHP4, RPGRIP1L/NPHP-8/MKS5 and 
TMEM216/MKS2/TBTS2 at the TZ.  Studies reveal that RPGRIP1L/NPHP-8 is required 
for TMEM237 to be recruited to the TZ in both mammalian and C. elegans cells, 
suggesting that RPGRIP1L acts as a connector between ciliary protein complexes 
(Huang et al., 2011). 
 
TMEM231 and TMEM17 are transmembrane proteins, which might indicate that the 
MSK complex is attached to a membrane. In cell membrane fractions of IMCD3 and 
murine embryonic fibroblasts (MEFs) other MKS proteins, such as B9D1, B9D2, MKS1 
and TCTN1 can also be detected, which might suggest that they are connected to the 
membrane via TMEM231 and TMEM17.  Loss of IFT particle protein IFT88 has no effect 
on the localisation of TMEM231, which suggests that the TZ can assemble in the 
absence of IFT. More severe phenotypes are only be seen in C. elegans double mutants 
(i.e. carrying mutations in a gene encoding a protein from each of the MKS and NPHP 
complexes (Bialas et al., 2009; Williams et al., 2010; Williams et al., 2008). In mammals 
(e.g. mice), a mutation in any of the components from the MKS complex can lead to 
catastrophic consequences. This difference may be explained by the fact that in both 
worms and flies, the only place that cilia are present is in sensory neurons, and cilia 
serve specific sensory functions. However, in vertebrates, cilia are ubiquitous cellular 
organelles and TZ proteins have developed other functions/mechanisms. TMEM107 
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was recently identified as a component of MKS module with TZ localisation. Together 
with TMEM231 and TMEM216, as well as NPHP1 display a periodic localisation pattern 
that is highly reminiscent of ciliary necklace strands or their underlying Y-linkers 
(Lambacher et al., 2016).  In C. elegans, the MKS module is proposed to assemble 
hierarchically (Huang et al., 2011; Roberson et al., 2015; Williams et al., 2011a). In 
Lambacher and co-workers C. elegans model, they have grouped three layers at TZ. 
Layer 1 contains NPHP8/MKS5, which is at the root of the hierarchy and it required for 
TZ localization of all MKS module components. Layer 2 or intermediate level consist 
MKSR-1, MKSR-2, TMEM231 and MKS2, and the localisation of the layer 2 proteins 
required for Layer 3 (peripheral level MKS3, JBTS14, MKS6 and TMEM17, which is not 
essential for other MKS protein to be localised to TZ), but not Layer 1 protein targeting. 
TMEM107, is required for the recruitment of some MKS module proteins (MKS1, 
TMEM231 and TMEM237) being to the TZ form an intermediate level.  Loss of 
TMEM107 also perturbs ciliary composition, and together with NPHP4 plays a critical 
role in TZ docking, Y-linker assembly and maintenance of cilium integrity (Lambacher 
et al., 2016).  
 
 
 1.2.2.3 The NPHP5-6 or Cep290 protein complex  
This protein module consists of only two proteins, NPHP5 (also known as IQCB1) and 
CEP290 (also known as NPHP6/MKS4/JBTS5), and is localised at the centrosome/basal 
body (Sang et al., 2011). CEP290 was originally identified using proteomic approaches 
and shown to have multiple cellular localisations within mammalian cells, including 
the centrosomes of dividing cells, the connecting cilium of retinal photoreceptors 
(Chang et al., 2006)  and pericentriolar satellites (Kim et al., 2008).  Additionally, 
CEP290 also appears to have nuclear and cytoplasmic localisations (Guo et al., 2004; 
Sayer et al., 2006). The C. reinhardtii, CEP290 protein localises to the Y-shaped linkers 
of the TZ, and mutations in the CEP290 gene cause defects in flagellar composition, an 
imbalance of IFT complexes A and B in the flagellum, and lead to abnormal levels of 
BBS4 and PKD2 proteins, which are implicated in human ciliopathies (Craige et al., 
2010). The localisation of CEP290 is highly dynamic and rapidly turned over at the TZ, 
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suggesting CEP290 is associated with signaling pathways between the cilium and cell 
body (Craige et al., 2010). Purification of the NPHP5-6 complex established the strong 
binding between these two proteins in all cell types examined (NIH 3T3 fibroblasts, 
IMCD3 and RPE cells), and that CEP290 is required for NPHP5 recruitment to the 
centrosome. Both NPHP5 and CEP290 are indispensable for ciliation in IMCD3 cells, 
but when either CEP290 or NPHP5 was depleted can lead to failure to form normal 
spheroids, suggesting their function in maintaining the integrity of centrosome/cilia in 
tissue organization (Sang et al., 2011). Among the MKS/NPHP proteins, only NPHP5 
interacts with IFT122 (Sang et al., 2011). However, it remains to be investigated 
whether the NPHP protein complex is functionally linked to IFT. In addition, CEP290 
also acts as an important hub between MKS and NPHP complexes via CC2D2A/MKS6 
in zebrafish. Specifically, the combined loss of function of CEP290 (Knockdown) and 
CC2D2A (sentinel mutation) results in pronephric cysts formation exacerbation, 
revealing a genetic interaction between CC2D2A and CEP290 and implicating CC2D2A 
in cilium/basal body function (Gorden et al., 2008). 
 
In C. elegans, CEP290 and NPHP8 are required for recruitment of TMEM218 (MKS 
protein) to the TZ, and together with other NPHP proteins facilitates ciliogenesis (Li et 
al., 2016). In the mouse model, CEP290 is required for BBSome assembly and 
Barbelanne and co-workers revealed CEP290 and NPHP5 physically interact with 
several BBSome proteins (BBS2 and BBS5), and that depletion of NPHP5 or CEP290, or 
expression of mutant NPHP5, causes the dissociation of BBS2 and BBS5.  Furthermore, 
loss of either protein perturbs the integrity of BBSome, as well as the delivery of 
BBSome cargo to the ciliary compartment; suggesting their novel role in regulating 
ciliary trafficking of the BBSome and maintenance of its integrity (Barbelanne et al., 
2015; Zhang et al., 2014).  However, the CEP290 gene is not recognised in the genomes 
of many ciliated unicellular and bilaterians, which may suggest that CEP290 is not 
required for ciliary function in all flagellated eukaryotes, or that sequence divergence 




1.2.2.4 Inversin compartment (IC) 
 
An additional ciliary segment localises distal to the TZ and proximal end of axoneme, 
termed the “Inversin compartment”, which contains INV/NPHP2; NPHP3/MKS7; 
NEK8/NPHP9) (Shiba et al., 2010). Previously, INV mutations had been shown to lead 
to nephronophthisis type 2, which can be found in patients with renal cystic disease 
(Otto et al., 2003).  Apart from INV, there are two more proteins NPHP3/MKS7 and 
NEK8/NPHP9 that have been identified within the INV compartment. The INV 
compartment is a small region that sits between the microtubule axoneme and the 
TZ, the exact function is yet to be understood.   However, the evidence suggests INV 
protein is required for two other components, NPHP3 and NEK8, to localise at the INV 
compartment. Loss of NPHP3 and NEK8 has no effect on INV protein localisation. The 
data indicates that INV protein acts as a hub to interact with both NPHP3 and NEK8 in 
the inversin compartment, but the role of this new structure remains mysterious. It 
has been suggested that INV protein, along with the protein AHI1/Jouberin forms a 
linkage which connects with the NPHP1-4-8, NPHP5-6 and MKS protein complexes 
(Shiba et al., 2010). There are two more proteins identified as members of the Inversin 
compartment called ANKS3 and ANKS6 (Ankyrin Repeat And Sterile Alpha Motif 
Domain Containing protein 3 and 6).  Mutations in both ANKS3 and ANKS6 can lead to 
autosomal dominant polycystic kidney disease (ADPKD) in mice and nephronophthisis 
in humans (Hoff et al., 2013; Yakulov et al., 2015). ANKS3 and ANKS6 interact directly 
via their SAM domains (Leettola et al., 2014), and co-localise in mouse renal cilia 
(Delestré et al., 2015). Yakulov and colleagues have recently shown that ANKS6 forms 
a protein complex containing INV, NPHP3, and NEK8. In zebrafish embryos, loss of 
ANKS3 causes NPHP-typical phenotypes, including ciliary defects and cyst formation. 
Moreover, ANKS3 also shows an association with NPHP1-4-8 protein complex via 
NPHP1 in multi-ciliated epidermal cells (Yakulov et al., 2015). ANKS6 has also been 
identified as activator and link to NEK8 to INV and NPHP3, without NEK8, ANKS6 failed 
to localise to the ciliary INV compartment. Mutations in ANKS6 (Strkr) can decrease its 
ability to interact with NEK8, and also prevent NEK8 binding to its kinase domain.  On 
the other hand, mutant NEK8 causes a loss of kinase function, but localisation of 
ANKS6 is unaffected at Inversin compartment (Czarnecki et al., 2015; Hoff et al., 2013). 
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1.2.2.5 Other proteins and lipids  
 
Apart from classic TZ proteins, there are number of other proteins and lipids which 
may be involved in establishing TZ complexes. These include septins, which are a large, 
conserved family of GTPases that form large, ordered structures such as apolar 
filaments, bundles and rings. They play important roles in mitosis, cell migration, and 
cell morphogenesis by forming scaffolds and diffusion barriers (Hu and Nelson, 2011; 
Hu et al., 2008). Septin proteins usually co-operate with other septins, for example in 
sperm cells Septin 7 is co-localised with Septin 4 at the annulus that forms at the base 
of the axoneme early in sperm flagellum biogenesis. Septin 4 is also part of the 
diffusion barrier that regulates flagellar proteins at the flagellum base (Ihara et al., 
2005; Kissel et al., 2005). In mouse IMCD3 cells, SEPT2 forms a ring-like structure at 
the ciliary base. Knockdown of this protein leads to ciliogenesis defects as barrier 
function is disrupted and more transmembrane proteins enter the ciliary 
compartment (Fliegauf et al., 2014; Hu and Nelson, 2011; Kim et al., 2010).   
 
In addition to a distinct protein composition at the TZ, phosphoinositide lipids PI (4,5) 
P2 and PI(4)Pare restricted to the proximal ciliary membrane by the ciliary enzyme 
Inositol Polyphosphate-5-Phosphatase E (Inpp5e). Loss of Inpp5e can cause disruption 
of Hh signalling pathway and levels of PI(4,5)P2 are increased.  Evidence suggests that 
Inpp5e is involved in both ciliogenesis and ciliary membrane trafficking and that 
Cep164 protein is required for recruiting this enzyme to the ciliary base (Chávez et al., 
2015; Garcia-Gonzalo et al., 2015). 
 
JBTS-MKS-NPHP ciliopathic-associated protein complexes have been identified at 
TZ/BB, which provided us valuable insights of their roles in cilium biogenesis, 
maintenance and signalling pathways. However, deeper understanding of molecular 
mechanisms of transition fibre and TZ function are still required, in addition to 
identifying components of the TZ and transitional fibres, other ciliary components and 
their transport machinery. As many of the TZ proteins described above show 
evolutionary conservation, in my PhD study, I have been using the flagellated 
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microbial organism; the African trypanosome Trypanosoma brucei (a pathogen of 
significant medical and veterinary importance in Sub-Saharan Africa) to investigate 





























1.3 Trypanosoma brucei – a model system for studying 
flagellum biogenesis 
 
1.3.1 Background and life cycle  
 
Trypanosomes belong to a group of flagellated protists called kinetoplastids. All 
members of this group have a unique and distinctive region called the kinetoplast 
which contains condensed mitochondrial DNA (Matthews, 2005).  The transmission of 
the trypanosome Trypanosoma brucei, the causative agent of African trypanosomiasis 
(also known as African sleeping-sickness), occurs following the bite of an infected 
tsetse fly (Glossina genus). The vector can only be found in tropical and subtropical 
areas in Africa, though only certain species of tsetse flies transmit disease. Without 
any effective diagnosis and treatment, the consequences of infection can be fatal. 
There are two human infective subspecies T. brucei rhodesiense and T. brucei 
gambiense. A third subspecies T. brucei brucei, causes a livestock wasting disease 
called Nagana, but does not normally infect humans.   
In humans, the transmission of the parasite starts when the tsetse fly takes a blood 
meal and injects metacyclic trypomastigotes into the human host. Once the parasites 
enter the host bloodstream, they transform into bloodstream-trypomastigotes (long 
slender form) and they can survive and move freely to the rest of the body (e.g. central 
nerve system).  Parasites can evade host immune responses due to the expression of 
the bloodstream stage specific variable surface glycoproteins (VSGs), which are 
attached to the parasite surface membrane by a glycosylphosphatidylinositol (GPI) 
anchor (Paulick and Bertozzi, 2008).  Long slender form trypomastigotes replicate by 
binary fission and as the number of parasites in the bloodstream increase the long 
slender form differentiates into a non-replicative short stumpy form (via quorum-
sensing-like mechanism); this form is preadapted for survival within the tsetse fly 
midgut (MacGregor et al., 2011). This transformation to a cell cycle arrested stage, is 
required to maximise the possibility of parasite transmission i.e. it ensures the host 
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does not die before the parasite can be transmitted to another host (Matthews et al., 
2004).  
Upon transmission to the insect host, short stumpy forms transform into procyclic 
trypomastigotes in the midgut and re-enter the cell division cycle. From there, 
procyclic form parasites migrate through peritrophic matrix to the proventriculus, 
then move to mouthparts, and eventually reach the salivary gland.  The short 
epimastigotes can attach to the epithelium of the salivary gland and undergo 
replication and differentiation (epimastigotes to metacyclic form), these are released 
from the gland epithelium into the salivary gland so they are available to infect other 
hosts (Fig 1.6).   
As pathogens of significant medical and veterinary importance, T. brucei has been 
widely studied. However, more recently T. brucei has also emerged as an attractive 
model to study the assembly of the eukaryotic flagellum; due to the conservation of 
genes/proteins involved in flagellum assembly between human and trypanosomes, 
and because of the tractable reverse genetic systems available in T. brucei (Vincensini 




Fig 1.6 The life cycles of T. brucei in tsetse fly and human host. During their life cycle, the 
parasites need to go through numbers of developmental and morphological transformation 




1.3.2 Cell Architecture 
 
The T. brucei cell is vermiform in shape, wider at the cell centre and tapering towards 
the poles. The anterior and posterior ends of the cell are defined based on the 
direction of cell movement. The majority of organelles are positioned towards the 
posterior pole of the cell (Fig 1.7). Trypanosomes assemble a single flagellum, which 
elongates from the basal body near the posterior end of the cell. The flagellum 
emerges from the cell body through an invagination known as flagellar pocket (FP) 
(Field and Carrington, 2009).  The flagellum is closely attached to the cell body by a 
network of electron-dense filaments and membranous connectors known as the 
flagellum attachment zone (FAZ) but also extends beyond the cell as a short free 
flagellum (Ralston et al., 2009).  As mentioned earlier, all trypanosomatids contain a 
network of circular DNA inside the kinetoplast within a single elongated 
mitochondrion (Lukes et al., 2002). The kinetoplast is connected to the mitochondrial 
membrane by unilateral kinetoplast filaments, and is also attached to the basal body 
via exclusion zone filaments, together called the tripartite attachment complex (TAC). 
The TAC is extremely important as it provides and maintains the structural and relative 
positioning of mitochondrion, kinetoplast, basal body during the cell cycle (Ogbadoyi 
et al., 2003).   As with other eukaryotic cells, T. brucei contains a nucleus, Golgi 
apparatus, lysosomes, endosome, MT cytoskeleton, but also glycosomes that can only 
be found in Kinetoplastids (which are involved in glycolytic processes) (Michels et al., 
2006; Opperdoes and Borst, 1977).  
 
The single T. brucei flagellum has a typical 9+2 microtubule-based axoneme, consisting 
of nine outer doublet microtubules (ODs) surrounding a central pair apparatus (CP) of 
singlet microtubules. Radial spokes extend from the outer doublet A tubules facing 
inwards toward to the CP. Both inner and outer dynein arms are also attached to the 
outer doublet microtubules (Fig 1.7). The paraflagellar rod (PFR) is another unique and 
characteristic morphological feature in the trypanosome flagellum (and a few related 
organisms). The PFR is a lattice-like structure that runs alongside of the axoneme, and 
is attached to axonemal outer doublets 4-7 via fibrous connections. The connection 
between the PFR and the axoneme only occurs after the flagellum has emerged from 
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the flagellar pocket and extends to the flagellar  tip (Koyfman et al., 2011).  In a cross 
section the PFR is observed to have three domains – proximal, intermediate and distal. 
The exact function(s) of the PFR are still unclear, but it is known that the PFR is 
essential and required for normal motility and viability in T. brucei (Bastin and Gull, 
1999; Bastin et al., 1998).  RNAi silencing of two components (PFR1 and PFR2) results 
in strong reduction in flagellum beating and cell paralysis, but with no obvious defect 
in axoneme structure (Bastin et al., 1998; Durand-Dubief et al., 2003).  Since the first 
discovery, more  than 40 additional proteins have been identified that show 
association with the PFR through biochemical, bioinformatics and immunological 
techniques, which provides increasing evidence for a PFR function in regulatory, 




Figure 1.7 Cartoon showing the cellular morphology of a procyclic form T. brucei cell. The 
trypanosome cell in G1 possesses a single large mitochondrion, a kinetoplast containing the 
mitochondrial DNA that is attached to the basal body via the tripartite attachment complex 
(TAC). The flagellum extends from the mature basal body exiting the cell via the flagella 
pocket; the only site of endo/exocytosis in the cell. The flagellum is attached to the cell body 
via the flagellum attachment zone or FAZ. The cellular DNA is contained in a nucleus. The 
vermiform shape of the cell is maintained by a highly organised microtubule based 
cytoskeleton, which underlies the plasma membrane, called the subpellicular corset. The 
direction of cell movement is indicated, the cell swims with its flagellum beading. The anterior 
and posterior ends are defined by this directionality of movement. Reproduced from (Ralston 




1.3.3 Flagellum biogenesis and cell cycle  
 
In common with other eukaryotes, trypanosomes need to proceed through a defined 
series of molecular events (coordinated in space and time) to produce two daughter 
cells. Different morphological forms of T. brucei cells can be identified at different 
stages during the cell division cycle; with observations based on the position of the 
kinetoplast DNA (kDNA), length of new flagellum growth, and the positioning of the 
nucleus along the anterior/posterior axis (Fig 1.9).  At the beginning of the cell cycle, 
the trypanosome cell contains a single nucleus, mitochondrion, kinetoplast, basal 
body and flagellum (Fig 1.8), all of which must be accurately duplicated and segregated 
prior to cell division. Flagellum assembly is one of the earliest events in the cell cycle 
in T. brucei (Sherwin and Gull, 1989b). 
 
At an early G1 stage, the T. brucei cell has a single flagellum with one mature basal 
body and one pro-basal body (triplet MT 93+0). When the cell enters G1/S phase, the 
pro-basal body matures and elongates anchors at the flagellar pocket membrane and 
extends into a transition zone (double MT 92+0), the MTs are connected to flagellar 
membrane by chalice-shaped filaments to form ciliary necklace (Gilula and Satir, 1972; 
Vaughan and Gull, 2015) (Fig 1.8). At the end of the TZ, the basal plate is where the 
elongation and assembly of flagellum (double MT 92+2) starts in T. brucei.  
 
The whole process is reliant on IFT-dependent movement of proteins, 19 of the IFT 
genes have identified as conserved in T. brucei (see table 1) (Absalon et al., 2008b; 
Davidge et al., 2006; Kohl et al., 2003a). IFT proteins are required for flagellum 
assembly. RNAi knockdown of the retrograde motor HC and IFT88 resulted in cells with 
short flagella and eventually non-flagellated cells (Kohl et al., 2003a).  Later work done 
by Absalon and co-workers revealed that 14 IFT proteins can be found in the axoneme, 
as well as at pro- basal body and basal body regions of both old and new flagella. 
Functional analysis by RNAi knockdown of these IFT proteins showed they are 
essential for new flagellum assembly but the old flagellum remains unaffected. 
Furthermore, data supported the idea that these complexes have separable functions 
in T. brucei, as knockdown of IFT complex A or B proteins appeared to have different 




were able to produce flagella, but these were short, indicating that retrograde ITF 
transport was defective. In contrast, when complex B proteins (e.g. IFT172 and IFT52)  
were inhibited, cells completely failed to build an axoneme (Absalon et al., 
2008b).  Another recent study also revealed that in the T. brucei system, when the 
flagellum is assembled, the function of IFT is to maintain the distribution of flagellum 
proteins and flagellar beating, but not flagellum length (Fort et al., 2016). In T. brucei 
and all members of the Trypanosomatid family, two distinct genes for IFT dynein heavy 
chain are encoded in the genome (DHC2.1 and DHC2.2), which form a heterodimer 
and are essential for retrograde IFT (Adhiambo et al., 2005; Blisnick et al., 2014). 
DHC2.1 can be found in both anterograde and retrograde IFT, indicating it participates 
in IFT (Buisson et al., 2013). RNAi knockdown of DHC2.2 leads to defects in flagellum 
formation (Kohl et al., 2003b). The stability of DHC2.1 and DHC2.2 at the flagellum 
base depends on the presence of the intermediate dynein chain (DIC5/XBX-1/D1bLIC) 
and dynein light intermediate chain (DLI1/FAP133/WDR34) (Blisnick et al., 2014). 
Furthermore, they also showed that in the IFT140 mutant (RNAi) background, IFT 
dynein components were unable to enter the flagellum. Their data might suggest that 
IFT dynein motors are assembled in the cytoplasm, migrate to the flagellum base, and 
the IFT-A complex is required for efficient entry of the IFT dynein in the flagellar 
compartment, as the data observed in Chlamydomonas (Pedersen et al., 2006). On the 
other hand, IFT-A complex could function as an adapter to allow IFT dynein proteins 
pass through the TZ (Blisnick et al., 2014). 
 
The axoneme exits the cell body through an invagination of the plasma membrane 
called the flagellar pocket (FP), which is also the sole site of endocytosis and exocytosis 
and so is critical for host and parasite interaction and immune evasion (Field and 
Carrington, 2009).  The flagellar pocket collar (FPC) is where axonemal MTs exit the 
FP, and is a borderline between the FP and pellicular membranes. Moreover, the FPC 
also serves a structural role, as it tightly connects the flagellar and cell membrane. For 
example, a calcium-binding, polymer-forming protein  named TbBILBO1 was identified 
as a component of FPC and is essential for biogenesis of the FPC (Bonhivers et al., 
2008). RNAi knockdown of TbBILBO1 disrupts the formation of the FPC, inhibits the 




endomembrane system, cell cycle arrest, and is ultimately lethal (Perdomo et al., 
2016; Vidilaseris et al., 2015). After this point, the T. brucei flagellum extends along 
the cell body and remains attached until the distal end of the cell body is reached, 
after which it extends as a free flagellum. The FAZ is a large cytoskeletal structure that 
connects the flagellum to the cell body after the flagellum exits the FP  (Sunter and 
Gull, 2016). FAZ filaments are located in a gap between sub-pellicular microtubules, 
which lie beneath the plasma membrane (Vaughan et al., 2008; Zhou et al., 2011). 
From the posterior end of the cell, the specialised quartet of subpellicular 
microtubules (MTQ) is on the left of the FAZ filament, and they are associated with 
smooth ER  (Sherwin and Gull, 1989a). The FAZ has been recognised as a key 
morphogenetic structure regulating both cell length and organelle positioning. There 
are only a handful of FAZ proteins that have been identified, for example, Flagellum 
adhesion glycoprotein 1 (FLA1) (LaCount et al., 2002). RNAi knockdown of FLA1 causes 
flagellar detachment and prevents cytokinesis.  Other studies have shown that the 
depletion of another FAZ protein – the calpain-like protein GM6 (ClpGM6) - produces 
epimastigote-like morphology cells with long, free flagella and that FAZ length was 
significantly reduced, with the kinetoplast, basal body, Golgi and FP being repositioned 
(Hayes et al., 2014).   Trypanosoma brucei calmodulin (CaM) is localised within the 
paraflagellar rod (PFR), and is essential for PFR assembly. RNAi knockdown of CaM had 
no discernible effect on axoneme assembly, but the consequence of PFR assembly 
defect further results in loss the connection between PFR and axoneme to the FAZ of 
the cell body. Therefore, similar phenotypes that are observed in FAZ proteins RNAi, 
can also be seen CaM RNAi. As CaM RNAi mutant reduced the length of FAZ, which 
cells appeared to be short (Ginger et al., 2013).  
 
As mentioned earlier, T. brucei is an attractive model organism to study basal body/TZ 
proteins as well as flagellum biogenesis and maintenance, because the trypanosome 
flagellum exhibits the canonical features of the TZ and the trypanosome genome 
encodes much of the known conserved biology required for TZ function (such as IFT, 
MKS, and BBS proteins) (Barker et al., 2014; Hodges et al., 2010).  A recent study was 
conducted by Dean and co-workers which identified a large number of TZ and Inversin 




highly conserved across eukaryotes, half of those proteins are kinetoplastid specific. 
Moreover, about 12 TZs proteins are conserved in Chlamydomonas genome. Using 
fluorescence microscopy and EM also revealed that the BBSome is more distal than 
the MKS complex within the TZ. Finally, RNAi analysis revealed some of the TZs 
proteins required in flagellar biogenesis. For example, TZP250 is an orthologue of 
human ODF3, knockdown of TZP250 leads to severe phenotype, and some are also 
involved in axonemal structures formation such as MT central pair (e.g. Knockdown of 
TZP103.8) (Dean et al., 2016). 
 
Like all eukaryotic cells, T. brucei has five distinct cell cycle stages - G0, G1, S, G2 and 
M. However, because T. brucei has two genomes (i.e. kinetoplast and nuclear), the cell 
cycle is more complicated, as both the nuclear and kinetoplast genomes must be 
replicated and segregated correctly. For the nuclear genome, S-phase is referred as 
SN, and in the kinetoplast SK. SK starts before SN and, as it takes less time to complete, 
kDNA enters the G2 phase and kinetoplast segregation (D) occurs before the nucleus 
enters mitosis (Woodward and Gull, 1990). The cell division cycle events take about 
8.5 hours in procyclic form cells and each step is highly regulated by molecular 
regulators of interconnected signal transduction pathways (Fig 1.8-A) (Hammarton, 
2007).   
 
At the early G1 phase all T. brucei cells have a 1K1N1F configuration i.e. a single 
nucleus, a single kinetoplast and a single flagellum. As the cell enters the cell cycle the 
pro-basal body matures to produce a new flagellum. During S phase, the new flagellum 
extends from the FP and elongates towards the anterior pole of the cell. The distal tip 
of the new flagellum is physically attached to the old flagellum by an unusual 
transmembrane mobile junction called the flagellar connector (Briggs et al., 2004b).  
The kinetoplast starts to divide during G2 phase (2K1N2F) with newly replicated 
kinetoplast DNA network continuing to move apart during nuclear mitosis. In 
trypanosomes, cytokinesis is initiated by an invagination of cell membrane between 
the new and old flagellum at the anterior end of cell. The cleavage furrow progresses 
unidirectionally along the longitudinal axis of the cell from anterior to posterior pole, 








Fig 1.8. The trypanosome flagellum in procyclic form.  Scanning electron micrograph (EM) 
of one single procyclic trypanosome (lower image). Schematic diagram shows that the T. 
brucei flagellum, its cross-section and their attached organelles in details. T. brucei has 
conserved canonical “9+2” axoneme structures as well as its unique structures of 








Fig 1.9 Cartoon showing the timing and order of the major morphological events 
during the cell cycle in procyclic T. brucei. (a) The duration of one cell cycle takes about 
8.5 hours. Kinetoplast replication (SK) initiates at ~3 hours, nuclear replication (SN) 
initiates slightly later and is of longer duration. There is a short period of time when 
kinetoplast segregation occurs (D). After G2, nuclear mitosis (M) occurs. The “A” phase 
in kinetoplast cycle is when cell start dividing into two, and basal bodies continue to 
move apart. (b) The phenotypic changes in trypanosome cells based on the time points 
shown in (a). The black arrow indicates the direction and position of the cleavage 
furrow. Diagram taken from (McKean, 2003) with permission, and data based on 
















1.3.4   The Importance of the T. brucei flagellum 
 
The contribution of the flagellum to parasite motility and host cell attachment was 
appreciated for many years; however, functional analyses of flagellar proteins have 
revealed surprising roles for the flagellum in cell morphogenesis and cell division. In 
the following sections, I will focus on the importance of flagellum in cell 
morphogenesis and cell division. 
 
1.3.4.1 Cell morphogenesis and cell division  
Outgrowth of the new flagellum defines the plane of cleavage furrow ingression and 
its point of initiation (Kohl et al., 2003b; Vaughan, 2010). The flagellum and associated 
basal body are also critically involved in segregation of the kinetoplast genome. The 
basal body is connected to the kDNA via the tripartite attachment complex (TAC) via 
a set of filaments (Ogbadoyi et al., 2003). This physical connection remains intact 
throughout cell division, during basal biogenesis TAC must go through an extensive re-
organisation process. However, precisely how this is orchestrated and regulated is not 
yet clear (Vaughan and Gull, 2015). During flagellum elongation, the old and new basal 
body move apart, because the basal body and kDNA are connected by the TAC, which 
allows the separation of the new and old kDNA and ensures each daughter cell has 
one basal body and one kinetoplast (Gluenz et al., 2011; Lacomble et al., 2010). The 
mechanism(s) that drive kinetoplast-basal body movements are unclear. However, it 
has been proposed that flagellum microtubule elongation is required for the 
kinetoplast-basal body movement, as the flagellum pushed the kinetoplast-basal body 
towards the cell posterior, after movement of flagellum tip toward anterior end is 
stopped (Absalon et al., 2008a; Robinson and Gull, 1991). The new FAZ is nucleated 
and assembled near the basal body area, before the formation of the new flagellum 
takes place (Kohl et al., 2003a). The elongation of the new FAZ follows the path of the 
new flagellum. Cytokinesis is initiated from the anterior tip of the new FAZ filament, 
proceeds along the longitudinal axis between the old and new flagellum, which 
appears to be in parallel with the mitotic spindle (Robinson et al., 1995; Vaughan and 




information for positioning the cleavage plane (Robinson et al., 1995; Sunter et al., 
2015; Sunter and Gull, 2016; Vaughan, 2010; Zhou et al., 2015; Zhou et al., 2011).  
 
As mentioned earlier in this section, T. brucei has to undergo extensive changes in size 
and morphology throughout the cell and life cycle. The different forms of T. brucei are 
defined on the relative position of the flagellum to the other organelles, emphasising 
the importance of flagellum in cell morphology. The length of T. brucei varies from 15 
to 30 m long within tsetse flies, and FAZ filament length shows directly correlated to 
the cell length/size and flagellum length (Kohl et al., 2003a, b; LaCount et al., 2002; 
Sun et al., 2013). When new flagellum formation is perturbed by RNAi knockdown of 
TbDHC1b or TbIFT88 short flagella result and the associated FAZ filament also appears 
to be shorter, which results in cell body size decreased too. Together, the data 
indicated that new flagellum elongation is required for FAZ assembly (Kohl et al., 
2003a).  
 
For several years, the laboratory has been interested in gaining a better understanding 
of flagellum assembly. First because of the importance that the flagellum has for 
parasite biology, but secondly because T. brucei can be used as a model to study 
generic (i.e. evolutionary conserved) flagellum assembly processes which could shed 
light on human ciliopathies. One major area of interest has been the role of a tubulin 
cofactor C-domain containing (TBCC) protein known as RP2 (retinitis pigmentosa). In 
the following sections, I provide more detail on the canonical tubulin folding pathway, 









1.4 Tubulin folding pathway 
 
The core structural component of eukaryotic cilia and flagella is the 9+2 microtubule-
based axoneme constructed from heterodimeric  -tubulin. The generation of 
tubulin heterodimer depends upon a canonical folding pathway, which involves 
five tubulin-specific cofactors (TBCA-E) to ensure - and -tubulin are correctly folded 
(See Fig 1.10-A) (Lewis et al., 1997; Tian et al., 1996). At the beginning of the tubulin 
folding pathway, newly formed -tubulin monomers interact with prefoldin and are 
transferred to cytosolic chaperonin (CCT) in an ATP dependent manner. ATP hydrolysis 
by CCT results in conformational changes to produce quasi-native folded tubulin 
(Llorca et al., 2001; Llorca et al., 1998). The products then bind with tubulin cofactors 
to carry on the folding process.  -tubulin specifically interacts with Tubulin Cofactor 
B (TBCB) and TBCE, whilst -tubulin independently interacts with TBCA and TBCD.  In 
vitro, both TBCA and TBCB are not required for tubulin folding, and it is proposed that 
their roles are to shift the reaction equilibrium to provide favourable target protein to 
bind TBCD and TBCE. Based on their position in the pathway, they could act as a 
reservoir for tubulin folding intermediates. The presence of TBCA and TBCB also 
ensures de novo of tubulin folding is favoured over the back-reaction that involves 
native -tubulin heterodimer refolding (Tian et al., 1997).  
 
Both - and -tubulin are GTP (guanosine triphosphate)-binding proteins. GTP bound 
with -tubulin is freely exchangeable. However, GTP binding with -tubulin is non-
exchangeable (Spiegelman et al., 1977). GTP bound with TBCE/-tubulin and TBCD/-
tubulin complexes help to maintain the stability of the intermediate complexes. 
Tubulin cofactor C (TBCC) plays a crucial role during the latter part of the tubulin 
folding pathway. It is proposed that tubulin cofactor C (TBCC) is involved in forming a 
super-complex with TBCD, TBCE and -tubulin. Biochemical studies suggest that 
TBCC, TBCD and TBCE behave as GTPase-activating proteins (GAPs) to stimulate -
tubulin (GTP-binding protein) within the super-complex to trigger the hydrolysis of 
GTP leading to release of the native -tubulin heterodimer components for 




coupled with polymerisation of -tubulin heterodimer and also controls and 










Fig 1.10 (A) Schematic diagram shows the canonical tubulin-folding pathway. The native - 
and tubulin monomers are folded into functional heterodimers by five specific tubulin 
cofactors A-E. (B) TBCC domain containing proteins includes human canonical TBCC, XRP2, 
TBCCD1 and Trypanosome brucei RP2 (TbRP2). The TBCC domain is shown in dark blue, and 
the light blue indicating two CARP domains (partially overlapped with TBCC domain) usually 
found in CAP proteins. The coiled-coil regions shown in pink is alpha model, which may be 
involved in protein–protein interaction, and the nucleotide diphosphate kinase (NDPK) shown 
in brown found on XRP2 is a phosphocarrier domain. The TOF is in green, and LisH is in yellow 











1.5 TBCC domain containing proteins  
 
The majority of eukaryotes encode three tubulin cofactor C (TBCC) domain-containing 
proteins; canonical TBCC, TBCC-domain containing protein 1 (TBCCD1) and retinitis 
pigmentosa 2 (RP2).  All eukaryotes encode canonical TBCC, which is essential for  
tubulin folding, but RP2 is found only in ciliated/flagellated eukaryotes, while TBCCD1 
is encoded in the genomes of both flagellated and non-flagellated eukaryotes.  From 
a structural viewpoint, TBCCD1 protein is an oddity, as it has been previously reported 
that a conserved arginine finger residue in the TBCC domain, which has a crucial 
catalytic function with respect to GAP activity, is missing (Stephan et al., 2007). 
However, it has been noted in a sequence alignment of Chlamydomonas TBCCD1, 
XRP2 and TBCC orthologues, that an arginine residue appears very close to the 
functional residue observed in TBCC and RP2 that might stimulate GAP activity 
(Feldman and Marshall, 2009); but the functionality of this arginine residue has been 
questioned (Gonçalves et al., 2010). The domain structures of all three human TBCC 




1.5.1 Canonical TBCC 
 
TBCC consists of three domains; N-terminus domain (alpha module), CARP repeats 
which occur in many cyclase-associated proteins (CAPs), and a TBCC domain located 
in the C-terminus of the sequence (Fig 1.10-B) (Garcia-Mayoral et al., 2011). GTP 
hydrolysis by -tubulin is essential for biogenesis of native tubulin, and TBCC was first 
proposed by Tian and colleagues to act as a GTPase-activating protein (Tian et al., 
1999).  The primary function of TBCC is involved in latter part of the tubulin folding 
pathway (Fig 1.10-A). Within the supercomplex of -tubulin/TBCE and -
tubulin/TBCD, TBCC acts together with TBCD as a GTPase-activating protein, to 
stimulate the hydrolysis of the exchangeable GTP and allows the native tubulin 




characterised nearly a decade ago (Saito et al., 2007) (PDB: 2YUH), and shown to 
stimulate GTPase activity of native tubulin in cooperation with TBCD (Bhamidipati et 
al., 2000). The GAP function of TBCC is proposed to assess ‘tubulin quality’, thus 
ensuring that the -tubulin heterodimer is competent to hydrolyse of GTP; essential 
for microtubule incorporation (Scheffzek et al., 1997). Mutation of the conserved 
arginine (R262) of canonical TBCC abolishes its GTPase activating protein (GAP) activity 
suggesting a role in regulation of microtubule polymerization in vivo (Bartolini et al., 
2002). 
 
The mammalian Arl (ADP-ribosylation factor (ARF)-like) proteins belong to the family 
of Ras-related small G proteins and share approximately 40 to 60% sequence similarity 
with ADP-ribosylation factor (Arf) protein (Clark et al., 1993). However, Arf and Arl 
proteins do not show functional overlap (Amor et al., 2001; Tamkun et al., 1991). Arl2 
protein has shown modulate tubulin-GAP activity for both TBCC and TBCD.  Arl2 may 
serve its functions via several ways: (1) down-regulate GAP activity of TBCC, TBCD and 
TBCE towards -tubulin in vitro. (2) GTPase defective and GTP-binding defective Arl2 
mutant showed that the GDP bound form of Arl2 more efficiently interacted with 
TBCD, which can prevent destruction of tubulin and microtubules due to the TBCD 





TBCCD1 (TBCC-domain containing 1) protein is an enigmatic member of the TBCC 
domain-containing protein family, as it lacks the key catalytic arginine residue 
responsible for GAP activity (Stephan et al., 2007). To date, only three functional 
studies have been undertaken on TBCCD1. 
The first study was conducted in C. reinhardtii model, where the ASQ2 
protein encodes the conserved protein TBCCD1 (Feldman and Marshall, 2009). In this 
study, the majority of cells showed TBCCD1 localises to the region between the 




the ASQ2 gene leads to multiple defects in C. reinhardtii cells, such as problems in 
centriole linkage that cause defects in centriole number and positioning.  In addition, 
cells showed problems in mitotic spindle orientation, but no effect on spindle 
formation per se(Feldman and Marshall, 2009). 
 
Human TBCCD1 also appears to have multiple locations; centrosome, spindle fibres 
and basal bodies of both motile and primary cilia (Gonçalves et al., 2010).  RNAi 
knockdown of human TBCCD1 led to cell cycle delay in G1 phase, as well as changing 
the localisation of the centrosome from the centre of the cell close to the nucleus, to 
a position about 2m away from the nucleus. TBCCD1 depletion also caused cilia 
formation defects and disruption of nucleating microtubules.  Microtubules play a 
critical role in ensuring that the Golgi apparatus (GA) is correctly organised and 
positioned close to nucleus. Therefore, it came as no surprise that knockout cells 
showed disorganised and fragmented GA (Rios and Bornens, 2003). The position of 
the centrosome and GA within a cell is essential for cell polarisation and migration 
(Vinogradova et al., 2009). The TBCCD1-knockout cells had defects in cell shape, 
organisation and migration, and the study concluded that TBCCD1 is a centrosomal 
protein responsible for connecting the centrosome and nucleus (Gonçalves et al., 
2010).  
 
T. brucei TBCCD1 has also been investigated, and shown to have an essential role in 
trypanosome viability (André et al., 2013). The trypanosome orthologue TbTBCCD1 
has three distinct localisations within the cell: the basal body region close to the 
kinetoplast, the Golgi-associated bi-lobe and anterior end of the cell body. The bi-lobe 
structure is an enigmatic cytoskeletal feature of T. brucei, which localises near the 
flagellar pocket and was originally suggested to provide a template for biogenesis of 
the Golgi complex in T.brucei (He et al., 2005).  
 
After TbTBCCD1 RNAi induction the Golgi bi-lobe structure became disorganised and 
interestingly, the connection between kinetoplast and basal body was affected. 




kinetoplasts, or some cells appeared to have no kinetoplast at all, indicating that loss 
of TbTBCCD1 resulting in mis-segregation of the kDNA networks. Based on previously 
published studies in Chlamydomonas and human cell lines (Feldman and Marshall, 
2009; Gonçalves et al., 2010) and the observations in T. brucei suggested that 
TbTBCCD1 had a function in orchestrating the formation of filament-based structures 




Human retinitis pigmentosa (RP) is a type of inherited retinal dystrophy, which is 
characterised by progressive degeneration of photoreceptor cells peripheral to the 
central retina. Patients with RP typically develop night blindness, with vision getting 
gradually worse until they eventually become completely blind.  More than 50 
different genetic defects have been identified; autosomal dominant, autosomal 
recessive, but the most severe form is X-linked RP (XLRP) with mutations in the XRP2 
gene responsible for up 15% of all XLRP cases (Schwahn et al., 1998).    
 
 
Fig 1.11 Diagram show the domain structure of XRP2 protein. XRP2 is a 350 amino acid 
protein; there are two main domains TBCC homology domain and NDK homology domain. 
R118H, L253R and S6 are the common mutation take place with RP patients. Taken from 





The human retinitis pigmentosa 2 (RP2) encodes a ubiquitously expressed polypeptide 
of 350 amino acids and is well conserved across different vertebrate species such as 
mouse and zebrafish, and loss of the RP2 gene gives similar phenotypes to that seen 
in humans (Li et al., 2013; Liu et al., 2015).  The XRP2 protein contains two domains 
(Fig 1.11); the N-terminus human XRP2 has dual functional acylation sites 
(MGCXFSK) and a TBCC domain with a right-handed -helix folds. Within this TBCC 
domain region, the tandem repeat cyclase associated proteins (CARPs) motif is also 
present; the -helix structure lies within this CARP motif. The N-terminus is post-
translationally modified by myristoylation and palmitoylation; modifications that 
target XRP2 to plasma membranes (Chapple et al., 2000; Schwahn et al., 1998). A 
disease-causing mutation (serine 6) which inhibits dual acylation of XRP2 and 
prevents localisation to the plasma membrane suggests that membrane localisation is 
required for RP2 function in photoreceptor cells (Grayson et al., 2002). At the C-
terminus of RP2, there is structural homology to nucleoside diphosphate kinases 
(NDPK) (residues ∼251–346) (Chapple et al., 2000; Evans et al., 2006b).  However, the 
NDPK-like domain of XRP2 lacks a critical catalytic residue and 
isothermal titration calorimetry (ITC) reveals XRP2 does not bind ADP indicating 
phosphotransferase activity is missing (Kuhnel et al., 2006). 
 
Initial studies suggested that XRP2 function had partial functional overlap with TBCC 
(Bartolini et al., 2002; Evans et al., 2006b; Grayson et al., 2002; Schwahn et al., 1998; 
Schwarz et al., 2012c). Bartolini and colleagues have shown that both XRP2 and TBCC 
simulated GAP activity of native tubulin in concert with TBCD in vitro. However, XRP2 
was unable to replace canonical TBCC in catalysing tubulin heterodimerisation 
(Bartolini et al., 2002). XRP2 and TBCC can partially compensate for the loss of CIN2 
(putative homolog of TBCC in S. cerevisiae) and act as GTPase activating protein to 
stimulate the hydrolysis of native tubulin in the presence of TBCD.  However, both 
TBCC and XRP2 fail to replace the function of GAP activity when carrying a mutation 
affecting the critical arginine finger motif, leading to a defect in the assembly of tubulin 




It has been proposed that the arginine finger motif is required for the activity of many 
GAPs (Scheffzek et al., 1998), and the R118H residue of XRP2 is conserved with R262A 
residue of TBCC. Intriguingly, mutations in this arginine finger motif completely abolish 
tubulin-GAP activity in both XRP2 and TBCC. The data indicates that the arginine finger 
motif plays a key role in tubulin-GAP activity (Bartolini et al., 2002). Mutation of R118H 
residue in XRP2 is the site of the most common pathogenic missense mutation found 
in patients with retinitis pigmentosa (Schwahn et al., 1998), which may be due to the 
loss of GAP activity for XRP2 in the retina (Bartolini et al., 2002).   
 
Grayson and colleagues confirmed the plasma membrane localisation of XRP2 
throughout the retina but that XRP2 ablation (Arg120 stop) has no effect on the 
expression level of TBCC or Arl3. They also demonstrated that Arl3 has a distinct 
localisation to XRP2, with immunofluorescent labelling showing that Arl3 localised to 
microtubule structures, including the connecting cilium, suggesting it is a microtubule-
associated protein (MAP). The labelling is particularly strong within the rod and cone 
photoreceptors, suggesting Arl3 may be involved in maintaining the architecture of 
the photoreceptor. Because Arl3 does not localise to the plasma membrane it is 
suggested that the interaction between XRP2 and Arl3 is not at plasma membrane 
(Grayson et al., 2002). The connecting cilium of retina is a specialised microtubule 
structure, and defects in connecting cilium lead to retinal degeneration. Interestingly, 
Arl3 can only be found in ciliated and flagellated organisms (Avidor-Reiss et al., 2004). 
Although, there is no evidence yet to link Arl3 to any human ciliopathies, Arl3-/- mice 
exhibit typical ciliopathic phenotypes includes impaired photoreceptor development 
but also cysts in kidney, liver and pancreas (die within 3 weeks of birth) (Schrick et al., 
2006).  In C. elegans, Arl3 is also strongly expression in cilium and involved in cilium 
formation.  Knockout Arl3 worms can still form cilia, but when over-expressing the 
active form of Arl3 lead to defective ciliogenesis, similar result has also been observed 
in L.  donovani  (Li and Hu, 2011).  Those phenotypes are suggesting the role of Arl3 is 
to act as a negative regulator in ciliogenesis. Intriguingly, depletion of Arl3 can partially 
rescue ciliogenesis defects in Arl13 mutants by restoring the association between IFT-




integrity of IFT-B complex and its kinesin motor OMS-3 (KIF17) through the effector 
deacetylase HDAC6 (Li and Hu, 2011).   
 
Several research groups have solved the crystal structure to identify the function of 
XRP2 and Arl3, and their binding regions (Kühnel et al., 2006; Veltel et al., 2008). The 
data has determined that XPR2 is a negative regulator of Arl3 and that the N-terminus 
and  helix domain of XRP2 are essential for XRP2-Arl3 interaction. Based on affinity 
measurements, Glu138 and Arg118 are two residues located on the surface of the  
helix, mutation in either Glu138 or Arg118 residues lead to XRP2 reduce affinity 
toward Arl3 drastically. The results suggest that failure of XRP2 to bind Arl3 may cause 
human retinitis pigmentosa (Kühnel et al., 2006).  Further studies by Veltel and 
colleagues, presented a crystal structure of the Arl3–GppNHp–RP2 complex. 
Biochemical analysis of this complex represents a 90,000-fold stimulation of the 
GTPase reaction, indicating that XRP2 is an efficient GAP for Arl3, with structural 
features similar to other GAPs (Veltel et al., 2008). 
 
Human Arl3 and Arl2 share significant homology. In 2006, Zhou et al., revealed that 
both Arl2 and Arl3 are localised at the centrosome, and expression of mutant Arl2 
leads to defects in microtubule formation and cell cycle arrest in M phase, which may 
indicate functions in regulating tubulin polymerization at centrosomes. However, no 
obvious phenotypic morphology was observed following Arl2 knockdown. Data 
suggested that Arl2 functions as a regulator of tubulin folding and microtubule 
integrity, but this function may not be essential (Zhou et al., 2006). The function of 
Arl2 also been studied using human adenocarcinoma cell lines and shown that 
changing Arl2 protein levels results in significant changes to tubulin content in 
polymerisable soluble heterodimers. The results suggested that Arl2 proteins are 





Several interactors/effectors of Arl3 that have been identified.  XRP2 act as a GAP for 
Arl3 and involved in vesicle transport and docking to the base of the human 
photoreceptor cells (Evans et al., 2010). Other effectors, including PDE6δ and UNC119, 
share a similar hydrophobic lipid binding pocket, which can bind with GTP-bound Arl3, 
and together with XRP2 regulate the delivery of lipid-modified cargo to the cilium 
(Schwarz et al., 2012a). In addition to a role in cilia formation, Arl3 proteins also 
function in ciliary signalling pathways via key signalling receptors/molecules; for 
example in C. elegans, the ciliary proteins Polycystin-1 and Polycystin-2, and in Arl3 
knockout worms, polycystins fail to target to cilia (Barr et al., 2001; Barr and Sternberg, 
1999). In mammalian model, RNAi ablation also disrupts the transportation of Gli3 
that participate in Hedgehog pathway (Lai et al., 2011).  
 
Some evidence suggests that Arl3-GTP will bind the effector protein Human retinal 
gene 4 (HRG4, also called UNC119; uncoordinated 119 protein) to form a temporary 
ternary complex Arl3:UNC119:XRP2 before XRP2 stimulates the hydrolysis of Arl3-GTP 
(Veltel et al., 2008). This ternary complex traffics cargo to the membrane (Ismail et al., 
2011; Wright et al., 2011). Mori and Toda were be able to identify Tbc1 and Alp42 
(orthologs of human TBCC and Arl2 respectively) in fission yeast model system and 
demonstrated that Tbc1 is not only act as GAP for the small GTPase Alp42, but also 
involved in heterodimerisation of tubulin (Mori and Toda, 2013).  
 
Apart from plasma membrane, XRP2 also localises at the basal body, ciliary apparatus 
of photoreceptor cells, Golgi, and periciliary ridge (Evans et al., 2010; Hurd et al., 2010; 
Hurd et al., 2011). The function of those organelles are closely related to control of 
protein export from the outer segment of photoreceptors; which suggests XRP2 may 
play role in vesicle trafficking and IFT (Maerker et al., 2008; Roepman and Wolfrum, 
2007; Schwarz et al., 2017).  In mammal, depletion of XRP2 causes dysregulation of 
Arl3 and disturbs Golgi complex cohesion. Loss of Arl3 and Kif3a (IFT anterograde 
motor) also leads to dispersal of Golgi complex and morphology changes. Depletion 




complex to the cilium, and dispersal of IFT20 from the peri-basal body pool.  
Therefore, results suggest GAP activity of XRP2, and its regulation of Arl3, is crucial for 
maintaining stability of Golgi complex cohesion and vesicle trafficking in 
photoreceptor pericentriolar cells (Evans et al., 2010; Follit et al., 2010).   
 
Recent work by Schwarz and co-workers has demonstrated that Kif17 and Kif7 (IFT 
anterograde motors) are novel interacting partners of Arl3 and its GAP-RP2, but that 
these two kinesins do not interact. The localisation of Kif17 and Kif7 to the cilia tips 
depends on the presence of Arl3 and RP2, as RNAi knockdown of either RP2 or Arl3 
significantly reduced the Kif17 and Kif7 level at the cilia tips, without affecting the 
other localisations of Kif17 such as nuclear or cytoplasm (Schwarz et al., 2017).  Kif7 is 
a kinesin family-4 member protein, which is not thought to be essential for IFT or the 
trafficking of Hh pathway proteins into cilia, but rather regulates the dynamics of 
microtubule plus ends and thereby controls the cilium architecture and organisation 
of primary cilia tips (He et al., 2014). Loss of either Kif7 or Kif17 leads to the levels of 
tubulin polyglutamylation significant reduced, but total cellular polyglutamylation 
levels remain unaffected, suggesting that Kif7 and Kif17 specifically stabilise cilia 
microtubules. Interestingly, RNAi knockdown of Arl3 effector proteins, such as 
UNC119 and PDE6D did not affect Kif17 and Kif7 at the cilia tips. Together their data 
suggests that that RP2 and Arl3 regulate the trafficking of specific kinesins to cilia tips, 
but not dependent upon lipidated protein trafficking (Schwarz et al., 2017). 
 
Apart from well-accepted XRP2-interacting partner protein Arl3, XRP2 also interacts 
with other proteins such as N-ethylmaleimide sensitive factor (NSF) (Holopainen et al., 
2010). Proteomic and biochemical analysis reveals that this interaction is mediated by 
the N-terminal domain of NSF, and can be observed in both retinal and cultured 
embryonic kidney (HEK293). Mutations in XRP2 (ΔI137 and E138G) lead to this 
interaction failing. Immunofluorescence analysis shows that XRP2 and NSF are co-
localised in photoreceptors and other retinal cells, with a more intense signal within 




cilium.  This might indicate that the function of XRP2 is not only as a regulator of Arl3, 
but also interacts with NSF to traffic NSF to the cilium and synaptic region of 
photoreceptors (Holopainen et al., 2010).  
 
 To date there are three main possible functions of XRP2; (1) Tubulin quality control 
(Bartolini et al., 2002); (2) vesicle trafficking (Schwarz et al., 2012b; Schwarz et al., 
2017; Schwarz et al., 2012c); (3) The demonstration that of XRP2 localised to the 
nucleus when HeLa or ARPE-19 cells were treated with DNA damaging agents (Yoon 




The T. brucei RP2 ortholog was identified by phylogenetic analysis (Figure 1.11-B), and 
localised to the transitional fibres of the mature basal body (BB) where it is involved 
in flagellum assembly (Stephan et al., 2007).  Initially, the function of TbRP2 was 
proposed to be in ensuring the 'quality' of tubulin imported into the cilium/flagellum 
(i.e. as GAP for β-tubulin) as TbRP2 RNAi-ablation caused axonemal microtubule 
defects, as well as a loss of YL1/2 signal at the BB. YL1/2 is a monoclonal antibody 
classically used to detect tyrosinated α-tubulin, and so the loss of basal body YL1/2 
labelling observed in T. brucei was taken as evidence for RP2 depletion affecting the 
recruitment of unpolymerised tubulin to the basal body. 
 
However, more recently the function of TbRP2 has been re-evaluated (Andre et al., 
2014). In this study, the targeting of TbRP2 to the basal body was investigated by 
expressing a series of TbRP2::YFP fusion proteins that contained; (1) just the N-
terminus of TbRP2 (up to but not including the TBCC domain), (2) the N-terminus of 
TbRP2 and the TBCC domain, and (3) almost full length TbRP2 protein that lacked just 
the acidic C-terminus. Bioinformatic analysis revealed that the N-terminal region 
encodes twinned TOF- LisH motifs and construct-1 (i.e. just the N-terminus of TbRP2 




of TbRP2 were required for basal body targeting and retention at the transitional 
fibres. Subsequent site directed mutagenesis experiments confirmed the importance 
of the TOF-LisH motifs. Interestingly, the use of the twinned TOF-LisH motifs to target 
RP2 to the basal body appears to be trypanosomatids specific (although TOF-LisH 
motifs are conserved in other eukaryotic conserved basal body/centrosome located 
proteins).   
 
In order to determine the GAP function of TbRP2, constructs were also made to 
express myc-tagged TbRP2R248H mutant protein (TbRP2R248H::myc). The R248H 
mutation affects the conserved arginine finger within the TBCC domain required for 
GAP activity in canonical TBCC and XRP2 (Ding et al., 2008). Compared with the control 
cell line (TbRP2::myc) cells expressing TbRP2R248H::myc had shortened flagella 
indicating that over-expression of TbRP2R248H::myc (i.e. protein lacking GAP function) 
had a dominant negative effect on flagellum assembly.   
 
To investigate potential functional overlap between XRP2 and TbRP2, the human XRP2 
protein was targeted to the basal body by creating a chimeric construct that paired 
XRP2 coding sequence with the sequence encoding the twinned LisH-TOF motifs 
present at the N-terminus of the TbRP2 protein. After TbRP2 RNAi induction, flagellum 
length was reduced, indicating that XPR2 targeted to the basal body could not 
functionally compensate for loss of TbRP2 and restore flagellum length (Andre et al., 
2014).  
Interestingly, loss of TbRP2 was also shown to affect the recruitment of both TbMKS1 
and TbMKS6 to the TZ, suggesting that the flagellum assembly defect resulting from 
loss of TbRP2 may also reflect problems in MKS complex assembly. Together, the 
available data suggested TbRP2 could have multiple roles in flagellum formation e.g. 
tubulin processing, general protein trafficking for flagellar assembly, as well 
influencing TZ protein complex assembly pathways such as those involved in the 
recruitment of IFT machinery (Andre et al., 2013; Garcia-Mayoral et al., 2011; Schwarz 





1.6 Project aims 
 
Work to date indicates that TbRP2 is localised to the mature basal body, by virtue of 
paired N-terminally located TOF-LisH motifs, and is essential for flagellum biogenesis. 
Homology to XRP2, the presence of a canonical TBCC domain, and the dominant 
negative phenotype that results from over-expression of mutant (i.e. GAP-negative) 
protein, strongly supports the view that TbRP2 is a bona fide GAP protein.  
 
In this project, I set out to identify and investigate proteins that interacted with TbRP2 
or were in close proximity to the protein. To achieve this TbRP2 was expressed as a 
fusion with bacterial biotin ligase and by using streptavidin affinity purification 
biotinylated proteins were purified identification by mass spectrometry; an approach 
known as BioID. It was envisaged that this approach would identify TbRP2-interacting 
proteins that might provide insight into (i) the molecular client of TbRP2 GAP activity; 
(ii) basal body and/or transitional fibre proteins to which TbRP2 is tethered (in a 
detergent resistant manner); and (iii) proteins responsible for targeting (in a TOF-LisH 
dependent fashion) to the mature basal body. The results of this BioID interrogation 












Chapter 2 Material and Methods  
2.1 Chemicals and Reagents 
 
Melford Laboratories 
Agarose, dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA), glycerol, 
glycine, piperazine-N,N’-bis(2-ethanesulfonic acid) (PIPES), phleomycin, Phosphate-




Ampicillin, acetic acid, acrylamide, acetonitrile, ammonium bicarbonate (ABC), bovine 
serum albumin (BSA), doxycycline, disodium phosphate, hemin, hydrochloric acid, 
imidazole, iodoacetamide, magnesium acetate, monopotassium phosphate, 
paraformaldehyde (PFA), sodium carbonate, sodium citrate, sodium hydroxide, tween 
20, Triton-X, Urea, tetramethylethylenediamine (TEMED), ammonium persulphate, 
Tris-acetate, Trypsin Singles: Proteomics Grade, Enzyme, Blasticidin, Doxycycline, 
Hygromycin, Kanamycin, Phleomycin, Puromycin   
 
Fisher Scientific  
Calcium acetate, ethanol, methanol, magnesium choloride, magnesium sulphate,  
 
Thermo Scientific 
Miniprep Kit, PCR Purification Kit, Gel Extraction Kit, Elution buffer, Halt Protease 
Inhibitor single-use Cocktail, Reddymix®PCR Master Mix, Streptavidin Magnetic 
Beads (Pierce™), Formic Acid, Trifluoroacetic acid 
 
Duchefa Biochemie  
LB broth, LB agar, potassium chloride 
 
BioSera 





Precision Plus (all blue) Pre‐stained Protein Standards 
Fluka Biochemika 
Nonidet P‐40 (NP‐40) 
 
Fermentas 
Restriction enzymes and their buffers 
 
GIBCO 






Vectashield with 4, 6 diamidino‐2‐phenylindole (DAPI) 
 
Promega 
T4 DNA Ligase and buffer, pGEMT‐Easy vector system 
 
Qiagen  
High fidelity PCR mix 
 
Marvel 
Skimmed milk powder  
 
Acros Organics 
Orange G  
Roche 




2.2 Solutions and Buffers 
• Agarose gel: 
• Blocking buffer for Immunofluorescence:  1xPBS, 0.05% Tween-20, 1% Bovine 
serum albumin 
• Blocking buffer for Immunoblotting: 1xPBS, 0.05% Tween-20, 5% or 1% 
skimmed milk powder 
• Dithiothreitol (DTT): 1M stock solution 
• DNA loading buffer (x6): 0.15% Orange G, 30% glycerol in Milli-Q 
• Elution buffer: 10mM tris (hydroxymethyl) amino methane (Tris-HCl), pH8.5. 
• Ethanol: absolute 
• Hemin Stock* (for SDM-79): 4% Hemin in 0.1 M NaOH 
• Immunofluorescence slide fixing solution: 3.7% (w/v) Paraformaldehyde in 
1xPBS 
• Insoluble Binding Buffer: 8M Urea, Tris-HCL (pH8.0), 500mM sodium chloride, 
0.02% Triton-X, 20mM Imidazole, 10% glycerol 
• Insoluble Elution buffer: 8M Urea, Tris-HCL (pH8.0), 500mM sodium chloride, 
0.02% Triton-X, 500mM Imidazole, 10% glycerol 
• Inhibitor Cocktail: Halt Protease Inhibitor single-use Cocktail, 200 mM TLCK, 
200 mM PMSF, 1 M Benzamidine 
• LB Agar: 30g LB agar powder made up to 1L with Milli-Q 
• LB Medium: 25g LB Broth powder made up to 1L with Milli-Q 
• Methanol: absolute  
• PBS: 1 tablet per 200ml Milli-Q water (137mM NaCl, 2.7mM KCl, 10mM 
Na2HPO4, 2mM KH2PO4) 
• Paraformaldehyde Fix for Slides: 3.7% (w/v) PFA in 1x PBS 
• PEME 1% NP40: 1% nonidet-P40 in 0.1M piperazine-N,N’-bis(2-ethanesulfonic 
acid) (PIPES), 2mM ethylene glycol tetraacetic acid (EGTA), 1mM magnesium 
sulfate, 0.1M ethylenediaminetetraacetic acid (EDTA), pH6.9 
• Procyclic trypanosome media: SMD-79 powder (Brun and Schönenberger, 




sterile filtered 450 mL into each autoclaved bottle. 7.5 mg/L haemin (10 mg/ml 
stock in 0.1 M NaOH) and 50 ml heat inactivated foetal calf serum (filtered) 
were added into the bottle before use. Stored the complete SMD-79 media 
(500 mL) at 4°C 
• Reddymix®PCR Master Mix: 0.625 units ThermoPrime Taq DNA Polymerase, 
75mM Tris-HCl (pH 8.8 at 25°C), 20mM (NH4)2SO4, 1.5mM MgCl2, 0.01% (v/v) 
Tween-20, 0.2mM each of dATP, dCTP, dGTP and dTTP  
• SDS loading buffer: 100mM Tris-HCL pH 6.8, 4% SDS (electrophoresis grade), 
0.20% Bromophenol Blue, 20% glycerol, 200mM dithiothreitol solution (DTT)  
• SDS-PAGE 10% resolving gel: 30% Acrylamide mix, 1.5M Tris-HCl (ph8.8), 10% 
SDS, 10% ammonium persulphate, 0.1% N,N,N’,N’,-
tetramethylethylenediamine (TEMED)  
• SDS-PAGE 5% stacking gel: 30% Acrylamide mix, 1M Tris-HCl (pH6.8), 10% SDS, 
10% Ammonium persulphate, 0.1% N,N,N’,N’,-tetramethylethylenediamine 
(TEMED) 
• SDS-PAGE running buffer (5x): 125mM Tris, 1.25M glycine, 0.5% SDS  
• Sodium acetate solution: 3M pH5.2  
• S.O.C medium: 2% Tryptone, 0.5% Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2, 10 mM MgSO4, 20 mM Glucose 
• TAE (Tris-Acetic acid-EDTA) buffer: 40mM Tris-acetate, 1mM EDTA, pH8 
• Transfer buffer for Immunoblot (1x): 48mM Tris-HCl, 39mM glycine, 0.037% 
SDS, 20% methanol 
• Wash buffer: 1xPBS with 0.05% Tween-20  
• ZMG buffer: 132mM Sodium Chloride, 8mM Potassium chloride, 8mM 
Disodium phosphate, 1.5mM monopotassium phosphate, 0.775mM 









2.1.1 Solutions and Buffers for Mass Spectrometry 
(BioID/SILAC) (OB-on beads digest, IG-in gel digest) 
 
• IG-ABC Solution: 100 mM Ammonium Bicarbonate  
• IG-DTT/ABC Solution: 10 mM DTT in 100 mM Ammonium Bicarbonate 
• IG-IAA/ABC Solution: 50 mM Iodoacetamide in 100 mM Ammonium 
Bicarbonate 
• IG-Extraction Buffer: 1:2 (v/v) 5% formic acid: 100% Acetonitrile  
• IG-ABC/MeCH Solution: 10 mM ammonium bicarbonate contains 10% (v/v) 
acetonitrile 
• OB-ABC Solution: 50 mM ammonium bicarbonate  
• OB-Elute Solution: 0.1% Trifluoroacetic acid, 70% Acetonitrile  
• OB-IAA Solution:  8 M Urea, 1% SDS, 50 mM Iodoacetamide  
• OB-Solubilisation Buffer: 8 M Urea, 1% SDS  
• OB-TFA Solution: 0.1% Trifluoroacetic acid 
• OB-TFA/MeCN Solution: 0.1% Trifluoroacetic acid, 70% Acetonitrile 
• Trypsin Singles: Proteomics Grade, Enzyme 
• Procyclic trypanosome media: SMD-79-SILAC 
Ingredient Product 500 mL 
SDM-79-SILAC Cassion Labs custom synthesis  
Heamin stock, 10 mg/mL 
in 0.1M NaOH 
Sigma H9039, 4 0C 375 L 
Sodium bicarbonate Sigma S5761, RT 1 g 
D-glucose 100 x, 9.3 g / 50mL  5 mL 
D-glucosamine 100 x, 0.25 g / 50mL 5 mL 
L-hydroxyproline 100 x, 10 mg / 50mL 5 mL 
L-proline 100 x, 3.08 g / 50mL 5 mL 
i-inositol 100 x, 6.5 mg / 50mL 5 mL 
L-methionine 100 x, 0.45 g / 50mL 5 mL 




Adjust to pH 7.3 with NaOH, sterile filter 
Glutamax 1, 100x Gibco 35050038, -20 0C 75 mL 
Penicillin-Streptomycin, 
100x 
Gibco 15140-122, -20 0C 5 mL 
Foetal bovine serum, heat 
inactivated, FS (add in the 
hood) 
Sigma F4135, -80 0C  5 mL 
Table 2.1 Recipe for making SDM-79-SILAC media for BioID experiments. Complete 
SILAC media was filter sterilised the microbiological safety cabinet.  
 
 
• SILAC labels:  
Label (100mg/ml, -20 0C) Mw 30% SDM-79 
L-Arg.HCl (R0) 210.6 64.5 mg/L 
L-Arg.HCl (R6-13C6) 216.6 66.3 mg/L 
L-Arg.HCl (R10-13C6,15N4) 220.6 67.5 mg/L 
L-Lys.HCl (K0) 182.6 21.6 mg/L 
L-Lys.2HCl (K4-2H4) 223.1 26.7 mg/L 
L-Lys.2HCl (K8-13C4,15N4) 227.1 27.3 mg/L 
   
 
Table 2.2 Recipe for making light-, medium- and heavy-labelled amino acids, which 
were added to the SDM-79-SILAC media for SILAC labelling experiments. Arg – 
Arginine; Lys – Lysine 
 
2.3 Antibiotics and drug stock solutions 







Ampicillin 100 mg/mL 100 µg/mL Selective 
marker for 
E. coli 
Blasticidin  10 g/L 10 g/mL Selection 
for T. 









Hygromycin  20 g/L 50 g/mL Selection 
for T. 
brucei  cell 
lines 
Kanamycin   10 g/ml  Selective 
marker for 
E. coli 
Phleomycin  7.5 mg/mL 3 g/mL Selection 
for T. 
brucei  cell 
lines 
Puromycin   7.5 mg/mL 2 g/mL Selection 
for T. 
brucei  cell 
lines 
Table 2.3 Antibiotics and drugs used during this study. All solutions involved in T. brucei cell 
culture was filter sterilised before use.  
 






















Figure 2.1 Vector maps. (A) pGEM®-T Easy vector (Dawson and House, 2010). (B) The 
TbRP2∆134-463::myc::BirA* was generated by gene synthesis (MWG Eurofins) and inserted into 
the pEX-K4 vector. (C) pDex-377 vector used for constitutive expression of myc-tagged 
proteins in procyclic trypanosomes (Kelly et al., 2007). (D) p2T7-177 vector was used for a 





2.5 Antibodies and PCR primers  
Table 2.5 Antibodies used for immunofluorescence microscopy  
Primary antibody Epitope Raised in  Dilution Secondary antibody Dilution Company 
Anti-Myc Myc Mouse 1:200 Anti-mouse IgG 
rhodamine conjugate 
1:200 Millipore 
L8C4 Paraflagellar Rod  Mouse 1:10 Anti-mouse IgG FarRed 1:200 Invitrogen 
Anti-TbRP2 
 





Table 2.6 Antibodies used for Immunoblotting detection 
Primary antibody Epitope Raised in Dilution Secondary antibody Dilution Company 
Anti-Myc Myc Mouse 1:1000 Anti-mouse IgG HRP 
conjugate 
1:80 000 Novagen 
KMX-1 beta-tubulin Mouse 1:1000 Anti-mouse IgG HRP 
conjugate 
1:80 000 Novagen 
Anti-GFP 
 
YFP-tag  Mouse 1:1000 Anti-mouse IgG HRP 
conjugate 












2.6 Oligonucleotide primers 
Oligonucleotide primers were ordered from Eurofins MWG Operon.  Forward and reverse primers for pPot tagging were designed using 
the pPOT design programme (Dean et al., 2015), and RNAi primers designed using RNAit (Redmond et al., 2003). All primers were re-
suspended in filtered Elution Buffer (Thermo Scientific) at a concentration of 100µM (stock) and stored at -20°C. Oligonucleotides were 







 Dilution Company 
Streptavidin conjugated to TRITC  
 
1:200 Roche 




Table 2.8 pPOT primer sequences used in PCR reactions 

















































































































                     








Table 2.9 Sequences of oligonucleotide primers used to generate constructs for RNAi knockdown experiments. 
Primer ID Direction Nucleotide sequence (For RNAi) Restriction site 
TbARL3 Like Forward  5’- GCGggatccTGAGCCGCGTGTACTGATAG -3’ BamHI 
TbARL3 Like Reverse  5’- GCGctcgagTTATTTGCTTTCAGCGCCTT -3’ Xhol 
TbBARTL1 Forward  5’- GCGggatccTTTACAGTTCACGCATTCGC -3’ BamHI 
TbBARTL1 Reverse 5’- GCGctcgagCCTGTAGCTGCAGATCCTCC -3’ Xhol 
TbHSP70 Forward 5’- TATggatccATCGAGATCGATGCACTCTTCG-3’ BamHI 
TbHSP70 Reverse 5’- GCGctcgagAATACCATTAGCGTCTAGGTCG -3’ Xhol 
TbKMP11 Forward 5’- GCGggatccAGATCGTGCTTTCAAGAGTA -3’ BamHI 
TbKMP11 Reverse 5’- GCGgtcgacGCATTGCGCTAGAAAAGTGG -3’ Sall 
TbMARP Forward 5’- GCGggatccGGCCACTTTAGGACAACTGC -3’ BamHI 
TbMARP Reverse 5’- GCGctcgagCGCTGCTTACACCTTGCATA -3’ Xhol 
TbCAP51 Forward 5’- GCGggatccGGAAGAAACCGAGGAGCAGA -3’ BamHI 





5’- TATggatccTTCTGCTTCTCGCAGACTGAGC -3’ BamHI 
TbProtein 
Kinase 




Tbp25 Forward 5’- GCGggatccTGGAAGCTGTCTTCTACGCA -3’ BamHI 
Tbp25 Reverse 5’- GCGctcgagCACATCGACCTGATCCACAC -3’ Xhol 
TbTCP-1- Forward 5’- GCGggatccTCTCGCATCTCTGAGGGGT -3’ BamHI 
TbTCP-1- Reverse 5’- GCGctcgagTGCGGAAGTATTCCTGCTCT -3’ Xhol 
TbVHS Forward  5’- GCGggatccTATTGTGCTGGAGTCGCTTG -3’ BamHI 
TbVHS Reverse  5’- GCGctcgagTCCTCGTCCGTTGGTAAAAC -3’ Xhol 
TbBBP590 Forward  5’- TATggatccAAATTGTCGAGTCTGCGATCC  -3’ BamHI 
TbBBP590 Reverse 5’- GCGctcgagCGTCAGCATAAAGCGTTGAAGC -3’ Xhol 
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2.7 PCR amplification  
For standard PCR procedure (i.e. for RNAi knockdown sequence amplification), 1 μl of 
10 μM forward primer, 1 μL of 10 μM reverse primer, 3 μL of gDNA template (50-100 
ng) and 7.5 μL of Milli-Q were added into Reddymix® PCR Master Mix (ThermoPrime) 
to make up final volume of 25 L (primers are shown in Table 2.9).  
Number of Cycles Stages Temperature (°C) Time 
1 Initial 
denaturation 
94 5 mins 
25-29 Denaturation 94 30s 
Annealing 53 30s 
Elongation 72 1 min / 1 Kb 
1 Extension 72 5 mins 
 Hold 4  
Table 2.10 Standard PCR program. 
For high fidelity PCR (i.e. for pPOT tagging), 2.5 μL of 10 μM forward and reverse 
primer, 3 μl of pPOT vector template (25 ng/μL), 1 μL of dNTPs (10 mM), 5 μL of buffer 
with 15 mM MgCl2 (10x), 1 L Expand™ Taq DNA Polymerase (2.5 U) and 33 μL Milli-
Q, which to make up final volume of 50 L (primers are shown in Table 2.8). 
Number of Cycles Stages Temperature (°C) Time 
1 Initial 
denaturation 
94 5 mins 
29 Denaturation 94 30s 
Annealing 55 30s 
Elongation 72 1 min / 1 Kb 
1 Extension 72 2 mins 
 Hold 4  
Table 2.11 High fidelity PCR program. 
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2.8 Purification of PCR products 
PCR products were purified using the GeneJET™ PCR purification kit protocol (see 
manufacturer’s protocols), eluted in 50µl of filtered Elution Buffer and stored at -20°C. 
DNA concentration was quantified by NanoDrop 2000c/2000 UV-Vis 
Spectrophotometer (Thermo Scientific).  
 
2.9 DNA Ligations 
A ligation calculator (in silico) was used to determine the amount of vector or PCR 
insert required to achieve an insert:vector ratio of 3:1.   
 
Ligation reaction:  
50ng (1µl) of vector  
Purified PCR products (X L) 
5µl x2 Rapid Ligase Buffer or 1µl of x 10 Rapid Ligase Buffer  
1µl of T4 DNA ligase  
Milli-Q (X L) - to make up final total volume to 10 L.   
 
Ligations were left at room temperature for one hour then incubated at 16°C 
overnight before transforming into competent cells.   
 
2.10 Transformation into Competent E. coli XL1-Blue 
cells   
For each transformation, 1-3µl ligation reaction was added into 50µl aliquot of E. coli 
XL1-Blue subcloning-Grade competent cells. The cells were incubated on ice for a 
further 30 minutes followed by heat-shock at 42° for 45 seconds. Transformants were 
further incubated on ice for 2 minutes before the addition of 800µl of LB (pre-warmed 
to 37°C) and incubated at 37°C for one hour in an orbital shaker. Post incubation the 
culture was centrifuged and the bacterial pellet re-suspended in 200µl LB, and spread 
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onto an LB agar plate containing appropriate selective antibiotics.  Plates were 
incubated at 37°C overnight.  
 
2.11 Plasmid purification using a Miniprep kit 
Single E. coli (XL1-Blue) colonies were carefully picked from selective agar plates and 
inoculated into 3mL of LB media containing appropriate antibiotics and incubated 
overnight at 37°C in orbital shaker at 250-300 rpm. The bacterial cultures were 
centrifuged and plasmid DNA isolated using a Plasmid Miniprep Kit.  Purified plasmid 
DNA was eluted in 50µl Elution Buffer then stored at -20°C. 
 
2.12 Gel extraction and purification of DNA  
Plasmid DNA was digested with appropriate restriction enzymes overnight at 37°C. 
DNA was resolved on agarose gels as described in 2.13 and DNA visualised under the 
UVP Dual-Intensity Trans-illuminator to allow the excision of the desired band.  
Extracted DNA was purified using GeneJET Gel Extraction kit.  Purified DNA was eluted 
in 50µl Elution Buffer and stored at -20°C.  
 
2.13 Restriction enzyme digests 
Plasmid DNA was digested with appropriate restriction enzymes (Roche) and 
incubated at 37°C for 1 hour. 
 
2.14 Agarose gel electrophoresis 
Gel electrophoresis was used to analyse PCR products and digested plasmid DNA. DNA 
samples were prepared by adding one volume of 6x loading buffer to five volumes of 
DNA.  A 0.8% agarose gel was cast using 1xTAE and Gel Red™ (1:10,000 dilution). The 
agarose gel was run in submarine gel electrophoresis tank in 1xTAE loading buffer.  
The voltage and time was set at 80V and 45 mins. All samples were visualised and 
imaged using Image Lab™ software 4.0 Gel Red protocol (BioRad).  
     
77 
 
2.15 Preparation of plasmid DNA for transfection into T. 
brucei 
Purified plasmid DNA was digested/linearised with NotI overnight at 37°C. The linear 
plasmid was ethanol precipitated by adding 1/10th volume of 3M sodium acetate 
(pH5.2) and 2.5X volume 100% ethanol. DNA was precipitated at -80°C overnight.  
Precipitated DNA was centrifuged at 22065 x g at 4°C for 45 minutes. The supernatant 
removed, the pellet washed in 250µl of 70% ethanol and centrifugation repeated.  70% 
ethanol was removed inside the Class II Microbiology safety cabinet to let residual 
ethanol evaporate. The dry DNA pellet was re-suspended in 50µl of sterile filtered 
Elution Buffer. For pPOT tagging, PCR reactions were purified and directly transfected 
into T. brucei (Dean et al., 2015). 
 
2.16 T. brucei cell culture 
Procyclic form T. brucei cells were cultured in SMD-79 medium, supplemented with 
10% foetal calf serum and Hemin (0.008mM) at 28°C (Adam, 2001).   
 
2.17 Transfection of DNA into T. brucei 
3x107 cells ml-1 were required for each transfection. An appropriate volume of cell 
culture was centrifuged, re-suspended in ZMG buffer (0.5mL) and transferred to 
electroporation cuvettes (Bio-Rad 0.4 mm size) prior to addition of 5-10 ng of 
linearised DNA. Cells were electroporated using a BTX Electro Square Porator ECM830 
(3 x 100 μs pulses at 1700 V with 200 ms intervals). Cells were transferred from the 
cuvette into 10ml of SMD-79 media (supplemented with 10% foetal calf serum and 
0.008mM Hemin) and left to recover overnight.  Following overnight recovery cells 
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2.18 Glycerol stock for T. brucei cultures 
For all transformed cell lines (once they had become healthy and a reasonable 
density), 4.5mL of cell culture and 0.5 mL of 100% autoclaved glycerol were mixed in 
a falcon tube, and 1 ml aliquoted into a cryovial.  1 mL aliquots were frozen first at -
80°C overnight, and then transferred to liquid nitrogen for long term storage. 
 
 
2.19 Sample preparation for mass spectrometry (BioID-
SILAC) 
 
2.19.1 Culturing of T. brucei in SILAC media 
 
SDM-79-SILAC liquid media was a custom synthesis from Cassion Labs, USA (See Table 
2.1). SDM-79-SILAC media lacks the essential amino acids L-arginine and L-lysine. 
Isotopically labelled L-arginine and L-lysine were made up according to Table 2.2 in 
Milli-Q and appropriate labels (light-, medium- or heavy-) added to the media.  
Different T. brucei cell lines were cultured in normal SDM-79 media first, and diluted 
to a starting density of 1x106 cells ml-1 in SDM-79-SILAC media in a final volume of 10 
ml.  The appropriate SILAC labels were added into designated flasks depending on the 
experiments. Parental cell line (T. brucei PTPs) were always cultured using light-labels 
(K0R0), cells expressing TbRP2∆134-463::myc::BirA* and cells expressing  
TbRP2::myc::BirA*  were cultured in medium-labels (K4R6) and heavy-labels (K8R10) 
respectively.  Flasks were kept at 28°C and cell counts carried out regularly (using a 
haemocytometer; Neubauer) to ensure cells had undergone at least seven cell 
divisions (the minimum number of divisions required to ensure all proteins 
synthesised within a cell had incorporated the isotopically-labelled amino acids) 
before being scaled up to a final volume of 40 ml in SDM-79-SILAC (plus appropriate 
labels) with a starting density of 2 x106 cells ml-1.  After cells were transferred into 
separate flasks with SDM-79-SILAC and appropriate labels, doxycycline was added to 
induce expression of the BirA* fusion protein. After 24-hour incubation at 28°C, excess 
biotin (final concentration 50 μM) was added to all cultures, and cells incubated for a 
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further 24 hours. For the experiments, 1x109 cells were needed (~ 3.33x 108 cells per 
cell line). It is critical to have equal number of cells per cell line, otherwise this affect 
the SILAC-MS results. The appropriate volume of each cell line (to give 3.33x 108 cells) 
was centrifuged at 1000 x g for 10 min at 4°C and the supernatant removed. Cell 
pellets were washed three times in filtered 1xPBS (40mL), re-suspended in 1ml and 
transferred into an Eppendorf tube. Cells were lysed in 1ml of ice cold filtered Milli-Q 
in the presence of an inhibitor cocktail (20 μl of the Halt Protease Inhibitor single-use 
cocktail, 0.1 mM TLCK, 1 mM benzamidine and 1 mM PMSF) and incubated at room 
temperature for 10 min. Lysed cells were divided into aliquots of 5x108 cell equivalents 
and stored at -80°C.  
 
- Cytoskeleton sample  
Cells were transferred into fresh Eppendorf tubes, centrifuged 1800 x g for 3 mins in 
bench-top microfuge and excess PBS removed. Cells were extracted in 1ml of 
extraction buffer per 1x109 cells, with protease inhibitors (see above). Samples were 
left on an orbital shaker for 15 mins at room temperature. Samples were centrifuged 
at 8502 x g in bench-top microfuge for 10 min and the supernatant transferred into a 
fresh Eppendorf tube. BOTH the pellet and supernatant were stored at -80 0C for 
future analysis. 
 
2.19.2 BioID Sample Preparation (on beads digest) 
 
T. brucei PTP cells and cells expressing TbRP2∆134-463::myc::BirA* and 
TbRP2::myc::BirA* on a PTP background were cultured in SDM-79-SILAC (light-, 
medium- or heavy- labels), and cells lysed and extracted using the protocol described 
in Section 2.19.1. The cells (pellet or solution) were defrosted on ice, diluted with 
solubilisation buffer at a 1:1 ratio (or 1ml solubilisation buffer for the pellet sample) 
and left on the orbital shaker for 30 mins at room temperature (and vortexed every 
10 mins until they became clear). The samples were centrifuged at 15, 521 x g 
(Beckman Coulter, AllegraTM X-22R centrifuge) at 4oC for 10 mins, and the supernatant 
transferred to a fresh LoBind Eppendorf tube (Sigma-Aldrich) and kept on ice.  
Streptavidin-coated magnetic beads (100 μl per column) were washed with filtered 1x 
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PBS (1mL x 3 time) in LoBind Eppendorf tube on a magnetic rack. Washed Streptavidin-
coated magnetic beads were mixed with the sample supernatant and incubated on a 
360-degree rotating wheel at 4°C for 4 hours (to ensure that biotinylated molecules 
adhered to streptavidin immobilised on the magnetic beads). After 4 hours incubation, 
the LoBind Eppendorf tubes were placed on a magnetic rack (for 2-3 mins) and the 
supernatant removed. The streptavidin-coated magnetic beads were then re-
suspended in 1 ml of IAA solution, which contained iodoacetamide for the reductive 
alkylation of free cysteine residues. The LoBind Eppendorf tube was wrapped in tin foil 
to exclude light and incubated on a 360-degree rotating wheel at room temperature 
for 20 min. The LoBind Eppendorf tube was again placed on the magnetic rack and the 
supernatant removed. The beads were washed with filtered 1ml of 1xPBS (x 5).  
- Digestion  
The reduced and alkylated beads/sample was re-suspended in 50L of 50mM ABC, 
followed by 1l trypsin. The sample was vortexed, the LoBind Eppendorf tube sealed 
with parafilm and then incubated at 37°C for at least 18 hours.  
 
- Peptide desalting  
After the beads/sample had been incubated overnight (the tube was given a quick 
pulse to break up any clumps). The magnetic column rack was used to separate the 
magnetic beads from the supernatant (containing digested peptides). The supernatant 
was transferred into a fresh LoBind Eppendorf tube. The beads were then washed with 
100L of 50mM ABC solution and the resulting supernatant separated from the 
magnetic beads using the magnetic rack and the supernatant combined with the 
previous supernatant in the LoBind Eppendorf tube. Finally, the beads were washed 
with 100L of 0.5 M NaCl and the supernatant separated from beads as previously 
described before being combined with the two previous supernatants (250L of 
digested peptides in total).  
 
A C18 microspin column (Harvard Apparatus) was washed with 100 L of methanol 
and centrifuged at 200g for 1 min and the flow-through discarded. The microspin 
column was then washed 3 x 100 L with solution containing 0.1% TFA and 70% MeCN 
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and centrifuged at 200g for 1 min and the flow-through discarded.  The column was 
then washed 3 x 100 L with solution contains 0.1% TFA and centrifuged at 200 x g for 
1 min and the flow-through discarded. TFA was then added to the LoBind Eppendorf 
tube containing the digested peptides (0.1% TFA final concentration). The peptides 
were then transferred to the microspin column for desalting. The microspin column 
was centrifuged at 200 x g for 1 min and the flow-through discarded. The microspin 
column was washed 3 x 100μl with 0.1% TFA solution and centrifuged at 200 x g for 1 
min.  The sample was eluted with 2x 100 L of 0.1% TFA, 70% MeCN solution, and 
centrifuged at 200 x g for 1 min and collected into a new LoBind Eppendorf tube. 
Finally, 200 L of sample was diluted with 500 L of filtered HPLC water and stored at 
-800C until the sample was frozen.  The frozen samples were then lyophilised (Freeze-
dryer, ALPHA 2-4 LD plus, Martin Christ) to await further analysis by mass 
spectrometry. 
 
2.19.3 BioID Sample Preparation (in gel digest) 
 
Cells were harvested as described in 2.20.2.  After the beads/sample was washed in 
1X PBS, the beads/sample was heated in 50l of Laemmli sample buffer at 95°C for 5 
min.  The beads/sample was centrifuged at 200g and the supernatant transferred to a 
fresh LoBind Eppendorf tube. The protein sample was run on a pre-cast 12% SDS-PAGE 
gel for 10 min at 200 V (the sample was allowed to migrate into the resolving gel for 
no more than 1-2 cm). The SDS-PAGE gel was stained with Instant Blue and de-stained 
using Milli-Q.  
 
After the de-stain solution was removed, the gel was transferred onto a clean plastic 
tray and a small amount of Milli-Q added to prevent the gel from drying out. The 
region containing the stained protein was excised using a scalpel and the gel cut into 
1x1 mm squares (taking care to ensure that the gel was not cut into pieces that were 
too small as these would clog pipette tips).  Gel pieces were transferred into a fresh 
LoBind tube and centrifuged and removed all the liquid.  100l of mixture of 100 mM 
ammonium bicarbonate and 100% acetonitrile (1:1, vol/vol) was added into the 
LoBind Eppendorf tube contains the gel pieces and incubated for 30 min with 
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occasional vortexing until the gel pieces were completely clear (removed all the 
liquid). 500l of 100% acetonitrile was then added into the tube and incubated at 
room temperature (about 10 mins) with occasional vortexing, until gel pieces become 
white and shrank. The supernatant was discarded and about 30–50l of the 10mM 
DTT in 100mM ammonium bicarbonate solution was added into the tube (enough to 
ensure gel pieces completely covered), and incubated at 56oC using air thermostat for 
30 min.  The tube was then cooled to room temperature (~ 22oC), followed by adding 
500l of 100% acetonitrile, the sample was incubated for a further 10 min and then 
all liquid removed.  About 30–50l of iodoacetamide solution (55mM iodoacetamide 
in 100mM ammonium bicarbonate) was added to the tube to cover the gel pieces, and 
incubated for 20 min at room temperature in the dark, before all liquid was removed.  
Finally, sufficient volume of 100% acetonitrile was added to shrink gel pieces for ~10 
min and the all liquid removed. 
 
Following the Sigma trypsin singles protocol (Sigma Aldrich):  
5 L Trypsin Solubilization Reagent was added to a Trypsin Singles vial, and the vial 
vortexed briefly to ensure trypsin is dissolved.  45 L of the Trypsin Reaction Buffer 
was also added to the same vial and mixed well (final trypsin concentration is 20 
mg/ml). 50L of trypsin buffer was added to cover the dry gel pieces and incubated 
on ice or in the fridge for 30 mins. (NOTE - after 30 minutes the tube was examined to 
determine whether all the solution had been absorbed, and if it had not then more 
trypsin buffer was added as gel pieces should be completely covered with trypsin 
buffer).  Gel pieces were incubated on ice for a further 90 minutes to saturate them 
with trypsin, and then 10–20l of 10mM ammonium bicarbonate containing 10% 
(vol/vol) acetonitrile buffer was added to the tube to cover the gel pieces (gel pieces 
must be kept wet during enzymatic cleavage).  The LoBind Eppendorf tube containing 
the gel pieces was sealed with Parafilm and incubated at 37oC overnight (NOTE - 
ensure that the volume added is recorded as this information is required). 
After tryptic digestion, digested peptides were extracted from gel pieces using 
extraction buffer (1:2 (vol/vol) of 5% formic acid/acetonitrile). An approximate ratio 
of 1:2 between volumes of digest and extraction was achieved and the sample 
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incubated at 37oC in an orbital shaker for 15 minutes. Supernatant was collected into 
a new LoBind Eppendorf tube (extracted gel pieces were not discarded). The desalting 
procedure using a C18 microspin column as described in Section 2.19.2 was followed 
and eluted peptides diluted with 500L of filtered HPLC water and stored overnight at 
-80°C. The frozen samples were then lyophilised (Freeze-dryer, ALPHA 2-4 LD plus, 
Martin Christ) for further analysis by mass spectrometry. 
 
2.20 Liquid chromatography mass spectrometry 
All lyophilised samples were sent to the FingerPrints Proteomics Facility at the College 
of Life Sciences, University of Dundee, for analysis by liquid chromatography tandem 
mass spectrometry (LC-MS/MS). 
 
2.21 Analysis of mass spectrometry data  
The methods and parameters for LC-MS/MS analysis was as described by Urbaniak et 
al., (Urbaniak et al., 2012). The raw data was processed using MaxQuant (Cox and 
Mann, 2008) version 1.5.2.8 which uses the Andromeda search engine (Cox et al., 
2011). Proteins identified by LC-MS/MS were searched against the T. brucei brucei 927 
annotated protein sequence database (Release 26, downloaded from TriTrypDB 
(Aslett et al., 2010); http://www.tritryp.org) and supplemented with frequently 
observed contaminants such as trypsin, BSA and human keratins. Search parameters 
specified a MS tolerance of 5 ppm, a MS/MS tolerance at 0.5 Da and full trypsin 
specificity, allowing for up to three missed cleavages. Carbamidomethylation of 
cysteine was set as a fixed modification and oxidation of methionines, N-terminal 
protein acetylation and N-pyroglutamate were allowed as variable modifications. 
Peptides were required to be at least 6 amino acids in length, and false discovery rates 
of 0.01 were calculated at the levels of peptides, proteins and modification sites based 
on the number of hits against the reversed sequence database. SILAC ratios were 
calculated using only peptides that could be uniquely mapped to a given protein. The 
output from MaxQuant was analysed using the Perseus framework.  
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2.22 Preparation of slides for fluorescence microscopy  
Approximately 1ml of cell culture was centrifuged at 1811 x g for 3 minutes in a bench 
top micro-centrifuge. The supernatant was discarded and the pellet washed with 1ml 
of 1xPBS. Centrifugation was repeated by adding ~800L of 1xPBS at 1811 x g for 3 
minutes. The cells were re-suspended and pipetted onto slides. After cells had settled, 
excess solution was removed. Whole cells were fixed in 3.7% paraformaldehyde (PFA) 
for 15minutes.  To prepare detergent-extracted cytoskeletons, 1% PEME NP-40 
(pH6.9) buffer was used, with cells extracted for 25 seconds before fixation in PFA. All 
slides were further fixed in 100% methanol at -20°C for a minimum for 10 minutes 
prior to storage in 100% methanol at -20°C. 
 
2.23 Probing slides for fluorescence microscopy 
Slides were rehydrated in 1xPBS for 10 minutes, and then incubated in blocking buffer 
for one hour in a hydration chamber.  Excess blocking buffer was removed and slides 
incubated in ~50µL of appropriate primary antibody for one hour. Slides were washed 
three times in wash buffer. The washed slides were incubated with the appropriate 
secondary antibody in the hydration chamber for further 40 minutes. Slides were 
washed three times in wash buffer again. Once excess wash buffer was removed, a 
single drop of Vectashield Mounting Medium with DAPI (Vectorlabs) was added on the 
slides before mounting.  Sealed the edges of the slides by using nail vanish and stored 
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2.24 Fluorescence microscopy 
Slides were imaged using an Applied Precision DeltaVision Deconvolution microscope 
and images processed using SoftWoRx software. All images were subsequently 
processed using Adobe Photoshop. 
 
2.25 Preparation of T. brucei protein samples  
5x106 cells were required per lane for SDS-PAGE experiments. Trypanosome cells were 
centrifuged at 9033 x g for 10 minutes, and the supernatant discarded. The pellet was 
re-suspended in 1ml of 1xPBS and transferred into an Eppendorf tube.  Re-suspended 
cells were centrifuged again for 3 minutes at 9033 x g and the supernatant removed.  
The cell pellet was re-suspended in 1xSDS loading buffer (pre-heated to 100°C) and 
samples heated on a heat block at 100°C for further 5 minutes.  Protein samples were 
stored at -80°C. 
 
2.26 SDS-Polyacrylamide gel electrophoresis (SDS-
PAGE) 
10% SDS-PAGE gels were prepared according to standard protocols (Brugerolle and 
Mignot, 2003). All protein samples in SDS loading buffer were heated at 100°C for 5 
minutes. 6µl of molecular weight marker ladder per lane (Precision Plus Protein™) and 
10µl of protein sample per lane (5x106 cell equivalents) were loaded in each well.  




Amersham Hybond-P PVDF Membranes (GEHealthcare) were incubated in 100% 
methanol for 10 seconds, and then incubated first in Milli-Q for 5 minutes, and then 
western blot transfer buffer for a minimum of 10 minutes. Blotting paper and sponge 
pads were also pre-incubated in western blot transfer buffer. The blotting papers, 
pads, membrane and SDS-PAGE gel were assembled in correct order and placed into 
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a BioRad blotting cassette. The SDS-PAGE gel was transferred at 100 volts for one hour.  
After transfer was complete the Amersham Hybond-P PVDF membrane was stored at 
4°C.  Membranes were re-permeabilised in 100% methanol for 10 seconds, in Milli-Q 
for 5 minutes, and then washed twice in 1xPBS for 5 minutes. Blots were blocked by 
incubation in blocking buffer for 1 hour. Membranes were then incubated in 
appropriate primary antibody for one hour.  After one hour incubation, primary 
antibody solution was removed and the membrane washed 3 x 10 minutes in western 
blot washing buffer. Membranes were then incubated with the appropriate secondary 
antibody for one hour at the recommended dilution.  Membranes were the washed 
3x 10 minutes in washing buffer before being incubated with Immun-Star™ 
WesternC™ Chemiluminescent Detection reagent for 5 minutes.  The membrane was 
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Chapter 3 Identification of putative TbRP2 
interacting/near neighbour proteins using 
proximity-dependent biotinylation 
 
3.1 Introduction  
Previous studies have demonstrated that TbRP2 localises to transitional fibres 
radiating from the mature basal body. RNAi mediated ablation of TbRP2 results in the 
assembly of short and structurally defective flagella indicating that TbRP2 performs 
critical flagellum assembly‐related functions (Stephan et al., 2007). However, the 
precise role of TbRP2 in flagellum biogenesis is unclear (Andre et al., 2014; Stephan et 
al., 2007).  To address this question, I set out to identify proteins that interacted with, 
or were close to, TbRP2 in trypanosome cells. By identifying TbRP2-proximal proteins, 
it was anticipated that further insight could be provided into: (i) trypanosome GTPases 
that were the molecular clients of TbRP2 GAP activity, (ii) cytoskeletal proteins that 
contribute to the overall architecture of the mature basal body, and/or transitional 
fibers, and (iii) proteins responsible for transporting TbRP2 to the mature basal body.  
Previous work from our laboratory (Andre et al., 2014), has shown that deletion 
constructs that (1) only contained the N-terminal TOF-LisH motif (and lacked the TBBC-
like domain); (2) contained the N-terminal TOF-LisH motif and part of the TBCC 
domain; (3) contained the N-terminal TOF-LisH motif, full length of TBCC domain and 
without C-terminus (Figure 3.1) were all targeted to and tethered at the mature basal 
body.  Therefore, the approach taken in this study was to express full length, truncated 
and mutant versions of the TbRP2 protein fused to a promiscuous bacterial biotin 
ligase; an approach referred to as proximity dependent biotinylation (BioID). The 
intention being to investigate if interaction proteins/near neighbours profiles 
identified by BioID approaches differed between full length (FL) and truncated 
versions of TbRP2.  
 
 






Fig 3.1 showing schematic architectures and localization of C-terminally deleted proteins 
generated by Andre et al., 2014. These constructs were further cloned into the pDEX_myc-




 3.2  BioID in theory  
 
Identifying potential interacting proteins/near neighbours can be very informative in 
investigating proteins of unknown function, i.e. to interrogate function in the context 
of an interaction network.  Additionally, mapping protein-protein interactions can 
provide key roles in understanding human disease processes, as major biological 
processes are mediated through protein interactions (Novarino et al., 2011). 
Proximity-dependent biotin identification (BioID) technique is a relatively newly 
developed method, which allows a forward screen to identify novel binding or nearby 
neighbour partner proteins (Roux et al., 2012). In T. brucei, BioID has been successfully 
employed to identify bilobe components interacting with the bilobe protein MORN1 
(Morriswood et al., 2013; Morriswood et al., 2009);  proteins that interact with Polo-
like kinase (TbPLK) (which localises to different places during the cell cycle; (McAllaster 
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The principle of BioID involves tagging a protein of interest with a modified form of 
the bacterial biotin ligase called BirA*, which can generate a highly reactive AMP-
biotin intermediate. When this active form of AMP-biotin is released into cytoplasm it 
will react rapidly with lysine residues on a protein substrate, leading to biotinylation 
of proximity proteins (within a 10-12nm radius) (Roux et al., 2012).  Potential 
interacting and/or proximity proteins within that biotinylation radius will get 
biotinylated; those are not close enough proteins will not. The biotinylated proteins 





Figure 3.2 Schematic showing the application of the BioID method.  Here I used a PTP cell 
line to inducibly express TbRP2::myc::BirA*. Cells were induced to express TbRP2::myc::BirA* 
with doxycycline for 24 hours and then 50 µM biotin added for a further 24h induction period. 
Cells were harvested, lysed and denaturated under stringent conditions. Biotinylated 
candidate proteins were affinity purified using streptavidin-conjugated beads, and samples 
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3.3 Generation of plasmids to allow expression of    
TbRP2::myc::BirA* fusion proteins 
 
My aims here were to generate constructs which allow T. brucei cells to express 
TbRP2∆134-463 (TOF-LISH), TbRP2∆171-463 (T3), TbRP2∆322-463 (T2) as well as TbRP2 full 
length (FL) BioID in an inducible fashion. The synthetic products of TbRP2∆134-
463::Myc::BirA* were sub-cloned into pEK-K4 Vector, after transformation and DNA 
extraction steps. Plasmid DNA was prepared and subjected to restriction mapping 
analysis.  Figure 3.3 shows plasmid DNA digested with HindIII and BamHI to identify 
plasmids that contained appropriate DNA inserts. Expected DNA fragments (~1500 bp) 
and vector (~2500bp) can be seen on the gel.  
 
Figure 3.3 (A) Schematic of DNA construct of TbRP2∆134-463::myc::BirA* in pEK-K4 vector. (B) 
Agarose gel showing DNA constructs digested with HindIII/BamHI; expected product size ~ 
1500bp and vector 3000bp.  
The TbRP2∆134-463::myc::BirA* insert was sub-cloned into the T. brucei pDex377 
expression vector. The pDex377 vector contains the tetracycline-inducible EP1 
procyclin promoter to control transgene expression, and allows the transgenes to be 
stably integrated into mini-chromosomes and intermediate-sized chromosomes (177 
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bp repeat) (Kelly et al., 2007). Restriction mapping results and schematic of the DNA 
construct of TbRP2∆134-463::myc::BirA* in pDex377 are shown in Fig 3.4. DNA constructs 
were digested with HindIII/BamHI (A), which released the TbRP2∆134-463::myc::BirA* 
fragment (~1500bp) and pDex-377 vector (~8000bp). When digested with HindIII/XhoI 
(B) the TbRP2∆134-463 fragment (~400bp) was released.  Positive results were seen in all 
five colonies.   
pDEX377-derived plasmids were linearised with NotI prior to transfection into 
procyclic T. brucei (SmOxP9). The DNA fragment encoding TbRP2∆134-463 was replaced 
by TbRP2∆171-463, TbRP2∆322-463 and Full Length TbRP2 for BioID experiments.  
 
 
Fig 3.4.  Gel analysis of restriction digested TbRP2∆134-64::myc::BirA* in pDex377 clones. (A) 
DNA constructs were digested with HindIII/BamHI, product size ~ 1500bp. (B) DNA constructs 
were digested with HindIII/Xhol, product size ~ 400bp.  
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3.4 Localisation of TbRP2::myc::BirA* expressing protein 
in T. brucei 
 
Before moving my experiments further, the intracellular localisation of the various 
TbRP2 proteins were investigated by immunofluorescence microscopy to ensure that 
adding the BirA* sequence did not affect the localisation of the TbRP2 protein.  A 
preliminary fractionation protocol was designed to accomplish a two stages 
purification (Fig. 3.5). Both detergent-soluble and detergent-insoluble samples were 
investigated, and cells expressing TbRP2::myc::BirA* and TbRP2∆134-463::myc::BirA* 
fractions were compared to achieve the optimised experimental condition for further 
BioID protocols.   
 
Fig.3.5 The diagram shows the purification procedures to determine the localisation and 
expressions of TbRP2::myc::BirA*. Cells were grown in media with/without doxycycline for 
24h, followed by incubation in excess biotin for a further 24h. Cells were harvested by 
centrifugation and incubated with 0.5% NP-40. Cells were further separated by centrifugation 
into detergent-soluble (S) and detergent-insoluble (P) fractions.  Localisation and expression 
was analysed by immunofluorescence analysis (IFA) and immunoblotting. 
 
     
93 
 
Indirect immunofluorescence analysis of detergent-extracted cytoskeletal cells from 
all four TbRP2::myc::BirA* cell lines are shown in Fig 3.6 to Fig 3.13. The expression 
and localisation of all four TbRP2::myc::BirA* proteins were analysed by probing cells 
with either anti-myc antibody or TRITC-conjugated streptavidin-- slides were imaged 
using Delta Vision (DV) microscopy. Fig 3.6 and Fig 3.7 show the TbRP2∆134-
463::myc::BirA* cells labelled with anti-myc and TRITC-conjugated streptavidin 
respectively. In the presence of doxycycline, a discrete signal of TbRP2∆134-
463::myc::BirA* is observed near/distal to the kinetoplasts (i.e. the expected basal body 
localisation). In the absence of doxycycline, no protein expression was detected with 
the anti-myc antibody. However, there was a trace of nuclear staining in cells labelled 
by streptavidin-TRITC, which might reflect naturally biotinylated proteins in the cells.  
 
In Fig 3.8 and Fig 3.9, detergent-extracted cells expressing TbRP2 FL::myc::BirA* fusion 
was labelled with anti-myc antibody and streptavidin-TRITC. In the presence of 
doxycycline, the TbRP2 FL::myc::BirA* fusion protein can be clearly localised at the 
basal body by both the anti-myc antibody and TRITC-streptavidin.  The localisation is 
again consistent with the published localisation of endogenous TbRP2 (Stephan et al., 
2007). In the absence of doxycycline, detergent-extracted cells showed no significant 
signal.  Expression of either full length or the C-terminally truncated TbRP2∆134-
463::myc::BirA* proteins had no effect on cell morphology. However, T. brucei cells 
expressing TbRP2∆322-463::myc::BirA* and TbRP2∆171-463::myc::BirA*,  appeared to have 
abnormal morphology after 24 hour of induction (Fig 3.10 - 3.13). The majority of cells 
appeared to have the kinetoplast positioned very close to the nucleus. A short new 
flagellum could also be observed in some of cells, which will lead to cell division 
defects, and cells with a 1 kinetoplast but no nucleus (i.e. a zoid) and 1 kinetoplast and 
2 nuclei were also observed.  Thus, even though these two truncated proteins 
correctly localised to the basal body following induction I decided not to use these two 
cell lines for BioID experiments due to the dominant negative phenotype that was 
induced.    
 




Figure 3.6 Immunofluorescence analysis of a detergent extracted cells expressing TbRP2∆134-
463::myc::BirA*. Anti-myc antibodies were used to detect the TbRP2∆134-463::myc::BirA* 
protein. No expression can be detected in non-induced cells. In induced cells, fusion protein 
was clearly observed in the region of the basal body. Scale bars = 10 µm. Inset box shows the 




















Figure 3.7 Immunofluorescence analysis of detergent extracted cells expressing TbRP2∆134-
463::myc::BirA* probed with TRITC-conjugated streptavidin. Weak nuclear staining can be 
observed in non-induced cells.  However, after induction, biotinylated proteins can only be 















Figure 3.8 Immunofluorescence analysis of a detergent extracted cells expressing 
TbRP2::myc::BirA*. Anti-myc antibodies were used to detect the TbRP2::myc::BirA* protein. 
No expression can be detected in non-induced cells. In induced cells, fusion protein was clearly 
observed in the region of the basal body. Scale bars = 10 µm. Inset box shows the indicated 


















Figure 3.9 Immunofluorescence analysis of detergent extracted cells expressing 
TbRP2::myc::BirA* probed with TRITC-conjugated streptavidin. Weak nuclear staining can be 
observed in non-induced cells.  However, after induction, biotinylated proteins can only be 














Figure 3.10 Immunofluorescence analysis of a cell inducible expressing TbRP2∆322-
463::myc::BirA* in the presence of excess biotin in detergent extracted fashion. Anti-myc 
antibodies were used to detect the tagged TbRP2∆322-463::myc::BirA*. No expression can be 
detected in non-induced cell. In induced cells, fusion protein was clearly observed in the 
region of basal body. Scale bars = 10 µm. Kinetoplast (K), Nucleus (N), black arrow solid line 
indicates short new flagellum and black arrow broken line indicates division defect. White 




















Figure 3.11 Immunofluorescence analysis of detergent extracted cells expressing TbRP2∆322-
463::myc::BirA* probed with TRITC-conjugated streptavidin. Weak nuclear staining can be 
observed in non-induced cells.  However, after induction, biotinylated proteins can only be 















Figure 3.12 Immunofluorescence analysis of a detergent extracted cells expressing 
TbRP2∆171-463::myc::BirA*. Anti-myc antibodies were used to detect the TbRP2∆171-
463::myc::BirA* protein. No expression can be detected in non-induced cells. In induced cells, 




















Figure 3.13. Immunofluorescence analysis of detergent extracted cells expressing TbRP2∆171-
463::myc::BirA* probed with TRITC-conjugated streptavidin. Weak nuclear staining can be 
observed in non-induced cells.  However, after induction, biotinylated proteins can only be 
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3.5 Analysis of expressing TbRP2::myc::BirA* and 
TbRP2134-463::myc::BirA* in T. brucei  by 
immunoblotting 
 
To determine whether the biotinylated protein profiles in TbRP2 FL::myc::BirA* and 
TbRP2134-463::myc::BirA* cells were similar or different, samples derived from non-
induced and induced cells were resolved by SDS-PAGE and immunoblotted using 
streptavidin-HRP and anti-myc antibody (Fig 3.14).  When samples were probed with 
anti-myc antibody, no protein expression was observed in the absence of doxycycline. 
Following induction, the expected band of TbRP2134-463::myc::BirA* (~50kDa) was 
detected. However, a clear band around 35kDa was also detected, which most likely 
represents a C-terminally tagged proteolytic cleavage product of myc-tag. A band of 
the expected size of TbRP2 FL::myc::BirA* (85kDa) was also detected by the anti-myc 
antibody. Two additional bands were also detected (~70kDa and 35kDa respectively-
products that also are likely to represent processed cleavage products of myc tag. 
However, immunofluorescence experiments confirmed that both FL and truncated 
TbRP2::myc::BirA* only localised to the basal body and so were suitable for further 
BioID experiments.  
 
Biotinylated proteins derived from both FL and TbRP2134-463 were analysed by probing 
replicate immunoblots with HRP-conjugated streptavidin. This confirmed that 
induction of full length TbRP2::myc::BirA* and TbRP2134-463::myc::BirA* resulted in a 
complexity of biotinylated proteins in these cells. No biotinylated proteins were 














Fig 3.14 Expression Immunoblots of TbRP2134-463::myc::BirA* and TbRP2 FL::myc::BirA*. 
Panel on the left is showing blots probed with anti-myc antibody. No expression can be 
observed in non-induced (-) cell populations. Following induction (+) bands of the the 
expected size of TbRP2134-463::myc::BirA* (~ 49kDa) and TbRP2 FL::myc::BirA* (~85kDa) can 
be seen, in addition to some cleavage products. Biotinylated proteins were detected using 
HRP-conjugated streptavidin (Panel on the right). Following induction, a complex profile of 
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3.6 Stable Isotope Labelling with Amino acid in the Cell 
culture (SILAC)  
 
Mass spectrometry-based proteomics has been used as a powerful tool for identifying 
and quantifying the components of multi-protein complexes for many years. However, 
errors can be introduced during protein fractionation or purification steps. To provide 
greater confidence in proteins identified in my BioID experiments, I used a 
quantitative proteomics method called stable isotope labelling of amino acid in cell 
culture (SILAC). This involves a metabolic labelling method that utilises the biological 
incorporation of stable isotopic labels into living cells  (Ong et al., 2002). Although 
SILAC was originally described for mammalian cell culture (Ong et al., 2002), it has 
been adapted to perform in other different organisms such as yeast (Gruhler et al., 
2005; Jiang and English, 2002), bacteria (Kerner et al., 2005), plants (Gruhler et al., 
2005), Plasmodium falciparum (Nirmalan et al., 2004) and T. brucei (Urbaniak et al., 
2012).  Basically, cells are grown in medium which contains the amino acids arginine 
and/or lysine labelled with either normal, medium or heavy isotopes of 13C and/or 
15N. The SILAC method relies on the complete incorporation of heavy amino acids 
during protein turnover (Ong and Mann, 2005, 2006).   
 
The SILAC approach has several advantages; such as different cell populations can be 
mixed and treated as a single sample, which allows for downstream sample 
preparation without the risk of introducing quantification errors. Since the cells are 
labelled with different amino acids (and C or N isotopes) this will create a distinct and 
predictable mass difference between proteins derived from different samples. During 
mass spectrometry analysis, the relative abundance of proteins from different 
samples can be calculated from the intensities of ‘heavy, medium and light’ peptides. 
SILAC can discriminate potential contaminants purified by the BioID approach from 
true TbRP2-interacting and near neighbour proteins, which gives greater confidence 
in the identified proteins (see Fig 3.15 for the SILAC workflow). 
 








Figure 3.15 SILAC workflow. Three T. brucei cell lines were metabolically labelled with either 
(1) light label (K0R0) containing 12C-Lysine and 12C-Arginine, (2) medium label (K4R6) 
containing 13C-Arginine and 4D-Lysine (3) heavy label (K8R10) containing 13C/15N-Arginine and 
13C/15N-Lysine respectively for at least seven cell doublings prior to harvest. Further 
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3.7 Validation of TbRP2-interacting proteins and near 
neighbours by BioID and SILAC  
 
Several preliminary experiments were performed to optimise the experimental 
conditions for analysis. Protein purification procedures were as described in Chapter 
2 - and digested peptide samples were analysed at the FingerPrints Proteomic Facility 
at the University of Dundee by liquid chromatography tandem mass spectrometry (LC-
MC/MS). The raw data obtained was processed using MaxQuant software (Cox and 
Mann, 2008) and the Perseus framework was used to complete proteomics analysis.  
 
In theory, for any proteins identified by this mass spectrometry analysis, the relative 
intensity of abundance of each protein could be calculated. The abundance of each 
protein was determined by the total of all individual medium and light, or heavy and 
light peptide intensities detected for each protein (on the y-axis using a log10 scale). 
The relative fold enrichment is shown using the log2 ratio (medium/light or heavy/light 
normalised ratio to avoid any protein loading errors) on the x-axis (e.g. Fig 3.16 left). 
By using SILAC in combination with BioID it is possible to distinguish background noise 
(i.e. contaminants) from putative interacting and nearby partner proteins. The SILAC 
ratio of non-specific proteins/contaminants should be 1:1; i.e. proteins would lie 
around the 0 line in the figure. In contrast, ‘real’ TbRP2-interacting partner proteins 
would appear at the far right of the 0 line (Fig 3.16 left – red circle). When comparing 
‘medium-labelled versus light-labelled’ against ‘heavy-labelled versus light-labelled’ 
(Fig 3.16 right), proteins which locate near the zero line from the y-axis are most likely 
an anomalous result. Those greatly enriched proteins from the experiment are more 
likely position at the far right hand corner (Fig 3.16 right – red circle).  
 
 




Figure 3.16 Example of a LC-MS/MS scatter plot showing the proteins identified in the SILAC-enriched ‘medium or heavy’ cell line ratio versus 
proteins identified in the ‘light’-labelled parental cell line plotted with respect to intensity (left).  On the right, The LC-MS/MS scatter plot comparing 
proteins identified in the SILAC-enriched ‘medium’-labelled cell line ratio versus ‘light’-labelled parental cell line against proteins identified in ‘heavy’-
labelled cell line ratio versus ‘light’-labelled parental cell line. Proteins, which locate around 0 line are more likely to be non-specific or contaminates. 
Proteins are in the red square are highly enriched and are likely to be ‘true’ putative interacting or nearby proteins.
















WC-1 R0K0 R6K4 R10K8  In Gel 
Cyto-1 A R0K0 R6K4 R10K8 On Beads 
B R0K0 R6K4 R10K8 On Beads  
Cyto-2 A R0K0 R6K4 R10K8 On Beads 
B R0K0 R6K4 R10K8 On Beads 
WC-2 A R0K0  R6K4 R10K8 On Beads 
B R0K0 R6K4 R10K8 On Beads 
 
Table 3.1 Summary of SILAC experiments performed in this thesis. Expt. WC-1 represents the 
first experiment performed by using whole cell samples. Expt. Cyto-1/2 represents two 
biological replicates using cytoskeleton samples - each one also had one technical replicate 
performed on the sample. Expt. WC-2 represents the last experiment performed in this study 
using whole cell samples, but was undertaken only with TbRP2 FL fusion protein as a label-
swap experiment. T. brucei procyclic forms were labelled with unlabelled L-Arg and L-Lys, 
designated as R0K0, or with [13C6]-L-Arg and [2H4]-L-Lys, designated as R6K4, or with [15N413C6]-
L-Arg and [15N213C6]-L-Lys, designated as R10K8. Tryptic peptides were generated either by 
trypsin in-gel digestion of protein bands from SDS-PAGE or in solution (on bead digestion) for 
analysis by MS. 
 
3.7.1 Experiment 1: Whole cell -1, in gel digestion 
 
The first BioID-SILAC experiment was performed with whole cell samples using in gel 
digestion to prepare peptides for MS analysis. The PTP parental cell line was grown in 
SDM-79-SILAC containing light label ((arginine (R0) and lysine (K0)).  The TbRP2134-
463::myc::BirA* cell line was grown in SDM-79-SILAC containing medium label (arginine 
(R6) and lysine (K4)), and TbRP2 FL::myc::BirA* cell line in media containing heavy label 
(arginine (R10) and lysine (K8)). Unfortunately, few proteins with a significant SILAC 
ratio were identified in this experiment (Fig 3.17). However, the TbRP2 protein was 
the top protein in the ID list (See appendix Excel files, CD), and in the graph in Fig 3.17 
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TbRP2 is positioned at top right corner (i.e. most enriched), which was a good 
indication that the BioID approach had worked.  There were some interesting proteins, 
such as αβ-tubulin, various chaperones and a large highly repetitive protein annotated 
in the T. brucei genome as “microtubule-associated proteins” (Table 3.2). This 
microtubule-associated protein was particular interesting as it could potentially be a 
component of the transitional fibres and was selected for localisation (Chapter 5) and 




















Figure 3.17 LC-MS/MS scatter plot comparing proteins identified in the SILAC-enriched 
‘Medium’-labelled TbRP2134-463::myc::BirA* cell line ratio versus ‘Light’-labelled PTPs 
parental cell line on the x-axis, against proteins identified in ‘Heavy’-labelled 
TbRP2FL::myc::BirA* cell line ratio versus ‘Light’-labelled PTPs parental cell line on the y-
axis. The samples were prepared in whole cells.  The peptide(s) derived from each protein 
(point on the plot graph) were detected by mass spectrometry and scales are logged so data 
is normally distributed and the ratios normalised to avoid any loading errors. TbRP2 shows the 


















Elongation Factor 2 TEF1 
TbRP2134-463/PTP ratio (Log2) 
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Table 3.2 Proteins identified in TbRP2 BirA* fusion protein expressing T. brucei by BioID-SILAC (WC-1).  Yellow highlight indicated bait protein TbRP2, 
and MARP protein in blue highlight was selected for further analysis. M/L:TbRP2∆134-463/PTP; H/L :TbRP2 FL /PTP 
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3.7.2 Experiment 2 - cytoskeletons, in solution/on bead 
digestion  
 
In-gel digestion is considered to be a very reproducible and effective method for 
sample preparation, as it ensures that detergents and salts can be removed from 
samples and thus avoids any harm to the mass spectrometer (Rosenfeld et al., 1992). 
However, because in-gel digestion is very time-consuming (Park and Russell, 2001), 
and there can be loss of peptides during extraction steps (i.e. peptides remain trapped 
within the gel matrix) this approach can be problematic (Rosenfeld et al., 1992). 
Therefore, I decided to alter experimental protocols for all subsequent experiments 
and digest proteins with trypsin while they were still attached to the streptavidin 
beads.  
 
In this experiment, SILAC labelling remained the same i.e. parental PTP cells -Light 
(R0K0); TbRP2134-463::myc::BirA*-Medium (R6K4) and TbRP2 FL::myc::BirA*-Heavy 
(R10K8). However, cultures were harvested using PEME 1% NP-40 extraction buffer 
containing protease inhibitors in the extraction buffer (see Materials and Methods for 
details) to prepare insoluble cytoskeleton samples (TbRP2 is a detergent insoluble 
protein). This experiment was repeated twice and each time the sample was analysed 
twice (i.e. two biological and two technical replicates).  The data from each individual 
experiment (Expt. cyto-1 A and B; Expt. cyto-2 A and B) and the combined data for all 
four experiments were analysed using MaxQuant software (Cox and Mann, 2008) and 
the EupathDB T. brucei protein database (Aslett et al., 2010).   
 
For proteins identified in cyto-1 and 2 and the combined data set, a pairwise 
comparison was performed of the log2 (M/L or H/L) ratios for proteins identified in 
the four individual or combined data sets. The Pearson’s correlation coefficient values 
were calculated using Perseus 1.3.0.4 (www.perseus-framework.org) (see appendix I 
Fig 9.1-9.3).  According to the Pearson coefficient analysis, there is a good correlation 
between TbRP2134-463/PTP and TbRP2 FL/PTP with Expt. cyto-1 A and B (Pearson 
coefficients above 0.8). However, technical replicates (between A and B) have weaker 
     
112 
 
correlations (Pearson coefficients around 0.5) (Appendix I Fig 9.1). This could be due 
to the fact that when only a few proteins have been identified by MS, Pearson 
coefficients only take the enriched proteins into account (i.e. there was not enough 
data to provide a strong correlation and so the scatter plots looked worse). Again, 
similar results were obtained to the Expt. cyto-2 A and B; there is very good correlation 
between TbRP2134-463/PTP and TbRP2 FL/PTP in both Expt. cyto-2 A and B (Pearson 
coefficients above 0.9). In this second set of technical replicates (between cyto-2 A 
and B), the Pearson coefficient is around 0.7 (Appendix I Fig 9.2). When I combined 
the Expt. cyto-1 A and B together (TbRP2134-463/PTP from A and B; and TbRP2 FL/PTP 
from A and B) to compare with Expt. cyto-2 A and B together (as biological replicates 
comparison), the Pearson coefficient analysis revealed that within cyto-1 and cyto-2, 
there was a relatively good correlation between TbRP2134-463/PTP and TbRP2 FL/PTP 
(~0.6-0.7). However, the correlation of biological replicates of TbRP2134-463/PTP was 
less strong (~0.3), but TbRP2 FL/PTP showed a better correlation value (~0.7) 
(Appendix I Fig 9.3).  
 
The proteins identified in the cyto 1+2 experiments (combined) is shown in Table 3.3. 
To prioritise appropriate proteins for further analysis, several initial bioinformatics 
approaches were used. Firstly, all proteins with a SILAC ratio above 1 were 
interrogated at GENEDB and TriTrypDB to determine what was known about the 
proteins, such as GO function(s) and occurrence in other proteomic datasets. Proteins 
with potential processing or structural roles were prioritised for further study 
(highlighted in blue in Table 3.3). As mentioned earlier, two types of scatter plot can 
be used to visualise the enrichment of proteins from the MS experiments (Fig 3.16). 
When comparing the TbRP2134-463::myc::BirA* cell line (medium-label) versus the 
PTPs cell line (light-label) (Fig 3.18-Top), proteins were considered to be enriched 
when they were above the cut-off threshold (SILAC ratio above 1). This included TbRP2 
itself (red diamonds, black square), which again was a good indication that the 
experiment had worked. Other proteins (red diamonds) were above the threshold, 
and so were selected for further study; these included TbCAP51, TbKMP-11, 
TbBBP590, TbHSP70 and TbProtein Kinase (see bioinformatics analysis in Chapter 4 for 
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further rationale as to why these proteins were selected for study). The TbMARP 
protein, which was identified previously in Expt1 WC-1 (Fig 3.17), is positioned much 
closer to the zero line (i.e. background noise) in this scatter plot.  Thus, TbMARP would 
not have been selected for further study on the basis on this cytoskeleton experiment.  
However, by the time I carried out and analysed Expt. cyto-1 -2 data, DNA constructs, 
and trypanosome cell lines had already been generated and so the decision was taken 
to continue to investigate the TbMARP protein (see Chapters 5 and 6). The scatter plot 
of each protein on the graph also reflected the heavy-labelled TbRP2 FL::myc::BirA* 
versus light-labelled PTPs (Fig 3.18-bottom). Here, the selected proteins are also 
marked as a red diamond-shape on the graph.  TbRP2 was one of the most enriched 
proteins located above the cut off threshold, and again TbMARP was in the region 
categorised as noise. In Fig 3.19, the plot shows the comparison between the 
‘medium-labelled versus light-labelled’ against ‘heavy-labelled versus light-labelled’ 
(Fig 3.19), all of the proteins selected for further study were highly enriched (i.e. 
located at the top right-hand corner of the graph).   
 
So far I have just presented scatter plots to give an overview of the proteins identified; 
i.e. where they are positioned on the plots based on their enrichment. In the following 
graphs, I illustrate how reproducible (based on SILAC ratios) the identification of the 
selected proteins were in the two biological experiments (cyto-1 and 2) (Fig 3.20).  The 
SILAC ratios (log2) on the y-axis show the combined value from all four experiments 
(cyto-1A; B and cyto-2A; B). The graphs show that the SILAC ratios for TbRP2134-
463/PTP in blue and TbRP2 FL/PTP in dark grey are very similar between the two 
biological experiments. However, there are some small differences between the SILAC 
ratios for TbHSP70 and TbProtein Kinase, and TbKMP11 and TbMARP show larger 
differences between the two biological experiments. For TbCAP51, the M/L SILAC 
ratios are very similar between two biological experiments, but not for the H/L 
labelling experiment. In addition, there are big differences between M/L and H/L in 
cyto-1 and 2, and TbBBP590 appears to have the same pattern as TbCAP51, with 
proteins more enriched in the TbRP2134-463 experiment.  
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Table 3.3 Proteins identified in TbRP2 BirA* fusion protein expressing T. brucei by BioID-SILAC (Cyto 1+2).  Yellow highlight indicated bait protein -TbRP2, 
and proteins highlighted in blue were selected for further analysis.  M/L :TbRP2∆134-463/PTP; H/L :TbRP2 FL /PTP. 
 





Figure 3.18 Scatter plot showing proteins identified in the SILAC-enriched ‘medium’-labelled 
TbRP2134-463-BirA* cell line (upper panel) or ‘heavy’-labelled TbRP2 FL-BirA* cell line (lower 
panel). The x-axis shows the log2 normalised ratio of ‘medium or heavy’ labelled proteins 
versus ‘light’-labelled proteins, and the y-axis represents the relative abundance of each 
protein.  
 
TbRP2134-463/PTPs ratio (Log2) 
TbRP2134-463 













Figure 3.19 LC-MS/MS scatter plot comparing proteins identified in the SILAC-enriched 
‘medium’-labelled TbRP2134-463::myc::BirA* cell line ratio versus ‘light’-labelled PTP 
parental cell line against proteins identified in ‘heavy’-labelled TbRP2 FL::myc::BirA*cell line 
ratio versus ‘light’-labelled PTPs parental cell line. The x-axis shows the ratio of ‘medium’-
labelled proteins versus ‘light’-labelled proteins, identified according to the peptides detected 
by mass spectrometry. The y-axis shows the ratio of ‘heavy’-labelled proteins versus ’light’-
labelled proteins, identified according to the peptides detected by mass spectrometry. Scales 
is normally distributed and the ratios normalised because the base peak originally lay to the 
left of zero. Proteins, which appear in the centre are more likely to be contaminant. 




















Figure 3.20 The SILAC ratio of each selected proteins in the BioID cytoskeleton cell fraction is indicated by the colour of each bar. M/L = TbRP2∆134-
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3.7.3 Experiment 3- whole cell, in solution/on bead digestion  
 
Based on the previous data, the number of the proteins identified using an on beads 
digestion protocol was much greater than in the first (in gel digestion) experiment and 
identified a number of proteins of interest that were selected for further study. 
However, one of my initial aims was to interrogate how TbRP2 was targeted to the 
basal body solely by the N-terminus TOF-LisH motifs, and so I was interested to see 
whether different protein profiles were identified in cells expressing TbRP2134-463 or 
full length TbRP2.  Based on the analyses I have just shown (i.e. cyto expts), little 
difference was observed between the peptides identified from medium and heavy 
labelled samples i.e. cells expressing TbRP2134-463 or full length TbRP2. Therefore, in 
subsequent experiments, I decided to use only cells expressing full length 
TbRP2::myc::BirA*; these cells were labelled using medium and heavy labels in a label 
swap experiment. Additionally, I decided to use whole cell preparations and not 
cytoskeletal extracts, as I was concerned that some TbRP2-interacting proteins/ 
proximal proteins may be detergent soluble and would therefore be lost from my 
analysis.    
 
The data from each individual experiment (WC-2 A, B) and the combined data for both 
experiments were analysed using MaxQuant software (Cox and Mann, 2008) and the 
EupathDB T. brucei protein database (Aslett et al., 2010).  For the proteins identified 
in the both Expt WC-2 A, B and combined data set, I again performed a pairwise 
comparison of the log2 (M/L or H/L) ratios with those for the proteins identified in the 
four individual or combined data sets. The Pearson’s correlation coefficient values 
were calculated using Perseus 1.3.0.4 (www.perseus-framework.org). This 
determined good correlations (Pearson coefficients are all above 0.9) between M/L 
and H/L of Expt. WC-2 A and B, indicating that the results are not biased (Appendix I 
Fig 9.4).  
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I compared the medium-labelled TbRP2 FL-MYC-BirA* cell line versus the light-labelled 
parental PTPs cell line (i.e. combined data; M/L: Expt-WC-A and B) against intensity 
(Log10) (Fig 3.21-Top). The number of proteins identified were considerably greater 
than when experiments were performed using cytoskeletal samples (Table 3.4). The 
TbRP2 protein was again above the threshold showing protein enrichment, indicating 
the BioID/SILAC experiment had worked. Five out of six of the proteins selected from 
the previous experiments were also identified on the scatter plot (apart from 
TbBBP590 protein), along with another five additional proteins that were selected for 
further study (labelled with red diamond-shaped on the plot).  Again, the criteria were 
used in WC-2 was same as described in the previous Cyto experiment; except BARTL1 
(below SILAC ratio 1, see chapter 4.12), all other selected proteins with SILAC ratio ≥1, 
bioinformatics analysis was also performed to prioritise candidates – again these were 
protines with potential roles in protein processing. The proteins were TbArl3, 
TbBartL1, TbP25-, TbTCP-1- and TbVHS-domain containing protein (see Chapter 4 
for further details). The scatter plot proteins identified in the ‘heavy-labelled’ TbRP2 
FL::myc::BirA* sample (expressed as a ratio against ‘light-labelled’ PTPs is shown in Fig 
3.21-bottom panel). Here, the selected proteins are also marked as a red diamond-
shape on the graph and are remarkably similar in position to the scatter plot shown in 
Fig 3.22 top panel. This confirmed that the label had no effect on detection of the 
protein.  TbRP2 was one of the enriched proteins located above the threshold. In Fig 
3.22, the plot shows the comparison between the ‘medium-labelled versus light-
labelled’ against ‘heavy-labelled versus light-labelled’ (Fig 3.22), it is clear that all the 
selected proteins are greatly enriched (i.e. located at the right top corner).  In Fig 3.23, 
I have combined all TbRP2 FL Cyto data together (H/L) to compare with the WC data 
(H/L). TbRP2 is still positioned at the right top corner (i.e. highly enriched), and other 
enriched proteins identified by both the Cyto and WC experiments are TbHSP70, 
TbCAP51 and TbMARP.  When I used the SILAC ratio generated from each experiment 
(Expt. WC-2 A and B, technical replicates) of each individual protein (Fig 3.24), the 
results are very similar between experiment, which suggested that Expt. WC 1 and 2 
are reproducible.   
 













Table 3.4 Proteins identified in TbRP2 BirA* fusion protein expressing T. brucei by BioID-SILAC (WC-2).  Yellow highlight indicated bait protein -TbRP2, and 
proteins highlighted in blue were selected for further analysis.  M/L :TbRP2 FL/PTP; H/L :TbRP2 FL /PTP. 





Figure 3.21 Scatter plot showing proteins identified in the SILAC-enriched ‘medium’-labelled 
TbRP2 FL-BirA* cell line (upper panel) or ‘heavy’-labelled TbRP2 FL-BirA* cell line (lower 
panel). The x-axis shows the log2 normalised ratio of ‘medium or heavy’ labelled proteins 




TbRP2 FL (H)/PTP ratio (Log2) 
TbRP2 FL (M)/PTP ratio (Log2) 













Fig 3.22 The LC-MS/MS scatter plot comparing proteins identified in the SILAC-enriched 
‘medium’-labelled TbRP2 FL::myc::BirA* cell line ratio versus ‘light’-labelled PTPs parental 
cell line against proteins identified in ‘heavy’-labelled TbRP2 FL::myc::BirA*cell line ratio 
versus ‘light’-labelled PTPs parental cell line. The x-axis shows the ratio of ‘medium’-labelled 
proteins versus ‘light’-labelled proteins, identified according to the peptides detected by mass 
spectrometry. The y-axis shows the ratio of ‘heavy’-labelled proteins versus ’light’-labelled 
proteins, identified according to the peptides detected by mass spectrometry. Scales is 
normally distributed and the ratios normalised because the base peak originally lay to the left 
of zero. Proteins which appear in the centre are more likely to be contaminant. 
 
































Fig 3.23 The LC-MS/MS scatter plot comparing proteins identified in the SILAC-enriched 
‘medium’-labelled TbRP2 FL::myc::BirA* cell line ratio versus ‘light’-labelled PTPs parental 
cell line against proteins identified in ‘heavy’-labelled TbRP2 FL::myc::BirA*cell line ratio 
versus ‘light’-labelled PTPs parental cell line. The x-axis shows the ratio of ‘medium’-labelled 
proteins versus ‘light’-labelled proteins, identified according to the peptides detected by mass 
spectrometry. The y-axis shows the ratio of ‘heavy’-labelled proteins versus ’light’-labelled 
proteins, identified according to the peptides detected by mass spectrometry. Scales is 
normally distributed and the ratios normalised because the base peak originally lay to the left 
of zero. Proteins, which appear in the centre are more likely to be contaminant.  
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3.8 Summary  
 
BioID combined with SILAC was used to identify TbRP2-interacting and near neighbour 
proteins. Expression of TbRP2 FL and TbRP2134-463 had no effect on cell growth or 
morphology. However, expression of TbRP2322-463::myc::BirA* and TbRP2171-
463::myc::BirA* resulted in dominant negative phenotypes and so analysis of the cell 
lines expressing these constructs was not undertaken. A number of proteins were 
identified in the successful BioID-SILAC experiments, including a large number of 
proteins which were potentially contaminants e.g. ribosomal proteins; it was here that 
the use of SILAC was highly informative in sorting ‘noise’ from potentially ‘real’ TbRP2 
proximal proteins. The identification of TbRP2 as greatly enriched in all the 
experiments indicated that the BioID approach was functioning correctly. Compared 
to other large proteomic studies the number of proteins identified was small 
(Urbaniak et al., 2013). In part, this was due to the fact that to get a SILAC ratio, a 
peptide has to be detected at least twice otherwise there would not be a SILAC ratio 
value.  Therefore, it is possible that some ‘real’ TbRP2-interacting proteins will have 
fallen with in the ‘noise’. Nevertheless, a number of proteins of significance were 
identified for further analysis. 
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In previous sections, I explained how BioID was used in conjunction with SILAC to 
identify putative TbRP2 proximal proteins. In this section, I describe how bioinformatic 
approaches were used to prioritise proteins for further analysis. Firstly, all proteins 
with a SILAC ratio >1 were analysed by GENEDB and TriTrypDB to determine what was 
known about the proteins, including proposed GO function(s) and occurrence in other 
proteomic datasets.  These initial steps, allowed me to gain some basic background 
information on the proteins identified from BioID. As the aim of my PhD was to 
interrogate the function(s) of the TbRP2 protein in PCF T. brucei, proteins that might 
be associated with TbRP2 functions were to be prioritised. For example, the BioID 
experiments identified several chaperone proteins, and proteins of high molecular 
weight, which could possibly, represented basal body/TZ components. Secondly, the 
amino acid sequence of each protein was interrogated using BLASTP, to identify the 
conservation between the T. brucei proteins of interest and homologous proteins in 
humans and other microbial eukaryotes (both flagellated/ciliated and non-ciliated 
eukaryotes were included in this organismal set Table 4.1).  
 
In the following sections, the domain structure for each protein will be presented, 
along with amino acid sequence alignments of T. brucei proteins and putative 
orthologues from Homo sapiens and diverse microbial eukaryotes. It should be noted 
that some proteins with ‘good’ SILAC ratio i.e. >1, were not selected for further 











Organisms Builds cilia/flagella 
Homo sapiens  Y 
Trypanosoma brucei Y 
Trypanosoma cruzi Y 
Leishmania major Y 
Plasmodium falciparum Y 
Chlamydomonas reinhardtii Y 
Giardia lamblia Y 
Paramecium tetraurelia Y 
Caenorhabditis elegans Y 
Saccharomyces cerevisiae N 
Dictyostelium discoideum N 
Capsaspora owczarzaki N 
Table 4.1 A broad range of microbial eukaryotes, including flagellated and non-flagellated 
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Homo sapiens  ✔ X X ✔ X ✔ ✔ ✔ ✔(N) X ✔ 
Trypanosoma 
cruzi 
✔ ✔ ✔ 
(only 
partial) 
✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
Leishmania  
major 
✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
Plasmodium 
falciparum 
✔ X X ✔ X ✔ ✔ ✔ X X X 
Chlamydomonas 
reinhardtii 




✔ X X ✔ X ✔ X ✔ X X X 
Paramecium 
tetraurelia 
✔ X X ✔ X ✔ ✔ ✔ X X ✔ 
Caenorhabditis 
elegans 





✔ X X ✔ X ✔ X ✔ X X X 
Dictyostelium 
discoideum 
✔ X X ✔ X ✔ X ✔ X X X 
Capsaspora 
owczarzaki 
✔ X X ✔ X ✔ X ✔ X X X 
Table 4.2 NCBI BLAST search of different organisms to the T. brucei BioID pull down proteins.  “✔” more than one BLAST hits (e-10 as cut-off 
point); “✔” only one BLAST hit and “X” no BLAST hits or very low e values. “✔” did not pass reciprocal BLAST and “X” no BLAST hits or 
very low e values (> e-10 ) (N) = only N-terminal amino acid sequence conserved between query and databases




Table 4.3 The T. brucei BioID pull down proteins compares with proteomic studies 
(1) Broadhead R, et al. (2006) Nature; 440(7081):224–227; (Flagellar proteome) 
(2) Subota I, et al. (2014) Mol Cell Proteomics; 13(7):1769–1786; (Intact flagella of procyclic Trypanosoma brucei) 
(3) Dean S, et al (2016) Proc Natl Acad Sci; 113(35): E5135-43; (Transition zone) 
 
  





























(Broadhead et al., 2006) 
Y Y N N N N N N N N N 
 Whole flagellum2 
(Subota et al., 2014) 
Y N Y N Y Y Y       Y Y N Y 
Transition zone3 
(Dean et al., 2016) 
Y Y Y Y Y Y N Y N Y N 
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4.2 Heat shock protein 70  
 
Proteins belonging to the heat shock protein 70 (HSP70) family have been highly 
conserved through evolution; being found in both prokaryotic and eukaryotic 
organisms (Daugaard et al., 2007). The HSP70 protein was first thought to be involved 
in a response to stress (Pelham, 1984), but later studies indicated that HSP70 might 
play distinct roles within different organisms (Daugaard et al., 2005). This concept was 
based on experiments performed in mice, where the deletion of different Hsp70 genes 
led to remarkably discrete phenotypes. For example, among the members of HSP70 
family; Hsc70, Hsp70-1t and Hsp70-2 are not stress-inducible proteins. Hsc70 can be 
found in cytosol and nucleus (Dworniczak and Mirault, 1987), and due to the essential 
role of Hsc70 for cell survival, a Hsc70 knockout cannot be generated (Daugaard et al., 
2005; Florin et al., 2004). RNAi knockdown of Hsc70 results in massive cell death not only 
in various cancer cell types (such as HeLa (cervix), MCF-7-S1 and MDA-MD-468 (breast), 
PC-3 (prostate), HuH-7 (liver), and LoVo-36 (colon)), but also in non-tumorigenic cells. 
However, only tumorigenic cell growth depended on Hsp70 and Hsp70-2 (Rohde et al., 
2005). Both Hsp70-1t and Hsp70-2 are also expressed in most of the tissues, but 
reported high levels in brain and testis (for Hsp70-1t) respectively (Daugaard et al., 
2007; Goate et al., 1987; Son et al., 2000).  In male mice, knockout of Hsp70-2 can 
result in massive germ cell apoptosis (Dix et al., 1996). Furthermore, Hsp70-2 has also 
been shown to be involved in the formation of the cyclin B/cdc2 complex during 
meiotic cell division and HSP70-2 knockout mice fail to complete meiosis I (Dix et al., 
1997; Zhu et al., 1997). Other fundamental functions of HSP70 for maintaining of 
cellular homeostasis, and coordinating a number of essential cellular processes via 
folding (newly synthesised) and refolding (misfolded) proteins, transport proteins 
between cellular compartments, control of regulatory proteins and preventing 
denatured or unstable proteins (Kabani and Martineau, 2008; Mayer and Bukau, 
2005).  
 
Within the HSP70 protein family, variations in motif/domain architecture give rise to 
a variety of protein isoforms. However, here I focus only on TbHSP70 
(Tb927.11.11330) and its homologous sequences in T. brucei and human. There are 
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two major families of the eukaryotic HSP70 superfamily, (1) HSPA, which includes 13 
of typical HSP70 proteins, and (2) HSPH that consist of four members of 
Hsp110/Grp170 proteins in human (Kampinga et al., 2009; Vos et al., 2008).  A number 
of proteomic studies have shown that most of the T. brucei HSP70 proteins are 
expressed in both bloodstream and procyclic form parasites (Berriman et al., 2005; 
Broadhead et al., 2006; El-Sayed et al., 2005; Glass et al., 1986; Jones et al., 2006; 
MacFarlane et al., 1990; Subota et al., 2014; Vertommen et al., 2008). This might 
indicate that TbHSP70 is likely to be involved in adapting parasites for different 
environment, and also suggests that TbHSP70 might be important for parasite 
differentiation (Daugaard et al., 2007; Folgueira and Requena, 2007).  A recent study 
by Drini and co-workers combined phylogenetic and comparative analyses of the 
TriTryp genomes, the draft genome of Paratrypanosoma (Flegontov et al., 2013), and 
the recently published genome sequences of 204 L. donovani field isolates (Imamura 
et al., 2016). This study provided novel understanding of how Leishmania HSP70 
proteins may be involved in a response to specific environmental changes over 
evolution (Drini et al., 2016).  
 
At the starting point of my analysis, I performed a BLAST search in which I used 
TbHSP70 (Tb927.11.11330) as my query against the predicted protein database for 
Homo sapiens and all of the organisms listed in Table 4.2. NCBI BLAST search revealed 
that there are more than one HSP70 proteins, which above the cut-off e-10 value in 
every organism listed in Tble 4.2.  In humans, the top protein hit is HSPA1A (also called 
inducible HSP70 or HSP72) (NP_005337.2). This protein has been well studied and is 
highly stress-inducible (Chen et al., 2013; Liu et al., 2012; Shi et al., 1998; Zhang et al., 
2014). I also performed a reciprocal BLAST using HSPA1A as the query sequence to 
check whether there are other HSP70 proteins in T. brucei that are more similar to the 
human HSPA1A sequence. This reciprocal BLASTP approach revealed TbHSP70 
(Tb927.11.11330) as the top hit; with an expectancy value of 0. Fig. 4.1-A displays the 
domain architectures of human and TbHSP70 proteins.  The human HSP70 is a 641 
amino acid long protein with several domains. An ATPase domain - when ATP is 
hydrolysed to ADP it can lead to conformational changes in the second domain called 
substrate/peptide domain to trigger the release of substrate. There is a short linker 
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segment (~7 amino acids) between these two domains. At the C terminus of the HSP70 
is a G/P-rich region, which contains an EEVD-motif that enables proteins to bind co-
chaperones such as HSP40 and HSP70/HSP90 organising proteins (HOP) (Goloubinoff, 
2017; Louw et al., 2010; Mayer et al., 2001; Mayer and Bukau, 2005; Odunuga et al., 
2004).  A similar domain structure can be found in TbHSP70 and the sequence 
alignment shows high degree of conservation between the different domains 
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H.sapiens      MAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVA 
TbHSP70        MTYEGAIGIDLGTTYSCVGVWQNERVEIIANDQGNRTTPSYVAFTDSERLIGDAAKNQVA 
               *:  .***************:*: :*********************:************* 
 
H.sapiens      LNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDG-DKPKVQVSYKGETKAFYPEEI 
TbHSP70        MNPTNTVFDAKRLIGRKFSDSVVQSDMKHWPFKVVTKGDDKPVIQVQFRGETKTFNPEEI 
               :** **************.* ***********:*:..* *** :**.::****:* **** 
 
H.sapiens      SSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAA 
TbHSP70        SSMVLLKMKEVAESYLGKQVAKAVVTVPAYFNDSQRQATKDAGTIAGLEVLRIINEPTAA 
               ***** ****:**:***  *::**:******************.****:*********** 
 
H.sapiens      AIAYGLDRTGKG-ERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLV 
TbHSP70        AIAYGLDKADEGKERNVLIFDLGGGTFDVTLLTIDGGIFEVKATNGDTHLGGEDFDNRLV 
               *******::.:* ****************::****.******** *************** 
 
H.sapiens      NHFVEEFKRKHK-KDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSI 
TbHSP70        AHFTEEFKRKNKGKDLSSNLRALRRLRTACERAKRTLSSAAQATIEIDALFENIDFQATI 
                **.******:* **:*.* **:****************::**::***:***.*** ::* 
 
H.sapiens      TRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGR 
TbHSP70        TRARFEELCGDLFRGTLQPVERVLQDAKMDKRAVHDVVLVGGSTRIPKVMQLVSDFFGGK 
               *********.****.**:***:.*:***:**  :**:************ :*:.***.*: 
 
H.sapiens      DLNKSINPDEAVAYGAAVQAAILMGDKSENVQDLLLLDVAPLSLGLETAGGVMTALIKRN 
TbHSP70        ELNKSINPDEAVAYGAAVQAFILTGGKSKQTEGLLLLDVAPLTLGIETAGGVMTALIKRN 
               :******************* ** *.**::.:.*********:**:************** 
 
H.sapiens      STIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVT 
TbHSP70        TTIPTKKSQIFSTYSDNQPGVHIQVFEGERTMTKDCHLLGTFDLSGIPPAPRGVPQIEVT 
               :*****::***:********* ***:****:**** :*** *:***************** 
 
H.sapiens      FDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVS 
TbHSP70        FDLDANGILSVSAEEKGTGKRNQIVITNDKGRLSKADIERMVSDAAKYEAEDKAQRERID 
               **:******.*:* :*.*** *:*.********** :*****.:* **:***:.****:. 
 
H.sapiens      AKNALESYAFNMKSAVEDEGLKGKISEADKKKVLDKCQEVISWLDANTLAEKDEFEHKRK 
TbHSP70        AKNGLENYAFSMKNTINDPNVAGKLDDADKNAVTTAVEEALRWLNDNQEASLDEYNHRQK 
               ***.**.***.**.:::* .: **:.:***: *    :*.: **: *  *. **::*::* 
 
H.sapiens      ELEQVCNPIISGLYQGAGGPGPGG-----------------FGAQGPKGGSGSGPTIEEV 
TbHSP70        ELEGVCAPILSKMYQGMGGGDAAGGMPGGMPGGMPGGMPGGMGGGMGGAAASSGPKVEEV 
               *** ** **:* :*** ** . .*                 :*.    ..:.***.:*** 
 
H.sapiens      D 
TbHSP70        D 
               * 




Figure 4.1 (A) Schematic of human HSP70 (NP_005337.2) and T. brucei HSP70 
(Tb927.11.11330) domain structure.  Different domains and co-chaperone-binding sites are 
indicated by different colours.  Typical cytosolic human HSP70 proteins with 3 domains: The 
N-terminal ATPase binding domain, a peptide (substrate) binding domain and characteristic 
C-terminal EEVD motif (can bind TPR-domain-containing proteins). (B) Multiple sequence 
alignments between those two HSP70 proteins by ClustalOmega analysis.  Two HSP70 proteins 
are very well conserved. “*” indicates identical aa and “:” indicates conserved, red highlights 
= ATPase binding domain; blue highlights = substrate binding domain; green highlights = 
variable region and black highlights = linker structure between the domains. 
 
(B) 
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When I performed a BLAST search using TbHSP70 (Tb927.11.11330) as my query 
against T. brucei itself, 11 proteins were identified with an e value above the e-10 cut-
off point (see table 3.5). The cartoons of all 12 HSP70 sequences and protein domains 
are presented in Fig 4.2 A-B; showing the proteins are well conserved in some regions 
(Appendix II Fig 9.5 sequence alignments). Most of the T. brucei HSP70 proteins are 
expressed in both bloodstream and procyclic form, and they can be further divided 
into four subdivisions based on their localisations, which are cytoplasmic HSP70s, 
mitochondrial HSP70s, endoplasmic reticulum HSP70s and other HSP70s. Based on 
their intracellular localisations, different HSP70s could serve different purposes (Jones 




In T. brucei there are four typical HSP70 proteins, including the query sequence 
TbHSP70 (Tb927.11.11330), which are predicted to have cytoplasmic localisations. The 
other proteins are TbHSP70.4, TbHSP70.c, and TbHSP110.  A sequence alignment of 
these four HSP70 proteins indicated a high degree of amino acid sequence 
conservation.  The alignment shows a key difference between cytoplasmic TbHSP70 
and the rest of the family is that the former, but not the latter, contains the C-terminal 
EEVD motif. TbHSP70.c has been identified as a cytosolic HSP70 protein (Burger et al., 
2014).  In silico analysis indicates that TbHSP70.c consists of atypical acidic residues in 
the substrate binding domain, and a RIEAINANTE sequence at the C-terminus of the 
protein, rather than the EEVD motif (Burger et al., 2014). TbJ2 protein (Tb927.2.5160), 
is one of the six T. brucei Type I Hsp40s, and evidence indicates that Tbj2 is a potential 
co-chaperone partner for TbHSP70.c, which can stimulate of TbHsp70.c ATPase 
activity and prevent thermal aggregation of malate dehydrogenase (MDH) and 
rhodanese (Ludewig et al., 2015).  TbHSP70.4 is very closely related to so-called typical 
TbHSP70. TbHSP70.4 and TbHSP70 share 64% of identity at an amino acid sequence 
level, which suggests they might be functionally related.  After HSP70 and HSP90, 
HSP110 is the third most abundant heat shock proteins in most all mammalian 
organisms (Easton et al., 2000; Lee-Yoon et al., 1995). Members of the HSP110 family 
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can also be found in plants and fungi as well (Easton et al., 2000). The exact role(s) of 
HSP110 is unclear, but some studies have suggested that HSP110 is involved in 
preventing protein aggregation and temperature resistance (Raviol et al., 2006), and 
further study has shown that HSP110 can act as a nucleotide exchange factors (NEFs) 
of HSP70s in the cytosol of many organisms (Andréasson et al., 2008).  From an amino 
acid alignment, the T. brucei HSP110 shares good conservation at the N-terminal 
ATPase binding domain region with HSP70 but lacks similarity at the C-terminal 
domain region.  So far, as with TbHSP70.4, little is known about HSP110 in T. brucei, 
however, HSP110 in the closely related kinetoplastid; Leishmania infantum, has been 




T. brucei possess three mitochondrial Hsp70 proteins - mtTbHSP70 protein (A-C), 
which share good conservation to typical TbHSP70 (Louw et al., 2010). All three 
mtTbHSP70 proteins possess ATPase binding domain that contains about 409 amino 
acids, and a partially conserved linker and substrate binding domain region at the C 
terminus of the sequence that comprises ~ 242 amino acids, but lacks the EEVD motif. 
Based on proteomic studies, mtTbHsp70A and mtTbHsp70C are expressed in both BSF 
and PCF, while mtTbHsp70B can only be detected in the membrane fraction of BSFs 
(Jones et al., 2006; Vertommen et al., 2008).  Interestingly, three copies of mtHsp70 
in the T. brucei genome are located on chromosome 6 and are 100% identical at the 
amino acid level. The presence of two identical mtHsp70s (mtTbHsp70A and 
mtTbHsp70B) in the BSF stage, could be that in mammalian host; the only food for the 
parasites in the mammalian host is glucose, and the level of ATP is much lower than 
in PCFs. Therefore, they have to keep the amount of mitochondrial machinery and 
function in the mammalian host low (Williams et al., 2008). The mtHSP70 proteins 
have been shown play multiple roles, such as cooperating with the mitochondrial 
nucleotide exchange factor mGrpE (Mge1p) in both importing and folding of 
mitochondrial proteins (Azem et al., 1997). Later studies demonstrated additional 
roles for mtHsp70 protein in T. brucei, including involvement in importing tRNA into 
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the mitochondrion (Tschopp et al., 2011) and its participation in kDNA replication and 
maintenance (Týč et al., 2015). 
 
 
Endoplasmic reticulum HSP70s 
ER-HSP70s can be divided in two groups: (1) BiP/Grp78 (Binding immunoglobulin 
protein/Glucose-regulated protein), which are both expressed in BSF and PCF (2) 
Grp170 that only can be found in BSF membrane.  The possible function(s) of those 
proteins play important roles in protein folding, post-translational modification, 
maintain cellular homeostasis under stress conditions (Dudek et al., 2009). The two 
genes TbBiP/Grp78A and TbBiP/Grp78B are identical but are transcribed separately 
on chromosomal 11 (Louw et al., 2010). The level of TbBiP/Grp78 proteins are much 
higher in BSF than PCF, which could be due to the level of VSG abundance that needs 
to be maintained (Bangs et al., 1993). The TbGrp170 protein belongs to ER-resident 
member of HSP110 family and homologous genes can be found in eukaryotes, but not 





Bioinformatics analysis has identified two novel HSP70s in the T. brucei genome - 
TbHSP70.a and TbHSP70.b. The exact functions of both proteins are still under 
investigation. However, the gene that encoded TbHSP70.b is flanked by genes 
encoding 40S ribosomal proteins, which may suggest that TbHSP70.b is involved in 
ribosomal assembly. Based on the phylogenetic tree generated by Clustal Omega, 
both HSP70.a and HSP70.b are more closely related to the Hsp110/Grp170 family, and 
HSP70.b in particular forms a well-supported distinct group within this family Fig 3.28 
C.  Furthermore, the TbHSP70.b is more similar to cyanobacterial DnaK than the rest 
of the Hsp110/Grp170 families, which might suggest that TbHSP70.b protein has a 
bacterial origin (Folgueira and Requena, 2007).  
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HSP70  Tb927.11.11330 
(Tb11.01.3110) 
0 BSF&PSF Cytoplasm  
HSP70.4 Tb927.7.710 0 BSF&PSF Cytoplasm 
BiP/Grp78B Tb927.11.7460 
(Tb11.02.5450)  
0 BSF&PSF ER 
BiP/Grp78A Tb927.11.7510 
(Tb11.02.5500)  
0 BSF&PSF ER 
HSP70.c Tb927.11.11290 
(Tb11.01.3080)  
0 BSF&PSF Cytoplasm 
Mitochondrial 
HSP70A 
Tb927.6.3740 0 BSF&PSF Mitochondria 
Mitochondrial 
HSP70B 
Tb927.6.3750 0 BSF&PSF Mitochondria 
Mitochondrial 
HSP70C 
Tb927.6.3800 0 BSF&PSF Mitochondria 
HSP70.b Tb927.7.1030 4E-45 Unknown Nucleoplasm ? 
HSP110 Tb927.10.12710 
(Tb10.389.0880) 








2E-26 BSF Unknown  










































Figure 4.2 (A) Schematic cartoon of T. brucei HSP70s domain structure.  Different domains and 
co-chaperone-binding sites are indicated by different colours.  Typical cytosolic human HSP70 
proteins with 3 domains: The N-terminal ATPase binding domain, a peptide (substrate) binding 
domain and characteristic C-terminal EEVD motif (can bind TPR-domain-containing proteins). 
“*” indicates identical aa and “:” indicates conserved aa. (B) Phylogenetic analysis of the 
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4.3 ADP-ribosylation factor-like protein 3-Like (Arl3L) 
protein  
 
Arl3 protein belongs to a member of the ADP-ribosylation factor family of GTP-binding 
proteins, which can be found in all ciliated organisms (Zhang et al., 2013). The protein 
cycles between an inactive Arl3-GDP-bound and an active Arl3-GTP-bound form. This 
interchange is tightly regulated by guanine nucleotide exchange factors (GEF) and 
GTPase-activating proteins (GAP) (Cavenagh et al., 1994). More recently, another 
small protein called ARL13b was identified from mice. Here it was proposed that 
ARL13b act as an GEF that can stimulate ARL3-GDP to exchange to Arl3-GTP (Gotthardt 
et al., 2015). In human, ARL3 localises to many cellular compartments, such as 
photoreceptor synaptic terminal, cell body, inner segment, and especially expressed 
strongly in connecting cilium of photoreceptor cells.  Arl3 has also been shown to 
specifically interact with RP2 (i.e. RP2 is the GAP for ARL3) at the connecting cilium 
(Grayson et al., 2002). Additionally, in many other studies ARL3 also co-localised with 
UNC119 (Ishiba et al., 2007) and PDEδ (Zhang et al., 2007). Although, to date there is 
no evidence that mutations in ARL3 lead to any human ciliopathies. , in Arl3-/- mice, 
typical ciliopathic phenotypes can be observed e.g. impaired photoreceptor 
development, but also cysts in kidney, liver and pancreas (and animals die within 3 
weeks of birth) (Schrick et al., 2006). There are three putative orthologues in 
trypanosomatids - ARL-3A (Sahin et al., 2004), ARL-3B  and ARL3-like (identified in this 
work). Previous studies have shown: RNAi knockdown of TbARL-3A causes significant 
shortening of flagella in T. brucei (Sahin et al., 2004), and that overexpression of 
constitutively 'active' LdARL-3A (blocked under the GTP-bound form) results in very 
short flagella in Leishmania donovani (Cuvillier et al., 2000).   
 
Like HSP70 protein, multiple ARL3 (like) genes can be found in all the organisms listed 
in Table 4.2, i.e. irrespective of whether they can produce cilia/flagella.  At the start of 
my bioinformatics analysis, I performed a straightforward NCBI BLAST research 
(Altschul et al., 1990),  using TbARL3-like as my query sequence against human 
genome databases. In this analysis human ADP-ribosylation factor-like protein 3 
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(NP_004302.1) was the top hit. The sequence alignment reveals that TbARL3L shares 
good homology to human Arl3, especially within the ARF domain (Fig 4.3-A).   I also 
checked by reciprocal BLAST if any other proteins, rather than TbARL3L, were more 
closely related to human ARL3.  The results showed that TbARL3-A (Tb927.6.3450) was 
the top hit (4e-72), followed by TbARL3-B (Tb927.10.8580; 1e-61), and TbARL2 
(Tb927.10.4250; 9e-55) and that TbARL3L (Tb927.6.3650) only comes out as the 4th top 
hit (2e-51).  This result indicates that TbARL3L fails the reciprocal BLAST test, and that 
it is not the orthologue of human ARL3.  Additionally, it might not be surprising that 
ARL2 also came back with a good e value, as ARL2 and ARL3 shares 53% identity and 
have a high degree of structural conservation in humans; with evidence suggesting 
that at a biochemical level Arl2 and Arl3 are remarkably closely related (Zhou et al., 
2006). Actually, when I use human ARL3 as my query to check how many Arl3 genes 
in human, the result revealed that there are a number of Arl-like proteins with good 
percentage identity and e-value, but they are not Arl3. Based on the NCBI BLASTP 
results, there are proteins annotated as Arl3 or its isoforms. In T. brucei, ARL2 protein 
has shown involved in cytokinesis and depletion or overexpressing TbARL2 cause a 
defect in cleavage furrow, which could leads to cell cycle arrest and multinucleated 
cells (Price et al., 2010).   TbARL3L is a 183 amino acid protein, with a small GTP-binding 
domain.   
Next, I analysed both proteins using Interpro Scan or Prosite to look more closely at 
their domain architecture. Human ARL3 is a 182 amino acid protein with a ARF domain 
located between amino acids 11 to 177, and TbARL3L appears to have very similar 
domain structure as well (Fig 4.3-B). The amino acid alignments and domain 
architecture between three ARL3 proteins shows good conservation Clustal Omega 














Human-ARL3     MGLLSILRK--LKSAPDQEVRILLLGLDNAGKTTLLKQLASEDIS---------HITPTQ 
TbARL3L        -----MLKGIRSRAKRDNEPRVLIVGLDNAGKTTVLNALGEDEVPVEGKVSHAAPEGPTQ 
                    :*:    ::  *:* *:*::*********:*: *..:::             *** 
 
Human-ARL3     GFNIKSVQSQGFKLNVWDIGGQRKIRPYWKNYFENTDILIYVIDSADRKRFEETGQELAE 
TbARL3L        GFNIKTLTRGNKRAKLCDLGGQRALRDYWQDYYSNTDCIMYVVDSSDHRRLEESHAAFVD 
               *****::   . : :: *:**** :* **::*:.*** ::**:**:*::*:**:   :.: 
 
Human-ARL3     LLEEEKLSCVPVLIFANKQDLLTAAPASEIAEGLNLHTIRDRVWQIQSCSALTGEGVQDG 
TbARL3L        VLK--GIEGAPVLVFANKQDLATAKDAQAIAECLHLHDFRDRKWHIQGCSAKTGAGLEEG 
               :*:   :. .***:******* **  *. *** *:** :*** *:**.*** ** *:::* 
 
Human-ARL3     MNWVCKNVNAKKK 
TbARL3L        VAWILSTCAP--- 

























Figure 4.3 (A) Multiple sequence alignments between human ARL3 protein (NP_004302.1) 
and T. brucei ARL3-like (Tb927.6.3650) by ClustalOmega analysis. (B) The ARF domains are in 
yellow highlights (B) Schematic cartoon of human ARL3 protein (NP_004302.1) and T. brucei 
ARL3-like (Tb927.6.3650) domain structure. Two ARL3 proteins are well conserved (especially 
within the ARF domain). “*” indicates identical aa and “:” indicates conserved, red highlights 
= ARF domain.  
 
(A) 
182aa  Small_GTPase_ARF 










TbARL3L      -----MLKGIRSRAKRDNEPRVLIVGLDNAGKTTVLNALGEDEVPVEGKVSHAAPEGPTQ 
TbARL3A      MGLLTLLRKL--RS-SDASPRILILGLDNAGKTSILRNLSGEDPT---------TTQATQ 
TbARL3B      MGLLEFLLKI--RPFSRRTRRILMLGLDNAGKTRLLRRICEEEVS---------DTFPTQ 
                  :*  :  *       *:*::******** :*. :  ::               ** 
 
TbARL3L      GFNIKTLTRGNKRAKLCDLGGQRALRDYWQDYYSNTDCIMYVVDSSDHRRLEESHAAFVD 
TbARL3A      GFNIKTVDCEGFKLNVWDIGGQKAIRAYWPNYFDEVDCLVYVVDSADKRRLDETAAELET 
TbARL3B      GFNIQNITADELKFVVWDVGGQKSLRSYWRHYFDHTDALVFVIDSADMERIEEARTELHY 
             ****:.:     :  : *:***:::* ** .*:...*.:::*:**:* .*::*: : :   
 
TbARL3L      VL--KGIEGAPVLVFANKQDLATAKDAQAIAECLHLHDFRDRKWHIQGCSAKTGAGLEEG 
TbARL3A      LLQEEKLREVPFLVLANKCDLATALSPEDISTALNLQNLRDRTWSIQKCSAKTGEGLQEG 
TbARL3B      ILEEEKLVGVPLLLFANKQDIPEAASQEEVMSSLNLRDTINRPWHIELCSAETGEGLSSG 
             :*  : :  .*.*::*** *:  * . : :  .*:*::  :* * *: ***:** **..* 
 
TbARL3L      VAWILSTCAP----------- 
TbARL3A      FMWAIKSIKK----------- 
TbARL3B      LSWVVDTLKKRRPSLRPDGQV 
























Figure 4.4 (A) Multiple amino acid sequence alignments between three ARL3 trypanosomatids 
orthologues; TbARL3-like (Tb927.6.3650), TbARL3A (Tb927.3.3450) and TbARL3B 
(Tb927.10.8580) with Clustal Omega using default parameters. (B) The ARF domains are in 
yellow highlights (B) Schematic cartoon of three ARL3 trypanosomatids orthologues domain 
structures. Three ARL3 proteins are well conserved (especially within the ARF domain). “*” 
indicates identical aa and “:” indicates conserved, red highlights = ARF domain.  
 
178aa  Small_GTPase_ARF TbARL3A 
190aa  Small_GTPase_ARF TbARL3B 
183aa  Small_GTPase_ARF TbARL3L 
(B) 
(A) 
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4.4 Kinetoplastid membrane protein-11 (KMP-11) 
 
KMP-11 was originally identified as an abundant membrane protein in Leishmania 
donovani, which can promote T-lymphocyte proliferation (Tolson et al., 1994). KMP-
11 is expressed in several other trypanosomatids including Trypanosoma cruzi, 
Crithidia fasciculata, Leptomonas collosma and Phytomonas spp (Stebeck et al., 1995). 
Data has shown that KMP-11 was more highly expressed in procyclic, epimastigote 
and metacyclic life cycle stages than in bloodstream forms (Stebeck et al., 1995).  In 
the list of selected organisms (Table 4.2), KMP-11 was only expressed in kinetoplastid-
specific species (with e value above e-10), and no orthologues of KMP-11 can be found 
in humans or any other organims. I then took all the BLAST hits into 
InterproScan/Prosite to interrogate domain architecture. T. brucei is a 92 aa protein 
that belongs to the KMP-11 super family, with 5 identical KMP-11 genes found in T. 
brucei.  By InterproScan analysis,  all T. brucei, T. cruzi (TcCLB.510755.89) and L. major 
(LMJLV39_350028900) KMP11 proteins are 92 aa long and the KMP11 superfamily 
designation the whole protein. When I used CLUSTAL OMEGA to align KMP-11 protein 
sequences , it revealed that the proteins are neralry idenitical and  share > 90 % 
homology (Fig 4.5). 
 
 
LmKMP11      MATTYEEFSAKLDRLDEEFNRKMQEQNAKFFADKPDESTLSPEMKEHYEKFERMIKEHTE 
TbKMP11      MATTYEEFAAKLDRLDAEFAKKMEEQNKRFFADKPDEATLSPEMKEHYEKFEKMIQEHTD 
TcKMP11      MATTLEEFSAKLDRLDAEFAKKMEEQNKKFFADKPDESTLSPEMKEHYEKFEKMIQEHTD 
             **** ***:******* ** :**:*** :********:**************:**:***: 
 
LmKMP11      KFNKKMHEHSEHFKQKFAELLEQQKAAQYPSK 
TbKMP11      KFNKKMREHSEHFKAKFAELLEQQKNAQFPGK 
TcKMP11      KFNKKMHEHSEHFKAKFAELLEQQKNAQFPGK 




Figure 4.5 Multiple amino acid sequence alignments between three KMP-11 Kinetoplastids 
orthologues; TbKMP11 (Tb927.9.13920), TcKMP11 (TcCLB.510755.89) and LmKMP11 
(LMJLV39_350028900) with Clustal Omega using default parameters. “*” indicates identical 







     
146 
 
4.5 Microtubule-associated repetitive protein (MARP) 
 
The microtubule-associated repetitive protein (MARP) encoded by Tb927.10.10360 
was identified as a potential interacting/nearby protein of TbRP2 by the BioID-SILAC 
approach. This MARP was first identified in T. brucei in 1988 by Schneider and co-
workers, who reported the protein consisted of more than 50 nearly identical tandem 
repeats with a periodicity of 38 amino acids, and localised along subpellicular 
microtubules. (Schneider et al., 1988). From Table 4.5, the results were only based on 
simple BLAST analysis. Apart from T. brucei, only  closely related species (T. cruzi and 
L. major), return with a good e value (see the table below). When I performed 
InterproScan/Prosite for protein domain analysis, no putative conserved domians 
were detected.  As a final step of the MARP analysis, I used CLUSTAL OMEGA to align 
the top hit proteins from T. cruzi and L. major with the T. brucei MARP.  This showed 
that there is not much conservation between thethree MARP sequences at the N-
terminus, but some similarity at the C-terminus (Appendix II Fig 9.6-A). However, when 
comparing the two TbMARPs sequences, they share a high degree of identity towards 
the C-terminus, and are almost identical within the last 308 aa (Appendix II Fig 9.6-B).  
 
Protein ID 
 (T. brucei) 
E-values Protein ID  
(T. cruzi) 
E-values Protein ID  
(L. major) 
E-values 
Tb927.10.10360 0 TcCLB.511633.79 
(Partial) 
0 LmjF.05.0380 0 
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4.6 TbBBP590  
 
TbBBP590 is another protein with high molecular weight (590.2kDa), and was 
identified very recently as a T. brucei basal body protein (McAllaster et al., 2015)Dang 
et al., 2017). Based on the NCBI BLAST analysis, TbBBP590 is a trypanosome-specific 
protein. Apart from T. cruzi (TCDM_02199-t26) and L. major (LmjF.36.5250), 
sequences derived from all other organisms failed to return hits  with a good 
expectancy value. The next step was to interrogate the domain structure of TbBBP590. 
InterproScan and Prosite identified multiple coiled-coil regions (31 are predicted) and 
a myosin heavy chain-related domain located at the C-terminus. Additionly, IUPred 
(Dosztányi et al., 2005) was used here to predict any intrinsically 
unstructured/disordered and/or ordered/glubular structure within the TbBBP590 
protein sequence. In this IUPred analysis sores above 0.5 indicate regions of 
disorder/unstructure and scores below 0.5 indicate that part of sequence has ordered 
structure (e.g. putative globular domain (1-89; 110-179; 204-318; 334-387; 463-595; 
639-841; 1698-1787; 1803-1973; 3016-3105; 3121-3291; 3367-3633; 3662-3839; 
3871-4021; 4038-4471; 4498-4648; 4856-5054; 5096-5228; 5260-5291)) (Fig 4.7-B). As 
a final step in the TbBBP590 analysis, I used CLUSTAL OMEGA to align the TbBBP590 
sequences with T. cruzi (TCDM_02199-t26) and L. major (LmjF.36.5250), which shows 
in Appendix II Fig 9.7. Compared to the TbBBP590 protein sequence, both T. cruzi and 
L. major orthologues are much shorter. T. cruzi shares a good deal of conservation 
with TbBBP590 towards the C terminus, but L. major is the opposite, showing good 













Myosin Heavy Chain related 
(A) 



























Figure 4.7 (A) Interpro Scan analysis of TbBBP590, a myosin heavy chain-related domain were 
detected at the C-terminus, and results also show possible coiled coil regions within the 
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4.7   Cytoskeletal-Associated Protein (CAP) 51 
 
TbCAP51 (Tb927.7.2640) along with another CAP protein TbCAP51V (Tb927.7.2650) 
were identified as a pair of paralogous proteins showing subpellicular microtubule 
localisation.  However, TbCAP51 is only expressed in the procyclic form, and TbCAP51V 
is detected only in the bloodstream form. This previous work also showed that both 
CAP51 and CAP51V play important roles in the organisation of the cytoskeleton and 
successful cytokinesis in their respective life cycle stages (Portman and Gull, 2014).  
There are no  domain architectures in the TbCAP51 protein that can be detected by 
either InterproScan or Prosite. However, as with TbBB590, the results did predict 
regions of coiled-coil within the sequence (Fig 4.8-A), and so I used IUPred and another 
tool called RONN (Yang et al., 2005) to predict possible regions of intrinsic protein 
disorder in TbCAP51. The IUPred analysis suggested that an intrinsically 
unstructured/disordered domain is likely at the N-terminus of the TbCAP51 protein, 
and a putative globular domian located between 160-275 aa (Fig 4.8-B).  Analysis using 
RONN also revealed a possible disorded region at the C-terminus (Fig 4.8-C). As a final 
step in the TbCAP51 analysis, I used CLUSTAL OMEGA to align the sequences of 
TbCAP51 with TbCAP51V, T. cruzi CAP (TcCLB.506859.180) and L. major 
(LMJLV39_220012800) (Fig 4.8-D to E respectively).  Compared to the TbCAP51 animo 
acid sequence,  TbCAP51V shares good conservation to TbCAP51, especailly in the 
middle of the sequence where it is nearly identical.  Both T. cruzi and L. major 

































TbCAP51       MSTTALSSAKNARSPGSNAAVSPGSKLASLREGASTGVAKDEAESAALGGLAGGDA---- 
TbCAP51V      MSTTALSSAKNARSPGSNAAVSPGSKSVSLREGALRSDRKSTRELSPQSELKSDRKSMRE 
              ************************** .******  .  *.  * :  . * ..       
 
TbCAP51       ---------------------EGLAAGAMSGLAETATEA----AADELGDAASEDQANFF 
TbCAP51V      ISHSELKSDRKSTRELSPQSELKSDRKSMSGVSPQSELKSDRKSMREISHSELK--S--D 
                                         :***::  :       :  *:..:  :  :    
 
TbCAP51       SEKLVEVIPQCN-------------------------------EIEGERD-LNGELLG-- 
TbCAP51V      RKSTRELSPQSELKSDRKSVRDSEMRSAGKSGRSVEARYGVRDDGDGEWSELGSEVTSEL 
               :.  *: **.:                               : :** . *..*: .   
 
TbCAP51       ----------------EEAPRTDEGDVNNVG-----CS----SAAESLPQEEVEETEEQI 
TbCAP51V      RSKAKSGRRSERRQGGADEFELSESDVDAHGENFFDSSRRSDRQPSSGAPEEEEETEEQI 
                               :  . .*.**:  *     .*       .*   ** ******* 
 
TbCAP51       IIRLQKELREFEAYEKEMQPNLNIYEDIIELRREAEQLEDDRKRALLQIDLGDISSYYDG 
TbCAP51V      IIRLREELREFEAYEEEMQPNLNMYEEVIELRREAEQLEDDRKRALLQIDLGDISSYYDG 
              ****::*********:*******:**::******************************** 
 
TbCAP51       DVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVNVKDLPSRLKDARASFD 
TbCAP51V      DVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVDIMKLGFRLREAKRSFD 
              *******************************************:: .*  **::*: *** 
 
TbCAP51       SSNRVAQDLYRAHEVKVNATTDSRDKAKAEIFNGMKAEIEATKGERERLRQLQKDQLFHL 
TbCAP51V      SSNRVAQDLYRAHEVKVNATTDSRDKAKAELRQEIAAELNELRQRRERLLVIDKEQRFHL 
              ******************************: : : **::  : .****  ::*:* *** 
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TbCAP51V      RRGTHVKELQVTSKRRQDALEARVVGEENRHFGASVELKRTVKDLEMELIQLRRELKDAK 
              *******:  :*:.:.:*  ****.. *.: .     *:. :*:*: ::  *:* *.* * 
 
TbCAP51       HASRETLETLKKQHVAVDSSRGELSEAREKYERENSELMLLKHDLQTVLHYIRVRAREAD 
TbCAP51V      VSGESIVQELRKHLLDVTRSGEEVRKARQDYEEENSDLMSLKHELQCVLHYIRVRAREAN 
               :... :: *:*: : *  *  *: :**:.**.***:** ***:** ************: 
 
TbCAP51       K 
TbCAP51V      Y 






L.major      MSAQQQPSE-----ENSDRMVAARTKAEAARMAVERRRSMNSDAQERSNSPDHHDTPTPL 
TbCAP5       MSTTALSSAKNARSPGSNAAVSPGSK-----LASL-REGASTGVAK---DEAESAALGGL 
T.cruzi      ---------------------------------------METNVET---QRQESGSPKEL 
                                                     .:..     .  .  :   * 
 
L.major      RGATQERSSS---VDLANGGI---EDPHGDSGEHR-PNSSIVKRRSSMPKNGVRDGSRRG 
TbCAP5       AGGDAEGLAAGAMSGLAETATEAAADELGDAASEDQANFFSEKLVEVIPQCNEIEGERDL 
T.cruzi      AGTRA--------QKAPEAAAEFDYRELGEAAVQEFEE---------------------- 
              *               : .        *::. .   :                       
 
L.major      SGVV-AVGP--------PNASYSGTKKTADPQ---TPEEYAAAIEEMRQEYERIIMKDAE 
TbCAP5       NGELLGEEAPRTDEGDVNNVGCSSAAE-SLPQEEV-EETEEQIIIRLQKELREFEAYEKE 
T.cruzi      ---------------------YSSASG-AAPGRRSSIRFVLASIEEKENELRELEAREKA 
                                   *.:   : *      .     * . .:* ..:   :   
 
L.major      LEERLQLYSDVVGLRKELVIVQEDEARLRQQLAATEAVIASSDPTVKKVVPIYEEEAQQS 
TbCAP5       MQPNLNIYEDIIELRREAEQLEDDRKRALLQIDL-GDISSYYDGDVEREVEELEAAVENS 
T.cruzi      VESQLQVYSEVIGLRKELRLVKEETERVRRQLDSINVFAEKYGNAVERDLNSAEEEAQRS 
             :: .*::*.::: **:*   ::::  *   *:     .    .  *:: :   *  .:.* 
 
L.major      VLQKLWMEESEC----HNPDTMEWAAIDVNNLRERVDAAHKKFTAAAEMADSLYLQQEEA 
TbCAP5       YLQACWTKERQRYIARNETDLPEWWRVNVKDLPSRLKDARASFDSSNRVAQDLYRAHEVK 
T.cruzi      HVQQVWTSVCRERPNESLGDPSSWTKVDLDNLSRRVEAARGKLQAASNAAAKVYASQEDM 
              :*  * .  .        *  .*  :::.:*  *:. *: .: :: . * .:*  :*   
 
L.major      INKTTDARERERATIAENHEREMEGLSEARVHARQVAAEQHFHRHRGTAQAPPVVLTQDK 
TbCAP5       VNATTDSRDKAKAEIFNGMKAEIEATKGERERLRQLQKDQLFHLRRGTHVKDQLLTTT-K 
T.cruzi      INKNTEERDKAKAKLLESVGVEMAKLVETRSRLKQLDDDQRYHFRRGTHVKQRHVPSL-K 
             :* .*: *:: :* : :.   *:      * : :*:  :* :* :***      : :  * 
 
L.major      KRTTRQRCVDEVEFHTTAQVGRMKDELTELMEQVKMLKRHLDDSRQVTEKKRREYEATLK 
TbCAP5       ERDIREARVADMESKLVQQRYALNNEMKELNGDIEGLKRLLTDQKHASRETLETLKKQHV 
T.cruzi      EQDIMKGRVYNDESRQFGDVVLLEDECKDLTEWVNGAKRELEDNKRSYAKEQSELEEQLQ 
             ::   :  * : * :   :   :::* .:*   ::  ** * *.::   :     :     
 
L.major      AVEADGSEAREMKEGLLKEEEELKELKADIQAVLHYVRAKNREEEGW 
TbCAP5       AVDSSRGELSEAREKYERENSELMLLKHDLQTVLHYIRVRAREADK- 
T.cruzi      VMEDNGKEARELRAFFERENDQLKGLKQDLQHVLIYVRMRNREAFT- 
             .:: .  *  * :    :*:.:*  ** *:* ** *:* : **     
 
Figure 4.8 (A) Interpro Scan analysis of TbCAP51, no domain structures were detected. 
However, results shows possible coil coil within the sequence. (B) Disorder prediction of 
structured regions performed by IUPRED. (C) Disorder prediction of structured regions 
performed by RONN. (D) Multiple amino acid sequence alignments between TbCAP51 
(Tb927.7.2640) against it paralouges TbCAP51V (Tb927.7.2650). (E) Multiple amino acid 
sequence alignments between TbCAP51, top hit in T.cruzi (TcCLB.506859.180) and L.major top 
hit (LMJLV39_220012800) by Clustal Omega using default parameters. “*” indicates identical 
aa and “:” indicates conserved. 
(E) 
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4.8   VHS (VPS-27, Hrs and STAM)-domain containing 
protein  
 
The VHS domain containing protein (Tb927.11.10770) was identified by BioID/SILAC 
when whole cell samples, rather than cytoskeletons, were used for the analysis. In 
almost all cases, the VHS domain can be found only at the N-terminus of proteins and 
the roles of these proteins are mainly associated with vesicular/endocytosis trafficking 
(Baiady et al., 2016). In addition, VHS domain-containing proteins often localise to 
membranes through interactions with the membrane and/or other mechanism like 
endocytosis (Misra et al., 2000). Moreover, evidence also suggests that VHS is also 
linked to other domains such as zinc finger-FYVE, SH3 and TAM, and together they play 
important functions in membrane binding (Mao et al., 2000). I used this 
Tb927.11.10770 sequence to perform BLAST analysis against the restricted set of 
eukaryotic organisms shown in Table 4.1. This NCBI BLAST analysis showed that 
proteins with e-10 value were only found in humans, C. elegans and trypanosomatids.  
In humans, a gene identified as a TOM (Target Of the Myb) protein 1 isoform 2 came 
back as the top hit (domain structures are shown in Fig 4.9-A).  A reciprocal BLAST 
confirmed that TbVHS (Tb927.11.10770) was the top hit of the human TOM protein 1 
isoform 2.  This human protein (NP_001129204.1) shares N-terminal VHS domain with 
T. brucei, and also consists of a domain called a GAT domain, which can be found in 
other vertebrate TOM proteins and eukaryotic GGAs (for Golgi-localized, gamma ear-
containing ADP ribosylation factor (ARF)-binding proteins).  The function of the GAT 
domain is involved in trans-Golgi network membranes, and interaction with small 
GTPases (GTP-bound form); additionally, it can also bind specifically to the Rab GTPase 
effector rabaptin5 and ubiquitin (Collins et al., 2003; Shiba et al., 2003; Yamakami et 
al., 2003; Zhu et al., 2004). Based on InterproScan/Prosite analysis, the VHS domain of 
both T. cruzi (TcCLB.458015.10) and L. major (LmjF.36.5140) proteins are all located at 
N-terminus just like in T. brucei.  In C. elegans, a HRS (Hepatocyte growth factor-
Regulated TK Substrate) protein (NP_501375.2) came back as the top hit to TbVHS. 
The domain structure analysis demonstrated that in addition to a VHS domain at the 
N-terminus, there is also a Zinc finger FYVE/FYVE-related domain and Ubiquitin-
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interacting motif (UIM) domain in the C. elegans protein.  As the last step of the TbVHS 
analysis, I used CLUSTAL OMEGA to align the TbVHS sequence with human TOM 
protein 1 isoform 2, and the T. cruzi and L. major VHS proteins, as well as the C. elegans 
HRS protein sequence (Fig 4.9-B).  The results show good conservation in the VHS 
domains of all five proteins (yellow highlights), other domains, which does not appear 


















































493 aa  VHS domain GAT 
TbVHS 








501 aa  VHS domain T.cruzi  VHS 





C.elegans      -----------------MATKFQ----RVLDQATDSTLVEPNWEGIILCTDMIRSGEVPA 
H.sapiens      -------------MDFLLGNPFSSPVGQRIEKATDGSLQSEDWALNMEICDIINETEEGP 
L.major        MVQLSLIEEVKDKVSRFIPNPFV----DIVEECTAPQLLIPTYEHVKFLCEQVNKKSEST 
TbVHS          MVLLSVLDKAKDMASRLLPTPYL----ELVEEATEPCLSTPKLSAVTLLCDNANTRAESV 
T.cruzi        MVVLSFLENVKDAASRLIPTPYM----DIVVEATKPELSTPQYESVAFLCDSANSSGDAA 
                                : . :       : :.*   *            :  .       
 
C.elegans      KPSLQAIRKRMQHEN-PHVVNHTLLVLDACVKNCGHKVHAEVATREFMEDF-KNLV---- 
H.sapiens      KDALRAVKKRIVGNKNFHEVMLALTVLETCVKNCGHRFHVLVASQDFVESVLVRTIL--P 
L.major        VDIVRAIRRRIADSH-IAVKHLTIQLLESMIKSCSTWFHIEVATQKGLLRDLVAVACVQP 
TbVHS          ADVVRAVRRRIANSD-PTVQYLTVIVLESLVKNCNTKLHTEVAAQKGIVKELYNIATRSA 
T.cruzi        EDVVRAVRRRITDSD-AKVQLLTVLVLGMLIKNCDNALHVEVASQKGLLRDLQNVAIRTP 
                  ::*:::*:  ..       :: :*   :*.*.  .*  **::. :             
 
C.elegans      -TENKYDEVKNKSLEMLQCWATAFANKPEYKMVVDTHN------LM---KLAGFDFPSLK 
H.sapiens      -KNNPPTIVHDKVLNLIQSWADAFRSSPDLT--GVVTIYEDLRRK-------GLEFPMTD 
L.major        -STGRAMQAKESALLLTLNLSIWFRGHPAEECYILTTLADDVRNEMGPNCFEGLEP-ERN 
TbVHS          -TSEKECLAKEAALALILNFSVWFAGHPNSRLKFLTSVAEAVRRAVGPNAFDGIQP-DID 
T.cruzi        CVTEKERMAKEAALALILNLSIWFTGHPDGRLYILTTISDDVRHAIGPNAFEGIQH-DTT 
                       .::  * :    :  * . *       .                *::      
 
C.elegans      EADAMFMAQVAPEWAD-------GPECYRCRSVFSVFTRKHHCRACGQIFCDKCSSRELA 
H.sapiens      LDMLSPIH--TPQRTVFNSETQSGQDSVGTDSSQQEDSGQHAAPLPAPPILSG---DTPI 
L.major        TRMKVEVH--APNRNR----QQPGQRSDAGPNYQG--PRSHGHRRDKRRIVDA---IAIN 
TbVHS          TRLSMAVG--PTGQRTRPPAKQPNKS-IHHPPET--------GLPPGAHVVDA---IGIV 
T.cruzi        QLNSSVMR--QQQHNPR-FNRQPRQTGRQQQHQQ--------QQRQQGLVVDA---VGIN 
                     :                                          . .         
 
C.elegans      LPQF-GIEKEVRVCETCYE--KKVAEV-KERYPAVKKQ--LDAAHG-RKGDSEADKAAKE 
H.sapiens      APTPEQIGKLRSELEMVSGNVRVMSEMLTELVPTQAEPADLELLQELNRTCRAMQQR-VL 
L.major        LPTSERLSAMLETCM-------TFSDYVNNA-------------ETNPNVCLRDDEV-VL 
TbVHS          LPTDEELGTMLDVCM-------TLAEYLNDI-------------KVNEDGSVEMDDV-IE 
T.cruzi        FPTEEDLAAMLDCCM-------TLAEYLNNA-------------KVQPDGSIKPDDV-IS 
                *    :                .::  .:              .         :.     
 
C.elegans      KLLREKEEEDLALAIAIS------QSEAEAKEKEKQNNLYSMYNGIKPEVDGYKGAAEPV 
H.sapiens      ELIPQIANEQLTEELL--------------IVNDNLNNVFLRHERFE-RFRT------GQ 
L.major        SYLSQLRDDHIYVTILLSSNLQL-DRDLLRTVSDSQSAVLAKVEKSMARPRT------DA 
TbVHS          SILSSIRSSNKLILLILGSDLKPSNREMLVDVCNSQNNLMQRLSKRAPSQDT------RQ 
T.cruzi        GFRDRILADHKRVTVLLSSDLKLNNRDTLRDVFDSQSALIQRLQSDVKLHPD------QT 
                       ..    :                  :. . :    .                 
 
C.elegans      TAPPPDDSSS--DPLARYLNRDYWQQK-KEGKVEDWSSRSSALSATAPPPSEPSIA-PSI 
H.sapiens      TTKAPSEAE-------------------PAADL--------IDMG--PDP----AATGNL 
L.major        ---APEGSSALPPALQQALMRSAVDTEQSGGDVSAFQE---TGMQQRPSP--PRAE---V 
TbVHS          --GGTTAQSTS-DSL-------------SGASV--------AATAKTPSA--SSKMTA-- 
T.cruzi        --PAPSRV--T-DVA-------------PTERY--------LPQVTTPNP--PAAAAASS 
                                                              *             
 
C.elegans      CSTLM--GPDDNSLNADIAAMSLGGTNGLNGTVSDDAKLQADDTMKWCQSIREQVSVMDN 
H.sapiens      SSQLAGMNLGSSSVRAGLQSLEAS------GRLEDEFD-MFALTR--GS------SLADQ 
L.major        PSRNVGMTRTSPAPMSTPP-LAAA------PAI--------EDLF--GN----------- 
TbVHS          ---ASAAKPSAPPETPKEQPVKLL------GASQTVKR-PVKPTG--GE----------- 
T.cruzi        GGQGVGMTPAMNPPMSQVEPVAVP------TALEAGTREAAGEAE--GS----------- 
                                   :                           .            
 
C.elegans      RIRSNLARGRPVFNDSAIQDLFTKLTELHSHVLS---RMHTLDEQRGYYESLQDHLANIG 
H.sapiens      --RKEVKYEAPQATDGLAGALDARQQSTGAI-----PVTQAC-----LMEDIEQWLSTDV 
L.major        ------GQSAPQATSSMPKSLSPTMEAPGSAPASSPPVASPEETANAAEPAVGDFATTAL 
TbVHS          ------SAAHPQNPLDLLDDLFP--AAPAQAPAAAPPAVEAV--GKGAENNCEDM----Y 
T.cruzi        ------QPSPAQEASKVMENLFV--SAPVTESLA--PAAETS--SREYNDNVDLL----L 
                                   *                                        
 
C.elegans      EA--------RQAIDEMR---EEHERKRQE--RMAEEQRLRQAQMQQTLEMMRMK----- 
H.sapiens      ---------------------------GND-----------------------------A 
L.major        TSSNAAALPPMRA--------ETSEAAGAEE--------VPAPLQHAASESTSAAATAAA 
(B) 
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TbVHS          SS---EEV---------------------------SEERNRKPVKH-------------- 
T.cruzi        TK---ADMPPSEPIPSVPEKEEEVLMAGKEENQSKQEETQKQPDPHE-----------KS                                                                          
 
C.elegans      --KHAMLMEQREQALQRFQQQQQEMAMRRHQQQAYYNPQQMGYGAPPPSGPQQPPQQSYY 
H.sapiens      EEPKG---VTSEGKFDKFLEER---AKAADRLP--------NLSSPSAEGPPGPPSG--- 
L.major        PTPPAADLPKDVDDFDTFLEGH---GVS-------------------------------- 
TbVHS          ----------VYTDFEDLLARQ---APK-------------------------------- 
T.cruzi        PEEKSKQPAGEDDEFDAFLEGR---LSK-------------------------------- 
                             :: :   :                                       
 
C.elegans      GYQQGPQSQAPPPSSQYQQSHASTQQQQQQYYQHYQANQTVTQPVQQAQQQYQQQYQGYY 
H.sapiens      -----P-----APRKKTQE------KDDDMLFAL-------------------------- 
L.major        ------------------------------------------------------------ 
TbVHS          ------------------------------------------------------------ 
T.cruzi        ------------------------------------------------------------ 
                                                                            
 
C.elegans      QQQQPYQQQAGYQNPQQHQNYQNGTTNENGQYQQQQSSEVKQEHQNHGYQQQQAQHPPAS 
H.sapiens      ------------------------------------------------------------ 
L.major        ------------------------------------------------------------ 
TbVHS          ------------------------------------------------------------ 
T.cruzi        ------------------------------------------------------------ 
                                                                            
 
C.elegans      VASNGHNGYGNVDQNAHHHQQQQPQIAEQPLISFD 
H.sapiens      ----------------------------------- 
L.major        ----------------------------------- 
TbVHS          ----------------------------------- 
T.cruzi        ----------------------------------- 






















Figure 4.9 (A) Schematic cartoons of VHS domain structure within different organisms.  
Different domains are indicated by different colours.  The VHS domain is normally located at 
N-terminus of the protein sequences (yellow highlights); In human TOM protein 1 isoform 2 
also contains GAT domain (blue highlights); The Zinc finger FYVE/FYVE-related domain (purple 
highlights) and Ubiquitin-interacting motif (UIM) domain (green highlights) in C. elegans. (B) 
Multiple sequence alignments between TbVHS protein against human, T. cruzi, L. major and 
C. elegans by Clustal Omega analysis.  “*” indicates identical aa and “:” indicates conserved 
aa.  
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4.9   P25-/TPPP (Tubulin-Polymerization-Promoting 
Protein) 
 
The TPPP or P25- is a 25 kDa protein originally identified as a brain specific protein 
that could be phosphorylated by Ser/Thr-Pro kinase (TPK II) (Takahashi et al., 1991).  
In eukaryotic cells, TPPP/p25 co-localises selectively with microtubules and promotes 
tubulin polymerization into normal and double-walled microtubules and induces their 
bundling activities. The role of TPPP/p25 is thought to be similar to Microtubule 
Associated Protein (MAP)-like stabilization of the microtubular network (DeBonis et 
al., 2015).  Overexpression of TPPP/p25 can lead to protein aggregation in transfected 
HeLa cells, this mimics the characteristic aggresome-like formations found in Lewy 
bodies (which contains α-synuclein, ubiquitin and neurofilaments (Lehotzky et al., 
2004), which enriched in human brains in certain neuropathological conditions. For 
instance, in neurodegenerative disorders such as Parkinson’s disease and other 
synucleinopathies, TPPP/p25 shows complete co-localisation with -synuclein in Lewy 
bodies (Kovács et al., 2004; Lindersson et al., 2005; Orosz et al., 2004). Later studies 
reported that the TPPP/p25 gene is conserved in organisms that produces 
cilia/flagella, but is absent from those that are non-ciliated organisms, this may 
suggest TPPP/p25 is associated with basal bodies/centrosomes and/or flagella 
structure (Orosz and Ovádi, 2008; Ovádi et al., 2005). 
 
In the T. brucei genome, there is only one TPPP-like protein (Tb927.4.2740). An initial 
BLAST search revealed that all three non-ciliated organisms failed to encode a TPPP-
like gene in their genomes.  In the selected flagellated organisms, only G. intestinalis 
and C. elegans failed this NCBI protein BLAST. However, it should be borne in mind 
that here I used the T. brucei sequence as my query and not the human TPPP protein. 
The top hit human protein came back as another TPPP-like protein superfamily 
member called Tubulin polymerisation-promoting protein family member 2 (TPPP2, 
also known as p18). The actual function of TPPP2 is not understood, but data suggests 
that p18 may also be involved in tubulin binding but has no microtubule bundling 
activity (Vincze et al., 2006).  In the human genome, one more gene sequence shows 
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homology with TPPP/p25 and TPPP2/p18; this protein is termed as p20 or TPPP3. 
These three TPPP-like proteins are identified in divergent eukaryotes that share a 
central p25 domain, and they display high amino acid sequence homology, apart from 
the N-terminal tail of TPPP/p25 (see Fig 4.10-C) (Vincze et al., 2006).  In addition, the 
data also indicates that while all three proteins are highly conserved in amino acid 
sequences, their structures are very different. TPPP/p25 has low helical content, but 
is more flexible and dynamic like other MAPs (Dunker et al., 2002; Orosz et al., 2004; 
Uversky, 2002). TPPP3/p20 shows similar characterisation to TPPP/p25 and behaves 
more like a disordered protein, while TPPP2/p18 has a rather stable structure and 
behaves in a more ordered fashion (Vincze et al., 2006). The reasons why the TPPP-
like proteins are predicted to behave differently is unclear. However, it cannot simply 
explained by N-terminal region differences (Otzen et al., 2005; Zotter et al., 2011).  
 
Domain structures of TPPP-like proteins in a variety of organisms are shown in Fig 
4.10-A. When I used InterPro Scan to analyse the domain architectures for each 
protein, the program also identified an EF-hand domain (participation in Ca2+-binding) 
shown on the cartoon (Fig 4.10-A). The CLUSTAL OMEGA sequences alignment 
between Tbp25 and human, T. brucei, L. major, P. falciparum, C. reinhardtii as well 
as P. tetraurelia, are shown in Fig 4.10-B to F respectively.  The results show good 



































TPPP2/p18      MASEAEKTFHRFAAFGESSSSGTEMNNKNFSKLCKDCGIMDGKTVTSTDVDIVFSKVKAK 
Tbp25a         ----MEAVFYAFASFGTAP--TKEMDNAHFSKMLKEAKI-IGKTFTSTDADLLFNKIKAK 
                    * .*: **:** :    .**:* :***: *:. *  ***.****.*::*.*:*** 
 
TPPP2/p18      NARTITFQQFKEAVKELGQKRFKGKSPDEVLENIYGLMEGKDPATTGATKATTVGAVDRL 
Tbp25a         GARKITFTEFNTRALPDIATKLK-MTPEQVAE----ILTKASPASNS-T---KAEAVKFH 
               .**.*** :*:  .     .::*  :*::* *    ::   .**:.. *   .. **.   
 
TPPP2/p18      TDTSKYTGTHKERFDESGKGKGIAGREEMTDNTGYVSGYKGSGTYDKKTK------- 
Tbp25a         DDKNLYTGVYKAG-----------GPTNVDRNAGSLSGVVDRRVDQVDVRGTTSSQK 









TPPP2/p18      ----------------------------------------------MASEAEKTFHRFAA 
TPPP/p25       MADKAKPAKAANRTPPKSPGDPSKDRAAKRLSLESEGAGEGAAASPELSALEEAFRRFAV 
TPPP3/p20      -----------------------------------------MAASTDMAGLEESFRKFAI 
                                                               :  *::*::**  
 
TPPP2/p18      FGESSSSGTEMNNKNFSKLCKDCGIMDGKTVTSTDVDIVFSKVKAKNARTITFQQFKEAV 
TPPP/p25       HGDARATGREMHGKNWSKLCKDCQVIDGRNVTVTDVDIVFSKIKGKSCRTITFEQFQEAL 
TPPP3/p20      HGDPKASGQEMNGKNWAKLCKDCKVADGKSVTGTDVDIVFSKVKGKSARVINYEEFKKAL 
               .*:  ::* **:.**::****** : **:.** *********:*.*..*.*.:::*::*: 
 
TPPP2/p18      KELGQKRFKGKSPDEVLENIYGLMEGKDPATTGATKATTVGAVDRLTDTSKYTGTHKERF 
TPPP/p25       EELAKKRFKDKSSEEAVREVHRLIEGKAPIISGVTKAISSPTVSRLTDTTKFTGSHKERF 
TPPP3/p20      EELATKRFKGKSKEEAFDAICQLVAGKEPANVGVTKAKTGGAVDRLTDTSRYTGSHKERF 
               :**. ****.** :*..  :  *: ** *   *.*** :  :*.*****:::**:***** 
 
TPPP2/p18      DESGKGKGIAGREEMTDNTGYVSGYKGSGTYDKKTK--- 
TPPP/p25       DPSGKGKGKAGRVDLVDESGYVSGYKHAGTYDQKVQGGK 
TPPP3/p20      DESGKGKGIAGRQDILDDSGYVSAYKNAGTYDAKVKK-- 
               * ****** *** :: *::****.** :**** *.:    
 
(A) 
150 aa  p25 superfamily/EF hand domain 
170 aa  p25 superfamily/EF hand domain 
219 aa  p25 superfamily/EF hand domain 








151 aa  p25 superfamily/EF hand domain Ch.reinhardtii 
 
151 aa  p25 superfamily/EF hand domain P.tetrarelia 
 









TbP25a                --MEAVFYAFASFGTAPTKEMDNAHFSKMLKEAKIIGKTFTSTDADLLFNKIKAKGARKI 
TcCLB.504199.20       MSIESAFYAFASFGGAPTKEMDNAHFSKMLKETKVIGKQFTSTDADLLFNKVKAKGARKI 
TcCLB.506635.130      MSIESAFYAFASFGGAPTKEMDNAHFSKMLKETKVIGKQFTSTDADLLFNKVKAKGARKI 
                        :*:.******** *****************:*:*** ************:******** 
 
TbP25a                TFTEFNTRALPDIATKLKMTPEQVAEILTKASPASNSTKAEAVKFHDDKNLYTGVYKAGG 
TcCLB.504199.20       TLSDFVDKAVPEIASKLKKSAEELIADISSCSPEARATKADAVKFHDDKNMYTGVYKAGG 
TcCLB.506635.130      TLSDFVDKAVPEIASKLKKSVEELIADISSCSPEARATKADAVKFHDDKNMYTGVYKAGG 
                      *:::*  :*:*:**:*** : *::   ::..** :.:***:*********:********* 
 
TbP25a                PTNVDRNAGSLSGVVDRRVDQVDVRGTTSSQK 
TcCLB.504199.20       PTNVDRNSGSLSGVVDRRVAQTDVRGTTASQK 
TcCLB.506635.130      PTNVDRNSGSLSGVVDRRVAQTDVCGTTASQK 




Tbp25a                 ---MEAVFYAFASFGTAPTKEMDNAHFSKMLKEAKIIGKTFTSTDADLLFNKIKAKGARK 
LMJSD75_340023800      ---------------------MDNSHFSKMLKECKIIGKSFTSTDADLLFSKVKAKEARK 
LmjF.34.1520           MDNFQATFEAFASFGSAPSKEMDNSHFSKMLKECKIIGKSFTSTDADLLFSKVKAKEARK 
LmjF.34.1530           ---------------------MDNSHFSKMLKECKIIGKSFTSTDADLLFSKVKAKEARK 
                                            ***:********.*****:**********.*:*** *** 
 
Tbp25a                 ITFTEFNTRALPDIATKLKMTPEQVAEILTK----------------------------- 
LMJSD75_340023800      ISFTEFKEKAIPEIAAKMKKTPADIEAMITNAAPKSSGTKADTVRFHDDKSTYTGAAKQG 
LmjF.34.1520           ISFTEFKEKAIPEIAAKMKKTPADIEAMIA------------------------------ 
LmjF.34.1530           ISFTEFKEKAIPEIAAKMKKTPADIEAMIA------------------------------ 
                       *:****: :*:*:**:*:* ** ::  :::                               
 
Tbp25a                 ---------------------------------------ASPASNSTKAEAVKFHDDKNL 
LMJSD75_340023800      ADERGPKRRLARGCRGKAIPEIAAKMKKTPADIEAMIANAAPKSSGTKADTVRFHDDKST 
LmjF.34.1520           --------------------------------------NAAPKSSGTKADTVRFHDDKST 
LmjF.34.1530           --------------------------------------NAAPKSSGTKADTVRFHDDKST 
                                                              *:* *..***::*:*****.  
 
Tbp25a                 YTGVYKAGGPTNVDRNAGSLSGVVDRRVDQVDVRGTTSSQK 
LMJSD75_340023800      YTGAAKQGGPTNVDRNAGSLAGVVDRRQETINNRGFTA--- 
LmjF.34.1520           YTGAAKQGGPTNVDRNAGSLAGVVDRRQETIDNRGTTAKQI 
LmjF.34.1530           YTGAAKQGGPTNVDRNAGSLAGVVDRRQETINNRGFTA--- 




































TPPP/p18             MASEAEKTFHRFAAFGESSSSGTEMNNKNFSKLCKDCGIMDGKTVTSTDVDIVFSKVKAK 
P.vivax              ----MENAFYIYTK------NEADMDSRTFVKILKDAKLLS-KKLTAVDADLTFAKVKAK 
P.tetraurelia        MQGNVQQVFLQFTA------NKPEMDGKTFAKVSKDCHLLD-KKLTSTDVDLIFAKIKPT 
Ch.reihardtii        MSDALKNAFIAFASYGKGQMMKQDMDNKNFSKCIKDSGILD-KVITSTEVDITFMKVKAK 
LmjF.34.1520         -MDNFQATFEAFASFGSA--PSKEMDNSHFSKMLKECKIIG-KSFTSTDADLLFSKVKAK 
Tbp25a               ----MEAVFYAFASFGTA--PTKEMDNAHFSKMLKEAKIIG-KTFTSTDADLLFNKIKAK 
TcCLB.504199.20      --MSIESAFYAFASFGGA--PTKEMDNAHFSKMLKETKVIG-KQFTSTDADLLFNKVKAK 
                          : .*  ::          :*:.  * *  *:  ::. * .*:.:.*: * *:* . 
 
TPPP/p18             N-ARTITFQQFKE-AVKELGQKRFKGKSPDEVLENIYGLMEGKDPATTGATKATTVGAVD 
P.vivax              G-AKRINYDQFVE-AVKHLVDKH--KLDYDQFVEKLCNE-ASSGPI----LYGTKAANVR 
P.tetraurelia        PAARSITYAQFEK-GLQMMAEKK--GVGVQDVHNQIL---NAGGPH----FQGTKADAVK 
Ch.reihardtii        T-DRTINFAQFCT-ALEHFAAKR--GVSVDSLHAK-V---EAASPT----SNATQAEAVK 
LmjF.34.1520         E-ARKISFTEFKEKAIPEIAAKM--KKTPADIEAM-I---ANAAPK----SSGTKADTVR 
Tbp25a               G-ARKITFTEFNTRALPDIATKL--KMTPEQVAEI-L---TKASPA----SNSTKAEAVK 
TcCLB.504199.20      G-ARKITLSDFVDKAVPEIASKL--KKSAEELIAD-I---SSCSPE----ARATKADAVK 
                        : *.  :*   .:  :  *        ..            *       .* .  *  
 
TPPP/p18             RLTDTSKYTGTHKERFDES--------GKGKGIAGREEM-TDNTGYVSGYKGSGTYDKKT 
P.vivax              FHDDKSTYTGVHKMGGPTTVDKNKTHFSDISEITDRSEC--NIRGVN-------LSVEKN 
P.tetraurelia        FHDDKNLYTGVHANGGPSTIDKN-H--GGLNTICDRSQA--DVRGSQ-------KMMKNI 
Ch.reihardtii        FHDDKNLYTGVYKNGGPTNIDKQAA--GGLAGHLDRSPA--DVRGVK-------F----- 
LmjF.34.1520         FHDDKSTYTGAAKQGGPTNVDRN-A--GSLAGVVDRRQETIDNRGTT-------AKQI-- 
Tbp25a               FHDDKNLYTGVYKAGGPTNVDRN-A--GSLSGVVDRRVDQVDVRGTT-------SSQK-- 
TcCLB.504199.20      FHDDKNMYTGVYKAGGPTNVDRN-S--GSLSGVVDRRVAQTDVRGTT-------ASQK-- 
                        *.. ***.       .        .      .*     :  *                
 
TPPP/p18             K 
P.vivax              L 
P.tetraurelia        - 
Ch.reihardtii        - 
LmjF.34.1520         - 
Tbp25a               - 



















Figure 4.10 (A) Schematic cartoons of p25 domain structure within different organisms. (B, D-
E) Multiple sequence alignments between Tbp25 protein against human, T. cruzi, L. major P. 
falciparum, C. reinhardtii, and P. tetraurelia using the ClustalOmega analysis. (C) Multiple 
sequence alignments between three human TPPP-like proteins. (F) Multiple sequence 
alignments compared all TPPP-like proteins that came back with good e-value(s) when Tbp25 
was the query sequences. The p25 domain/EF hand domain is normally located at central of 
the protein sequences (yellow highlights) “*” indicates identical aa and “:” indicates conserved 
aa.  
(F) 
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4.10   TCP-1- (T-Complex Protein 1 subunit epsilon) 
 
The TCP-1-is a molecular chaperone that belongs to chaperonin containing TCP-1 
complex (CCT), also known as the TCP1 ring complex (TRiC). The common structure of 
this complex consists of two identical stacked rings, each containing eight different 
proteins, but homologous subunits, which are designated as CCTα, CCTβ, CCTγ, CCTδ, 
CCTε, CCTζ, CCTη, and CCTθ (Liou and Willison, 1997). TCP-1 complex was first 
identified as chaperone for actin and tubulin filaments assembly in biogenesis (Yaffe 
et al., 1992), later studies demonstrated that TCP-1 also involved in the folding of 
newly synthesised cytosolic protein substrates (Dekker et al., 2008; Spiess et al., 2004; 
Yam et al., 2008). Furthermore, proteomic and genomic approaches reveal that TCP-
1 complex interacts with a large number of proteins associated with either the spindle 
pore, protein degradation pathways or the cell wall/membrane (Dekker et al., 2008). 
Like all the chaperones, TCP-1 complex can bind with ATP, but rather through 
cofactors, it has a built-in lid located in the apical domain of each subunit responsible 
for closing the central cavity (Leitner et al., 2012). 
 
In human, mutation in TCP-1-CCT5 gene can lead to hereditary sensory and 
autonomic neuropathy with spastic paraplegia (HSNSP) (Min et al., 2014).  Moreover, 
evidence also suggests that as part of the BBS/CCT complex, it might also be involved 
in BBSome assembly in order to regulate the transport of vesicles to cilia during 
ciliogenesis (Seo et al., 2010). The TCP-1 complex is conserved in all organisms; 
eukaryotes, archaebacteria and eubacteria (Kubota et al., 1995).   
 
At the starting point for my bioinformatics analysis, I performed a NCBI BLAST search, 
using TbTCP-1- as my query against human and all the organisms listed in the Table 
4.1. Considering the critical roles of TCP-1 complex in protein folding it was not 
surprising that all the selected organisms appear to have multiple TCP-1 genes. 
Because there are so many hits with a good e value, I only took the top hit from each 
organism for further domain and multiple sequence alignment.  Fig 4.11 –A shows the 
domain structures of all organisms in the table. Both ciliated and non-ciliated 
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organisms share extremely similar domain architectures. In most of the organisms 
(apart from in C. elegans), three possible domains are detected by InterproScan 
analysis; (1) GroEL-like equatorial domain that carries ATPase activity (2) GroEL-like 
apical domain, and (3) TCP-1-like chaperonin intermediate domain involved in 
substrate binding (Pappenberger et al., 2002; Roseman et al., 1996).  The CLUSTAL 
OMEGA sequences alignment between TbTCP-1- to the top hit TCP-1 protein from 
each organism is shown in Fig 4.11-B.  The results reveal good conservation within the 
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Figure 4.11 (A) Schematic cartoons shows the domain structures of TCP-1- in different 
organisms. Different domains are indicated by different colours. (1) GroEL-like equatorial 
domains that locate at both C and N terminus are in red; (2) GroEL-like apical domain is located 
at the central of the sequences in orange; (3) TCP-1-like chaperonin intermediate domain, 
which can be found between the GroEL-like equatorial and apical domain shows in blue. (B) 
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4.11   Protein Kinase (Tb927.9.6560) 
 
In eukaryotes, protein kinases are enzymes that play an essential role in 
communicating intracellular signals within cells and are invovled in many cellullar 
process, such as cell division, proliferation, apoptosis, and differentiation (Manning et 
al., 2002a).  In humans, there are more than 568 members within the eukaryote 
protein kinase (ePKs) family, which constitutes more the 2% of the entire human 
genome (Manning et al., 2002b). ePKs share a high degree of conservation at the 
amino acid sequence level and in their catalyitic domian structures (Hanks et al., 1988; 
Taylor and Radzio-Andzelm, 1994). Among all the ePKs, the majority of members are 
invovled in phosphorylation of proteins on serine/threonine residues, and are derived 
from protein-serine/threonine kinases (STKs) that evolved in the early metazoan 
evolution (Rokas et al., 2005). There is another group of kinases, named as atypical 
protein kinases. Family members of this kinase group shares less sequence identity 
and structural similarity to most of the typical protein kinases. There is less 
information on these atypical protein kinases, however, some studies suggest they 
diverged early in evolution and have followed a distinct evolutionary track (Leonard 
et al., 1998; Middelbeek et al., 2010).  Protein kinases are also found in bacteria, 
plants, worms and flies. However, some of the conserved functions or pathways have 
been lost or expanded during each evolution lineage (Manning et al., 2002a).  For 
example, some kinases can be found in both humans and flies and share conservation  
in morphogenesis and neurobiology function, but are missing from the worm gemone, 
which indicates these functions could have evolved after nematodes diverged from 
main metazoan lineage (Manning et al., 2002a). 
 
The protein kinase encoded by Tb927.9.6560 is 726 amino acid long; the protein 
kinease domain covers the N-terminus and nearly reaches the central region.  The 
Tb927.9.6560 protein kinase is currently annotated as a NAK pseudokinase (Parsons 
et al., 2005), as it is missing an essential catalytic residue. When I performed a NCBI 
BLAST using the Tb927.9.6560 as my query, all of the chosen organisms came back 
with good e values.  Again, for further protein domain and multiple sequence 
alignment I only took the top hit for each organism.  The protein domain analysis was 
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performed by InterProScan/Prosite (Fig 4.12-A), and all proteins encoded a protein 
kinase domain within their amino acid sequence. However, where the domain is 
located differed slightly from organism to organism, and the length of the top hit 
proteins also varied. Proteins from most of the organisms shown in Fig 4.12 appear to 
have N-terminal protein kinase domain; apart from C. reinhardtii where the protein 
kinase domain covers nearly the entire sequence.  Some data has suggested that the 
N-terminal protein kinase domain is normally a glycine-rich region close to a lysine 
residue, which has been shown to be involved in ATP binding.  When the protein 
kinase domain is located in the central part, it consists a conserved aspartic acid 
residue which plays an important role in the catalytic activity of the enzyme (Knighton 
et al., 1991). Tbprotein kinase (Tb927.9.6560) only shares 30% amino acid identity to 
human Adaptor-Associated Kinase 1 (AAK1) protein (AAI43711.1), which acts as a 
positive regulator in the Notch pathway (Gupta-Rossi et al., 2011).  To date, in T. brucei 
there are 158 eukaryotic PKs (ePKs), 12 predicted pseudokinases and 20 atypical PKs 
(aPKs; despite their lack similarly of conserved sequence to the ePK domain HMM, but 
aPKs still have protein kinase activity) (Nett et al., 2009; Parsons et al., 2005; Urbaniak 
et al., 2012). 
 
I have also performed a reciprocal BLAST using the human AAK1 protein as the query 
sequence to check if there are any other protein kinases in T. brucei that are more 
similar to this human protein.  This analysis showed that the Protein Kinase 
(Tb927.9.6560) was the second hit, and a protein called NIMA-related protein kinase 
(Tb927.10.460) came back as the top hit.  Pradel et al., (2006) have shown that this 
protein is a basal body-cytoskeletal NIMA-related kinase (NRK) protein (TbNEKC), 
which plays critical roles in basal body segregation.  RNAi knockdown of TbNRKC and 
overexpression of kinase-null TbNRKC can lead to the accumulation of cells with four 
basal bodies and cytokinesis defects (Pradel et al., 2006). CLUSTAL OMEGA sequence 
alignment comparisons between Tbprotein kinase and the top hit of protein kinase in 
each organism is shown in Fig 4.12-B.  The results reveal that when all sequences were 
compared they did not show good amino acid conservation.  However, when I just 
used T. brucei, T. cruzi and L. major the conservation at the N-terminus was much 
improved Fig 4.12-C.  


























































































L.major             MN--FLGGSL----RSGGGHRREKGFSAK---------NKVQQYHGDGSESIVLAGRPFR 
T.brucei            -------MGS----DSKSSKSKDKNFSSK---------GKIEKYNKDGTETILIMGRPFR 
T.cruzi             MSTFRMAQAR----ITGRKSNKDKSFSSK---------GKIEKYNQDGTETIIVMGRPFR 
G.intestinalis      ------------------------------------------------------MSHTLR 
Ch.reinhardtii      MKK------------------------------------LFGGNKKKEKEGTLVGKT-VM 
H.sapiens           MKKFFDSRREQ----------GGSGLG---------SGSSGGGGSTSGLGSGYIGRVFG- 
C.owczarzaki        MKKFLSSAANAVNTISSSAGRGGGVFSSAAGGASANSSSLVGGAADDSGAQAFIGRTISM 
C.elegans           -----------------------MAFARA----LGVIQSVGRGAGISEQSELYDRGQTFS 
S.cerevisiae        -------------------------------------------MNQPQIG-TYNVGTQLT 
D.discoideum        --------------------------------------------------MGNNQGKTLK 
P.falciparum        ------------------------------------------MLKFRSICTTLIGGKVYN 
P.tetraurelia       -----------------------MNF----------------FMNLFGQGSSGPQPESYE 
                                                                                 
 
L.major             VLQKISDVPP-PYMVTRQRSTKYGEGGSSYVYLVENTSHLPE-FPRHLALKRSFFG-VDQ 
T.brucei            IVQRLSEKVLNPEAKSSKKSSKKAKDVYSYIVVVENIEALPM-FARYVVVKRTFFK-IDE 
T.cruzi             VLQNIGASENHI-SSHKERDHKFAKHLRSFVFLVENTENLSE-FPRHFALKRSFFN-VNE 
G.intestinalis      FGD-----------KDIVVGQEIAKGGSARIYSASCA-------GEQYVLKHLSVTDPKI 
Ch.reinhardtii      VGP-----------FSVRVEAIVGEGGFATIYRCIDGK-----TGLAYALKHMRLA-PDT 
H.sapiens           IGR-----------QQVTVDEVLAEGGFAIVFLVRTS------NGMKCALKRMFVNNEHD 
C.owczarzaki        TGG-----------SRVMVESLIAEGGFAYVFRARDLG-----NGQAVALKRVSVA-SED 
C.elegans           ING-----------NNYRVEKVIAKGGFGTVFLATNTK------GKQVAVKIMLSHDAAA 
S.cerevisiae        VGS-----------HQVEIIKYLTSGGFAQVYSALINPPDPHSNSSVACLKRVIVPDKPS 
D.discoideum        IGS-----------YHLNFVKQIAEGGFSYVFLVKDSN-----TSKHYALKRILIRDEDE 
P.falciparum        ING-----------KTIREEKLISEGAYSFVYMAKDLN-----TNRAYTIKKTICQDKEK 
P.tetraurelia       ING-----------QEYHELNLIAEGGYGFIWRAIETK-----TRKFCVIKKIICQSKEA 
                                            .   . :                  :*          
 
L.major             VMEAHKEVEIVSRIE-DKNIVRVYHSEISRS----------------------------- 
T.brucei            VLLAHREPEILNRVR-DKGILHVFHSEVTRN----------------------------- 
T.cruzi             VLLAHREPEVLARVS-DKNIVRVFHTEVTRS----------------------------- 
G.intestinalis      YDDAITEIYFHLQFNNEKCVVRLHGLLLDDTYIPANFARFDEYLTLNDMHSSQSHLASSI 
Ch.reinhardtii      VDEVKAEAKVMARLKGHPNILRLHAVAFGGP----------------------------- 
H.sapiens           LQVCKREIQIMRDLSGHKNIVGYIDSSINNV----------------------------- 
C.owczarzaki        VAKIKSEIDFMQILSGHKNIVALKDYTLSQV----------------------------- 
C.elegans           TKDIDNEIDMMKKLQ-HENIIQLFDASAESR----------------------------- 
S.cerevisiae        LNTLRAEVDAMRLLKNNRYVVSYIDSHAAKA----------------------------- 
D.discoideum        LKGVKHEISIMKRLTKHKNIVKILDYHKVS------------------------------ 
P.falciparum        IDMAHKEINILKSLPPHKNIVQYYGSTIIS------------------------------ 
P.tetraurelia       IEQAQLELDLHRKLQ-HPNIVKCYNGVIKFN----------------------------- 
                          *      .  .  ::                                        
 
L.major             --------------------------------------EGRLGVSIAMEYCSNNLYHRIR 
T.brucei            --------------------------------------DGRLGTTVAMEYCPGSLEQRLQ 
T.cruzi             --------------------------------------DGKLGVTVAMEYCSNNLYRQLR 
G.intestinalis      KSSQFANQEPGLNLSSSALPVPGVSHGGHDSNRRNTTKLPCTNIRLLLEYCSGGNCVKLL 
Ch.reinhardtii      -------------------------------------TGAETDGFMLLDFCPLTLLE-VM 
H.sapiens           -----------------------------------S-SGDVWEVLILMDFCRGGQVVNLM 
C.owczarzaki        -----------------------------------R-AG-LYQGFMAMELCTGGQVIDLM 
C.elegans           -----------------------------------SSNRSVKEYKISMEYCKFSIA-DVL 
S.cerevisiae        -----------------------------------MLHNGSYEVFVLMEYCERGGLIDFM 
D.discoideum        -------------------------------------DKNNTEMFILMEYCSGGHLVEIM 
P.falciparum        -------------------------------------ENNYKIVIMLMEYCERGNLLNIF 
P.tetraurelia       -----------------------------------K-KLNQTIAYMVLELCEGGTLIDLL 
                                                                 : :: *       .  
 
L.major             SSAGTGIVTRLTEAEICHVMFAVTSAVGYLHAQQPPITHRDIRPENILINNKHA------ 
T.brucei            QE------TRMLESEVVQVLLALASVLGYLHSRQPPVAHRNINPSNVLIHSESA------ 
T.cruzi             PD------TRVPEGEIVQVLLGITSAVGYLHSRQPPIAHRDICPENILIHSGST------ 
G.intestinalis      IKCS-EHRVFLPEPLIWRFAYNITLAILCLHSK--GCSHRDLKLENILILEPYTLDDILE 
Ch.reinhardtii      Q-RN---NFALDDFLVYEVFQDVVWAVAHMHKCNPPLAHRDLKAENVLKNG--------- 
H.sapiens           NQRL---QTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHD--------- 
C.owczarzaki        NSH----RNGIPEAEVLRILSDVVEAVAFMHSRSPPIIHRDLKVENVLIAS--------- 
C.elegans           LKYK-----EVSIDFVVRIIYFTTRALVYLHSV--GAIHRDIKAENLLING--------- 
S.cerevisiae        NTRL---QNRLHEFEILQIMSQVTQGVAAMHALQPPLIHRDIKIENVLISA--------- 
D.discoideum        QKRL-SSGSKFTDQEILKIFQDICESVAYMHSQQPLIIHRDLKVENVLLDEE-------- 
P.falciparum        QKNK----DKIKEIHIVNILKDIITGLCFLHNQEIPIIHRDIKLENILCDK--------- 
P.tetraurelia       KRYN---EKRLSEQQVLLVLKQLVQAIKYLHTQQPPITHRDLKVENVLLH---------- 
                              .    :  .       :  :*       **::  .*:*             
 
L.major             -------GPTAYKLTNFGNATTEAYQCE-------TREEANMAIADIQMHTNPAFRAPEM 
T.brucei            -------GASAYRLYNFRSAMTEAYHCE-------NHEEVVAAMEDFARYTTAGYRAPEM 
T.cruzi             -------GAASYRLCNFSSATTEAYHCA-------NREEVAMAVEDIERNTSPGYRAPEM 
(B) 
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G.intestinalis      NNGCTTKFPEFLRLCDFGSCTMESYDSERLRDMMENEQGMKELMRSLELKTTPCFRAPEQ 
Ch.reinhardtii      --------EGRWVICDFGSATSRAQVYD-------SSADIAAEEDVIRRTTTPAYRAPEM 
H.sapiens           --------RGHYVLCDFGSATNKFQNPQ-------T-EGVNAVEDEIKKYTTLSYRAPEM 
C.owczarzaki        --------PGHYKLCDFGSATDKAVVPK-------S-PHIPDIEEDIQKHTTIQYRAPEM 
C.elegans           --------NGKLKLCDFGSATTKSIEMA-----PLSNSERLAVQEEMFKYTTPITRSPEV 
S.cerevisiae        --------NNKYKLCDFGSVCGIIRPPR-------NSQELSYVQQDILKNTTAQYRSPEM 
D.discoideum        --------SGIYKLCDFGSATEEITRMK-------NKTEMQNAEDDISRHTTLQYRAPEI 
P.falciparum        --------NGVYKICDFCSHSISNSFFP----NDLSKSELSNLKEEIERDTTLIYRPPEL 
P.tetraurelia       --------NKVFKICDFGSASTENIDLKY---CQSNKHQISQYEENFAKQTTEIYRPPEM 
                                 : :* .                .          :   *.   * **  
 
L.major             ADPWSKKRICEKTDMWSMGVLLYYMMYMSLPFDPST-TIVKDWALTFPSE---------- 
T.brucei            LDPSSHKRIDEQVDMWALGVLLYYTMYQRLPFTDACWGLARKPKLRYPVE---------- 
T.cruzi             ADPGSGKRIDERVDLWSIGVLLYYMMYLRLPFGETNMGLTGRLKLRFPAG---------- 
G.intestinalis      IKIDPEFPLGTAVDVFAFGILLYRLMYRRLPFPDNDLRYNYRAEFSFQD----------- 
Ch.reinhardtii      WDLYTRQRIDTAVDVWALGVLLYVLAFGKLPFPGDSKLAILYGNEASGGSNGAGAPPDAP 
H.sapiens           VNLYSGKIITTKADIWALGCLLYKLCYFTLPFGES-QVAICDGNFTIPD---------NS 
C.owczarzaki        IDLYSGKCIDTKADIWALGCMLFRLCYFVTPFEES-SVRIISGTYTTPA---------TP 
C.elegans           CDVYSNWPIGKQQDNWAMGCLIYFVAFGEHPFD-GSALAIINGKYKKPPP---------- 
S.cerevisiae        IDTFRGLPIDEKSDIWALGIFLYKLCYYTTPFEKGGDLAILSGKFEFPLY---------- 
D.discoideum        VDFYRSPVINEKIDIWALGCLLYKLLFYVTPFEDSGSLGILNSNYTIPPN---------- 
P.falciparum        IDLYSNFEISWKIDIWMVGCILYLLLFKIHPFQNNNFLSIINATFTIPYC---------- 
P.tetraurelia       TDLYLKYEINEKVDIWMLGCILYTMCFYNPPFQESSKLAIVEASYVIPKE---------- 
                     .      :    * : .* :::   :   **                             
 
L.major             ---ATASYTPSLRVI-TEHLLDPDPCSRW-------DVFALINYMRFDEDCSRHLGTFC- 
T.brucei            ---AEVWYTGSLRIV-LEHLLEPDPEKRW-------DAFALINFMRFDNDLCRHIGPFC- 
T.cruzi             ---TEMWYTGSLRVV-LAHLLEPDPDKRW-------DIFALTNFLRFDDEIGKHIGTFF- 
G.intestinalis      ---KRVKYSDALKNI-ISLCLVQHPKDRV-------SIFEIHKLVRNEVRNLGFIETNI- 
Ch.reinhardtii      TVPHPHPYPAPMPPQPYPYPQHPHPQAAQAHPGAVARVPVQPQQQPDLLGDACPEPPVT- 
H.sapiens           R------YSQDMHCL-IRYMLEPDPDKRP-------DIYQVSYFSFKLLKKECPIPNVQ- 
C.owczarzaki        V------YSDPIHRL-IKYMLDVDPDYRP-------NMTEVAHAVFTVRGLQSPIPLVA- 
C.elegans           ---VQQNQLSAFADL-IAKCLTPNPDERI-------TAAKIEEYMKLAMQKQPKLAAKTD 
S.cerevisiae        ---PN--YSEQLKGL-IRDILVQDPRHRP-------NVYQLLKRISIMQNVPC----P-- 
D.discoideum        ---HT--HSNDLISL-IKIMLNPDPINRP-------NIFEITNQLNLLRNQQPLFPSH-- 
P.falciparum        ---TK--YSKRIISI-LLMTLNKNPQKRI-------DTSTLLFILENYADLKKWFVHI-- 
P.tetraurelia       ---NK--YSNKMINL-IGIMLQPNPKDRA-------SIFQIEDILKNYDTLTQIVINN-- 
                               :           .*                                    
 
L.major             FTKTEWPEGWEEQDVKVLGRTPPPKAPPVSYNEPGHEQLDSRGLRGQERVHGHTNGHQPP 
T.brucei            FSQTERPEGWEPQDVKVIGRPVPAKVLPERLRNTGQSDDPAAAARDNRDEAAAT-----S 
T.cruzi             FAQTEWPDGWEQQDVKVVNRQVPRKAPPIRVNTPKHADNTKNATDAGTKNRMQA-----S 
G.intestinalis      FSTTGQSN-SLARSTRVSILHAAPEA--------AHPPATENTVNIV------------- 
Ch.reinhardtii      -ARLQP-E-RA---------------------EVARLAAHNAALE--------------- 
H.sapiens           -NSPIP-A-KLPEPVKAS-EAAAKKT-QPKARLTDPIPTTETSI-AP----RQ------R 
C.owczarzaki        -QQRGE------RPVQPV-QSA------PVKLQVTPIASTASPVQSR----RE------R 
C.elegans           FTDILD-L-MNVQPVQAE-QSIESQAAKGFFTMQDKLFSNLTSLKNTVV--QQ------T 
S.cerevisiae        INDIQ--------VVQAP-SSH------LNLTQLHQLSATQNILSLN-S--PT------T 
D.discoideum        KSNIL--------LSYNE---------------NNNINNNNNNINNN-N--NN------N 
P.falciparum        PADIK--------KRV------------------NQIFEKMNELNMN-N--KH------T 
P.tetraurelia       INDQD--------SK-------------------NQQEDDFGEFQSG-D--QK------T 
                                                                                 
 
L.major             DDRGNGRDSAVVDGAAVQEAMIVLGGDPADDDPAVAKYRHQIIMVQQEAWRRAKAAAGLR 
T.brucei            VKSRTAAQESGDNDQMVLKAVTALSSDTASTDPEVLAYREKLIREQEEAWQVAESAHKKR 
T.cruzi             SEMERGSSMGGDVGELDAAALAALGLDGDSKDPEMRKYYKMLIQEQEDAWRMAKSASQAS 
G.intestinalis      -----------------------------------LAYKPMIPKTVHGDL------TVVL 
Ch.reinhardtii      ---GRVRQ-----------------------LEGLVAAQGSALQRLAADL------SA-- 
H.sapiens           PKAGQTQP-----------------------NPGILPIQPALTPRKRATV------QP-- 
C.owczarzaki        PKASA------------------------------------------------------- 
C.elegans           NKMGWGME---------------------------------------------------- 
S.cerevisiae        MEN--TMP-----------------------NATF---QISM------------------ 
D.discoideum        IVNGKNIP-----------------------KP-----LPKV------------------ 
P.falciparum        D----LIE-----------------------VS-----HEKL------------------ 
P.tetraurelia       Q----E-------------------------QQ-----Q--------------------- 
                                                                                 
 
L.major             DSPPTEPQESSAAP-----A-----------------------PT-RANN----EAQKDV 
T.brucei            DKEDKDGATSGPADVDSLFGPTEKKEAVKE-NKASAIDDLFGGME-TQPS----QSQKPT 
T.cruzi             AKNKSG-DTTNVNNRQ---AQETREEKQREEEPPKQIQ------D-NPPN----DNTPNL 
G.intestinalis      DKEDSGGLDLSQASMGNLSLLEDTIASV---TSASQ---TVTGIDTGQSLSHSK----YA 
Ch.reinhardtii      ---------------------------T-----SER---QVSG---SAPY--PP------ 
H.sapiens           -PPQAAGS----------SNQPGLLASV---PQPKP---QAPP---SQPL--PQ----TQ 
C.owczarzaki        ---------------------PATLVSF---NQ------QAGP----------------- 
C.elegans           -------------------------PTN---TTPRP---GHPS---TSPKLVPKTHRSNQ 
S.cerevisiae        -------------------------ADN---TTTAQ---MHPN---R------------- 
D.discoideum        -------------------------VSQ---TTPTP---TPPP---P------------- 
     
171 
 
P.falciparum        -------------------------IDV---KISSQ---KYE------------------ 
P.tetraurelia       --------------------------------QKTV---QYD------------------ 
                                                                                 
 
L.major             FDDLFASASPTVFPA-SQAS--PAMGPSAPPATHQPPE------KDVF------------ 
T.brucei            TDDLFGGASTATAS-------------NQIPPQGSQVGANDSWKDDLFAAPP-------Q 
T.cruzi             FDDLFAPSPAAQASS-GS-----LQAPSQPTVSRNPVTGGQNWPDSLFSGVPPSQPLSQQ 
G.intestinalis      FTRSLAGSVGVNINLGLSASGVPACGDRGH----------TGARDRLTVSAIS----GLA 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           AKQPQAPPTPQQTPS-TQAQGLPAQAQATP----------QH-QQQLFLKQQQ---QQQQ 
C.owczarzaki        --------ASQ-QPF-GSAQ---------------------------------------- 
C.elegans           QQEKNAPPRPPTTAS-PRAA---------------------------------------- 
S.cerevisiae        --------KPSQI------A---------------------------------------- 
D.discoideum        --------APSQSPS---PS---------------------------------------- 
P.falciparum        ------------TNL---PK---------------------------------------- 
P.tetraurelia       ------------DSL---I----------------------------------------- 
                                                                                 
 
L.major             ------------SASDLFSTSAPQLDPSYPVMNTYGQAP--------------------- 
T.brucei            QPQMQPQPAFPMAADSSWSTGAPTSVPMNPTGGMMGQQQAPMGW---------------- 
T.cruzi             QPPLHAQNSYDMMMDSGWGTGAPTMAPVG---GAYDVGAMYAG----------------- 
G.intestinalis      DPR----AAYPGRFMQSPQCDVGLSESILMALGTPEAPHLVEELRNSIS----------- 
Ch.reinhardtii      ---I--GYEDLT------------------------------------------------ 
H.sapiens           PPPA--QQQPAGTFYQQQQAQTQQFQAV-H----PATQQPA------------------- 
C.owczarzaki        -PFA--GTQEQAAFYQQQQQQQQMFAAQ-QQMMHMSLQHHA------------------- 
C.elegans           ---------PVATFKVSWPTDSSQNDSA-NDWGDFSQAPPAVNV---------------- 
S.cerevisiae        ---------YDASFSNSAKGSQPLFDKS-QNMYHALDPPLVEPLASSVSNNDNELKANSA 
D.discoideum        ---------PSPTVVNNIENNSNGLEHS-NSNGNISQPSPTPPKRR----------ATPG 
P.falciparum        ---------SNNNFL-------KFFTTS-NLSGDIFKKKIEKEE---------------- 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             -----------------------------------QQMAMGGWGSGAPVMGSGGYPMQQ- 
T.brucei            --------GNGVTAPGFQ----------PMQTPQMQQQVPGGWGNGATASG--FQPMQT- 
T.cruzi             --------TQMATAPTFS----------MPPHPPL-QQITPSWGISAPPG---------- 
G.intestinalis      ----------------------------------------DGLTN----AC--------- 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ----------------------------IAQFPVVSQ------------GGSQQQLMQNF 
C.owczarzaki        ----------------------------PAQHHPLPH------------SHHQQQQQQ-- 
C.elegans           --------------------------SKKDVFDPFSESASHNLSA----KHSE------- 
S.cerevisiae        TKLKQAIVSEAHTFRQNNSIDFPLQNIIPQY----ED---------------SSSSSDES 
D.discoideum        T------------TPSLQPVSFPPNNSNNSFDDPFRDSPRTNLSN----NPFNVNSNDNS 
P.falciparum        T------------KKEIKQVGN-------KQVSETEKEPKDKLEN----NPDGNKLQNDK 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             --PQNQQ-------------QAPWGYGVSNANNYAPPLPPQ------QQQQQLQP----F 
T.brucei            --PQMQQ-------------QVPGGWGNGATA---PSFQPM------QTPQMQQQVPGGW 
T.cruzi             -----------------------------------PQSTPM------QQQQQQQP----F 
G.intestinalis      -------------------------------------ITDQQALK-------LEQVE--- 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           YQQQQQQQ----------QQQ---------QQQLATALHQQ---QLMTQQAALQQKP-TM 
C.owczarzaki        -QQQQQQQ----------QQQ---------QQQYHEHASEH------------ASHA-TF 
C.elegans           ---------------DLLSLQ--------------------------------------- 
S.cerevisiae        YSGDVDE---LKKTRSLGSYS-----------TRGNIKKNQSV----------------- 
D.discoideum        NSS--------------NNNNNNNNNNNNNNNNNGNNITNEEILNIITQLTNNDQTN-TF 
P.falciparum        DSGKLQNDNKLQNDKDSGKLQNDKVSGKLQNDRDGNKLQNNHIIDYTDNKMDNDKKN-KS 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             TNF---------L-------------PP---------------------LSGQQPGQQQS 
T.brucei            GNG---------ATAPGF--QPMQT-PQ-M----------------QQQVPGGAPGFMGG 
T.cruzi             NHQ-------------------------------------------------TTMDFAQG 
G.intestinalis      -------------TLPTT--SPVKVSPPAIPEDSLAFKAYSLLPE-TIK----------- 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           AAGQQPQPQPAAAPQPAPAQEPAIQAPV-R--QQP-------------KVQTTPPPAVQG 
C.owczarzaki        GSDQQSA--Y-WAAHRGMTQSAPIVAPV-A--TLV-------------QFDSAPPPAQPS 
C.elegans           -------------NWPGTAEHKPEVRSQ-SSRDL--FDFDDLM------LRHTTPSAE-S 
S.cerevisiae        ----KES--LTSSSLPGTSFTPTSTK---------------------VNLKHENSPFK-S 
D.discoideum        DSGLLLK--LKS-MKPGKGTMHIIVKRP-LKEPLVCFK--SLLLVHALLSEGNNIQFK-S 
P.falciparum        DE-ISEN--IT---SSGDKQNSVPDQSE-NQSKSHSYNLIKIQSKDTLIIDHVDRDFP-S 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             QQQETSQP---------------------------------------------------- 
T.brucei            NDLFQRPQ---------------------------------------------------- 
T.cruzi             SLPTAVPA---------------------------------------------------- 
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G.intestinalis      ERVQTIT----------LY------------ESLHSRLQVN------------IGTLRLE 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           QKVGSLTPP----------------SSPKTQRAGHRRILS-DV----------------- 
C.owczarzaki        ATFDSSDPFSDMPAFAPTASDFPVPSSHSVPPSSAQHLTA-IP----------------- 
C.elegans           SQAV-LQ-PIR-QVENKNLTKVDVSK-NGIGSSSSSASLDDMVSDMMKMSTKK------- 
S.cerevisiae        TFVNTIDNSKD-DLNKPSYEDLDVSK-QSLKNSIQQRMIDKLNSSEESFNARKMSKVKLH 
D.discoideum        DVHD----SKD-LFNN-LYLGW--SK-Q------------------------KD---RYL 
P.falciparum        DKTN----TDF-SFQD-TLCEF--EK-K-------------------------------- 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             -----------------------------------------------------R------ 
T.brucei            -----------------------------------------------------Q------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      PLLPLLL-ETANLFKI-------------------------------------------- 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ------TH--SAVFGVPASKSTQLLQAAAAEASLNKSKSATTTPSGSPRTSQQNVYNPSE 
C.owczarzaki        ------AH--LHLFSPQTDHSPGP-R-SAPPHSFPGPPPAATTQPGA---PPQVTIAPPP 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        EKGEID--------KPIMLKSSGP-------ISKDKKTK--PTPPPKPSHL---KPKPPP 
D.discoideum        QLGELLSHYSLLLYKFILFHQK-N-------YMIDGSFAFEEMKWGIPESL---DSNNHP 
P.falciparum        ----------------CMNNSS-N-------YSNDKKVA---------GDI---KKDDCS 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ----TARATTKRDPFADLFN---------------------------------------- 
T.brucei            ----QQPQQPEKDPFASLFK---------------------------------------- 
T.cruzi             ----EPKPEAKKDPFADLFL---------------------------------------- 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           G--------STWNPFDDDNFSKLTAEELLNKD-F--AKLGEGKHPEKLGGSAESLIPGFQ 
C.owczarzaki        S--------STFAPLNRQTSSLANWDGAPARPLP--AHLGH----RRIGSSPADIRFGHH 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        KPLLLAGRKLSLDK---------------------------------------------- 
D.discoideum        --ISINTIKALFDIMDHLFLVQNNLSDYCINNICSSNSSGSGNVPISLLQHCVN------ 
P.falciparum        --VNI--------------QVVNNNNDVCHND-------------MKDVNECTN------ 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           --STQGDAFATTSFSAG-TAEKRKGGQ----------TVDSG--LPLLSV--------SD 
C.owczarzaki        APPAAGEPFAHS-FSGESVTSSSSAGS----------TWGADFLSPDSST--------NR 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        --ILNSSSYSIFCFISGSIDV--------------------------------------- 
P.falciparum        --LLNLDVFEYENETNDSIKKINDGDFIKQSGCDFIKQNGGDFIKPNDSNCIFADINFNN 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ---------------PFIPLQ---------------VPDAPEKLIEGLK----------- 
C.owczarzaki        ---------------SISPLQ---------------EEDNAK-LVQL------------- 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        -------------------------------LS-KQFSDVDMKLISCVNQFQSMYTRLRE 
P.falciparum        DINLNNDINLNNDIDFFDVIQNHDLKKKEDVLNINRNNEHDKNAITCSNEYYNLS----- 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           -------SPDTSLLLPDLLP----MTDPFGSTSDAVIGKVIISVSSVMHDMCACFKNDKY 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        QYTKLAQVPCFSDIFFPTLPNTAPTFTIVRSNSFNR-------LNSSLSDLNLNNNNNNN 
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P.falciparum        -------------LFYDPWNNNTKDNHFFGDDDYNVNKSSFIFNNDLFDNYELCTNNNTE 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           LVNQSLGNSPA----------------TPEAKAI-------------------------- 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        NNSNNSNNSNNSNSGNLSGNASLNSSFD----NINSSNPFSTEPTFNPFSATTTNTSESG 
P.falciparum        KSTHHVKNNCMDINNNIFSNKNYDEHVDKKEKNISYDYNVKSHPIYSSYKNEK----R-- 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ------------------------------------------------------------ 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        FGNFGLSEPTSNPSPRYQQSNNNNNNNNNNNGTPISLTPGSLSPVIGAKKPPLPPNIHHL 
P.falciparum        ---CNLNDIKQNNSSKYIMSDKND----------------KFSELL-----------DEF 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ------------------------------------------------------------ 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        QQQQHPQQQQQQQQQQQQQQQQQQQQQQQQQQQHPQQQGLRFPHSASLEDARLYTLILTP 
P.falciparum        QKCT-----------------------------------IK------------------- 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ------------------------------------------------------------ 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        SSSPPLSPSTGPTTAAQQQQQQQQSQHTFDNFNINGHAPPVPQSTQPSFQPHVSFAPNVN 
P.falciparum        ------------------------------------------------------------ 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ------------------------------------------------------------ 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        INNNNNSHVSAPHSLNSSSSSISSISNPNLGGIAQKGSGNSLMPPPLYKPAARGHRRSQS 
P.falciparum        ------------------------------------------------------------ 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             ------------------------------------------------------------ 
T.brucei            ------------------------------------------------------------ 
T.cruzi             ------------------------------------------------------------ 
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G.intestinalis      ------------------------------------------------------------ 
Ch.reinhardtii      ------------------------------------------------------------ 
H.sapiens           ------------------------------------------------------------ 
C.owczarzaki        ------------------------------------------------------------ 
C.elegans           ------------------------------------------------------------ 
S.cerevisiae        ------------------------------------------------------------ 
D.discoideum        SNGDEVRRRNLLQQQLEQNRDFLNHNRLLNKQSRMNNPNNLFDEGDSGFGDGEEEDEGLL 
P.falciparum        ------------------------------------------------------------ 
P.tetraurelia       ------------------------------------------------------------ 
                                                                                 
 
L.major             - 
T.brucei            - 
T.cruzi             - 
G.intestinalis      - 
Ch.reinhardtii      - 
H.sapiens           - 
C.owczarzaki        - 
C.elegans           - 
S.cerevisiae        - 
D.discoideum        N 
P.falciparum        - 
P.tetraurelia       - 






L.major       MN--FLGGSLRSGGGHRREKGFSAKNKVQQYHGDGSESIVLAGRPFRVLQKISDVPP-PY 
T.brucei      -------MGSDSKSSKSKDKNFSSKGKIEKYNKDGTETILIMGRPFRIVQRLSEKVLNPE 
T.cruzi       MSTFRMAQARITGRKSNKDKSFSSKGKIEKYNQDGTETIIVMGRPFRVLQNIGASENHI- 
                      .  :     ::*.**:*.*:::*: **:*:*:: *****::*.:.        
 
L.major       MVTRQRSTKYGEGGSSYVYLVENTSHLPEFPRHLALKRSFFGVDQVMEAHKEVEIVSRIE 
T.brucei      AKSSKKSSKKAKDVYSYIVVVENIEALPMFARYVVVKRTFFKIDEVLLAHREPEILNRVR 
T.cruzi       SSHKERDHKFAKHLRSFVFLVENTENLSEFPRHFALKRSFFNVNEVLLAHREPEVLARVS 
                  ::. * .:   *:: :*** . *  * *:..:**:** :::*: **:* *:: *:  
 
L.major       DKNIVRVYHSEISRSEGRLGVSIAMEYCSNNLYHRIRSSAGTGIVTRLTEAEICHVMFAV 
T.brucei      DKGILHVFHSEVTRNDGRLGTTVAMEYCPGSLEQRLQQE------TRMLESEVVQVLLAL 
T.cruzi       DKNIVRVFHTEVTRSDGKLGVTVAMEYCSNNLYRQLRPD------TRVPEGEIVQVLLGI 
              **.*::*:*:*::*.:*:**.::***** ..* :::: .      **: *.*: :*::.: 
 
L.major       TSAVGYLHAQQPPITHRDIRPENILINNKHAGPTAYKLTNFGNATTEAYQCETREEANMA 
T.brucei      ASVLGYLHSRQPPVAHRNINPSNVLIHSESAGASAYRLYNFRSAMTEAYHCENHEEVVAA 
T.cruzi       TSAVGYLHSRQPPIAHRDICPENILIHSGSTGAASYRLCNFSSATTEAYHCANREEVAMA 
              :*.:****::***::**:* *.*:**:.  :* ::*:* ** .* ****:* .:**.  * 
 
L.major       IADIQMHTNPAFRAPEMADPWSKKRICEKTDMWSMGVLLYYMMYMSLPFDPST-TIVKDW 
T.brucei      MEDFARYTTAGYRAPEMLDPSSHKRIDEQVDMWALGVLLYYTMYQRLPFTDACWGLARKP 
T.cruzi       VEDIERNTSPGYRAPEMADPGSGKRIDERVDLWSIGVLLYYMMYLRLPFGETNMGLTGRL 
              : *:   *. .:***** ** * *** *:.*:*::****** **  ***  :   :.    
 
L.major       ALTFPSEATASYTPSLRVITEHLLDPDPCSRWDVFALINYMRFDEDCSRHLGTFCFTKTE 
T.brucei      KLRYPVEAEVWYTGSLRIVLEHLLEPDPEKRWDAFALINFMRFDNDLCRHIGPFCFSQTE 
T.cruzi       KLRFPAGTEMWYTGSLRVVLAHLLEPDPDKRWDIFALTNFLRFDDEIGKHIGTFFFAQTE 
               * :*  :   ** ***::  ***:*** .*** *** *::***::  :*:* * *::** 
 
L.major       WPEGWEEQDVKVLGRTPPPKAPPVSYNEPGHEQLDSRGLRGQERVHGHTNGHQPPDDRGN 
T.brucei      RPEGWEPQDVKVIGRPVPAKVLPERLRNTGQSDDPAAAARDNRDEAAAT-----SVKSRT 
T.cruzi       WPDGWEQQDVKVVNRQVPRKAPPIRVNTPKHADNTKNATDAGTKNRMQA-----SSEMER 
               *:*** *****:.*  * *. *   .   : :    .          :       .    
 
L.major       GRDSAVVDGAAVQEAMIVLGGDPADDDPAVAKYRHQIIMVQQEAWRRAKAAAGLRDSPPT 
T.brucei      AAQESGDNDQMVLKAVTALSSDTASTDPEVLAYREKLIREQEEAWQVAESAHKKRDKEDK 
T.cruzi       GSSMGGDVGELDAAALAALGLDGDSKDPEMRKYYKMLIQEQEDAWRMAKSASQASAKNKS 
              . . .   .     *: .*. *  . ** :  * . :*  *::**: *::*     .  . 
(C) 




L.major       EPQESSAAP-----A-----------------------PTRANNEAQKDVFDDLFASASP 
T.brucei      DGATSGPADVDSLFGPTEKKEAVKE-NKASAIDDLFGGMETQPSQSQKPTTDDLFGGAST 
T.cruzi       G-DTTNVNNRQ---AQETREEKQREEEPPKQIQ------DNPPNDNTPNLFDDLFAPSPA 
                  :.        .                            .:      ****. :   
 
L.major       TVFPASQASPAMGPSAPPATHQPPE------KDVF------------------------S 
T.brucei      ATAS----------NQIPPQGSQVGANDSWKDDLFAAPP-------QQPQMQPQPAFPMA 
T.cruzi       AQASSGS---LQAPSQPTVSRNPVTGGQNWPDSLFSGVPPSQPLSQQQPPLHAQNSYDMM 
              :             .      .         ..:*                          
 
L.major       ASDLFSTSAPQLDPSYPVMNTYGQAP----------------------QQMAMGGWGSGA 
T.brucei      ADSSWSTGAPTSVPMNPTGGMMGQQQAPMGWGNGVTAPGFQPMQTPQMQQQVPGGWGNGA 
T.cruzi       MDSGWGTGAPTMAPVG---GAYDVGAMYAG-TQMATAPTFSMPPHPPL-QQITPSWGISA 
               .. :.*.**   *     .  .                          *    .** .* 
 
L.major       PVMGSGGYPMQQPQNQQQAPWGYGVSNANNYAPPLPPQQQQQQLQP----FTNFL----- 
T.brucei      TASG--FQPMQTPQMQQQVPGGWGNGATA---PSFQPMQTPQMQQQVPGGWGNGATAPGF 
T.cruzi       PPG-----------------------------PQSTPMQQQQQQQP----FNHQ------ 
                                              *   * *  *  *     : :        
 
L.major       -----PP----LSGQQPGQQQSQQQETSQPRTARATTKRDPFADLFN 
T.brucei      QPMQTPQMQQQVPGGAPGFMGGNDLFQRPQQQQPQQPEKDPFASLFK 
T.cruzi       --------------TTMDFAQGSLPTAVPA-EPKPEAKKDPFADLFL 















Figure 4.12 (A) Schematic cartoons shows the domain structure of protein kinase in different 
organisms. Protein kinsae domian is hightlighed in red. (B) Multiple sequence alignments 
compared all top hit protein kinase that came back from NCBI BLAST when Tbprotein kinase 
was the query sequences. (C) Multiple sequence alignments between T.brcui, T. curzi and L. 
major. Red bracket indicates protein kinase domain.  “*” indicates identical aa and “:” 
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4.12   ARL2-binding protein (BART, Binder of Arl Two) 
like 1 
 
BARTL1 (or Cilia- and flagella-associated protein 36 (CFA36), or Coiled-coil domain-
containing protein 104 (CCDC104)) was identified by my TbRP2 BioID-SILAC anlaysis 
using the whole cell sample. The SILAC ratio of 0.9 means the protein was only twice 
as enriched in TbRP2::BirA* induced cells than in the parental cell line and so was 
below the 1.0 cut-off value that I intially selected. However,the reason this protein 
was selected for further analysis was that during the time of my study Lokaj et al., 
(2015), identified BARTL1 as a novel Arl3-interacting protein with structural homology 
to the binder of Arl2 (BART). Their data showed that BARTL1 is a transition zone 
protein, which enhances the interaction between Arl3 and RP2 (Lokaj et al., 2015). 
Addtionally, the BART-like domain of the BARTL1 protein can recognise and interact 
with a LLxILxxL motif at N-terminal amphipathic helix of Arl3 that may suggest tat 
BARTL1 is involved in the Arl3 transport network in cilia. However, no noticeable 
phenotype was detected in mouse renal epithelial (IMCD3) cells depleted for BARTL1 
(although it was suggested that this might be have been due to the low efficacy of 
siRNA) (Lokaj et al., 2015). Bioinformatics analysis shows that there is only one BARTL1 
gene (Tb927.10.5810) in the T. brucei genome and when I used it as my query 
sequence in NCBI BLAST, homologous sequences could not be identified in most the 
organisms (apart from P. tetraurelia and C. reinhardtii) shown in table 4.2. 
Unsurprisngly, the two species closely related to T. brucei (i.e. T. cruzi and L. major) 
both contained sequences with a good e values. The top hit in the human genome is 
CCDC104 protein (AAH10011.1) and a reciprocal BLAST confirmed that TbBARTL1 is 
likely a orthologue of the Human CCDC104 protein.  A BARTL1-like protein was not 
detected in P. falciparum, G. Lamblia, C. elegans, or in all three non-ciliated organisms. 
However, the green algae C. reinhardtii and the protist P. tetraurelia encode a BARTL1 
protein in their genomes. When I used the human CCDC104 protein as my query, NCBI 
BLAST revealed that apart from three non-flagellated organisms, P. falciparum and G. 
lamblia did not show any CCDC104-like protein, but the rest of the organisms all 
appear to have at least one BARTL1 gene. InterProScan was used to analyse the 
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domain structures of the BARTL1 protein (Fig 4.13-A).  All proteins share a N-terminal 
ADP-ribosylation factor-like 2 (ARF2) binding domain (also known as BART). BART was 
first identified as an effector for Arl proteins, and specifically interacts with ARL2·GTP 
form with high affinity, but not to ARF2-GDP (Sharer and Kahn, 1999). BART is  
predominantly localised in the cytosol,  but also appears to be associated with 
mitochondria, and is involved in binding to an adenine nucleotide transporter (ANT1) 
in vitro assays (Sharer et al., 2002). Coiled-coil domains can also be detected,which 
locate either at the C-terminus, or the central region or both locations within the 
protein sequence. Moreover, in T. cruzi and  P. tetraurelia another motif called 
Ubiquitin Interacting Motif (UIM), or 'LALAL-motif' is also detected. UIMs normally 
form a short alpha-helix, and they can bind to ubiquitin and serve as a specific 
targeting signal for ubiquitination and ubiquitin metabolism (Hofmann and Falquet, 
2001; Young et al., 1998).  
 
In the next following two chapters, I undertake a functional interrogation of the 



























C.reinhardtii 381 aa 
H.sapiens 
T.brucei 
430 aa T.cruzi 
443 aa L.major 
440 aa P.tetraurelia  
(A) 
UIM  







Ch.reinhardtii      -----------------------------MSAEAAWLSEAIVEFLKARRSAHVVAEGPMY 
L.major             ------------------------------MTESRWITEALVQFS----------ASPIW 
T.brucei            --------------------------------DERGILESILQFT----------HSPMW 
T.cruzi             ------------------------------MSDDSWIIESIVQFT----------RSPLW 
H.sapiens           -------------------------MAAEEEDEVEWVVESIAGFL----------RGPDW 
P.tetraurelia       MGSDNSKAKAQKKQNPPQNSAPKPPPKRKPQEENNWMYDLILQYL----------ASPVW 
                                                    :   : : :  :            .* : 
 
Ch.reinhardtii      INPLMGFIDEKCLIFTPEEENKFEYTIYHNEFKELVDGLLTEFLEDLGVVAKAQGSDQLT 
L.major             LTPIDNFVDDNCCIFSNESEMQLEYTVAHNKFKKLIDSLLTCFLMELGVSMETAVEALQS 
T.brucei            RTPVDNFIDERCALFTDDEEMKVEQTEVHMQFRKITDDILSKYVKELGITLEDALNAVVN 
T.cruzi             RTPINNFVDDNCSMFSDDGEMKVEQTEVHLAFRKLADDLITSFVGELGVPLETVLAVVYK 
H.sapiens           SIPILDFVEQKCEVFDDEEESKLTYTEIHQEYKELVEKLLEGYLKEIGINEDQFQEACTS 
P.tetraurelia       RNPISDFLDEHCIIFDDEEENKIVYQEIHKKFKNMIEAMMEQLMQDIGVDDEEYLRKVIE 
                      *: .*:::.* :*  : * :.     *  :::: : ::   : ::*:  .         
 
Ch.reinhardtii      SFVVQP---------AYHQALRRTILTVDDFLMFKAMMVRRNIDLTNQVLEAVEEARRLE 
L.major             SLAVSVQTSEGLSEQQAAKKLLKQIFNADNFSHFHTMMVKRNLELDILANAALSSDGVCG 
T.brucei            SMDTAS------QTNRLGKKFMQEIFYIEDFPTFHKMMVRRNIELDILAQCEISQKRENS 
T.cruzi             CVNGQS------PMRQPAEQFLHNIFYMDDFCSFHKMMLRRNIQLDILAARALQRQQEGL 
H.sapiens           PL----------AKTHTSQAILQPVLAAEDFTIFKAMMVQKNIEMQLQAIRIIQERNGVL 
P.tetraurelia       IG----------LKNKKHKKYFEQLLVVENFLVFKKLMLKRNKELEYEALKELQKIDGGK 
                                      :   . ::  ::*  *: :*:::* ::   .   :.       
 
Ch.reinhardtii      AKAAAASKPEASGG-------SLTAKAAATAAEEDALKEAMALSNKLAAEWDETDRLHKA 
L.major             NGGAALSTEEVEKETRARARVQRAIDVNGDVSEDDALRRAIEVSLQ----DGTAQQQVQA 
T.brucei            G-------------------------AKTANDEEEAMRLAIEASLN----DEEKTRRLME 
T.cruzi             PA-------------------QASVEEEAAMDEEEALRLAIKLSLQ----DEETARRMMK 
H.sapiens           PDCLTDGSDVVS------------------DLEHEEMKILREV----------------- 
P.tetraurelia       NLEMDL-KVKQA------------------ELEKERMEIEHAVAMSIAVEQE-------- 
                                                    *.: :.                       
 
Ch.reinhardtii      MRALQLEDEDVAFPAAIAASLREQAKYDSELADIEQAGVGE-----------W------- 
L.major             YRKACIQEDA-NLQ--LTA---VEHQANSEKAQL--EAVLQTQSAQNLPEGEHFRQNHVE 
T.brucei            LEDLQLQEAL-ALS--IAA---EHERARNTFEKISQEAVEEAKVVGKAAAEET-KLKKLT 
T.cruzi             LEDMQIQEAL-ALS--IAA---EEARVRREGETVNDGATGRAAEAGGVATGQA-AKEKLS 
H.sapiens           ----------------LRKSKEEYDQEEER---KRKKQ------------------L--- 
P.tetraurelia       KSKLQIQEEE-ELQEAIKMSQKLFEQQQSE---ILKSNVEQQNQ------------LHQQ 
                                    :        :                                   
 
Ch.reinhardtii      -------------G-----RRSHP-------------------------VIA-------- 
L.major             PINKQKESQLQPIRA-------HAM-SGKG---------------------QKGCDEAEP 
T.brucei            AAEEEKEKTIVKLEERALEVRQQAMLQRLTATMVVEPTPVAPKKEAPAPAPAKAPAESKP 
T.cruzi             SLKEEKEQVIGKLEARALEVRKETMMRGISATQNVPPSSSDVSSAKSTSVVG---DES-- 
H.sapiens           -SEAKTEEPTVHSSE----AAIMNNSQGDGEHFAHPPSEVKMHF---------------- 
P.tetraurelia       PQASQQQQPIVPDQK----VESILIFEDDGLPDKNPPIVVEQQQ---------------- 
                                                                                 
 
Ch.reinhardtii      ----RAAPQAPS-LAPLKANL---------VKSSSVRNRGAGYKTEAAG-V---DLE--- 
L.major             QKANFNSPESPCPLPALQVPAAASAPVAAPVSVPALPSIGQRQAALPSIPSTI---TASV 
T.brucei            AATAAKAPTAPPAVPPGPLSRGRPIMPSLHTDHGADSGKKFGFSKLPTHQPSFKQLEATM 
T.cruzi             ----KQQKEGPPALA----SAAEKLPVKAALPPCAPPGKGFGFKALPSIQPSFKQLESLV 
H.sapiens           -------ANQS--IEPLGRKV-------ERSETSSLPQKGLKFPG-LEHASIE---GPIA 
P.tetraurelia       -------QQVEVKNEPKQQRV-----------RDPLPQIVQEKKEVLSLAQER---EALM 
                                                                                 
 
Ch.reinhardtii      --AIRK-AAQQAA-------ESQKKLVGKGDVNDAATKWLQEAKLKLIAQKQAEREREMV 
L.major             LKSAPSAPAHQAHGTAVSATPAPTPIPTK-EELEKRAQYMREQREKLLARNRASRQEQLN 
T.brucei            AKGIAG-ASSAGGGAA--GAGAASSKVED-EELARRAEHMRKQRELILQKNRETREEELR 
T.cruzi             LQTVTP-PPPQPAKRTDDTPKTALPPPTL-EEMEERARHMREQREKILMQNKANREKELK 
H.sapiens           NLSV-----------------------LGTEELRQREHYLKQKRDKLMSMRKDMRTKQIQ 
P.tetraurelia       NQGNQL---KENLKEIEETFKQNMKNQQDQETLEQRKLRLQQQRELIKQKKMKERKDEIE 
                                                  :        ::: :  :   .   *  ::  
 
Ch.reinhardtii      DYKAASAGKPKPSGPST-------TAA------------AADDAKRAALREALAQKMKQN 
L.major             TFLQNNSSSTTT-SSSA-------A--------------LAATGAAQSVTVEIARRLRGD 
T.brucei            NYMNTKTT-NPA------------D--------------SSVGRVERQMTLDLAQRLRND 
T.cruzi             DYSVSGGKTSVK------------P--------------SGLRESEKQMTLELARRLRED 
H.sapiens           ---NMEQKGKPTGEVEEMTEKPEMTA------EE---------KQTLLKRRLLAEKLKEE 
P.tetraurelia       QYKAIGDQDKPAQDLHDKEKGPLVVDMNDFVADQKRAQELELKKQELRKRAELLRKIKQD 
                                                                        : .::: : 
 
(B) 
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Ch.reinhardtii      IMGAN----- 
L.major             LIGEARKSSG 
T.brucei            ILDETKK--- 
T.cruzi             IVHEATK--- 
H.sapiens           VINK------ 
P.tetraurelia       AQQQEQS--- 







































Figure 4.13 (A) Schematic cartoons shows the domain structure of BARTL1 proteins in 
different organisms. BART domian is hightlighed in red, Ubiquitin Interacting Motif (UIM) in 
black and coiled-coil is in blue. (B) Multiple sequence alignments compared all organisms 
which has BARTL1 like proteins (NCBI BLAST) when TbBARTL1 was the query sequence. Red 
bracket indicates BART domain.  “*” indicates identical aa and “:” indicates conserved aa 
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Chapter 5 Localisation of putative TbRP2 
interacting /near neighbour proteins 
 
5.1 Introduction  
In this chapter, I describe the localisation of 11 putative TbRP2-interacting/near 
neighbour proteins identified in the BioID experiments described in Chapter 3; with a 
pPOT-tagging strategy (Dean et al. 2015) employed to generate procyclic cell lines in 
which proteins of interest were expressed as endogenous gene fusions.  
 
5.2 Generation of procyclic cell lines expressing YFP-
tagged proteins  
A PCR only tagging (pPOT) approach was employed to generate T. brucei procyclic cell 
lines capable of constitutively expressing YFP-tagged versions of the putative TbRP2-
interacting/near neighbour proteins. In brief, DNA sequence encoding the YFP open 
reading frame and a drug resistance cassette was amplified by PCR, using long primers 
that incorporated 80 nucleotides of homology to the target gene and its adjacent 
untranslated region (UTR)  (Dean et al. 2015).  Unless otherwise stated, all amplicons 
generated in this study were designed to allow expression of C-terminal YFP fusion 
proteins. As pPOT tagging amplifies the same plasmid template and incorporates ~80 
nucleotides of homology to a target gene and UTR, amplicons to tag the C-terminus of 
a target protein are of similar size (~2500bp). Amplicons to tag the N-terminus of a 
target protein are smaller (~1500bp). The PCR amplicons generated for all eleven 
potential TbRP2 interacting/nearby partners are shown in Fig 5.1. The PCR amplicons 
were subsequently purified and used to transfect procyclic T. brucei, with the gene 
specific ORF and UTR sequences enabling the amplicon to recombine into the T. brucei 
genome such that YFP coding sequence was fused with the gene of interest. 
Recombinant cell lines were obtained by using appropriate drug selection. 




Fig 5.1 PCR products of all selected candidate proteins, which resolved on a 0.8% agarose gel 
and visualised with Gel red.  Lane 1-5 and 7-11 were C-terminal tagged with ~ 2000bp, and 
lane 6 was N-terminal tagged with predicted size ~ 1500bp.  
 
Immunoblotting was used to confirm the expression of YFP-tagged proteins in the cell 
lines generated. Whole-cell lysates were resolved by SDS-PAGE, transferred to PVDF 
membranes and probed with antisera against GFP (Fig 5.2); the anti-GFP antisera 
cross-reacts with YFP. The immunoblotting experiments revealed YFP-fusion proteins 
corresponding to the expected molecular weights were expressed in eight of the cell 
lines generated. However, in the cell line expressing Tbp25-::YFP (Figure 5.2, lane 2) 
two bands were detected; the higher MW band corresponds to the expected size of 
the Tbp25-::YFP fusion protein (~43kDa), and the lower MW band of a cleavage 
product of Tbp25-::YFP (~25kDa). A protein of this MW cannot be detected in any 
other cell line generated in this study. In the immunoblotting experiments, the 
SmOxp9 parental cell line acted as the negative control, and the anti--tubulin 
antibody (KMX-1) used to ensure equivalence of protein loading. The immunoblotting 
experiments revealed variation in protein expression between the cell lines, even 
though the KMX-1 control indicated protein (and hence cell number) loading was 
approximately equivalent. For example, compare expression of TbHSP70::YFP (Figure 
5.2, Lane 1) with TbARL3::YFP (Figure 5.2, Lane 3). It was not possible to visualise 
expression of TbBBP590::YFP or TbMARP::YFP by immunoblot analysis, due to the high 
molecular weight of these fusion proteins; ~600kDa and 400kDa respectively.  




 Fig 5.2 Confirmation of the expression of YFP-tagged proteins by immunoblotting. Protein 
samples were resolved on 10 % SDS-PAGE gel, transferred on PVDF blotting membrane, 
probed with anti-GFP antibody and visualised with ChemiDocTM imaging system. Expected 
molecular size list as follow; Lane 1:TbHSP70::YFP (98kDa); Lane 2:TbP25-a::YFP (43kDa); Lane 
3:TbArl3 Like::YFP (47kDa); Lane 4:TbBart Like::YFP (75kDa); Lane 5:TbTCP-1-e::YFP (86kDa); 
Lane 6:TbVHS domain containing protein::YFP (76kDa); Lane 7:TbCytoskeleton associated 
protein::YFP (78kDa); Lane 8:TbProteinKinase::YFP (107kDa) and Lane 9:TbKMP-11::YFP 
(38kDa). The expression of two large candidate proteins (TbBBP590 and TbMARP) are not 
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5.3 ADP-ribosylation factor-like protein 3 Like (ARL3L) 
 
The expression and intracellular localisation of TbARL3L::YFP was determined in whole 
cells at various stages of the cell division cycle (Figure 5.3). At beginning of the cell 
cycle (1K1N), a discrete focus of TbARL3L::YFP was detected close to the kinetoplast, 
as T. brucei progressed thorough the cell cycle (divK1N), the signal resolved as two 
discrete foci that segregated with dividing kinetoplasts; The TbARL3L::YFP is a 
detergent-extractable protein, as the YFP signal lost in cytoskeletons. To further 
interrogate the TbARL3L::YFP localisation, cells were co-labelled with a polyclonal 
antibody against TbRP2, revealing the TbARL3L::YFP signal was coincident with TbRP2 
at the mature basal body. In addition to the mature basal body localisation, 
TbARL3L::YFP also appeared to localise to the nucleus (Figure 5.3). The TbARL3L::YFP 
signal within the nucleus was much weaker, and was not uniformly distributed but 
presented with a distinct punctate pattern. However, nuclear foci followed no 
interpretable cell cycle-specific pattern, and it remains unclear what these foci 
represent. For instance, there is no evidence that TbARL3L::YFP locates to the mitotic 









Figure 5.3 Immunofluorescence images showing the localisation of TbArl3L::YFP in procyclic 
form T. brucei.  Whole cells were co-labelled with the TbRP2 antibody (red) specific for the 
mature basal body and DAPI (blue). Cells were visualised by DeltaVision Deconvolution 
microscopy. Scale bar = 5μm 
 
TbArl3L::YFP DAPI TbRP2 DAPI Merge 
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5.4 Kinetoplastid membrane protein 11 (KMP-11) 
The localisation of TbKMP-11::YFP was investigated in detergent-extracted cells using 
fluorescence microscopy, revealing TbKMP-11::YFP at several distinct localisations 
within procyclic cells (Figure 5.4-(A-F)). At the beginning of the cell division cycle 
(1K1N), two foci of TbKMP-11::YFP were observed close to the kinetoplast. Co-
labelling TbKMP-11::YFP expressing cells with the anti-TbRP2 antibody revealed the 
TbKMP-11::YFP foci were positioned between the DAPI stained kinetoplast and TbRP2, 
or partially overlapped with the TbRP2 signal (Figure 5.4-(A)).  Later in the cell cycle 
(i.e. two TbRP2 foci and two mature basal bodies) four TbKMP-11 foci were observed; 
a labelling pattern that may indicate TbKMP-11::YFP may associate with both basal 
and probasal body (Figure 5.4-(B-F)). In addition to this putative basal/probasal body 
signal, TbKMP-11::YFP also localised to both new and old flagella throughout the cell 
cycle. However, TbKMP-11::YFP signal was not evenly distributed along the old 
flagellum, being, (i) stronger in the region where the old flagellum is attached to the 
cell body, (ii) present as a distinct focus at the anterior pole of the cell body, (iii) fainter 
in the region of the flagellum that extends beyond the cell body (Figure 5.4-(A); white 
arrow). In contrast, the TbKMP-11::YFP signal was uniform in the new flagellum, 
presumably, as it does not extend beyond the anterior pole of the cell. The white 
arrow with broken line indicated that TbKMP-11::YFP could be also possible has 
flagellar connector localisation (Figure 5.4-(E-F); white arrow).  
 
5.4.1 Further interrogation of TbKMP-11::YFP flagellum 
localisation  
 
To provide further insight into the intraflagellar localisation of TbKMP-11::YFP, cells 
were co-labelled with the monoclonal antibody L8C4, which recognises the PFR 
protein PFR2 (Figure 5.5). Visualisation of TbKMP-11::YFP and PFR2 at various stages 
of the cell division cycle indicated the two proteins overlapped in both new and old 
flagella. However, it was observed that the TbKMP-11::YFP signal also extended to a 
more proximal position within the flagellum (i.e. closer to the kinetoplast) than the 
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PFR (Figure 5.5; Inset square). This result is intriguing since the PFR is only assembled 
onto the axoneme after the flagellum has exited flagellar pocket, so the proximal 
extension of TbKMP-11::YFP towards the kinetoplast may suggest TbKMP-11 is 
associated with the axoneme at this proximal location. Furthermore, as the TbKMP-
11::YFP signal within the flagellum becomes fainter as the flagellum extends beyond 
the end of the cell body while the PFR signal remains strong, it also suggests KMP-11 
is not integral to the PFR structure. 
 
During the course of undertaking these various immunolabelling experiments a clear 
focus of TbKMP-11::YFP was also observed at the distal tip of elongating new 
flagellum. To investigate whether this foci of TbKMP-11::YFP could be associated with 
the flagellar connector (which forms at the end of the new flagellum to guide its 
outgrowth), cells were co-labelled with the monoclonal antibody AB1 (a defined 
antibody marker for the flagellar connector; (Briggs et al. 2004)).  In cells with two 
flagella, the TbKMP-11::YFP signal associated with the tip of the new flagellum was co-
localised with AB1, indicating flagellar connector association (Figure 5.6 Panels A-C).  
As the cell progresses through the cell division cycle (2K1N) and the new flagellum 
extends further, AB1 and a weak TbKMP-11::YFP signal is still detectable at the tip of 
the new flagellum. However, when cells have entered the later stages of the cell 
division cycle (2K2N), neither AB1 nor the TbKMP-11::YFP signal could be detected at 
the tip of the new flagellum.   




Figure 5.4   Fluorescence images showing localisation of TbKMP-11::YFP in cells at different 
stages of the cell cycle. T. brucei procyclic cells expressing TbKMP-11::YFP (yellow) were 
detergent extracted and co-stained with an antibody specific for TbRP2 (red) and DAPI (blue). 
White arrows (solid line) indicate intense signal at the end of cell, however beyond this point 
where the flagellum is no longer attached to the cell body, the TbKMP-11::YFP signal is 
noticeably weaker. White arrows (broken line) indicate TbKMP-11 signal in the vicinity of the 












Fig. 5.5 Immunofluorescence images of cells expressing TbKMP-11::YFP co-labelled with the 
anti-PFR antibody L8C4. T. brucei procyclic cells at various stages of the cell division cycle were 
visualised, revealing that TbKMP::YFP signal partially overlaps with the PFR and extends 
beyond the posterior pole of the cell (Inset). White arrow indicates the tip of the new 










Fig. 5.6 Immunofluorescence images of T. brucei procyclic cells showing localisation of 
TbKMP-11::YFP in relation to the flagellar connector antibody AB1. In cells that are 
elongating a new flagellum, TbKMP-11::YFP also co-localises with the FC, as detected 
by the antibody AB1. AB1 and TbKMP::YFP labelling is not observed at the tip of the 
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5.5 Binder of Arl2 (BART) Like 1 
The localisation of TbBARTL1 was examined in both whole cells and detergent-
extracted cytoskeletons (Figure 5.7).  In whole cells, TbBARTL1::YFP appears to have a 
uniform signal throughout the cytoplasm, but is excluded from the nucleus (Insert 
Panel A) and is also present within the flagellum.  However, TbBARTL1::YFP was lost 
on detergent-extracted cytoskeleton cells. When TbBARTL1::YFP expressing procyclic 
cells were co-labelled with anti-TbRP2 polyclonal antibody and only small number of 
cells appeared to have slightly elevated YFP signal at the base of flagellum (Insert Panel 
B) coincident with TbRP2. However, in majority of the cells are not.  




Figure 5.7 Immunofluorescence images showing the localisation of TbBARTL1::YFP in 
procyclic form T. brucei. Both whole cells and cytoskeletal cells were co-labelled with the 
TbRP2 antibody (red) specific for the mature basal body and DAPI (blue). Cells were visualised 
by DeltaVision deconvolution microscopy. Inset indicates that the YFP signal of TbBARTL1 
partially co-localised with TbRP2 at the base of the flagellum. N indicates nucleus, which shows 
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5.6 Tubulin Polymerisation Promoting Protein 
(TPPP)/p25- 
 
The intracellular localisation of TbP25-::YFP was also investigated in both whole cell 
and detergent-extracted cytoskeletons (Figure 5.8). In whole cells TbP25-::YFP 
appeared to be uniformly distributed throughout the cell body and flagellum, but in 
contrast to detergent extracted cytoskeletons TbP25-::YFP also appeared to be 
present in the nucleus of whole cells. It is difficult to conclude that any TbP25-::YFP 
signal is enriched at the base of the cilium, which co-localising with TbRP2 antibody at 
basal body on whole cell sample. However, in detergent-extracted cytoskeleton cells, 
the TbP25-::YFP signal was largely lost, but, some signal remained including at the 
base of the flagellum co-localising with TbRP2 (Figure 5.8; inset square). TbP25-::YFP 
was also observed along the line of the flagella and as a faint punctate intra-nuclear 












Figure 5.8 Immunofluorescence images showing the localisation of TbP25-::YFP in 
procyclic form T. brucei. Both whole cells and cytoskeletal cells were co-labelled with the 
TbRP2 antibody (red) specific for the mature basal body and DAPI (blue). Cells were 
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5.7 T-complex protein 1 epsilon (TCP-1-) 
 
The intracellular localisation of TbTCP1-::YFP was investigated and revealed to be 
cytosolic, present within the cytoplasm, but was not observed in the nucleus (Figure 
5.9; inset square) , nor the flagellum (Figure 5.9; white arrows). In detergent-extracted 
cytoskeletons, the TbTCP-1-::YFP signal was largely absent. When the cells were co-
labelled with the anti-TbRP2 antibody, the foci of TbTCP-1-::YFP at the base of the 
flagellum appeared to co-localise with TbRP2 only in some (but not all) detergent-
extracted cells.  




Figure 5.9 Immunofluorescence images showing the localisation of TbTCP-1-::YFP in 
procyclic form T. brucei. Both whole cells and cytoskeletal cells were co-labelled with the 
TbRP2 antibody (red) specific for the mature basal body and DAPI (blue). Cells were visualised 
by DeltaVision deconvolution microscopy. White arrows/white square indicate that no 
expression of TbTCP-1-::YFP on flagella and nuclei respectively.  Faint YFP signal of TbTCP-1-
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5.8 VHS-domain containing protein  
 
The localisation of TbVHS::YFP was determined in whole cells at various stages of the 
cell cycle (Figure 5.10). At beginning of the cell cycle (1K1N), TbVHS::YFP is observed 
in the vicinity of the kinetoplast, but the signal appears to be located distal to the 
kinetoplast in a region of the cell associated with the endocytic pathway. As the 
trypanosome cell progresses thorough the cell cycle (2K1N), the TbVHS::YFP signal 
duplicates and remains positioned distal to the two kinetoplasts throughout cell cycle. 
Co-labelling with the anti-TbRP2 polyclonal antibody revealed little evidence of any 
co-localisation with TbVHS::YFP largely distal to TbRP2 at the mature basal body. 
 
The localisation of TbVHS::YFP was then analysed in detergent-extracted 
cytoskeletons (Figure 5.11).  A discrete focus of TbVHS::YFP signal was retained at a 
position close to the kinetoplast; this pattern was retained as the cell progressed 
thorough the cell division cycle.  When cells were co-labelled with the anti-TbRP2 
antibody, the TbVHS::YFP signal was observed to be positioned more towards the 
anterior of the cell than TbRP2 and the kinetoplast, thus there was no evidence of 












Figure 5.10 Immunofluorescence images showing the localisation of TbVHS::YFP in 
procyclic form T. brucei. Whole cells were co-labelled with the TbRP2 antibody (red) 
specific for the mature basal body and DAPI (blue). Cells were visualised by DeltaVision 












Figure 5.11 Immunofluorescence images showing the localisation of TbVHS::YFP in procyclic 
form T. brucei. Detergent extracted cytoskeletons were co-labelled with a TbRP2 specific 
polyclonal antibody (red) and DAPI (blue). Cells were visualised by DeltaVision deconvolution 
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5.9 Heat Shock Protein 70 (HSP70) 
The intracellular localisation of TbHSP70::YFP was investigated in detergent-extracted 
cytoskeletons. In these experiments, cells at various stages of the cell cycle were also 
co-labelled with anti-TbRP2 antibody (Figure 5.12).  In 1K1N cells, a discrete focus of 
TbHSP70::YFP was observed close to kinetoplast, but this signal did not seem to co-
localise with TbRP2. However, a fainter TbHSP70::YFP focus was observed coincident 
with the TbRP2 label (Figure 5.12; A-inset). A weak TbHSP70::YFP signal was also 
evident along the flagellum at this stage (Figure 5.12; A).  As the cell progresses 
through the cell division cycle (Figure 5.12; B-C) before a new mature basal body has 
formed (this would be detected as a second TbRP2 signal) the TbHSP70::YFP signal 
remained strong (Figure 5.12; B-inset). Later in the cell cycle, as evidenced by the 
detection of a second TbRP2 positive mature basal body, TbHSP70::YFP signal closer 
to the new basal appeared to be weaker than the TbHSP70::YFP signal associated with 
the old basal body (Figure 5.12; C-inset). Later still, when the kinetoplasts were 
completely segregated, the intensity of TbHSP70::YFP signals distal to the old and new 
basal body (as detected by TbRP2), appeared to be more equivalent (Figure 5.12; D-
inset). During mitosis, the TbHSP70::YFP signal seemed to be more elongated than at 
previous stages of the cell cycle. Throughout the cell cycle, TbHSP70::YFP also 
appeared to be localised in the flagellum, but it was noticeable that the TbHSP70::YFP 
signal appeared to be more intense in the new flagellum than the old (see white 
arrows Fig 5.12; D-E).   
We then investigated whether TbHSP70::YFP was retained in flagella preparations by 
treating cells with a high salt buffer (0.5M NaCl) which preferentially depolymerises 
microtubules of the subpellicular cytoskeleton. The localisation of the TbHSP70::YFP 
was analysed in flagella preparations co-labelled with the anti-TbRP2 antibody (Figure 
5.13).  In these flagella preparations TbHSP70::YFP signal was clearly evident both 
towards the flagellum base, and partially overlapping with TbRP2, but also along the 
length of the flagellum.  The TbHSP70::YFP signal in the short new flagellum (Figure 
5.13, Panel C) appeared particularly strong, which agreed with the labelling pattern 
observed in detergent-extracted cytoskeletons (Figure 5.12). 




Figure 5.12 Immunofluorescence images showing the localisation of TbHSP70::YFP in 
procyclic form T. brucei.  Cytoskeletal cells were co-labelled with the TbRP2 antibody (red) 
specific for the mature basal body and DAPI (blue). Cells were visualised by DeltaVision 


















Figure 5.13 Immunofluorescence images showing the localisation of TbHSP70::YFP in 
procyclic form T. brucei. Cells were treated with 0.5M of NaCl and co-labelled with the TbRP2 
antibody (red) specific for the mature basal body and DAPI (blue). Flagella were derived from 
cells expressing TbHSP70::YFP, and visualised by DeltaVision deconvolution microscopy. Scale 
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5.10 Protein Kinase (PK) (Tb927.9.6560) 
The intracellular localisation of TbPK::YFP was determined in whole cells at various 
stages of the cell cycle and shown to localise close to the kinetoplast, but not 
coincident with the mature basal body identified by TbRP2 (Figure 5.14). The 
TbPK::YFP signal extends into the region between the kinetoplast and nucleus and as 
cells enter the cell cycle (i.e. kinetoplast undergoing replication and separation and 
new flagellum assembly has begun), a ‘two-dot’ pattern of TbPK::YFP can be seen 
distal to both the basal bodies identified by TbRP2 (Fig 5.14-B). Once kinetoplast 
division is complete (2K1N), each kinetoplast remains associated with a focus of 
TbPK::YFP (Fig 5.14-C). In cells at the 2K2N stage of the cell cycle, the TbPK::YFP signal 
still appeared distal to the kinetoplasts and TbRP2 (Fig 5.14-D). TbPK::YFP labelling was 


















Figure 5.14 Immunofluorescence images showing the localisation of TbPK::YFP in procyclic 
form T. brucei.  Both whole cells and cytoskeletons were co-labelled with the TbRP2 antibody 
(red) specific for the mature basal body and DAPI (blue). Cells were visualised by DeltaVision 













     
204 
 
5.11 Microtubule associated repetitive protein (MARP) 
(Tb927.10.10360) 
The localisation of YFP::TbMARP was investigated in whole cells co-labelled with anti-
TbRP2 antibody (Figure 5.15).  In cells at an early stage of the cell cycle (1K1N), a 
distinct and intense YFP::TbMARP signal was observed between the nucleus and 
kinetoplast. YFP::TbMARP also localised at: (i) the subpellicular microtubule 
cytoskeleton (present as a weak and dispersed signal), and (ii) adjacent to the 
kinetoplast/mature basal body (again as a weak signal) (Figure 5.15-A). From this 
imaging it was not apparent that YFP::TbMARP co-localised with TbRP2 at the mature 
basal body. When two TbRP2 signals are present (i.e. after the probasal body has 
matured to a basal body and the kinetoplast is initiated replication), there is a single 
intense focus of YFP::TbMARP distal to the basal bodies and kinetoplast. The basal 
body and subpellicular microtubule localisation of YFP::TbMARP can also still be seen 
(Figure 5.15-B). When kinetoplasts are fully segregated, the intense YFP::TbMARP 
signal seemed elongated (Figure 5.15-C).  After mitosis is completed, two strong 
YFP::TbMARP signals (between N and K) can be observed in addition to the weaker 
microtubule cytoskeleton and basal body proximal signals (Figure 5.15-D).   
  
Detergent extraction resulting in the generation of T. brucei cytoskeletons revealed 
that the intense signal between nucleus and kinetoplast was lost, but that the basal 
body and microtubule cytoskeletal localisation of YFP::TbMARP became more evident. 
Cytoskeletons were also co-labelled with the anti-TbRP2 antibody, and indicated that 
YFP::TbMARP at least partially co-localised with TbRP2 (Figure 5.16). To investigate the 
basal body localisation in more detail, isolated flagellar preparations were made on 
cells expressing YFP::TbMARP and co-labelled with the anti-TbRP2 antibody. 
Visualisation of flagella from various stages of the cell division cycle revealed the 
YFP::TbMARP signal was retained on isolated flagella and appeared to be located distal 
to the TbRP2 signal i.e. further from the kinetoplast and more proximal to the 
axoneme (Figure 5.17).  





Figure 5.15 Immunofluorescence images showing the localisation of TbMARP::YFP in 
procyclic form T. brucei.  Whole cells were co-labelled with the TbRP2 antibody (red) specific 
for the mature basal body and DAPI (blue). Cells were visualised by DeltaVision deconvolution 
















Figure 5.16 Immunofluorescence images showing the localisation of TbMARP::YFP in 
procyclic form T. brucei.  Detergent-extracted cytoskeletons were co-labelled with the TbRP2 
antibody (red) specific for the mature basal body and DAPI (blue). Cells were visualised by 
DeltaVision deconvolution microscopy. Scale bar = 5 μm. 
 
YFP::TbMARP DAPI 




Figure 5.17 Immunofluorescence images showing the localisation of YFP::TbMARP in 
procyclic form T. brucei. Salt-extracted flagella were co-labelled with the TbRP2 antibody 
(red) specific for the mature basal body and DAPI (blue). Flagella were derived from cells 
were expressing YFP::TbMARP, and visualised by DeltaVision deconvolution microscopy. 
Scale bar = 5 μm.  
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 5.12 TbBBP590 
The localisation of TbBBP590::YFP was investigated in detergent-extracted 
cytoskeletons that were co-labelled with the anti-TbRP2 antibody (Figure 5.18).  
During the early stage of the cell cycle (1K1N1F), a single discrete foci of 
TbBBP590::YFP was evident, and which overlapped with TbRP2. In addition, there was 
a rather weaker and diffuse TbBBP590::YFP signal adjacent to TbRP2 (Figure 5.18-A).  
Interestingly, when the cell proceeds through the cell cycle, and two mature basal 
bodies clearly identified by the anti-TbRP2 antibody, TbBBP590::YFP can only be 
detected at the newly formed mature basal body and not on the ‘old’ basal body 
(Figure 5.18-B). As the cell cycle progresses and the kinetoplast elongates prior to 
segregation, TbBBP590::YFP signal was reacquired on the older basal body (initially as 
a slightly fainter signal) (Figure 5.18-C). As the cell cycle progresses, and the 
kinetoplasts begin to segregate, the TbBBP590::YFP signal associated with the older 
basal body increases in intensity (Figure 5.18-D), and remains equal through the rest 
of the cell division cycle (Figure 5.18 D-H).  
 
Expression of TbBBP590::YFP was also examined in isolated flagella. This confirmed 
the unusual pattern of TbBBP590::YFP expression shown in Figure 5.18; the detection 
of TbRP2 was again used as marker for the mature basal body. From these images it is 
clearly evident that the TbBBP590::YFP signal associated with the basal body that 
nucleates the flagellum is initially present, but then lost as a new basal body is formed 
and the new flagellum nucleated. The ‘new’ basal body is now TbBBP590::YFP positive, 
and TbBBP590::YFP is only reacquired by the old basal body at a later time point 
(Figure 5.19; A-E).  





















Figure 5.18 Immunofluorescence images showing the localisation of TbBBP590::YFP in 
procyclic form T. brucei.  Detergent-extracted cytoskeletons were co-labelled with the TbRP2 
antibody (red) specific for the mature basal body and DAPI (blue). Cells were visualised 

























Figure 5.19 Immunofluorescence images showing the localisation of TbBBP590::YFP in 
procyclic form T. brucei. Salt-extracted flagella were co-labelled with the TbRP2 antibody (red) 
specific for the mature basal body and DAPI (blue). Flagella were derived from cells were 
expressing TbBBP590::YFP, and visualised by DeltaVision deconvolution microscopy. Scale bar 
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5.13 TbCytoskeletal-associated protein (CAP51) 
(Tb927.7.2640) 
 
The localisation of TbCAP51::YFP was examined in both whole cells and in detergent-
extracted cytoskeletons. In whole cells, TbCAP51::YFP clearly localised to the cell body 
with the signal stronger at the periphery indicating a subpellicular corset location.  In 
detergent-extracted cells, TbCAP51::YFP was retained on the subpellicular 
microtubule cytoskeleton, but there were also punctate signals within the cell body.  
Both the whole cells and cytoskeletons were co-labelled with the anti-TbRP2 antibody 
(to locate the mature basal body); there was no obvious co-localisation between 
TbCAP51::YFP and TbRP2 (Fig 5.20). 
 




Figure 5.20 Immunofluorescence images showing the localisation of TbCAP51::YFP in 
procyclic form T. brucei.  Whole cells and detergent-extracted cytoskeletons were co-labelled 
with the TbRP2 antibody (red) specific for the mature basal body and DAPI (blue). Cells were 
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5.14 Summary  
The localization of all eleven selected proteins in whole cells and/or detergent-
extracted cells was determined (see summary Fig 5.21 and table 5.1). This was 
accomplished by pPOT system, which provides high-throughput and scalable 
endogenous tagging of target genes with C or N-terminal YFP fusion proteins (Dean et 
al. 2015). Among all eleven proteins, four proteins (TbArl3L, TbMARP, TbBBP590 and 
TbKMP-11) localised near the basal body area. TbVHS, Tbprotein Kinase (TbPK) are 
appeared to localise to the endomembrane system. TbHSP70 has cell body and 
flagellum localisation on whole cell. However, in cytoskeleton cells, the expression of 
the TbHSP70::YFP is more distal to TbRP2, possibly near bilobe area and is 
continuously distributed on the flagellum.  TbBARTL1, TbP25a and TbTCP-1- all have 
cell body localisation, only TbTCP-1- does not show any expression in flagellum, but 
the other two also localised to the flagellum.  There are some additional localisations 
of TbKMP-11 have been identified in this study; rather than co-localisation with the 
BB, TbKMP-11 expression appeared to have 2-dot coincidence with one TbRP2 at the 
basal body, and with more proximal signal. Moreover, the expression on the flagellum 
is not evenly distributed, as the expression goes weaker after the end of the cell body, 
an elevated signal was also observed at the end of cell body. The flagellar connector 
localisation was also confirmed when cells were co-labelled with AB1 (Briggs et al. 
2004).  The only non-BB or cell body related protein is TbCAP51, which localised to the 
subpellicular microtubules. In the next chapter, the functionality of those proteins will 
be investigated by RNAi ablation.  
 
Figure 5.21 Schematic summarising localisations of putative TbRP2-intereacting proteins 
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                            Proteins Localisation(s) 
TbArl3L Basal body; Nucleus 
TbBARTL1 Cell body; Flagellum 
HSP70 Bilobe area and consciously on the 
flagellum 
TbVHS Endomembrane system 
TbP25- Cell body; Flagellum 
TbTCP-1- Cell body 
TbMARP Basal body; subpellicular microtubules  
TbBBP590 Basal body  
TbProtein Kinase  Endomembrane system 
TbKMP-11 Basal body; Flagellum; Flagellar 
connector; 
End of cell body 
TbCAP51 Subpellicular microtubules 
Table 5.1 Table summarising the localisation(s) of selected putative TbRP2-interacting/near 
































     
217 
 
Chapter 6 Further characterisation of TbRP2-
proximal proteins 
 
6.1 Introduction  
In this chapter, the putative function(s) of selected TbRP2 interacting/proximal 
proteins are investigated using RNAi-mediated ablation.  The effect of gene specific 
RNAi on growth and morphology of procyclic T. brucei cells was assessed, along with 
the effect on flagellum biogenesis and the expression and/or localisation of TbRP2. 
Additionally, for a selected subset of these putative TbRP2 interacting/proximal 
proteins, the effect of TbRP2 RNAi ablation on the expression and/or localisation of 
the protein of interest was investigated.  
 
To carry out these studies, DNA encoding the open readings frames of interest (or 
defined sub regions thereof) were amplified by PCR and the resulting amplicons 
cloned into pGEMT© for nucleotide sequence validation. Following confirmation of 
wild type sequence (See Appendix III), DNA fragments were excised from pGEMT and 
sub-cloned into the vector p2T7-177 (Wickstead et al., 2002). Cell lines were 
established in smOX P9 cells (Poon et al., 2012), which allowed for inducible induction 
of RNAi, in cell lines that had been previously engineered to express YFP-tagged 
versions of the particular proteins of interest. This allowed for the efficiency of RNAi-
mediated protein ablation to be assessed by immunoblotting and fluorescence 
microscopy approaches.   
 
6.2 TbKMP-11  
 
TbKMP-11 was identified on multiple occasions in the BioID/SILAC experiments 
reported here, suggesting this protein is likely to be a genuine TbRP2-
interacting/proximal protein. However, TbKMP-11 has a complex intracellular 
localisation pattern in T. brucei (See Chapter 5.4), localising near to the basal body and 
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within the flagellum compartment itself. Thus, understanding where (but also why) 
TbKMP-11 comes into close proximity to TbRP2 is a challenge. For instance, is TbKMP-
11 juxtaposed to TbRP2 at the basal body, or does it come into contact with TbRP2 as 
it passes TbRP2 located at the transitional fibres which demarcate the dynamic 
boundary between the cell body and flagellum i.e. the ‘ciliary gate’. 
 
Although the effect that TbKMP-11 RNAi has on T. brucei cells has been investigated 
previously (and shown to affect basal body segregation and cytokinesis in both 
procyclic and bloodstream form cells; (Li and Wang, 2008)), TbKMP-11 RNAi induction 
was repeated here to investigate the effect that TbKMP-11 depletion had on TbRP2 
expression and basal body localisation. Preliminary experiments confirmed TbKMP-11 
RNAi resulted in the phenotypic defects previously described (Li and Wang, 2008). 
Following induction of TbKMP-11 RNAi, a dramatic reduction in cell growth was 
evident within 24 hours (Fig 6.1-A). Analysis of cell growth was terminated after 48 
hours of RNAi induction, as the induced cells became too ‘monstrous’ to allow a 
meaningful cell counts to be undertaken after this time. To confirm the efficiency of 
TbKMP-11 RNAi knockdown, TbKMP-11::YFP expression was monitored by probing 
immunoblots of samples collected 24 and 48 hours post induction with an anti-GFP 
antibody (Fig 6.1-B). These immunoblotting experiments demonstrated that 24 hours 
post RNAi induction, TbKMP-11::YFP expression was dramatically reduced compared 
to non-induced controls. After 48 hours of induction, TbKMP-11::YFP expression was 
further reduced, although low levels of protein were still detectable. The anti-β-
tubulin antibody KMX-1 was used as a loading control to confirm equal loading from 
non-induced and RNAi induced cell populations (and in all subsequent RNAi induction 
experiments).  
 
Cells from induced and non-induced were also prepared for immunofluorescence 
microscopy (Fig 6.1-C (1-4)). In non-induced cells (Fig 6.1-C-(1)), TbKMP-11 localisation 
was identical to that reported in Chapter 5.4, but following RNAi induction the basal 
body and flagellar TbKMP-11::YFP signal was significantly reduced, and the reduction 
of the YFP signal is more obvious on flagella, as KMP-11 localisation near the 
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kinetoplast is still detectable (Fig 6.1-C (2-4)). From these experiments, it was also 
evident that 48h after induction, TbKMP-11 RNAi induced cells exhibited numerous 
cytological problems; (i) kinetoplast and basal body positioning/segregation defects, 
(ii) detached flagella, and (iii) cells possessed either multiple nuclei or were anucleate 
zoids (i.e. 1K0N). As these cells were co-labelled with an anti-TbRP2 antibody, the loss 
of TbKMP-11 on the basal body targeting and tethering of TbRP2 was also evaluated.  
Despite the severe phenotypic abnormalities resulting from loss of TbKMP-11, 
expression and localisation of TbRP2 at the basal body was clearly unaffected (Fig 6.1-













Figure 6.1 RNA interference-mediated ablation of TbKMP-11 results in multiple defects in 
procyclic form cells. (A) Graph showing growth of TbKMP-11-RNAi induced (black dotted line) 
and non-induced (black solid line) procyclic trypanosome cells. (B) The TbKMP-11::YFP 
expression level was monitored by western blotting. Non-induced and induced cells were 
harvested after 24h and 48 h induction. KMX1 detection of -tubulin was included as a loading 
control. (C) Non‐induced cells at 24h/48h post induction TbKMP-11-RNAi cell line were 
harvested for immunofluorescence analysis. Morphological abnormalities in TbKMP-11 RNAi 
cells can be observed after 24h induction, including kinetoplast/basal body segregation 
defects, flagella detachment and unequal segregation of nuclear DNA.  Non‐induced and RNAi 
cells were stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 
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6.2.1 TbKMP-11 flagellum localisation – relationship to FLAM3  
 
The trypanosome flagellum emerges from the flagellar pocket and remains attached 
to the cell body for most of its length via the flagellum attachment zone (FAZ), but 
then extends a short distance beyond the anterior pole of cell as a ‘free flagellum’ 
(Ralston et al., 2009). Detailed analysis of TbKMP-11 localisation indicated the TbKMP-
11::YFP signal was more intense where the flagellum was attached to the cell body, 
and became weaker where the flagellum extended beyond the anterior pole of the 
cell. This pattern was strikingly similar to that observed for a protein designated FLAM 
3; which is reported to be a component of the FAZ (Sunter et al., 2015). In PCF cells, 
RNAi ablation of FLAM3 leads to a short new FAZ and results in a dramatic change in 
cell morphology with the generation of epimastigote-like cells (Sunter et al., 2015). 
The typical features of an epimastigote-form cell is a long free flagellum (i.e. the 
flagellum attached to the cell body is shortened) and the kinetoplast is juxtaposed to 
the nucleus toward the anterior end of the cell body. 
 
To investigate the relationship between TbKMP-11 and FLAM3, cell lines were 
generated that allowed for inducible ablation of FLAM3 in procyclic cells expressing 
TbKMP-11::YFP. Although a growth defect was evident 24 hour after induction of 
FLAM3 RNAi (Fig 6.2-A), immunoblotting revealed that TbKMP-11 expression was 
unaffected (Fig 6.2-B). Although knockdown of FLAM3 expression was not directly 
ascertained in these induction experiments the phenotypic consequence of FLAM3 
RNAi was examined by immunofluorescence microscopy (Fig 6.2-C-(1-4)). FLAM3 RNAi 
induced cells clearly displayed the previously reported FLAM3 RNAi phenotype as 
early as 24 hours post induction; i.e. the majority of cells were undergoing 
morphological change from trypomastigote to epimastigote-like cells (Fig 6.2-C-(2); 
white square).  Following longer periods of RNAi induction (48h and 72h) cells were 
observed in which both the kinetoplast and nuclei had duplicated and segregated, but 
these cells were unable to undergo cytokinesis resulting in the generation of multi-
nucleate cells (Fig 6.2-C-(3-4)).  However, even in these grossly abnormal cells, the 
localisation of TbKMP-11::YFP within the flagellum was unaffected; i.e. TbKMP-11::YFP 
signal was strong where the flagellum was attached to cell body and of diminished 
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intensity in the ‘free flagellum’. The interpretation of this result is discussed in the 























Figure. 6.2 The expression and localisation of TbKMP-11 is not dependent upon FLAM 3. Cell 
lines capable of FLAM 3 inducible RNAi and expressing TbKMP-11::YFP were generated. (A) 
Growth curves of TbKMP-11::YFP, FLAM 3 RNAi - smOXP9 cells – RNAi induced (broken black 
line) and non-induced (solid black line). (B) The expression of TbKMP-11::YFP level on FLAM3 
RNAi background was analysed by immunoblotting with anti-GFP antibody; KMX-1 acting as 
loading control. (C) FLAM3 RNAi causes a dramatic change in cell morphology, but the 
expression level and localisation of TbKMP-11 (yellow) in detergent extracted cytoskeletons 
remains unaffected. The box designated with broken white line indicates an epimastigote-like 
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In T. brucei, the Ca2+ binding protein calmodulin (CaM) is present within all three 
structural domains of the PFR, as well the linkage between PFR and axoneme, and PFR 
to FAZ (Ridgley et al., 2000). Based on the localisation study of TbKMP-11::YFP in 
chapter 5.4, the TbKMP-11::YFP signal extends beyond the anti-PFR2 antibody (L8C4) 
at proximal end of the flagellum, suggesting TbKMP-11 is more likely to be associated 
with the axoneme than the PFR. To investigate the effect of CaM-depletion on TbKMP-
11 expression and localisation, cell lines were established to allow CaM-RNAi ablation 
on cells expressing TbKMP-11::YFP. Following CaM RNAi induction, cell density was 
determined in induced and non-induced populations of cells (Fig 6.3-A) and a 
pronounced growth defect was observed 24 hours after induction of RNAi. Expression 
of TbKMP-11::YFP was investigated by immunoblotting and revealed to be unaffected 
by CaM depletion until 48 hours post induction, but the expression was slightly 
reduced at 72 hours post induction (Fig 6.3-B). Specific detection of CaM was not 
possible in this experiment (due to the lack of available CaM-specific antibodies), but 
the flagellum detachment observed following induction of CaM RNAi was in 
accordance with the phenotypic effect previously published for this protein (Ginger et 
al., 2013). 
 
The localisation and expression of TbKMP-11::YFP was investigated in CaM-RNAi 
induced cells by immunofluorescence microscopy; with cells co-labelled with anti-
TbRP2 antibody to demarcate the mature basal body (Fig 6.3-C-(1-5)).  In the non-
induced cells, the localisations of TbKMP-11::YFP appeared as described earlier (Fig 
6.3-C-(1)).  After 24 hours of induction, TbKMP-11::YFP expression and localisation to 
near the kinetoplast seemed unaffected. However, short cells with an abnormally long 
free flagellum began to appear in the cell population (Fig 5.3-C-(2-4)). The depletion 
of CaM is reported to cause a PFR assembly defect, although the structure of the 
axoneme remains unaffected (Ginger et al., 2013).  However, as the loss of CaM 
disrupts connection between the axoneme and the PFR (and thus to the cell body via 
the FAZ); cells with detached flagellum arise following CaM RNAi ablation (Fig 6.3-C-
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(3)). At later time points following RNAi induction, cells with grossly abnormal 
morphologies and multinucleate cells were observed (Fig 6.3-C-(5)). Interestingly, in 
the CaM RNAi cells where the flagellum is clearly detached from the cell body, a foci 
of TbKMP-11::YFP is observed at the end of cell body (white rectangular box), along 
with a ‘blob-like’ signal at the distal tip of the flagellum (yellow rectangular box). In 
cells where the flagellum was still evidently attached, TbKMP-11::YFP signal was only 
detected within the flagellum attached to the cell body, and not in the free flagellum 


















Figure 6.3 The level of TbKMP-11::YFP expression was examined following CaM RNAi 
induction. (A) Growth curve of the TbKMP-11::YFP-CaM RNAi cells (Non-induced - solid black 
line; RNAi Induced - broken black line). (B) Immunoblot analysis of TbKMP-11::YFP expression 
following induction of CaM RNAi with anti-GFP antibody. (C) Immunofluorescence analysis of 
TbKMP-11 expression and localisation. In cells with detached flagella, or flagella, which 
extended beyond the cell body, TbKMP-11 YFP could not be detected.  Both non-induced and 
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6.3 TbCytoskeletal-associated protein (CAP51)  
 
Identification of the TbCAP51 encoded by Tb927.7.2640 as a TbRP2-interacting/near 
neighbour protein is difficult to reconcile due to its localisation on the SPMT 
cytoskeleton (see Chapter 5.13). Nevertheless, the effect of TbCAP51 RNAi induction 
on cell growth, cell morphology and flagellum biogenesis was investigated, along with 
its effect on the localisation of TbRP2 at the mature basal body. TbCAP51 RNAi was 
induced and cell growth monitored every 24 hours (Fig 6.5-A). RNAi mediated ablation 
of TbCAP51 led to an effect on cell growth so that by 48 hours post RNAi induction, 
cell growth was reduced by half compared to the non-induced cell population. The 
efficiency of TbCAP51 RNAi was investigated by immunoblotting, using an anti-GFP 
antibody to detect TbCAP51::YFP expression (Fig 6.5-B). After 24 hours of TbCAP51 
RNAi induction, TbCAP51::YFP expression was knocked down compared to non-
induced controls, and by 48 hours almost no TbCAP51::YFP expression was detected. 
Curiously, the expression of TbCAP51::YFP started to recover, so that by 96 hours post 
RNAi induction the expression of TbCAP51::YFP appeared to be equivalent in RNAi 
induced and non-induced cells.   
 
To study the morphogenetic phenotype in TbCAP51 RNAi induced cells, and the effect 
on TbRP2 protein expression/localisation, cells were processed for 
immunofluorescence microscopy and co-labelled with the anti-TbRP2 antibody (Fig 
6.5-C-(1-8)). In non‐induced cells, TbCAP51::YFP localised to the sub-pellicular corset 
(as shown in Chapter 4) and cells had a normal morphology (Fig 6.5-C-(1)).  However, 
after 24 hours of TbCAP51 RNAi induction, TbCAP51::YFP signal was absent from the 
posterior pole where new MT growth takes place during the cell division cycle. There 
was also accumulation of TbCAP51::YFP in the middle region of the cell body, which is 
the posterior pole of the cell with old flagellum still positive, while the signal of the 
new flagellum is devoid (Fig 6.5-C-(2)).  On the very same cell, it seems that kinetoplast 
duplication, separation has occurred, and the nucleus has undergone mitosis.  
However, there was no TbRP2 labelling next to the new kinetoplast, which might 
suggest that loss of TbCAP51 might has on TbRP2 recruitment to the new basal body 
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in some cells of the population (Fig 6.5-C-(2); inset). Based on the cell growth curve, 
even TbCAP51 RNAi ablations introduce abnormality to the cell quickly after induction, 
still some cells were managed to replicate and divide. However, loss of TbCAP51 might 
cause asymmetrical division, therefore, numbers of anucleate zoids cells and multi-
nucleated cells within the population (Fig 6.5-C-(3)).  In some of cells of the 24h 
induction population, due to the cytokinesis defect, cells were unable to separate. 
Those cells appear to be long, and the old and new flagellum at each side of the cells 
(Fig 6.5-C-(4-5)).  After 48 hours of induction, zoid cells and cells with multi-nucleus 
can be observed (Fig 6.5-C-(6-8)).  Kinetoplast and nuclei DAPI counts for the TbCAP51 
RNAi cell line are also analysed. Cell counts were carried out on cells from cultures, 
which were non‐induced and 24 hours post induction of RNAi. The counts reveal that 
most of the cells are 1K1N in non-induced in the population and followed by 2K1N 
cells. After 24 h time point there is an increase number of 2K2N and zoid cells and also 
huge number multi-nucleated cells (Fig 6.5-D). The observation might suggest that 
TbCAP51 RNAi ablation could block the mitosis and/or cytokinesis process. By 48h post 
induction, the majority of the cells counted were multinucleated cells followed by 












































































Figure.6.5 RNA interference-mediated ablation of TbCAP51 results in multiple defects in 
procyclic form cells. (A) Graph showing growth of TbCAP51-RNAi induced (black broken line) 
and non-induced (dotted solid line) procyclic trypanosome cells. (B) The expression level of 
TbCAP51::YFP was monitored by western blotting. Both non-induced and induced cells were 
collected after 24h, 48, 72 and 96 h and probed with anti-GFP antibody. KMX1 detection of -
tubulin was included as a loading control. (C) Non‐induced and induced cells at 24 h and 48h 
were collected, and stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the 
anti-TbRP2 antibody, which labels the mature basal body. Scale bar = 10 m. (D) The TbCAP51 
RNAi cell line was induced and cells were harvested, settled onto slides and labelled with and 
TbRP2 antibody.  Samples were taken from a non‐induced culture and cells, which were 24 
and 48 hours post induction. 100 non‐induced cells, 250 cells of 24h-and 100 cells of 48 hours 
post induction was counted based on the number of kinetoplasts and nuclei they possessed. 
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6.4 T-complex protein 1 subunit epsilon (TCP-1-ε)  
 
T-complex protein 1 subunit epsilon is part of the group II chaperonin complex called 
CCT (chaperonin containing TCP-1 or Tailless Complex Polypeptide 1). The TCP1 
complex acts as a molecular chaperone for various proteins, including tubulin and 
actin, and so the identification of TCP-1-ε is intriguing in the context of its role in 
tubulin chaperone activity. However, TCP-1 is a large hetero-oligomeric structure, 
comprising multiple subunits, and so it is unclear why only the TCP 1 epsilon subunit 
would be biotinylated in the BioID experiments reported in this thesis.  
 
Nevertheless, to investigate the role of TbTCP-1- and its association with TbRP2, 
TbTCP-1- RNAi was induced and cell growth monitored every 24 hours (Fig 6.6-A).  
TbTCP-1- RNAi Induction caused a severe growth defect indicating that TbTCP-1- is 
essential for cell viability. Knockdown of TbTCP-1- expression was analysed by 
immunoblotting using an anti-GFP antibody to detect the TbTCP-1-::YFP fusion 
protein (Fig 6.6-B). At 24 h RNAi induction, the YFP expression did not appear to be 
different between induced and non-induced samples. After 48 hours of TbTCP-1- 
RNAi induction, expression of TbTCP-1-::YFP was reduced in induced cells compared 
to non-induced controls. After 72h and 96 h after induction, the level of YFP expression 
came back, when compared to the induced lane at 48 hours. KMX-1 control indicating 
equivalence of protein loading between lanes, detection of TbTCP-1-::YFP was 
variable in non-induced and RNAi-induced samples; although TbTCP-1-::YFP 
expression did uniformly appear reduced in RNAi-induced cell populations compared 
to control samples.  
 
To study the morphogenetic phenotypes resulting from TbTCP-1- RNAi induction, and 
the effect on TbRP2 expression/localisation, cells from the TbTCP-1- RNAi depletion 
experiment were processed for immunofluorescence microscopy (Fig 6.6-C-(1-6)). In 
non‐induced cells TbTCP-1-::YFP expression was evident throughout the cell body as 
expected and cells showed normal morphology (Fig 5.6-C-(1)). However, after 24 
hours of TbTCP-1-RNAi induction, the TbTCP-1-::YFP cell body localisation was 
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severely affected, the YFP signal was no longer uniformly dispersed throughout the 
cytoplasm, and the TbTCP-1-::YFP signal was focussed into distinct foci (Fig 6.6-C-(2-
5). In cells in which expression of TbTCP-1-ε was targeted by RNAi induction, 
kinetoplasts and nuclei were clearly still able to undergo replication and segregation, 
however their overall morphology was abnormal. The mid-point of many cells was 
expanded (Fig 6.6-C-(2); black arrow) as early as 24 hours post RNAi induction.  Cells 
which showed a ‘monstrous’ appearance also accumulated, i.e. cells with multiple 
nuclei and abnormal kinetoplast complement indicating defects in cell division 
developed in the TbTCP-1-ε depleted cells. TbTCP-1-::YFP RNAi also produced cells 
with detached flagella and kinetoplasts that were incorrectly positioned with respect 
to nuclei (Fig 6.6-C-(3-4); white arrows). The cytokinesis defects were clearly evident 
in TbTCP-1-ε depleted cells which showed abnormally long posterior ends or cells 
which remained attached via their posterior ends (Fig 6.6 C-(5-6)). Although loss of 
TbTCP-1-protein cells resulted in severe morphogenetic defects the expression and 
localisation of TbRP2 remained unaffected. However, in a small number of cells TbRP2 
was detected in a region of the cell not associated with kinetoplast DNA (Fig. 6.6 C-(3-
4), white asterisks), suggesting that TbTCP-1-depletion could disturb the connection 
between the mature basal body (detected by TbRP2) and kinetoplast DNA.   
 
In the previous experiments, it was difficult to distinguish that a flagellum was present 
on some cells. To investigate whether by TbTCP-1-εknock-down affected flagellum 
assembly, cells were analysed by immunostaining cells with the anti-PFR2 monoclonal 
antibody L8C4 (Fig. 6.7 D-(1-5)). These experiments demonstrated that the majority of 
the cells induced for TbTCP-1-ε RNAi were able to assemble flagella but confirmed the 
flagella detachment phenotype. This might suggest that loss of TbTCP-1-ε disrupts 















































































































Figure 6.6 RNA interference-mediated ablation of TbTCP-1-results in multiple defects in 
procyclic form cells. (A) Graph showing growth of TbTCP-1- RNAi induced (black broken line) 
and non-induced (black solid line) procyclic trypanosome cells. (B) The TbTCP-1- expression 
level was monitored by western blotting. Both non-induced and induced cells were collected 
24h, 48 h, 72h and 96h post induction and probed with anti-GFP antibody. KMX1 detection of 
-tubulin was included as a loading control. (C) Non‐induced and induced cells at 24h/48h 
post induction of TbTCP-1- RNAi cell line were harvested for immunofluorescence analysis. 
Cells were stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 
antibody, which labels the mature basal body. (D) TbTCP-1- RNAi cell line were harvested for 
immunofluorescence analysis. Cells were stained with L8C4 to label the flagella. Scale bar = 10 
m.  AF attached flagellum; DF detached flagellum. 
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6.5 ADP-ribosylation factor-like 3 (ARL3)-like  
 
 
The identification of an ARL3-like protein as a putative TbRP2-interacting/near 
neighbour protein was anticipated given that; (i) human RP2 protein is reported to act 
as a GAP for an ARL3 protein and, (ii) it has previously been reported that RNAi 
knockdown of an ARL3-like protein (TbARL3A) in T. brucei leads to a flagellum 
assembly defect (Sahin et al., 2004), similar to that observed following RNAi ablation 
of TbRP2. However, the ARL3-like protein studied by Sahin et al (Sahin et al., 2004) 
and the ARL3-like protein identified in the BioID study reported here are not the same 
protein. Thus, to investigate the role(s) of the TbARL3-like protein identified in this 
thesis, TbArl3L RNAi was induced in procyclic cells and cell growth monitored every 24 
hours (Fig 6.7-A).  Little difference in growth was observed for the first 48 hours 
following RNAi induction, but thereafter cell growth was impaired, until the 
termination of the induction experiment at 96 hours.  Knockdown of TbArl3L 
expression was confirmed by immunoblotting using the anti-GFP antibody to detect 
TbArl3LYFP with detection of β-tubulin by KMX-1 used as a loading control (Fig 6.7-
B).  After 24 hours of RNAi induction, TbARL3L::YFP expression was reduced in RNAi 
induced cells, and after 48 hours very little TbARL3L::YFP expression could be 
detected.    
 
To study the morphogenetic phenotypes resulting from TbARL3L RNAi ablation, cells 
from a non‐induced culture and from 24, 48, 72 and 96 hours post RNAi induction 
were processed for immunofluorescence microscopy. The cells were co-labelled with 
anti-TbRP2 antibody to investigate the effect TbARL3L RNAi had on the expression and 
basal body localisation of TbRP2 (Fig 6.7-C-(1-9)). In Fig 6.7-C-1, non‐induced cells 
clearly show TbARL3::YFP co-localised at the basal body with TbRP2, but also to the 
nucleus where the TbARL3::YFP signal was diffuse throughout the nucleus.  After 24 
hours of RNAi induction, in most cells TbARL3::YFP signal was undetectable at the 
basal body and nucleus, although the morphology of these cells appeared normal (Fig 
6.7-C-2).  However, by 48 hours post induction, a number of cells displayed a detached 
flagellum (Fig 6.7-C-(3-4); white arrows), and the flagellar pocket may be enlarged in 
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approximately 20% of cells (Fig 6.7-C-3, 4 and 6; white square). One of the 
consequences of having a detached flagellum is that the T. brucei cells are unable to 
divide correctly and organelle positioning is affected. Thus, multinucleate cells and 
kinetoplast/nuclei mispositioning defects were prevalent in the population (Fig. 6.7-C-
5, 7, 8 and 9).  In addition, depletion of TbARL3Lalso led to cytokinesis defects, with 
cells apparently unable to divide and remaining attached via their posterior pole (Fig. 
6.7-C-6; white asterisk). Despite these gross morphological defects, in the majority of 
cells TbRP2 was expressed and localised adjacent to the kinetoplast, consistent with a 
mature basal body localisation. However, closer scrutiny revealed that TbRP2 labelling 
was (i) not associated with all kinetoplasts (Fig.6.7-C-5) and (ii) present at locations 
within the cell where kinetoplasts were absent. This suggests the linkage between the 
basal body and kinetoplast DNA, established by the TAC, was also affected in some 
























































Figure 6.7 The effect of RNA interference-mediated ablation of TbARL3L on procyclic form 
cells. (A) Graph showing growth of TbARL3L RNAi induced (black broken line) and non-induced 
(black solid line) procyclic trypanosome cells. (B) The TbARL3L expression level was monitored 
by western blotting. Both non-induced and induced cells were collected 24h, 48 h, 72h and 
96h post induction and probed with anti-GFP antibody. KMX1 detection of -tubulin was 
included as a loading control. (C) Non‐induced and induced cells at 24h, 48 h, 72h and 96h 
post induction of TbTCP-1- RNAi cell line were harvested for immunofluorescence analysis. 
Cells were stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 
antibody, which labels the mature basal body. White arrow indicates flagellum detachment, 
white square indicates enlarged flagellar pocket, and white asterisk cell unable to divide and 
remaining attached via their posterior pole.  
(8) 
(9) 
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6.6 ARL2-binding protein (BART, Binder of ARL Two) like-
1 
 
The identification of a BART-like1 protein was particularly intriguing given that during 
the course of my PhD studies, it was published that BARTL1 has a regulatory role in 
ciliary assembly; potentially aiding the presentation of active ARL3 to RP2 (or 
hindering ARL3 membrane binding at the transition zone). To investigate the role(s) of 
TbBARTL1, its expression was knocked down by RNAi and cell growth monitored every 
24 hours (Fig 6.8-A).  This revealed only a modest effect on cell growth. The expression 
of TbBARTL1::YFP was monitored by immunoblotting using the anti-GFP antibody, 
with detection of β-tubulin by KMX-1 acting as a loading control (Fig 6.8-B). This 
experiment confirmed TbBARTL1::YFP expression was almost undetectable within 24 
hours of initiating RNAi induction. Fluorescence microscopy also confirmed the 
efficacy of TbBARTL1 RNAi knockdown, with TbBARTL1::YFP significantly reduced 
within 24 hours. Despite the robust knockdown of TbBARTL1 expression, no gross 
phenotypic abnormalities were observed in RNAi induced cells; even after prolonged 
(96 hours) of RNAi induction (Fig 6.8-C-(1-5)).  A small proportion of cells showed some 
abnormality e.g. detached flagella and multinucleate phenotype (Fig 6.8-D-(1-3)) 
which might explain the modest effect on cell growth, but as all cells showed 
TbBARTL1 depletion it is uncertain why phenotypic abnormalities would only be 
present in a small proportion of the cells.  What was clear from these experiments was 
that loss of TbBARTL1 expression had no effect on expression or basal body 





















































Figure 6.8. The effect of RNA interference-mediated ablation of TbBARTL1 on procyclic form 
cells. (A) Graph showing growth of TbBARTL1 RNAi induced (black broken line) and non-
induced (black solid line) procyclic trypanosome cells. (B) The TbBARTL1 expression level was 
monitored by western blotting. Both non-induced and induced cells were collected 24h, 48 h, 
72h and 96h post induction and probed with anti-GFP antibody. KMX1 detection of -tubulin 
was included as a loading control. (C) Non‐induced and induced cells at 24h, 48 h, 72h and 96h 
post induction of TbBARTL1 RNAi cells were harvested for immunofluorescence analysis. (D) 
Immunofluorescence analysis revealed that small number of cells were appeared with cell 
division defect and flagellum detachment after TbBARTL1 RNAi ablation. Cells were stained 
with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 antibody, which 
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6.7 Heat Shock Protein 70 (HSP70) 
 
In this chapter, I focus on the effect(s) that TbHSP70 RNAi ablation has on TbRP2 
protein expression and localisation.  The candidate protein TbHSP70 is a detergent-
insoluble protein, and TbHSP70::YFP localised to the basal body, which co-localised at 
with TbRP2 at 1K1N stage. There is also an intense focus of TbHSP70::YFP signal 
localised distal to TbRP2, and this YFP signal continues along on the flagellum. As the 
cell cycle progresses, the TbHSP70 signal at basal body and old flagellum diminishes, 
however, the TbHSP70 signal distal to the basal body duplicates and segregates with 
the replicated kinetoplast.  
 
To investigate the putative association between TbHSP70 and TbRP2 in T. brucei (as 
indicated by the BioID experiments), the expression of TbHSP70 was ablated by RNAi 
and cell growth monitored every 24 hours in RNAi induced and non-induced cell 
populations (Fig 6.9-A). Although cell growth appeared to be impaired within the first 
48 hours of RNAi induction, cell growth unexpectedly recovered from 48 hours post 
induction. The expression of TbHSP70::YFP was monitored by immunoblotting using 
the anti-GFP antibody to detect TbHSP70::YFP, with detection of β-tubulin by KMX-1 
used as a loading control (Fig 6.9-B). The immunoblotting experiments revealed that 
expression of TbHSP70::YFP was successfully knocked down by RNAi up to 72 hours 
post induction, but that at 96 hours, expression of TbHSP70::YFP had recovered to wild 
type levels. Immunofluorescence analysis confirmed that expression of TbHSP70::YFP 
was knocked down within the 72 hours of RNAi ablation. At 96 hours post induction, 
a distinct focus of TbHSP70::YFP distal to the basal body was detected by fluorescence 
microscopy. Despite the apparent efficacy of TbHSP70 RNAi knockdown (at least up to 
72 hours post induction), no obvious phenotype could be observed (Fig 6.9-C-(1-5)), 
nor did the loss of TbHSP70 have any effect on the expression or localisation of TbRP2 
(with TbRP2 clearly detectable in a position close to the kinetoplast in all cells).  
 
 










































































Figure 6.9. The effect of RNA interference-mediated ablation of TbHSP70 on procyclic form 
cells. (A) Graph showing growth of TbHSP70 RNAi induced (black broken line) and non-induced 
(black solid line) procyclic trypanosome cells. (B) The TbHSP70 expression level was monitored 
by western blotting. Both non-induced and induced cells were collected at 24h, 48 h, 72h and 
96h post induction and probed with anti-GFP antibody. KMX1 detection of -tubulin was 
included as a loading control. (C) Non‐induced and induced cells at 24h, 48 h, 72h and 96h 
post induction of TbHSP70 RNAi cells were harvested for immunofluorescence analysis. Cells 
were stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 
antibody, which labels the mature basal body. Scale bar = 10 m.  
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6.8 Vps-27, Hrs and STAM (VHS) domain containing 
protein 
 
The identification of a VHS domain-containing protein as a putative TbRP2-
interacting/near neighbour protein was intriguing, given the proposed role(s) of VHS 
domain-containing proteins in vesicular trafficking in other eukaryotes. To investigate 
the role(s) of the TbVHS domain-containing protein, expression of TbVHS was ablated 
by RNAi and cell growth monitored every 24 hours (Fig 6.10-A). No growth defect was 
detected following RNAi knockdown of the TbVHS protein. The knockdown of 
TbVHS::YFP expression was monitored by immunoblotting, using the anti-GFP 
antibody, with detection of β-tubulin by KMX-1 used as a loading control (Fig 6.10-B). 
The immunoblotting experiment indicated that RNAi mediated ablation of TbVHS::YFP 
was successful.  
 
RNAi ablation of TbVHS was also investigated by fluorescence microscopy (Fig 6.10-C-
(1-5)). In non-induced cells (Fig 6.10-C-1), TbVHS::YFP can be observed accumulating 
in the region between the kinetoplast and nucleus, and the TbVHS::YFP signal that 
appear to be more distal to TbRP2. After induction of TbVHS RNAi, the TbVHS::YFP 
signal is progressively diminished, but no obvious phenotype can be observed, even 
96 hours after induction of RNAi (Fig 6.10-C-(2-5)). Moreover, depletion of TbVHS from 























































































Figure 6.10 The effect of RNA interference-mediated ablation of TbVHS on procyclic form 
cells. (A) Graph showing growth of TbVHS RNAi induced (black broken line) and non-induced 
(black solid line) procyclic trypanosome cells. (B) The TbVHS expression level was monitored 
by western blotting. Both non-induced and induced cells were collected at 24h, 48 h, 72h and 
96h post induction and probed with anti-GFP antibody. KMX1 detection of -tubulin was 
included as a loading control. (C) Non‐induced and induced cells at 24h, 48 h, 72h and 96h 
post induction of TbVHS RNAi were harvested for immunofluorescence analysis. Cells were 
stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 antibody, 
which labels the mature basal body. Scale bar = 10 m.  
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6.9 Protein kinase 
 
To investigate the putative function(s) of the protein kinase (TbPK) identified in the 
BioID experiments its expression was knocked by gene specific RNAi and growth of 
RNAi induced and non-induced cells monitored every 24 hours (Fig 6.11-A). Based on 
cell growth data, the RNAi knockdown of this protein kinase has no effect on the 
growth and proliferation of procyclic form cells. RNAi knockdown of TbPK expression 
was confirmed by immunoblotting using anti-GFP antibody to detect TbPKYFP; with 
KMX-1 detection of β-tubulin used as a loading control (Fig 6.11-B).  After 24 hours of 
RNAi induction, TbPKYFP expression was reduced in RNAi induced cells, and after 96 
hours very little TbPKYFP expression could be detected in the RNAi induced 
population.  
 
TbPK RNAi induced (and non-induced) cells were also analysed by fluorescence 
microscopy to detect TbPKYFP expression and TbRP2 (Fig 6.11-C-(1-5)). In non-
induced cells (Fig 6.11-C-1), TbPK::YFP can be seen localised close to the kinetoplast; 
aligning in part with TbRP2 at the basal body but also extending to a position more 
distal to TbRP2.  However, although 24 hours after initiation of TbPK RNAi induction, 
TbPK::YFP expression was successfully knocked down no obvious phenotype was 
observed, even after extended (96 hour) induction (Fig 6.11-C-5). Loss of TbPK also has 

























































































Figure 6.11 The effect of RNA interference-mediated ablation of TbPK on procyclic form 
cells. (A) Graph showing growth of TbPK RNAi induced (black broken line) and non-induced 
(black solid line) procyclic trypanosome cells. (B) The TbPK expression level was monitored by 
western blotting. Both non-induced and induced cells were collected at 24h, 48 h, 72h and 
96h post induction and probed with anti-GFP antibody. KMX1 detection of -tubulin was 
included as a loading control. (C) Non‐induced and induced cells at 24h, 48 h, 72h and 96h 
post induction were harvested for immunofluorescence analysis. Cells were stained with DAPI 
to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 antibody, which labels the 
mature basal body. Scale bar = 10 m.  
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6.10 Microtubule-associated repetitive protein (MARP)  
 
To investigate the putative function(s) of the microtubule associated repetitive 
protein (MARP) identified by TbRP2 BioID, the protein was depleted by RNAi and the 
effect on cell growth monitored every 24 hours (Fig 6.12-A). Based on cell counts, 
TbMARP RNAi knockdown has no effect on the proliferation and growth of procyclic 
form cells. Detection of YFP::TbMARP expression by western blotting was not possible 
due to its very large molecular weight (attempts to resolve this protein on 8% SDS-
PAGE were unsuccessful). However, expression of YFP::TbMARP was analysed by 
fluorescence microscopy (Fig 6.12-B-(1-5)). Non-induced cells are shown on the top 
panel (Fig 6.12-B-1), and YFP::TbMARP is localised (as expected) at the basal body (co-
localised with TbRP2), but also with the sub-pellicular microtubule cytoskeleton.  After 
24 hours of RNAi induction, YFP::TbMARP signal is depleted in most cells. At later time 
points (48-96 hours), YFP::TbMARP was unable to be detected in RNAi induced cells, 
however, no gross morphological phenotype could be observed (even after 96 hours 
of RNAi induction). However, RNAi cells collected at 72 and 96 hours post induction 
looked more elongate and thinner than non-induced cells and to RNAi induced cells 
collected at early RNAi time points (Fig 6.12-B-(2-5)). However, loss of TbMARP from 









Figure 6.12 The effect of RNA interference-mediated ablation of TbMARP on procyclic form 
cells. (A) Graph showing growth of TbMARP RNAi induced (black broken line) and non-induced 
(black solid line) procyclic trypanosome cells. (B) Non‐induced and induced cells at 24h, 48 h, 
72h and 96h post induction were harvested for immunofluorescence analysis. Cells were 
stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 antibody, 
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6.11 TbBB590  
 
To investigate the putative function(s) of TbBB590, the protein was depleted by RNAi 
and the effect on cell growth monitored every 24 hours (Fig 6.13-A). Based on cell 
counts, TbBB590 RNAi knockdown has no effect on the proliferation and growth of 
procyclic form cells (there is only slightly cell number drop between 72h to 96h of 
induction). Detection of TbBB590::YFP expression by western blotting was not 
possible due to its large molecular weight (all attempts to resolve this protein by SDS-
PAGE were unsuccessful). However, TbBB590::YFP expression could be analysed by 
fluorescence microscopy in RNAi induced and non-induced cells (Fig 6.13-B-(1-5)). In 
non-induced cells (Fig 6.13-B-1), TbBB590::YFP is localised at the basal body, co-
localised with TbRP2.  As previously described (Chapter 4), TbBB590::YFP localisation 
at the mature basal body has an unusual (unprecedented?) cell cycle pattern; i.e. 
TbBB590::YFP expression is more intense on the new basal body than the old, but as 
the cell progresses through the cell cycle (i.e. 2K2N) the TbBB590::YFP signal appears 
to be equal on both basal bodies. Following induction of TbBB590 RNAi, TbBB590::YFP 
is rapidly lost from the cell but no obvious phenotype can be observed even after 96 
hours (Fig 6.13-B-(2-5)). Loss of TbBB590 does not have any effect on TbRP2 










Figure 6.13 The effect of RNA interference-mediated ablation of TbBBP590 on procyclic form 
cells. (A) Graph showing growth of TbBBP590 RNAi induced (black broken line) and non-
induced (black solid line) procyclic trypanosome cells. (B) Non‐induced and induced cells at 
24h, 48 h, 72h and 96h post induction were harvested for immunofluorescence analysis. Cells 
were stained with DAPI to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 
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6.12 Tubulin polymerization promoting protein 
(TPPP/P25-)  
 
The identification of the tubulin polymerization promoting protein (TPPP/P25-α) as a 
putative TbRP2-proximal protein was intriguing, given (i) the proposed role of TPPP in 
the polymerisation of tubulin into microtubules, and (ii) its restriction to eukaryotes 
that form cilia/flagella. To investigate the putative function(s) of the T. brucei TbP25-
α orthologue, its expression was knocked by gene specific RNAi and the growth of 
RNAi induced and non-induced cells monitored every 24 hours (Fig 6.14-A).  
 
Based on this analysis, RNAi knockdown of TbP25-α has no effect on the growth and 
proliferation of procyclic form cells. RNAi knockdown of TbP25-α expression was 
analysed by immunoblotting using the anti-GFP antibody to detect TbP25-αYFP 
fusion protein; with KMX-1 detection of β-tubulin used as a loading control (Fig 6.14-
B). In Fig 6.14-B, a dominant band of ~43 kDa (expected size of the TbP25-αYFP fusion 
protein) and a faint band of ~27 kDa (predicted size of YFP) was detected in the non-
induced cells. The lower MW band is interpreted as being a cleavage product of the 
TbP25-α::YFP fusion protein.  After induction of TbP25-α RNAi, the expression of 
TbP25-α::YFP was moderately reduced, however, TbP25-YFPwas still detectable 
after 96 hours of induction. Detection of β-tubulin by KMX-1 indicated that equal 
loading of non-induced and RNAi induced samples.    
 
Fluorescence microscopy analysis reveals that in the absence of TbP25-α RNAi 
induction, TbP25-αYFP localises at cell body and the flagellum (Fig 6.14-C-1). 
However, after induction of TbP25-α RNAi, the expression of TbP25-YFP was 
successfully depleted in some cells, while in others TbP25-α::YFP expression appeared 
to be unaltered 96 hours after induction. No obvious phenotype was induced 
following loss of TbP25-α even after 96 hours (Fig 6.14-C), nor did loss of TbP25- 
have any effect on TbRP2 expression or localisation.  
 
 











































































Figure 6.14 The effect of RNA interference-mediated ablation of TbP25-on procyclic form 
cells. (A) Graph showing growth of TbP25- RNAi induced (black broken line) and non-induced 
(black solid line) procyclic trypanosome cells. (B) The TbP25- expression level was monitored 
by western blotting. Both non-induced and induced cells were collected at 24h, 48 h, 72h and 
96h post induction and probed with anti-GFP antibody. KMX1 detection of -tubulin was 
included as a loading control. (C) Non‐induced and induced cells at 24h, 48 h, 72h and 96h 
post induction were harvested for immunofluorescence analysis. Cells were stained with DAPI 
to label nuclei (N) and kinetoplasts (K) and with the anti-TbRP2 antibody, which labels the 
mature basal body. Scale bar = 10 m.  
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6.13  Effect of TbRP2 RNAi on the expression and 
localisation of selected putative TbRP2-interacting/near 
neighbour proteins 
 
As RNAi mediated knockdown of all putative TbRP2-proximal proteins failed to perturb 
the basal body localisation of TbRP2, the reciprocal experiment was undertaken for a 
selected cohort i.e. the effect of TbRP2 RNAi on the expression and localisation of 
KMP-11, HSP70, TbBBP590, ARL3 and BARTL1 was investigated.  Cell lines capable of 
expressing YFP-tagged versions of KMP-11, HSP70, TbBBP590, ARL3 and BARTL1 were 
generated in a TbRP2 RNAi (smOX P9) cell line. As described previously, following RNAi 
induction (in this instance TbRP2 RNAi) cell growth was monitored and the expression 
and intracellular localisation of TbRP2 and YFP-tagged proteins of interest 
investigated.  
 
6.13.1   KMP-11 
 
The induction of TbRP2 RNAi results in a profound growth defect 48 hour after 
induction of gene-specific RNAi (Fig 6.15-A). Although TbRP2 expression was not 
directly monitored in immunoblotting experiments, the flagellum assembly defect 
that arises following TbRP2 depletion was apparent in RNAi induced populations (Fig 
6.15-C-(1-4)). However, expression of TbKMP-11::YFP is clearly unaffected by 
induction of TbRP2 RNAi-mediated ablation (Fig 6.15-B). Immunofluorescence analysis 
was also carried out; non-induced cells expressing TbKMP-11::YFP and co-labelled 
with the anti-TbRP2 antibody are shown on the top panel (Fig 6.15-C-(1)). At 24 hours 
after induction of TbRP2 RNAi the majority of cells look normal, TbRP2 can still be 
detected by immunofluorescence analysis and there is no effect on TbKMP-11::YFP 
expression (Fig 6.15-C-(2)).  At 48 hours post induction, cells in the culture flask were 
observed to be moving abnormally. When RNAi induction proceeds for 72 hours, more 
severe phenotypic abnormalities were observed in the population, the short flagellum 
formed in TbRP2 RNAi induced cells demonstrated in cytokinesis defect resulting in an 
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accumulation of multi-nucleate cells (Fig 6.15-C-(4)).  As described earlier, that 
TbKMP-11 has multiple localisations within the PCF cells. When TbRP2 is depleted PCF 
trypanosomes cells form an abnormally short new flagellum. The T. brucei flagellum is 
an essential and multifunctional organelle, which plays important roles in cell motility, 
but also in cellular morphogenesis and cell division.  The consequence of forming a 
short new flagellum is the generation of multi-nucleated cells that have failed to divide 
correctly.  In these cells, which have failed to assemble flagella, TbKMP-11::YFP 



















Figure 6.15 The effect of TbRP2 RNAi mediated ablation on TbKMP-11 localization and 
expression. (A) Graph showing growth of TbRP2 RNAi induced (black broken line) and non-
induced (black solid line) procyclic trypanosome cells. (B) The expression of TbKMP-11::YFP 
on TbRP2 RNAi background was monitored by western blotting. Both non-induced and 
induced cells were collected at 24h, 48 h, 72h and 96h post induction and probed with anti-
GFP antibody. KMX1 detection of -tubulin was included as a loading control. (C) 
Immunofluorescence images of TbKMP-11::YFP, TbRP2 RNAi cell line. Cells at 24h, 48 h, 72h 
and 96h post induction were harvested, and co-labelled with DAPI to label nuclei (N) and 
kinetoplasts (K) and with the anti-TbRP2 antibody, which labels the mature basal body. Scale 
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6.13.2   HSP70 
 
The cell growth curve (Fig 6.16-A) shows that the TbRP2 RNAi defect again became 
apparent 48 hours post RNAi induction, but immunoblotting experiments reveal 
TbHSP70::YFP expression is not affected by TbRP2 depletion (Fig 6.16-B). 
Immunofluorescence analysis confirmed the loss of TbRP2 expression at the mature 
basal body and the development of morphologically abnormal cells following TbRP2 
RNAi induction (Fig 6.16-C-(1-4)).  Due to the loss of TbRP2, only accumulated 
TbHPS70::YFP signal can be seen within the shortened flagella (Fig 6.16-C white 
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Figure 6.16 The effect of TbRP2 RNAi mediated ablation on TbHSP70 localisation and 
expression. (A) Graph showing growth of TbRP2 RNAi induced (black broken line) and non-
induced (black solid line) procyclic trypanosome cells. (B) The expression of TbHSP70::YFP on 
TbRP2 RNAi background was monitored by western blotting. Both non-induced and induced 
cells were collected at 24h, 48 h, 72h and 96h post induction and probed with anti-GFP 
antibody. KMX1 detection of -tubulin was included as a loading control. (C) 
Immunofluorescence images of TbHSP70::YFP, TbRP2 RNAi cell line. Cells at 24h, 48 h, 72h and 
96h post induction were harvested, and co-labelled with DAPI to label nuclei (N) and 
kinetoplasts (K) and with the anti-TbRP2 antibody, which labels the mature basal body. Scale 
bar = 10 m. White arrow indicates short flagellum, and White square indicates accumulation 
of TbHPS70::YFP signal in shortened flagella  
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6.13.3   TbBBP590 
 
The cell growth curve again shows the TbRP2 RNAi defect became apparent 48 hours 
post RNAi induction (Fig 6.17-A) and subsequent immunofluorescence analysis 
confirmed loss of TbRP2 expression resulted in the development of morphologically 
abnormal cells (Fig 6.17-B). Due to the large MW of the TbBBP590 protein it was not 
possible to investigate the expression of this protein by immunoblotting however, the 
expression of TbBB590::YFP was monitored by fluorescence microscopy (Fig 6.17-B-
(1-5)). The expected basal body localisation pattern of TbBB590::YFP in non-induced 
cells is shown in the top panel of Fig 6.17-B-1.  
 
In the presence of doxycycline, at 24 hours post induction, no obvious defect on cells 
can be observed (Fig 6.17-B-(2-3)). The expression of TbRP2 was depleted in the 
majority of cells but there was no effect on the expression or localisation of the 
TbBBP590::YFP at that time.  By 48 hours post-induction, visualisation of cells in 
culture revealed that cells had started to exhibit motility problems, and 
immunofluorescence analysis showed cells also displayed cell division defects (Fig 
6.17-C-4; inset) leading to the formation of multi-nucleated cells.  In this cell, which 
has three kinetoplasts, TbBBP590::YFP is associated with only one kinetoplast, but it 
is impossible to distinguish whether this is an ‘old’ or ‘new’ kinetoplast.  When the 
RNAi induction time point reaches 72 hours, cells exhibiting more severe phenotypes 
were accumulating within the population; these were the consequence of cytokinesis 
defects arising from the expected short flagellum phenotype and the generation of 
multi-nucleated cells (Fig 6.17-C-5).   Although TbRP2 RNAi ablation might cause 
TbBBP590 segregation problems in some cells, the TbBBP590::YFP signal can still be 










































Figure 6.17 The effect of TbRP2 RNAi mediated ablation on TbBBP590 localisation and 
expression. (A) Graph showing growth of TbRP2 RNAi induced (black dotted line) and non-
induced (black solid line) procyclic trypanosome cells. (B) Immunofluorescence images of 
TbBBP590::YFP on TbRP2 RNAi background. Cells at 24h, 48 h, 72h and 96h post induction 
were harvested, and co-labelled with DAPI to label nuclei (N) and kinetoplasts (K) and with the 
anti-TbRP2 antibody, which labels the mature basal body. Scale bar = 10 m. Inset indicates 
that the segregation of TbBBP590::YFP at the basal body might affect by the depletion of 
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6.13.4   BART LIKE 1  
 
The induction of TbRP2 RNAi results in a profound growth defect 48 hours after 
induction of gene-specific RNAi (Fig 6.18-A) but immunoblotting reveals that the 
expression level of TbBARTL1::YFP remains unchanged 96 hours after TbRP2 RNAi 
induction(Fig 6.18-B). Thus TbBARTL1::YFP expression is not affected by the loss of 
TbRP2 from cells. Subsequent immunofluorescence microscopy confirmed loss of 
TbRP2 expression and the development of morphologically abnormal cells expected 
following TbRP2 depletion (Fig 6.18-C-(1-5)). The localisation of TbBARTL1::YFP to the 
cell body and flagellum in non-induced cells is shown in the top panel (Fig 6.18-C-1); 
the cells were co-labelled with anti-TbRP2 antibody to show the position of the mature 
basal body. After 24 hours of TbRP2 RNAi induction, most cells have a normal 
morphology but TbRP2 expression at the basal body is showing evidence of depletion. 
However, there is no effect on the expression of the TbBARTL1::YFP (Fig 6.18-C-2).  At 
48 hours post induction, cells in culture were moving abnormally slowly and when 
these cells were examined by immunofluorescence microscopy, TbRP2 expression had 
been lost and cells presented with short flagella (Fig 6.18-C-3).  After 72 hours of TbRP2 
RNAi induction, cells with anticipated cytokinesis defects and multi-nucleated cells 
accumulated within the population (Fig 6.18-C-4). However, there was no evidence 
that loss of TbRP2 (and the generation of sever morphological abnormalities) affected 
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Figure 6.18 The effect of TbRP2 RNAi mediated ablation on TbBARTL1 localisation and 
expression. (A) Graph showing growth of TbRP2 RNAi induced (black broken line) and non-
induced (black solid line) procyclic trypanosome cells. (B) The expression of TbBARTL1::YFP on 
TbRP2 RNAi background was monitored by western blotting. Both non-induced and induced 
cells were collected at 24h, 48 h, 72h and 96h post induction and probed with anti-GFP 
antibody. KMX1 detection of -tubulin was included as a loading control. (C) 
Immunofluorescence images of TbBARTL1::YFP, TbRP2 RNAi cell line. Cells at 24h, 48 h, 72h 
and 96h post induction were harvested, and co-labelled with DAPI to label nuclei (N) and 
kinetoplasts (K) and with the anti-TbRP2 antibody, which labels the mature basal body. Scale 
bar = 10 m.  
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6.13.5   ARL3 Like  
 
The induction of TbRP2 RNAi results in a profound growth defect 48 hours after 
induction of gene-specific RNAi (Fig 6.19-A) but immunoblotting experiments revealed 
that the expression of TbARL3L::YFP remained unaltered 96 hours after induction 
TbRP2 RNAi (Fig 6.19-B). Subsequent immunofluorescence microscopy confirmed loss 
of TbRP2 expression and the development of morphologically abnormal cells expected 
following TbRP2 depletion (Fig 6.19-C-(1-5)). The localisation of TbARL3L::YFP in non-
induced cells are shown on the top panel of Fig 6.19-C-1; cells were co-labelled with 
the anti-TbRP2 antibody, confirming the co-localisation of both proteins. Following 
induction of TbRP2 RNAi, not only was the TbRP2 protein lost from the basal body but 
intriguingly so was TbARL3L::YFP. This is most clearly observed 24 hours after TbRP2 
RNAi induction, where in one of the cells the old basal body is still TbRP2 and 
TbARL3L::YFP positive, yet the basal body nucelating the new flagellum is negative for 
both proteins (Fig 6.19-C-2; see inset).  At 48 hours post induction, the basal body 
localisation of both TbRP2 and TbARL3L::YFP is abolished (Fig 6.19-C-3).  However, 
TbARL3L::YFP expression is not lost entirely (confirming the immunoblotting result) as 
TbARL3L::YFP accumulated within cells with a punctate, yet dispersed, pattern. This 
result suggests that the basal body recruitment and/or retention of TbARL3L::YFP is 
dependent upon TbRP2 expression. After 72/96 hours of RNAi induction, more severe 
phenotypes were evident within the population i.e. cells with cytokinesis defects and 
multi-nucleate cells with a short flagellum. In these cell types, TbARL3L::YFP is clearly 
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Figure 6.19 The effect of TbRP2 RNAi mediated ablation on TbARL3L localisation and 
expression. (A) Graph showing growth of TbRP2 RNAi induced (black broken line) and non-
induced (black solid line) procyclic trypanosome cells. (B) The expression of TbARL3L::YFP on 
TbRP2 RNAi background was monitored by western blotting. Both non-induced and induced 
cells were collected at 24h, 48 h, 72h and 96h post induction and probed with anti-GFP 
antibody. KMX1 detection of -tubulin was included as a loading control. (C) 
Immunofluorescence images of TbARL3L::YFP, TbRP2 RNAi cell line. Cells at 24h, 48 h, 72h and 
96h post induction were harvested, and co-labelled with DAPI to label nuclei (N) and 
kinetoplasts (K) and with the anti-TbRP2 antibody, which labels the mature basal body. Scale 
bar = 10 m.  
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6.14 Summary  
 
This chapter describes the functional investigation of selected putative TbRP2 
interacting/nearby proteins by RNAi in PCF trypanosomes. Based on the 
bioinformatics analysis in Chapter 4, a total of 11 proteins were selected for analysis; 
4 proteins are kinetoplastid-specific (TbBBP590, TbCAP51, TbMARP and TbKMP-11) 
and the other 7 have conserved sequences in other organisms (Summary Table 6.1).  
The localisation(s) of each protein are listed in the table below, as are the phenotypic 
consequences of RNAi ablation. Among these proteins, TbKMP-11 (Li and Wang, 2008; 
Stebeck et al., 1995) and TbCAP51 (Portman and Gull, 2014) have been studied 
previously and shown to be essential for cytokinesis in PCF trypanosomes. A sub-set 
of proteins were selected to investigate the phenotypic consequences of TbRP2 RNAi 
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nucleus 
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Yes No gross 
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then recovers  
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Table 6.2 Summary of experiments investigating if loss of TbRP2 affects the 
localisation and expression of a selected subset of the proteins identified by the 
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Chapter 7 Discussion 
 
In my PhD study, I used BioID to identify candidate near neighbouring and/or 
interacting proteins of TbRP2. To give greater confidence to candidate proteins 
identified by Mass Spectrometry (MS), I also combined the BioID approach with SILAC 
methodology. In that regard, I note that another group recently combined SILAC with 
more conventional immunoprecipitation to identify with confidence novel 
components of the mitochondrial kinetoplast tripartite attachment complex (or TAC) 
(see section 1.3.2) (Käser et al., 2016). Bioinformatics analysis was subsequently 
carried out to prioritise which candidate TbRP2 near-neighbour/interacting proteins 
would be subject to functional analysis on a basis of their evolutionarily conservation 
with trypanosomatids and other organisms. In Table 7.1, a summary of the work 
undertaken in this thesis in relation to the putuative TbRP2-interacting proteins is 
presented. In addition, a discussion of what emerged from my BioID-based analysis of 
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Protein ID Localisation RNAi 
phenotype(s) 
RNAi knockdown 
efficiency   
SILAC experiment 
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BARTL1 Cell body 
/flagellum 
No gross defects 
(abnormalities in 











HSP70 basal body, distal 
to BB/flagellum  
Cell growth defect 
between 24h – 
48h but then 
recovers  
Expression came 







































































              Yes  Cyto Yes                No  
MARP Basal body No apparent 
defect 
Yes Both  Yes  No  
KMP-11 Basal body, 
flagellum, flagellar 



















Reduction   
             WC No  No  
                                   
Table 7.1 Summary table of all proteins selected for further studies in T. brucei following BioID analysis of TbRP2::BirA*. ‘Evidence for functional 
interaction’ refers to whether RNAi ablation experiments have provided evidence of functional interdependency between TbRP2 and the stated 
protein. 
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There was no evidence from either the SILAC ratio derived from MS experiments or by 
immunofluorescence analysis that axonemal tubulin is processed by TbRP2. Thus it is 
unlikely that TbRP2 functions in quality control processing for tubulin as originally 
hypothesised (Stephan et al., 2007). It is more likely that TbRP2 functions in more 
generalised protein trafficking capacity required for flagellum assembly. For example, 
I identified the likely ADP-ribosylation factor-like 3 (Arl3) related protein (Arl3L) with 
confidence as the interacting partner for RP2 GAP activity from MS and also from 
subsequent co-localisation and RNAi analyses. Following MS identification of TbARL3L 
as a candidate partner for TbRP2, immunofluorescence microscopy showed that 
TbARL3L was localised to the basal body, where it co-localised with TbRP2. TbARL3L 
also appeared to be present in the nucleus throughout the cell cycle although both 
signals were only seen on intact fixed cells (Fig 5.3). However, RNAi knockdown of 
TbArl3L did not lead to a shortening in flagellum length, as seen in TbRP2 RNAi 
experiments, but in some cells caused flagellum detachment, cytokinesis defect and 
also overly enlarged flagellar pockets. The recruitment of TbRP2 to the basal body was 
not dependent on TbArl3L expression, despite that they co-localised at the basal body 
(Fig 6.7). However, when TbRP2 was knocked down the basal body localisation of 
TbArl3L was abolished and it relocated to the cytosol, providing the strongest evidence 
that TbARL3L is the partner protein for TbRP2 GAP activity (Fig 6.19). In mammals 
there is plenty of evidence to indicate a variety of Arl-dependent complexes are 
associated with IFT and vesicular traffic necessary for cilium assembly and even in 
trypanosomatids additional Arl3-like proteins are involved in flagellum assembly and 
length control (Sahin et al., 2004). No additional Arl proteins, however, were identified 
from my BioID analysis. Fig 7.1 and Table 7.2 summarise current understanding of 
some of the Arl (Arf-like) and Rab proteins that have been shown participating in cilia 
formation and/or function in mammals (Li and Hu, 2011; Li et al., 2012). 
 
Of all the small GTPase proteins, Arl6 is one of only two proteins that have been 
associated with ciliopathies (Fan et al., 2004). Genetic mapping and comparative 
genomic analysis identified that ARL6 was the causal locus for BBS3 (Bardet-Biedl 
syndrome (BBS)) (Chiang et al., 2004). Later crystal structure analysis confirmed 
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mutations around the ARL6 GTP binding motif were present in patients with BBS; 
suggesting the importance role of small GTPase activity in ciliopathies (Wiens et al., 
2010). In ciliated IMCD3 cells, Arl6 localised at the distal end of the basal body.  
Mutations in Arl6 reduce the length and number of primary cilia, and abolish its 
function in the Wnt signalling pathway (Wiens et al., 2010). In the mouse model, Arl6 
is not essential for BBSome formation, but is required for localising melanin 
concentrating hormone receptor 1 (MCHR1) to the ciliary membrane and 
somatostatin receptor 3 to the entire cilium (Jin et al., 2010; Zhang et al., 2011).  
Additionally, Arl6 may also be involved in the SHH signalling pathway, as loss of Arl6 
can disturb the retrograde transport of the sensory receptor of Smoothened (Zhang 
et al., 2011).  
 
Arl13b was the second protein identified in patents with the classical form of Joubert 
Syndrome (JBTS). JBTS is characterised by polydactyly, cystic kidney, blindness, and 
abnormalities of the CNS (Cantagrel et al., 2008). Arl13b null mouse embryos also 
exhibit typical ciliopathic phenotypes, such as defects in neural tube patterning, limbs 
and eyes that mimic the JBST phenotype (Caspary et al., 2007). Originally, Arl13b was 
identified in zebrafish as a highly-enriched cilium protein and critical for cilia formation 
in multiple organs (Duldulao et al., 2009; Sun et al., 2004). Ultra-structurally, cilia 
in both arl-13−/− worms and Arl13bhnn mice, are highly similar (i.e. truncated axoneme 
plus defective B-tubule closing) indicating an evolutionarily conserved function ARL-
13/Arl13b in cilia (Caspary et al., 2007). In 2012, Humbert and collegues identifeid a 
protein-protein interaction network that consists of ARL13B, phosphodiesterase 6δ 
(PDE6δ), centrosomal protein 164 (CEP164) and inositol polyphosphate-5-
phosphatase E (INPP5E) in mammalian cells (Humbert et al., 2012).  INPP5E is localised 
to primary cilia through a motif near the C terminus and prenyl-binding protein 
phosphodiesterase 6D (PDE6D)-dependent mechanisms and mutations in this gene 
can be found in JBTS patients (Bielas et al., 2009; Jacoby et al., 2009). Loss of Innp5e 
activity leads to organ developmental defects such as cerebral developmental, skeletal 
defects, cystic kidney etc. (Bielas et al., 2009; Jacoby et al., 2009).  In humans, Arl13b 
(not ARL2 or ARL3) is responsible for INPP5E targeting to the cilia, and mutations in 
Arl13b abolish the connection between ARL13B and INPP5E. This finding provides us 
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with addition information on proteins complexed at the base of the cilium that are 
linked to ciliopathies (Humbert et al., 2012).  
 
Rab GTPases are the largest family of small GTPases, and their function and distinct 
localisation at intracellular membranes have been studied extensively. However, the 
association of several Rab proteins with ciliary trafficking and aberrant functions in 
ciliopathies has only recently been appreciated (Stenmark, 2009).  So far Rab8, Rab10, 
Rab11, Rab17 and Rab23 have been shown to be involved in ciliary trafficking (Hsiao 
et al., 2012). One of the well-known functions of Rab8 is involvement in exocytic 
targeting in epithelial cells and neurons, as well as being a key player in rhodopsin 
transport and maintenance of the outer segment disk structure of rod cells (Deretic et 
al., 1995; Huber et al., 1993). Nachury and colleagues demonstrated that Rab8 
GDP/GTP is functionally linked to the BBS complex, which localises to the basal body 
(Nachury et al., 2007). Later, other studies suggested that Rab8 may not function 
alone, but rather its activity is co-ordinated with other Rab proteins, such as Rab11 
(Knödler et al., 2010). These workers demonstrated that Rab11-GTP-bound form 
interacts with Rabin8 directly, which stimulates the GEF activity of Rabin8 toward 
Rab8.  Loss of Rab11, by RNAi or mutation, blocks primary ciliogenesis. This highlights 
the importance of Rab GTPases and their coordinate action with each other in the 
regulation of vesicular trafficking during primary ciliogenesis (Knödler et al., 2010).  
 
Rab23 was first identified as the gene mutated in the open-brain mouse 
(Eggenschwiler et al., 2001), and acts as a negative regulator of Shh signalling. Rab23 
localises to the plasma membrane, endosomes, as well as the cytosol. In humans, 
mutations in the Rab23 gene cause Carpenter’s syndrome, which is characteristic by 
obesity, craniosynostosis, polydactyly, and soft-tissue syndactyl (Jenkins et al., 2007).  
By using FRAP (fluorescence recovery after photobleaching), Boehlke and co-workers 
showed that when Rap23 is depleted it alters the steady state levels of Smo in the 
cilium, but have no effect on the microtubular tip protein EB1 or the receptor protein 
Kim1. Based on their proposed model, the function of Rab23 is to mediate the ciliary 
turnover of Smo, and may possibly function in a recycling pathway (Boehlke et al., 
2010). 





Fig 7.1.  Working model of the role of Arls and Rabs in the cilium. Arl13-GTP enhance the 
interaction between IFT A and B complexes. The SUMOylation of Arl13 by UBC19 is required 
for ciliary targeting.  The BBSome recruitment is needed by Arl6 and move into cilium cross 
the ciliary gate.  RP2 acts as a GAP for Arl3, which release the NPHP3 into the cilium, and 
stabilise IFT-B and KIF17 motors associations and trafficking. BB-basal body. Adapted from 
(Zhang et al., 2013)  
 
 
Basal body  




Name GAP/GEF Effector(s) Functions 








• Negative regulator for 
Ciliogenesis  
• Signalling pathway  
ARL6 ? The BBSome 
(human) 
• Membrane trafficking  
• Regulating BBSome  








myosin Vb • Cilia formation  
• Regulating ciliary membrane 
sorting and trafficking  
Rab10 ? SEC16A; 
GDI1-2 
• Membrane transport  
 
Rab11 ? myosin Vb • Upstream for Rab8 
• Ciliary membrane assembly  
Rab23 Evi5-L/? patched 1 • Regulating hedgehog pathway  
Rab28 ? ?  • Protein trafficking in 
photoreceptor cells 
          Table 7.2. Some of the ciliary Arls, Rabs and their possible interactors.  
 
 
I draw attention to the identification of BARTL1 in Figure 7.1; an orthologous T. brucei 
protein was identified in my BioID analysis albeit without the confident SILAC ratio 
seen for other candidate near neighbour/interacting proteins to TbRP2 (Fig 7.1). 
Despite the unfavourable SILAC ratios I also subjected TbBARTL1 to experimental 
analysis. During the course of my study, Lokaj and colleagues identified BARTL1 
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localised to the transition zone in mouse inner medullary collecting duct (IMCD3) cells, 
act as a binding partner for Arl3 and GTP-bound form of Arl2. The presence of the 
BARTL1 protein enhances the interaction between RP2 and Arl3-GTP, which promoted 
the release of carrier proteins such as PDE and Unc119a/b (Lokaj et al., 2015). 
Therefore, even though the SILAC ratio for BARTL1 was not above the threshold I had 
selected, further analysis was carried out out this protein. In mammalian cells, BARTL1 
both biochemical and structural analysis shows that the BART-like domain can 
recognise and interact with a LLxILxxL motif within an N-terminal amphipathic helix of 
Arl3, which might suggest BARTL1 is involved the Arl3 transport network in cilia.  
However, RNAi ablation of either BARTL1 or Arl3 had no effect on the localisations of 
the reciprocal protein in mouse renal epithelial cells (IMCD3). The explanation for this 
was suggested as relating to the low efficacy of siRNA. In T. brucei, BARTL1 protein was 
linked to suramin efficacy and potential resistance (Alsford et al., 2012). In this study, 
immunofluorescence microscopy showed that TbBARTL1 is localised to the cell body, 
as well as into flagellum throughout the cell cycle (Fig 5.7). Again, the majority of cells 
in the population did not appear to present with any overt morphological phenotype 
when TbBARTL1 was subjected to RNAi knockdown. However, I did observe that a 
small number of cells appeared to have some problems; e.g. multinucleated cells with 
segregation and cell cytokinesis defects, and also detached flagella. Whether the 
phenotype I observed was caused by loss of TbBARTL1 or for other reasons is not clear 
at present. However, TbRP2 expression and localisation was not dependent on 
TbBARTL1 (Fig 6.8).  
 
Of the proteins identified as candidates near neighbour/interacting of TbRP2, none of 
the ciliary gate components that have previously been shown to be required for 
cilium/flagellum assembly (see section 1.2.2) were present in my data sets. Instead, 
what emerged is the possibility that TbRP2 functions alongside a variety of chaperone 
and other accessory proteins. For instance, proteins I tagged in my study included 
HSP70, TCP-1-, VHS and p25-HSP70 is probably one of the most well studied and 
most conserved proteins in evolution (Daugaard et al., 2007), and like most 
chaperones plays an important role in catalysing folding (Mayer and Bukau, 2005). 
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Moreover, HSP70 proteins have also been associated in ciliary protein transport 
(Bhogaraju et al., 2013; Kampinga et al., 2009).  As early as 1995, Bloch and Johnson 
identified a putative flagellar Hsp70 in the green algae C. reinhardtii (Bloch and 
Johnson, 1995). They showed the localisation of HSP70 in the flagellum is enriched at 
the distal end; i.e. the site of axonemal assembly in vivo.  Axonemal-bound HSP70 was 
released when the cells were treated under ionic conditions. Together this may 
suggest HSP70 chaperone targets tubulin to the flagellar tip, where it participates in 
axonemal assembly (Bloch and Johnson, 1995). In the  BHK21 (kidney) cell line, HSP70 
was purified from membrane-bound organelles (MBOs), and can release cargo from 
kinesin-driven anterograde IFT in an Mg-ATP-dependent and N-ethylmaleimide-
sensitive manner, which might indicate HSP70 functions by releasing kinesin from 
cargo in specific subcellular domains to effect flagellar protein transport (Tsai et al., 
2000). Later studies carried out by Shapiro and colleagues confirmed the co-
localisation of HSP70A and the FLA10 (IFT kinesin-II) by immunofluorescence analysis, 
and they additionally proposed that instead of acting as part of the IFT machinery 
HSP70 was cargo carried by IFT (Shapiro et al., 2005). More recently, a study suggested 
that the function of HSP70 in the cilium/flagellum might be to co-operate with other 
ciliary proteins. IFT88 belongs to IFT B complex and is essential of ciliogenesis. By using 
Yeast two-hybrid and pulldown assays in vitro, IFT88 was shown to directly interact 
with a mammalian relative of DNAJ (MRJ) protein. Evidence was also shown that MRJ 
is associated with specific membrane protein guanylyl cyclase 1 (GC1) in retinal 
photoreceptor cells and that RNAi knockdown caused a reduction of GC1::GFP in the 
cilium. Furthermore, MRJ/HSP70 chaperone pair are co-immunoprecipitated with 
KIF3A and IFT88. It is possible therefore that MRJ/HSP70 enhances the interaction 
between membrane proteins GC1 and IFT88 in ciliary transport (Bhowmick et al., 
2009).  
 
Based on genome annotation, there are 12 HSP70 proteins in  T. brucei (Folgueira and 
Requena, 2007) (see section 4.1). In this study, the localisation of TbHSP70 was in part 
at basal body, but also can be found in flagellum as well, and so the question is 
whether this TbHSP70 is functioning as a chaperone alone, or whether it works 
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together with other heat shock proteins to function in the cilium/flagellum. It has been 
widely accepted that HSP70 interacts with HSP40 to stimulate HSP70 ATPase activity 
to bind nearby client proteins (Schlecht et al., 2011). However, I draw attention to the 
fact that in Chlamydomonas both HSP40 and HSP70 are found in the flagella (Bloch 
and Johnson, 1995; Yang et al., 2005).  In fact, HSP40 is a component of the radial 
spoke complex in Chlamydomonas, and in sperm flagella of the ascidian Ciona 
intestinalis (Satouh et al., 2005). Depletion of RSP16 (a member of HSP40 family) 
results in normal length flagella, but flagella movement is affected, resulting in a 
twitching flagellum phenotype (Yang et al., 2008). In mammalian cells, heat shock 
factor-1 (HSF-1) plays a critical role in maintaining cilia beating and possibly by 
regulating the expression of HSP90 during tubulin polymerisation (Takaki et al., 2007).  
Inhibition of HSP90 leads to a reduction in the average length and beat frequency of 
primary cilia. In addition, when the cells were treated with elevated temperatures 
(from 37oC to 42oC) reveals that the frequency and length of cilia were shortened 
further, which might indicate a possible role for HSP90 in the maintenance of primary 
cilia (Prodromou et al., 2012). 
 
Other chaperones which involved in cilia function are three chaperonin-like BBS 
proteins BBS6, BBS10, and BBS12 (not components of the BBSome) form a protein 
complex with other six CCT chaperonins (BBS/CCT complex) localised to the 
centrosomes and is required for BBSome assembly (Seo et al., 2010).  BBS6, BBS10, 
and BBS12 are all share sequence homology to the CCT/TRiC family of group II 
chaperonins (Katsanis et al., 2000; Stoetzel et al., 2006; Stoetzel et al., 2007).  Although 
those three proteins form a complex with CCT chaperonins, but their function do not 
involve in protein folding with ATPase activity, as they lack the ATP binding motif to 
server the purpose. The possible roles of those chaperones could be involved in 
preserving ciliary proteins’ native functional conformation during and after 
ciliogenesis, i.e. participating in the assembly or maintenance of large ciliary protein 
complexes. Interestingly, neither BBSome nor IFT were identified as near-neighbours 
of TbRP2 and given the volume of traffic through the TFs one might expect some 
degree of biotinylation.  This might indicate the TbRP2 and other identified proteins 
as a distinct protein complex at the base of the flagellum.  
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I also identified a variety of cytoskeletal proteins such as TbCAP51, TbBBP590 and 
TbMARP. TbMARP was the first protein identified in my BioID-SILAC experiments. 
Although in later experiments the SILAC ratio for this protein fell into the ‘background 
noise’, as this protein was recognised with large molecular weight and highly 
competitive repeated (Schneider et al., 1988) it was of interest as it could function in 
supporting basal body architecture at the base of flagellum. The localisation of 
YFP::TbMARP on whole cells was revealed as the subpellicular MT corset, with an 
additional signal distal to the basal body possibly being associated with an endosomal 
compartment (Fig 5.15). However, a pool of TbMARP at the basal body became more 
obvious when I analysed detergent-extracted cells and isolated flagella (Fig 5.16-5.17). 
These observations speak to the  growing evidence that many proteins  are 
multifunctional in cells, and are often found in multiple locations (Ginger, 2014). The 
identification of TbCAP51 from the BioID experiments was not expected, as this 
protein has subpellicular corset localisation and the SILAC ratio suggests it is a good 
candidate. During the time of my study, Portman and Gull also identified TbCAP51, 
along with another protein TbCAP51V (Tb927.7.2650), as being localised to the 
subpellicular microtubule cytoskeleton, but the two proteins are subject to stage-
specific expression in PCF and BSF respectively. TbCAP51 plays an essential role in 
PCFs, RNAi ablation leads to a cytokinesis defect and results in the accumulation of 
multi-nucleated cells and/or cells with abnormal numbers of kinetoplasts, and a large 
number of zoids (i.e. 1K0N cells) (Fig 6.5). Interestingly, in another study of basal body 
proteins - TbSAS-4 (which also localises to the tip of the FAZ), TbCAP51 was also 
identified by BioID, but no further comment was made on the reason why TbCAP51 
had been identified in this study (Hu et al., 2015). 
 
From my BioID candidates, there was another high molecular weight protein (encoded 
by Tb927.11.10660) with a predicted highly repetitive secondary structure, which 
localised to the basal body. During the time of my PhD, Dang and co-workers also 
identified this protein and named it TbBBP590, from BioID studies carried out using 
TbCEP57 as bait. TbCEP57 has been shown to localise between the mature and 
probasal body, and is essential for basal body separation (Dang et al., 2017).  In their 
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study, a single TbBBP590 signal was found near the mature basal body (Dang et al., 
2017).  However, the distinct temporal pattern of TbBBP590 observed in this study (Fig 
6.18-6.19) was not mentioned in Dang et al., (2017). At the beginning of the cell 
division cycle, the trypanosome cell possesses a single basal body, from where the 
single flagellum nucleates, and an immature (pro-basal) body lying immediately 
alongside. This stage is normally called 1K1N, and these cells display a single focus of 
TbBBP590 at the mature BB that co-localises with TbRP2. As the cell division cycle 
progresses, the kinetoplast starts to replicate and the pro-basal body elongates to 
mature into a basal body and nucleates a new flagellum; these cells have two foci of 
TbRP2. Curiously, I observed that the focus of TbBBP590 on the old basal body is lost 
at this stage (or is below the level of detection by DeltaVision microscopy), but is 
retained on the new basal body. However, by the G2 phase of the cell division cycle 
the ‘old’ basal body reacquires TbBBP590 expression and both ‘old’ and ‘new’ basal 
bodies then remain TbBBP590 positive until the end of the cell cycle (see Fig 7.2). 
Based on my RNAi analysis, loss of TbBB590 does not lead to any obvious phenotype 
in procyclic form cells after 96 hours of induction. Loss of TbBB590 also has no effect 
on TbRP2 localisation or expression at the mature basal body (Fig 6.13).  The spatial 
and temporal pattern of expression shown here for TbBB590 is, to my knowledge, 
unprecedented in T. brucei. However, this unusual inheritance pattern is unlikely to 
be due to selective proteolytic cleavage of the YFP tagged TbBB590 protein, as both 
the N- and C-terminally tagged TbBB590 proteins show the same inheritance pattern 
on both cytoskeletons and isolated flagella.  But, at present the function and thus the 
reason for loss and reacquisition is unclear. 
 




Figure 7.2 Schematic diagram of the recruitment of TbBBP590 in T. brucei procyclic (insect) 
form cells during cell division cycle. (I) G1 cells possess a single kinetoplast and nucleus 
(termed 1K1N), as well as one mBB (where the flagellum nucleated) and a ProBB (1 focus 
TbRP2 and 1 focus TbBBP590 co-localising at the mBB). The maturation and elongation of the 
ProBB in to a basal body, and new flagellum emerging from the flagellum pocket (2 foci TbRP2 
on both new and old mBB, but the focus TbBBP590 can only be seen on the new mBB, not on 
the old). (II)-(IV) as the cell cycle progresses, the accumulation of TbBBP590::YFP focus 
reappear on the old mBB again.  
 
KMP-11 can be found in wide variety of kinetoplastids (Stebeck et al., 1995), however, 
the KMP-11 localisation of varies between species.  Two independent studies have 
shown that KMP-11 is localised at the basal body and flagellum, and that it plays an 
essential role in cytokinesis and is critical for kinetoplast/basal body segregation in PCF 
and BSF cells (Li and Wang, 2008; Zhou et al., 2015).  RNAi ablation of KMP-11 also 
disturbs the FAZ filament in PCF trypanosomes (Zhou et al., 2015).  Zhou and 
colleagues also indicated that KMP-11 endogenously tagged with a triple HA tag also 
localised to the FAZ filament in detergent-extracted cytoskeletons. KMP-11::3HA 
protein signal overlapped with CC2D (Zhou et al., 2011) at the FAZ in 
immunofluorescence experiments (i.e. two distinct KMP-11 signals were evident on 
the flagellum and FAZ).  Moreover, the study confirmed that depletion of KMP-11 
disturbs the stability of the FAZ and causes flagellar detachment (Zhou et al., 2015).  
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Based on my work, additional localisations of KMP-11 have been identified which were 
not mentioned in previous studies (Fig 5.4-5.6).  Firstly, KMP-11::YFP does not exactly 
co-localise with TbRP2 at the mature basal body, but is positioned more proximal, and 
there is always a “two-dot” pattern of KMP-11 coincident with TbRP2. Interestingly 
after 24 hours of KMP-11 RNAi induction, KMP-11 was barely detectable in the 
flagellum, but the KMP-11::YFP signal near the kinetoplast was still visible. Considering 
that the KMP-11 protein is positioned between the DAPI stained kinetoplast- and the 
basal body protein TbRP2 (at least in this study), might suggested that KMP-11 plays a 
role in connecting the kinetoplast and the basal body (e.g. part of the tripartite 
attachment complex). As RNAi knockdown of KMP-11 resulted in defective kinetoplast 
segregation (Fig 6.1).  
 
I also noticed that the localisation pattern of flagellum of KMP-11 and FLAM3 were 
similar (Sunter et al., 2015). FLAM3 was first identified as a new FAZ protein involved 
in flagellum adhesion in PCF (Rotureau et al., 2014). However, later studies showed 
that the flagellum detachment phenotype could be due to the mis-interpretation of 
FAZ reduction, and a longer unattached flagellum in PCF (Sunter et al., 2015).  FLAM3-
deleption leads to a reduction in FAZ length and causes morphological changes in cells, 
similar to the phenotype showed by the RNAi depletion of the calpain-like protein 
ClpGM6 (Hayes et al., 2014). Intriguing, KMP-11 RNAi ablation only inhibits new FAZ 
formation, which lead to detachment of new flagellum in the PCF, but not in BSF (Li 
and Wang, 2008).  The FAZ has been proposed to control the position and polarity of 
the cleavage plane (Kohl et al., 2003), and is required for flagellum attachment and 
cytokinesis in PCF (Li and Wang, 2008; Vaughan et al., 2008).  Together, the data may 
indicate that BSF and PCF trypanosomes may have different mechanisms of 
cytokinetic initiation. However, knockdown of FLAM3 does not affect KMP11 
localisation or expression (Fig 6.2).  This might indicate that KMP-11 (flagellum to cell 
body) is linked via FLAM3 (flagellum side) and so might explain why loss KMP-11 
results in more severe aberrant phenotypes than FLAM3 RNAi.    
 
In the KMP-11 localisation chapter, I mentioned that when cells were co-labelled with 
the anti-PFR2 antibody L8C4 (Fig 5.5), the KMP-11::YFP signal extended beyond the 
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L8C4 signal towards the posterior end of the cell. This indicated that KMP-11 is likely 
to be associated with the axoneme rather than the PFR because the PFR attaches to 
the axoneme only after it emerges from the flagellar pocket (Koyfman et al., 2011).  
Many PFR proteins are required for maintaining normal cell motility; for examplePFR1 
and PFR2 (the two main protein components of the PFR) are required for normal 
motility (Bastin and Gull, 1999; Bastin et al., 1998; Hughes et al., 2012; Koyfman et al., 
2011). Calmodulin (CaM) RNAi also disturbs PFR assembly and leads to a reduction in 
the FAZ, but has no obvious effect on axonemal microtubules. Flagellum detachment 
is due to the fact that cells lose the FAZ connection to the cell body. KMP-11 
localisation and expression remains unaffected around the kinetoplast/basal body 
area, however, there is a ‘blob-like’ accumulation of KMP-11 signal at the distal end of 
the flagellum and/or end of the cell body (Fig 5.3). This accumulation can also be seen 
in other PFR RNAi mutants (Bastin et al., 1999).  One possible explanation could be 
that KMP-11 protein is transported by IFT to the end of cell body but due to a PFR 
assembly defect (e.g. as seen following CaM-depletion) KMP-11 cannot be delivered 
beyond. However, it remains unclear whether a KMP11-containing filament 
equivalent to the FAZ filament is formed in flagellum along the adhesion zone and 
whether FLAM3 physically interacts with CaM or any other protein(s) such as FLAM3. 
Nevertheless, it is very clear that the KMP-11 protein plays important roles in 
maintaining the flagellum to cell-body connection which might require protein-protein 
interactions from both the flagellum and cell body (see summary figure 7.3 below). 
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Figure 7.3 Potential interactions and localisations of selected FAZ proteins. (A) Schematic 
illustration of a trypanosome cell showing the relative locations of its single-copied organelles. 
(B) Cross-section of a trypanosome cell visualised via transmission EM. (C) Proteins within the 
black circle have been experimentally studied, and “?” indicates possible interaction. (A) and 
(C) adapted from (Sunter and Gull, 2016) and B taken from (Zhou et al., 2014) 
 
 
A possible working model of how TbRP2 and the putative TbRP2-interacting/proximal 
proteins idenitified by my BioID study may interact at the basal body is summarised in 
Fig 7.4.  RNAi-mediated ablation of most of the putative TbRP2 interacting proteins 
had no effect on TbRP2 expression/localisation (with the possible exception of 
TbCAP51 and TbTCP-1-).  This indicates recruitment and retention TbRP2 at the basal 
body does not depend on any of these proteins.   
 
Based on my DeltaVision microscopy analysis, TbPK and TbVHS do not appear to co-
localise with TbRP2, but both are positioned close to TbRP2 at the basal body; which 
might indicate localisation to the endomembrane system. Bioinformatics analysis 
reveals that Tbprotein kinase (Tb927.9.6560) sharea 30% of amino acid identity to 
human Adaptor-Associated Kinase 1 (AAK1) protein (AAI43711.1). Like mammalian 
GAK family members, AAKs have been shown associated clathrin-mediated trafficking 
processes and essential for T. brucei endocytosis (Allen et al., 2003), and act as a 
positive regulator of Notch pathway (Gupta-Rossi et al., 2011). Orthologues of this 
protein kinase are well conserved across different organisms and in other closely 
related trypanosomatids, which might suggest this protein has a conserved role in 
(C) 
(A) (B) 
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membrane-trafficking system.  In a most recent study, this protein Kinase has been 
named as TbAAKL, and is a clathrin-associated protein, which is not essential for 
flagellum assembly and maintaining endocytic transport (Manna et al., 2017).  
 
Immunofluorescence microscopy showed that TbVHS::YFP was localised to the basal 
body, and also distal to the basal body in a region that could be endosomal (Fig 5.10-
5.11). In eukaryotic organisms, endosomes are positioned at such crucial area as 
numbers of trafficking pathways are passing from there, such as endocytic, 
phagocytic, Golgi to lysosome trafficking etc., which ensures that effectors and cargo 
proteins correctly reach their final destination (Jovic et al., 2010). Several 
experimental and structural studies have indicated that different trafficking pathways 
passing through the endosomes are coordinatedly regulated by proteins belongs to 
ENTH (Epsin NH2-terminal homology) / ANTH (AP180 N-terminal homology) / VHS-
domain containing proteins (De Craene et al., 2012; Ford et al., 2001; Hyman et al., 
2000; Itoh and De Camilli, 2006; Maldonado-Báez and Wendland, 2006; Mao et al., 
2000). Interestingly, crystal structure analysis reveals that VHS and ENTH domain are 
very similar (Hyman et al., 2000; Mao et al., 2001). In T. brucei, the ENTH-domain 
protein (TbEpsinR) also localised to the endosomal compartment as well as the plasma 
membrane. RNAi knockdown suggested that TbEpsinR is required for endocytosis, as 
loss of this protein results in reduce intracellular pools of multiple surface antigens 
and cell growth defects in BSF (Gabernet-Castello et al., 2009). The data might indicate 
that the TbVHS is somehow associated with TbRP2 as part of the trafficking pathway 
for ciliary proteins. As the base of the flagellum/cilium is undoubtedly a highly dynamic 
area it is possible that some of the cytosolic proteins identified in my study, reflect 
proteins that do not pass the ciliary gate and enter the flagellum (e.g. TCP-1-ε), 
whereas other proteins (e.g. TbP25-, TbBARTL1) are transported into this 
compartment. Furthermore, as highly abundant proteins found in the flagellum (PFR 
proteins, αβ-tubulin), are not present in the TbRP2-proximity proteome, this suggests 
that the proteins identified by my study have an association with TbRP2. 





Figure 7.4 Working models of possible TbRP2 interacting/nearby partners, which are 
identified by BioID-SILAC approach in T. brucei.  TbRP2 is possibly in the centre of the complex 
with TbBBP590, TbMARP, TbArl3L, and TbKMP11 at the basal body. TbRP2 might involve in 
vesicle trafficking direct or indirect connection with TbPK and TbVHS. TbMKS1 and TbMKS6 
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Chapter 8 Future Work 
In this study, all the selected putative proteins were suggesting that TbRP2 is more 
likely to involve in general protein trafficking and act as a distinct module from the 
rest of known protein module at the base of the flagellum. In addition to a putative 
molecular client of TbRP2 GAP activity (ARL3L) many of the tagged proteins identified 
in this study are consistent withTbRP2 being located at a highly dynamic region of the 
cell involved in protein trafficking into the flagellum. In addition, there are proteins 
that could potentially be of importance as structural components of the basal body. 
However, many questions remain unanswered; therefore, the following experiments 
would be informative to expand upon the work described in this thesis: 
 
1) Investigate other proteins identified for my BioID studies (see table 8.1).  
During the writing of my thesis, re-interrogation of these proteins was 
undertaken and I suggest that proteins such as the ruvB-like protein 
(Tb927.4.2000) should be prioritised for analysis. The TbruvB-like protein is 
homologous to human ruvB-like 2 isoform 1 (NP_006657.1) and studies have 
shown thatRuvBL1 and another related RuvB-like protein RuvBL2 along with 
other proteins form the R2TP complex (Boulon et al., 2008; Zhao et al., 2005).  
The R2TP complex is associated with many cellular processes (such as RNA 
polymerase II assembly) (Kakihara and Houry, 2012)but also interacts with 
Hsp90-associated proteins (R2TP-Hsp90 complex) and is implicated in 
ciliogenesis.  Equally intriguing is the Pih1/Nop17 protein (Tb927.10.12860) 
which shares ~ 25% identity with human protein kintoun (Ktu/PF13) isoform 2 
(NP_001077377.1). This protein belongs to the PIH1 family proteins, which are 
involved in pre-assembly of axonemal dynein arm. Mutations in Ktu cause 
primary ciliary dyskinesia (PCD) (due to an axonemal dynein arm defect) 
(Omran et al., 2008; Yamamoto et al., 2010).  In mice, Ktu/PF13 has been 
shown to act as a co-chaperone to interact with Hsp70, and is also involved in 
the cytoplasmic pre-assembly of dynein arms (Olcese et al., 2017).   
 




Figure 8.1 Proposed interaction/localisation model of ruvBL and pih1/Nop17 
proteins to TbRP2 and in HSP70/90-mediated axonemal dynein assembly, based on 


























Table 8.1 Selected proteins with good SILAC ratio (above 1). However, their functionality did not investigate in this study.  
     
309 
 
2) Loss of TbRP2 leads to a short flagellum and axonemal defects (missing/mis-
aligned central pair and disrupted outer doublet MTs) (Stephan et al., 2007).  
However, recent work from the laboratory of Philippe Bastin (Santi-Rocca et 
al., 2015) suggests that loss of TbRP2 affects IFT.  The effect of TbRP2 RNAi on 
IFT and on the transport of flagellar membrane proteins needs to be explored 
further. For example, use of high throughput pPOT tagging techniques to tag 
candidate flagellum membrane proteins on a TbRP2 RNAi background.  
 
3) As mentioned in chapter 3, T. brucei cells expressing TbRP2::(T2)::myc::BirA* 
and TbRP2::(T3)::myc::BirA* exhibit abnormal morphology 24 hour after 
induction of protein expression (Fig 3.10 to Fig 3.13). As a result, these cell lines 
were not included in the BioID experiments.  However, as expression of these 
truncated proteins results in a dominant negative phenotype, it would be 
interesting to examine whether the proteins identified by BioID/SILAC in these 
cells differed from those identified in this study. Similarly, expression of 
TbRP2R248H mutant protein (i.e. which will lack GAP activity) gives dominant 
negative effect when over-expressed on a wild type background. Therefore, it 
would be interesting to ask how the profile of proteins identified by BioID 
differed in cells where flagellum formation was compromised.  
 
4) Reciprocal tagging analysis, for example by investigating putative 
interacting/nearby proteins of TbHSP70::myc::BirA* and KMP-11::myc::BirA* 
to check if TbPR2 or any other identified proteins would appear in their protein 
profile.  
 
5) To understand and expand our knowledge of the protein complex at the base 
of the flagellum or how their might involve in flagellum assembly. We could 
use a systematic BioID analysis to use other TZ or basal body proteins as baits.  
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Chapter 9 Appendices 
Appendix I 
 
 Cyto1 A (M/L)  Cyto1 A (H/L) Cyto1 B (M/L) Cyto1 B (H/L) 
 
Cyto1 A (M/L)  0.819 0.491 0.487 
Cyto1 A (H/L) 0.819  0.497 0.485 
Cyto1 B (M/L) 0.491 0.497  0.856 
Cyto1 B (H/L) 0.487 0.485 0.856  
Fig 9.1 Correlation of technical replicate experiments of Expt cyto-1.  Pair wise Pearson 
correlations of the Log2 M/L (TbRP2134-463/PTP) ratio and H/L (TbRP2 FL/PTP) ratio of two 
individual experiments (A and B) of the same sample set.  Table shows the Pearson’s 
correlation value, which were generated by Perseus software.  
     M/L Cyto1 A               H/L Cyto1 A             M/L Cyto1 B                M/L Cyto1 B                   
        
           
 








   
   
   
   








   
   
   








   
   
   
   








   
   
   
   
   
   




 Cyto2 A (M/L)  Cyto2 A (H/L) Cyto2 B (M/L) Cyto2 B (H/L) 
 
Cyto2 A (M/L)  0.926 0.701 0.660 
Cyto2 A (H/L) 0.620  0.750 0.664 
Cyto2 B (M/L) 0.701 0.750  0.917 
Cyto2 B (H/L) 0.926 0.664 0.917  
 
Fig 9.2 Correlation of technical replicate experiments of Expt cyto-2.  Pair wise Pearson 
correlations of the Log2 M/L (TbRP2134-463/PTP) ratio and H/L (TbRP2 FL/PTP) ratio of two 
individual experiments (A and B) of the same sample set. Table shows the Pearson’s 
correlation value, which were generated by Perseus software.  
     M/L Cyto2 A               H/L Cyto2 A            M/L Cyto2 B         M/L Cyto2 B                   
        
           
 








   
   
   








   
   








   
   
   








   
   
   
   
   
   
 




Fig 9.3 Correlation of biological replicate experiments of Expt cyto-1 and Expt cyto-2. Pair 
wise Pearson correlations of Log2 M/L (TbRP2134-463/PTP) ratio and H/L (TbRP2 FL/PTP) ratio 
of combined data (e.g. M/L of Cyto1 A+B and M/L of Cyto2 A+B as a set of biological replicate). 
Table shows the Pearson’s correlation value, which were generated by Perseus software. 
 Cyto1 A+B 
(M/L) 
Cyto1 A+B  
(H/L) 
Cyto2 A+B  
(M/L) 
Cyto2 A+B  
(H/L) 
 
Cyto1 A+B  
(M/L) 
 0.648 0.139 0.262 
Cyto1 A+B  
(H/L) 
0.648  0.595 0.691 
Cyto2 A+B  
(M/L) 
0.139 0.595  0.694 
Cyto2 A+B  
(H/L) 
0.262 0.691 0.694  
    M/L Cyto1 (A+B)    M/L Cyto2 (A+B)    H/L Cyto1 (A+B)     H/L Cyto2 (A+B)                 
 













































   
   
   
   
   





Fig 9.4 Correlation of technical replicate experiments of Expt WC-2 A and B. Pair-wise 
Pearson correlations of the Log2 M/L (TbRP2 FL/PTP) ratio and H/L (TbRP2 FL/PTP) ratio from 
Expt WC-2 A and B (label swap). Table shows the Pearson’s correlation value, which were 
generated by Perseus software. 









WC-2 A  
(M/L) 
 0.959 0.951 0.934 
WC-2 A  
(H/L) 
0.959  0.929 0.938 
WC-2 B  
(M/L) 
0.951 0.929  0.956 
WC-2 B  
(H/L) 
0.934 0.938 0.956  
    M/L WC-2 A              H/L WC-2 A                   M/L WC-2 B          H/L WC-2 B                 
 







   
   
   







   
   
   
   







   
   







   
   
   
   
   
 





Appendix II contains multiple amino acid sequence alignments of some of the selected 
putative TbRP2-interacting proteins in either (1) T. brucei only; or (2) trypanosomatids 
only, or (3) compared with other organisms (Table 4.2). Amino acid identity (asterisk) 
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Grp170          ---------------MRVLAN--------------------EIRRM-----LVAFLLTAA 
HSP70.a         ---------------MSMLCL--------------------AQWAL-----LLVLCLVGC 
HSP70.b         MHCCKVFSFRLTAGLLQRLPMPMPPPRPGVSVNMQHAVEIEAKRRVELDEATRARYVVVK 
HSP110          ------------------------------------------------------------ 
mtHSP70A        --------------------M--------------------LARRVCA-PMCLASAPFAR 
mtHSP70B        --------------------M--------------------LARRVCA-PMCLASAPFAR 
mtHSP70C        --------------------M--------------------LARRVCA-PMCLASAPFAR 
Hsp70.c         ------------------------------------------------------------ 
Bip/Grp78B      ---------------MSRMWL--------------------TTAAVFL-TVTVAAVSAAP 
Bip/Grp78A      ---------------MSRMWL--------------------TTAAVFL-TVTVAAVSAAP 
HSP70           ------------------------------------------------------------ 
HSP70.4         ------------------------------------------------------------ 
                                                                             
 
Grp170          FGYDVTSANVIGVDFGSDYIE----VAGPIN--GVNVDIILNEQSHRKTDNYIGFRN--- 
HSP70.a         CCTVSGGSEVLAVDIGADWAKGATRVIGGST--APRASIVLNDQTNRKSPQCIAFRIVPN 
HSP70.b         EETRASGDRVIGIDLGTTNSC-----ISYIDKKTNRPKIIPSPTGSWVFPTAITFDKS-- 
HSP110          -------MSVFGVDFGNLNTT-----VAITR--HGGVDIVTNEVSKRETTTIASFVDN-- 
mtHSP70A        WQSSKVTGDVIGIDLGTTYSC-----VAVME--GDRPRVLENTEGFRTTPSVVAFKGQ-- 
mtHSP70B        WQSSKVTGDVIGIDLGTTYSC-----VAVME--GDRPRVLENTEGFRTTPSVVAFKGQ-- 
mtHSP70C        WQSSKVTGDVIGIDLGTTYSC-----VAVME--GDRPRVLENTEGFRTTPSVVAFKGQ-- 
Hsp70.c         ----MTYEGAIGIDLGTTYSC-----VGVWQ--NERVEIIANDQGNRTTPSYVAFVNN-- 
Bip/Grp78B      ESGGKVEAPCVGIDLGTTYSV-----VGVWQ--KGDVHIIPNEMGNRITPSVVAFTDT-- 
Bip/Grp78A      ESGGKVEAPCVGIDLGTTYSV-----VGVWQ--KGDVHIIPNEMGNRITPSVVAFTDT-- 
HSP70           ----MTYEGAIGIDLGTTYSC-----VGVWQ--NERVEIIANDQGNRTTPSYVAFTDS-- 
HSP70.4         -----MPAPAIGIDLGTTYSC-----VGVFK--NDQVEIVANDQGNRTTPSYVSFSET-- 
                          ..:*:*           .          :: .            *      
 
Grp170          --------GERSIGAQAKSLAARFPTNMIAMINHLVGITYNSSDFAN-FKKLQCEFDPHP 
HSP70.a         AGNDTLRSVERLFAEEARSLEPRFPQQSICGPSLLAGLIVSKEISAG-QKHHEQTGNQRS 
HSP70.b         -------HKVRLYGEEARACVRTSASATLCSGKRLIGRGVGELGRVQSQLHKTNMVTLN- 
HSP110          ---------ERFIGEPGLDRYVRNSSNTIFLLKRFIGMYMDDPSLESERRFLTCAIKGD- 
mtHSP70A        ---------EKLVGLAAKRQAITNPQSTFFAVKRLIGRRFDDEHIQHDIKNVPYKIIRS- 
mtHSP70B        ---------EKLVGLAAKRQAITNPQSTFFAVKRLIGRRFDDEHIQHDIKNVPYKIIRS- 
mtHSP70C        ---------EKLVGLAAKRQAITNPQSTFFAVKRLIGRRFDDEHIQHDIKNVPYKIIRS- 
Hsp70.c         ---------EVLVGDAAKNHAARGSNGVIFDAKRLIGRKFSDSVVQSDMKHWPFKVEEG- 
Bip/Grp78B      ---------ERLIGDGAKNQLPQNPHNTIYTIKRLIGRKYTDAAVQADKKLLSYEVIAD- 
Bip/Grp78A      ---------ERLIGDGAKNQLPQNPHNTIYTIKRLIGRKYTDAAVQADKKLLSYEVIAD- 
HSP70           ---------ERLIGDAAKNQVAMNPTNTVFDAKRLIGRKFSDSVVQSDMKHWPFKVVTK- 
HSP70.4         ---------ERLVGDAAKNQVAMNPTNTVFDAKRIIGRKYDDPDLQADMKHWPFKVTVK- 
                             .  .           .   . : *    .                   
 
Grp170          EERGTVGFRFE------------------------------DNNDTYTAEEIYAMMLNYC 
HSP70.a         EREGVISFSDTDRFTYVVVPQIRRKSAVVRITPGGSSEGTTTAPIEFTVEELIGMILGHM 
HSP70.b         -ERGEVAVEI--------------------------------MGRTYTVTHIIAMFLRYL 
HSP110          -DKGRLMFGV---------------------NY-------CGELTYFYPEQVLAMMLQRL 
mtHSP70A        -NNGDAWVQ-------------------------------DGNGKQYSPSQVGAFVLEKM 
mtHSP70B        -NNGDAWVQ-------------------------------DGNGKQYSPSQVGAFVLEKM 
mtHSP70C        -NNGDAWVQ-------------------------------DGNGKQYSPSQVGAFVLEKM 
Hsp70.c         -EKGGAVMRV---------------------EH-------LGEGMLLQPEQISARVLAYL 
Bip/Grp78B      -RDGKPKVQV---------------------MV-------GGKKKQFTPEEISAMVLQKM 
Bip/Grp78A      -RDGKPKVQV---------------------MV-------GGKKKQFTPEEISAMVLQKM 
HSP70           -GDDKPVIQV---------------------QF-------RGETKTFNPEEISSMVLLKM 
HSP70.4         --EGKPVVEV---------------------EY-------QGERRTFFPEEISAMVLQKM 
                   .   .                                          .: . .*    
 
Grp170          RSI------SEKA-GVPNPQNVVITLPFHSSLGRRQTILEAARLVHINTLGLLHSTTATA 
HSP70.a         KRS------AERSLDGAPVRHLVLVVPTSSSLAYRQAMVDAAAVVGLRTIRLVHGSAAAA 
HSP70.b         KKE------AEKF-LKEPVNAVVVSVPAFFTPQQKVATEDAALAAGFDVLEVIDEPSAAC 
HSP110          RGYVNLASLSDSK-VTVDSRECVLTVPCYYTAEQRKLLMQACEIAGLNCLSLVNDTTAAG 
mtHSP70A        KET------AENF-LGRKVSNAVVTCPAYFNDAQRQATKDAGTIAGLNVIRVVNEPTAAA 
mtHSP70B        KET------AENF-LGRKVSNAVVTCPAYFNDAQRQATKDAGTIAGLNVIRVVNEPTAAA 
mtHSP70C        KET------AENF-LGRKVSNAVVTCPAYFNDAQRQATKDAGTIAGLNVIRVVNEPTAAA 
Hsp70.c         KSC------AESY-LGKQVAKAVVTVPAYFNDSQRQATKDAGTIAGLEVLRIINEPTAAA 
Bip/Grp78B      KEI------AETY-LGEKVKNAVVTVPAYFNDAQRQSTKDAGTIAGLNVVRIINEPTAAA 
Bip/Grp78A      KEI------AETY-LGEKVKNAVVTVPAYFNDAQRQSTKDAGTIAGLNVVRIINEPTAAA 
HSP70           KEV------AESY-LGKQVAKAVVTVPAYFNDSQRQATKDAGTIAGLEVLRIINEPTAAA 
HSP70.4         KEI------AESY-LGEKVSKAVVTVPAYFNDSQRQATKDAGSIAGLEVLRIVNEPTAAA 
                :        ::           *:  *   .   :    :*   . :  : ::.  :*:  
 
Grp170          LYYGV-----RRR-GF---GNRTVHLLVYDIGSTHTEVGVYKFSPPVQEQGKRTKNVESF 
HSP70.a         TQLAHLNTETLFR-GHPSNTTERKYAMIYDMGSSKTEVAVFRFTPATAR--------DDF 
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HSP70.b         LAHTVLQPSNASSREHLSGSKRIVRSLVFDLGGGTLDCAVMEND-------------RRR 
HSP110          IDYGIFRGSSLGETE---D--KGQVVGILDMGYGTTVFAVACF---------------WR 
mtHSP70A        LAYGLDKTK-------------DSLIAVYDLGGGTFDISVLEI---------------AG 
mtHSP70B        LAYGLDKTK-------------DSLIAVYDLGGGTFDISVLEI---------------AG 
mtHSP70C        LAYGLDKTK-------------DSLIAVYDLGGGTFDISVLEI---------------AG 
Hsp70.c         IAYGLDKAD-----E---G--KERNVLVFDFGGGTFDVSIISV---------------SG 
Bip/Grp78B      IAYGLNKAG-------------EKNILVFDLGGGTFDVSLLTI---------------DE 
Bip/Grp78A      IAYGLNKAG-------------EKNILVFDLGGGTFDVSLLTI---------------DE 
HSP70           IAYGLDKAD-----E---G--KERNVLIFDLGGGTFDVTLLTI---------------DG 
HSP70.4         IAYGMDRSS-----E---G--AMKTVLIFDLGGGTFDVTLLNI---------------DG 
                                           : *:*       :                     
 
Grp170          GTLTTMGIVSDATLGGRALDSCIAKGIEAEAISKMKISP---VLGGS--TVSQRKAQFSL 
HSP70.a         GTVTLVASATNHTLGGRSFDRCLARYVERNLFPAAKPTPVTPVLDRKPVTATTRRAVVSL 
HSP70.b         GTFTLVATHGDPLLGGNDWDAVLSQHFSDQFER-KWRVPLE---DAEGNVGQGVATYRQL 
HSP110          GHLKLLSRTFDRHLGTRDIDYKLFEYMAEEVKK-KYHVDVK---ENK-------RASLRL 
mtHSP70A        GVFEVKATNGDTHLGGEDFDLCLSDHILEEFRK-TSGIDLS---KER-------MALQRI 
mtHSP70B        GVFEVKATNGDTHLGGEDFDLCLSDHILEEFRK-TSGIDLS---KER-------MALQRI 
mtHSP70C        GVFEVKATNGDTHLGGEDFDLCLSDHILEEFRK-TSGIDLS---KER-------MALQRI 
Hsp70.c         GVFEVKATNGDTHLGGEDVDAALLEHALADIRNRYGIEQGS---LSQ-------KMLSKL 
Bip/Grp78B      GFFEVVATNGDTHLGGEDFDNNMMRHFVDMLKK-KKNVDIS---KDQ-------KALARL 
Bip/Grp78A      GFFEVVATNGDTHLGGEDFDNNMMRHFVDMLKK-KKNVDIS---KDQ-------KALARL 
HSP70           GIFEVKATNGDTHLGGEDFDNRLVAHFTEEFKRKNKGKDLS---SNL-------RALRRL 
HSP70.4         GLFEVRATAGDTHLGGEDFDSRLVDYFATEFRT-RTGKDLR---GNA-------RAMRRL 
                * .   .   :  ** .  *  :                                    : 
 
Grp170          FRAAKRAREVLSVNSKTPVTVEGIAPD-------RDFSTEVSRKEFETNCSELLKRFPRV 
HSP70.a         LRAVNAARERLSVNQNVPFVVPGVRED---G---GDFIANISRAQFEEACGELFNEAVRL 
HSP70.b         LLEAEKAKIHFTHSTEPYYGYNRAFHFSEKLRDIVPLEATLTLEEYIELTRPLRVRCVEC 
HSP110          LQACERLRYLLSGNQVAQLNVENLMDV-------DVNIPSFPRSTLEELSVCLVERFKAV 
mtHSP70A        REAAEKAKCELSTTMETEVNLPFITANQDGA---QHVQMMVSRSKFESLADKLVQRSLGP 
mtHSP70B        REAAEKAKCELSTTMETEVNLPFITANQDGA---QHVQMMVSRSKFESLADKLVQRSLGP 
mtHSP70C        REAAEKAKCELSTTMETEVNLPFITANQDGA---QHVQMMVSRSKFESLADKLVQRSLGP 
Hsp70.c         RSRCEEVKRVLSHSTVGEIALDGLLPD---G---EEYVLKLTRARLEELCTKIFARCLSV 
Bip/Grp78B      RKACEAAKRQLSSHPEARVEVDSLT-E---G---FDFSEKITRAKFEELNMDLFKGTLVP 
Bip/Grp78A      RKACEAAKRQLSSHPEARVEVDSLT-E---G---FDFSEKITRAKFEELNMDLFKGTLVP 
HSP70           RTACERAKRTLSSAAQATIEIDALF-E---N---IDFQATITRARFEELCGDLFRGTLQP 
HSP70.4         RTACERVKRTLSSSASTNIEIDALY-E---G---FDFFSKITRARFEEMCRDQFERCLEP 
                    :  :  ::                            .                    
 
Grp170          AQEAVTKSSL---TLKDIDAFEMMGGASRTPKIISDLSTFWG-KEV-NRTLNSDEAAAMG 
HSP70.a         RDHAITQTNGTVRSLNELVRLELIGGATRMPKLQERLSEGYG-KPA-DRTLNSDEAVVSG 
HSP70.b         LNKLFDHTSI---RPADIDNVLLVGAMTRDPPIRHLLTEYFGRHVESEASCPADYAVAIG 
HSP110          IKKGFEESGL---SPDQFHSIEMIGGGSRIPMFKSAAEELLG-RAP-NFTLNASETAARG 
mtHSP70A        CKQCIKDAAV---DLKEISEVVLVGGMTRMPKVVEAVKQFFG-REP-FRGVNPDEAVALG 
mtHSP70B        CKQCIKDAAV---DLKEISEVVLVGGMTRMPKVVEAVKQFFG-REP-FRGVNPDEAVALG 
mtHSP70C        CKQCIKDAAV---DLKEISEVVLVGGMTRMPKVVEAVKQFFG-REP-FRGVNPDEAVALG 
Hsp70.c         VQRALKDASM---KVEDIEDVVLVGGSSRIPAVQAQLRELFRGKQL-CSSVHPDEAVAYG 
Bip/Grp78B      VQRVLEDAKL---KKSDIHEIVLVGGSTRVPKVQQLISDFFGGKEL-NRGINPDEAVAYG 
Bip/Grp78A      VQRVLEDAKL---KKSDIHEIVLVGGSTRVPKVQQLISDFFGGKEL-NRGINPDEAVAYG 
HSP70           VERVLQDAKM---DKRAVHDVVLVGGSTRIPKVMQLVSDFFGGKEL-NKSINPDEAVAYG 
HSP70.4         VRKVLKDAEV---DASAVDDVVLVGGSTRIPRVQQLVQNFFNGKEP-NRSINPDEAVAYG 
                  . . .:         .  . ::*. :* * .          :         . :.. * 
 
Grp170          AAYYALRLSPHYRPH----SFRIIERVPYTFLF-------------AVSPEVKNSSNSKR 
HSP70.a         AALMIHD-----TLS----RIRVMESLTNDIYF-------------TASPPIKESNETKP 
HSP70.b         AAVRGAMLQGGFDDLLSNTRFVTGTA--QALKQGG------------------------- 
HSP110          AAITAAVYSPKFK----VREFVVSDIPTYPIKLGYYMENASAVSHVPFLPDINKVVSVQG 
mtHSP70A        AATLGGVLRGD------VKGLVLLDV--TPLSLGIETLGGVFTRMIP------------- 
mtHSP70B        AATLGGVLRGD------VKGLVLLDV--TPLSLGIETLGGVFTRMIP------------- 
mtHSP70C        AATLGGVLRGD------VKGLVLLDV--TPLSLGIETLGGVFTRMIP------------- 
Hsp70.c         AAVQAHVLSGGYGESSRTAGIVLLDV--VPLSIGVEVDDGKFDVIIR------------- 
Bip/Grp78B      AAVQAAVLTGE---SEVGGRVVLVDV--IPLSLGIETVGGVMTKLIE------------- 
Bip/Grp78A      AAVQAAVLTGE---SEVGGRVVLVDV--IPLSLGIETVGGVMTKLIE------------- 
HSP70           AAVQAFILTGGK--SKQTEGLLLLDV--APLTLGIETAGGVMTALIK------------- 
HSP70.4         AAVQAHIVSGGK--SKQTKDLLLVDV--TPLSLGVETAGGVMSVLIP------------- 
                **                  .         :                              
 
Grp170          M------LANNPIIGSRWSITVNR---TDDFSIQLFDSDARIGN-VNITGVKGALERLGF 
HSP70.a         HRNLLFAKRNTTVPAARSLIFPNR---TADFTLTLHDGNGRYSRSVLVSGVSGSMNAARE 
HSP70.b         ---------------------------------------------FLRR----CCNRIGS 
HSP110          --TDDHYPKVLEITIKRPGGFKLY---------AFYDSEHPKVKAYLPR----KDFVIGE 
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mtHSP70A        --------KNTTIPTKKSQTFSTAADNQTQVGIKVFQGEREM-----AS----DNQMMGQ 
mtHSP70B        --------KNTTIPTKKSQTFSTAADNQTQVGIKVFQGEREM-----AS----DNQMMGQ 
mtHSP70C        --------KNTTIPTKKSQTFSTAADNQTQVGIKVFQGEREM-----AS----DNQMMGQ 
Hsp70.c         --------RNTTIPYLATKEYSTVDDNQSEVEIQVFEGERPL-----TR----HNHRLGS 
Bip/Grp78B      --------RNTQIPTKKSQVFSTHADNQPGVLIQVYEGERQL-----TK----DNRLLGK 
Bip/Grp78A      --------RNTQIPTKKSQVFSTHADNQPGVLIQVYEGERQL-----TK----DNRLLGK 
HSP70           --------RNTTIPTKKSQIFSTYSDNQPGVHIQVFEGERTM-----TK----DCHLLGT 
HSP70.4         --------RNTSVPAQKSQTFSTNADNQRSVEIKVYEGERPL-----VS----QCQCLGT 
                                                                             
 
Grp170          FQPKLNHTNNSHI-----------IRIQVRFNESGLLEVEEAGVFY-----RYAVNVS-- 
HSP70.a         KEKEMSTERANKVTKTSVVLRQVEVVVEVVLSRSGLPYVAGSYVHA-----RYAEQVTVL 
HSP70.b         LV--SSSVNP-------NAIGQ-----RWRGRAKGLSDEEIANYAKELVEFEAACDRRLL 
HSP110          WE--IGTQR--------KDSNATEVRVRVRLLPNGLVSV------------ESAVSVEVY 
mtHSP70A        FD--LVGIPP-------APRGVPQIEVTFDIDANGICHV------------TAK------ 
mtHSP70B        FD--LVGIPP-------APRGVPQIEVTFDIDANGICHV------------TAK------ 
mtHSP70C        FD--LVGIPP-------APRGVPQIEVTFDIDANGICHV------------TAK------ 
Hsp70.c         FV--LDGITP-------AKHGEPTITVTFSVDADGILTV------------TAA------ 
Bip/Grp78B      FE--LSGIPP-------AARGVPQIEVTFDVDENSILQV------------SAM------ 
Bip/Grp78A      FE--LSGIPP-------AARGVPQIEVTFDVDENSILQV------------SAM------ 
HSP70           FD--LSGIPP-------APRGVPQIEVTFDLDANGILSV------------SAE------ 
HSP70.4         FT--LTDIPP-------APRGKPRITVSFDVNVDGILVV------------TAV------ 
                                                 ..:                         
 
Grp170          -----------------SSTKTTGVQADSNS--------SNESG--YVVEMK-----R-- 
HSP70.a         -----------------PSVKKTGDNETTAQKDENNNPSQNETD--TTSTISPGREKRSG 
HSP70.b         LERAENDANFVMRRVTADSSKRQGMQE--------------------------------- 
HSP110          EVEEPAD--------AEEGGKGETANEEGEQPAEKKPMVKKQKQRRVELSVTPRL----- 
mtHSP70A        ---------------DKATGKTQNI------------------------TI--T------ 
mtHSP70B        ---------------DKATGKTQNI------------------------TI--T------ 
mtHSP70C        ---------------DKATGKTQNI------------------------TI--T------ 
Hsp70.c         ---------------EELGSVTKTL------------------------VV---E----- 
Bip/Grp78B      ---------------DKSSGKKEEI------------------------TI--TN----- 
Bip/Grp78A      ---------------DKSSGKKEEI------------------------TI--TN----- 
HSP70           ---------------EKGTGKRNQI------------------------VI--TN----- 
HSP70.4         ---------------EETAGKTQAI------------------------TI--SN----- 
                                                                             
 
Grp170          --------KSARLS---ARVTFTNPEPLSYELL-------------NNSRVKIFQLLEK- 
HSP70.a         GSPSAANSNSAKMQNSRADEAKENETPTGDEILEVNERDAGTGGKNNNAKVRHFALRFPL 
HSP70.b         ----------------------KRVRQLSEQLK-------------------FWQYMVHN 
HSP110          ----------------------DVIGLTGQEIV-------------------EFQKKETE 
mtHSP70A        ----------------------AHGGLTKEQIE-------------------NMIRDSEM 
mtHSP70B        ----------------------AHGGLTKEQIE-------------------NMIRDSEM 
mtHSP70C        ----------------------AHGGLTKEQIE-------------------NMIRDSEM 
Hsp70.c         ----------------------NSERLTSEEVQ-------------------KMIEVAQK 
Bip/Grp78B      ----------------------DKGRLSEEEIE-------------------RMVREAAE 
Bip/Grp78A      ----------------------DKGRLSEEEIE-------------------RMVREAAE 
HSP70           ----------------------DKGRLSKADIE-------------------RMVSDAAK 
HSP70.4         ----------------------DKGRLSREQID-------------------KMVAEAEK 
                                              ::                             
 
Grp170          --------------ERKKHEAATAKNNLETY-----------LFWAKTEGI-LENTTALE 
HSP70.a         NNTPAPSSTSQGGVNMNKEEALAARNRLRALQRLDDERLRRSGLLNDVESL-LLHYKSLD 
HSP70.b         F------HDHEDELLRTVRELEQALDELEGLAEDNTSGLTTAGTVDFSSVTPVNHCEEEE 
HSP110          M------ND-RDALI---TKTRDSKNELESYILDNRPRIADGGIL--------------- 
mtHSP70A        H------AE-ADRVK---RELVEVRNNAETQANTAERQLTEWKYV--------------- 
mtHSP70B        H------AE-ADRVK---RELVEVRNNAETQANTAERQLTEWKYV--------------- 
mtHSP70C        H------AE-ADRVK---RELVEVRNNAETQANTAERQLTEWKYV--------------- 
Hsp70.c         F------AL-TDATA---LARMEATERLTQWFDRLEAVMETVP----------------- 
Bip/Grp78B      F------ED-EDRKV---RERVDARNSLESVAYSLRNQVNDKDKL--------------- 
Bip/Grp78A      F------ED-EDRKV---RERVDARNSLESVAYSLRNQVNDKDKL--------------- 
HSP70           Y------EA-EDKAQ---RERIDAKNGLENYAFSMKNTINDPN-V--------------- 
HSP70.4         F------AE-EDRAN---AEKIEARNSVENYTFSLRSTLSDPD-V--------------- 
                                         :                                   
 
Grp170          PYTP----EEVNSLKNALAEAQEWLEDGDGSNE-SCSKEEYENKLATLKELVKNSGKN-- 
HSP70.a         AWSAQQSDDNSNDWRSVVKDVSRWFEEVGGDVN-VTELQ---KQYQRLKDLKLGE----- 
HSP70.b         RDCSSVSAASRSAQLRT-AHGDGKLKERTQDEEG--EKPKGRKIMRR------------- 
HSP110          --CEYVTKEQQAKFIQLANEYENWLYEDGADA-ELNVYQERVKTLRAIADAASDRRRNFE 
mtHSP70A        ------TDAEKENVRTLLA-ELRKVMENPNVTKD--ELSASTDKLQKAVM---------- 
mtHSP70B        ------TDAEKENVRTLLA-ELRKVMENPNVTKD--ELSASTDKLQKAVM---------- 
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mtHSP70C        ------TDAEKENVRTLLA-ELRKVMENPNVTKD--ELSASTDKLQKAVM---------- 
Hsp70.c         ---QPYSEKL-QKRIAFLPHGKEWVGTQLHTYTDAASIEAKVAKIERLAK---------- 
Bip/Grp78B      --GGKLDPNDKAAVETAVAEAIRFLDENPNAEKE--EYKTALETLQSVTN---------- 
Bip/Grp78A      --GGKLDPNDKAAVETAVAEAIRFLDENPNAEKE--EYKTALETLQSVTN---------- 
HSP70           --AGKLDDADKNAVTTAVEEALRWLNDNQEASLD--EYNHRQKELEGVCA---------- 
HSP70.4         --QQNISQEDQQKIQTVVNAVVNWLDENRDATKE--EYDAKNKEIEQVAH---------- 
                                        .                                    
 
Grp170          ----------------KNTTNTTSGSD-----DAVKG----------------------- 
HSP70.a         ------------------------------------------------------------ 
HSP70.b         --AVPLPRASAEAQ-----ELVEA------GHPALRGADVSMTE---------------- 
HSP110          DVEFELPTFKQEVNKAKNTALAAIGKEAHITEEELRGAAAKCDEALAWAENEMEKYRKQH 
mtHSP70A        ------------------------------------------------------------ 
mtHSP70B        ------------------------------------------------------------ 
mtHSP70C        ------------------------------------------------------------ 
Hsp70.c         ------------------------------------------------------------ 
Bip/Grp78B      ------------------------------------------------------------ 
Bip/Grp78A      ------------------------------------------------------------ 
HSP70           ------------------------------------------------------------ 
HSP70.4         ------------------------------------------------------------ 
                                                                             
 
Grp170          ----------------------------------------------------DL------ 
HSP70.a         ------------------------------------------------------------ 
HSP70.b         -----ST-RSAFFEAQ----VEERAWRE-PPTP-PG-EHGSW-QEVKRAVDAGEPVGSPI 
HSP110          KSESPVLTCSTLREKQKEVAEAVRAVVKRPPPPKPKEATPEA-KDGETAADGNVP----- 
mtHSP70A        ----ECGRTE---Y-Q------QAAAAN-------S-GSSGS---SSTEGQGEQQQQQAS 
mtHSP70B        ----ECGRTE---Y-Q------QAAAAN-------S-GSSGS---SSTEGQGEQQQQQAS 
mtHSP70C        ----ECGRTE---Y-Q------QAAAAN-------S-GSSGS---SSTEGQGEQQQQQAS 
Hsp70.c         ----RALKSA---R--------------------RE-GKDGWAPGNEDNGSGDDNDGDDN 
Bip/Grp78B      ----PIIQKT---Y-Q------SAGGGDKPQPM-DD-L---------------------- 
Bip/Grp78A      ----PIIQKT---Y-Q------SAGGGDKPQPM-DD-L---------------------- 
HSP70           ----PILSKM---Y-Q------GMGGGDAAGGM-PG-GMPGGMPGGMPGGMGGGMGGAAA 
HSP70.4         ----PILSAY---Y-V------KRAMEQAPPAP-PS-GE------------GEGN----- 
                                                                             
 
Grp170          ------------------------------------------------------------ 
HSP70.a         ------------------------------------------------------------ 
HSP70.b         GLQELQRPMTHEEMLQVLN-----NIAPIDDPVSEEHARKRDHSIDMRTMTIVEGAVDMV 
HSP110          -----------PEVSQAG----DGEKPPSDDQLD-------------------------- 
mtHSP70A        ---------GEKKE---------------------------------------------- 
mtHSP70B        ---------GEKKE---------------------------------------------- 
mtHSP70C        ---------GEKKE---------------------------------------------- 
Hsp70.c         --------SDEDDELQRGRGVTEGSGRPPIRKRDRIEA------INANTE---------- 
Bip/Grp78B      ------------------------------------------------------------ 
Bip/Grp78A      ------------------------------------------------------------ 
HSP70           ------------------------SSGPKVEEVD-------------------------- 
HSP70.4         --------------------------APVPDDVD-------------------------- 
                                                                             
 
Grp170          --------------------------------------- 
HSP70.a         --------------------------------------- 
HSP70.b         ALQELLEEEAKRAEELQRAQKKGEKQLVADSSAKLFAMD 
HSP110          --------------------------------------- 
mtHSP70A        --------------------------------------- 
mtHSP70B        --------------------------------------- 
mtHSP70C        --------------------------------------- 
Hsp70.c         --------------------------------------- 
Bip/Grp78B      --------------------------------------- 
Bip/Grp78A      --------------------------------------- 
HSP70           --------------------------------------- 
HSP70.4         --------------------------------------- 
                                                        












LmjF.05.0380         KVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGNGYEKVPVDPAMYNTTTKDAYKPYDP 
Tb927.10.10360       MRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDP 
TcCLB.511633.79      PRHVDPDHFRSTTQDAYRPVDPSAYKRALPLEEEEDVGPRHVDPDHFRSTTQDAYRPVDP 
                        **   : :**::**:* **. *::     :        **   : :**::**:* ** 
 
LmjF.05.0380         DAYRREQPTDDGEGYEKVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEGYERVPVDP 
Tb927.10.10360       SEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDE 
TcCLB.511633.79      SAYKRALPLEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEEEDVGPRHVDP 
                     . *::     :        **   : :**::**:* **. *::     :        **  
 
LmjF.05.0380         AMYNTTTKDAYKPYDPDAYRREQPTDDGEGYEKVPVDPAMYNTTTKDAYKPYDPDAYRRE 
Tb927.10.10360       SHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQK 
TcCLB.511633.79      DHFRSTTQDAYRPVDPSAYKRALPLEEQEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRA 
                       : :**::**:* **. *::     :        **   : :**::**:* **. *::  
 
LmjF.05.0380         QPTDDGEGYERVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEGYERVPVDPAMYNTT 
Tb927.10.10360       RTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTT 
TcCLB.511633.79      LPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEEEDVGPRHVDPDHFRST 
                         :        **   : :**::**:* **. *::     :        **   : :* 
 
LmjF.05.0380         TKDAYKPYDPDAYRREQPTDDGEGYERVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDG 
Tb927.10.10360       THEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEE 
TcCLB.511633.79      TQDAYRPVDPSAYKRALPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEE 
                     *::**:* **. *::     :        **   : :**::**:* **. *::     :  
 
LmjF.05.0380         EGYERVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGNGYEKVPVDPAMYNTTTKDAYK 
Tb927.10.10360       VATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYK 
TcCLB.511633.79      EDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEQEDVGPRHVDPDHFRSTTQDAYR 
                            **   : :**::**:* **. *::     :        **   : :**::**: 
 
LmjF.05.0380         PYDPDAYRREQPTDDGNGYEKVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEGYEKV 
Tb927.10.10360       PIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMR 
TcCLB.511633.79      PVDPSAYKRALPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEEEDVGPR 
                     * **. *::     :        **   : :**::**:* **. *::     :        
 
LmjF.05.0380         PVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEGYERVPVDPAMYNTTTKDAYKPYDPDA 
Tb927.10.10360       HVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSE 
TcCLB.511633.79      HVDPDHFRSTTQDAYRPVDPSAYKRALPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSA 
                      **   : :**::**:* **. *::     :        **   : :**::**:* **.  
 
LmjF.05.0380         YRREQPTDDGEGYEKVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEGYERVPVDPAM 
Tb927.10.10360       YRQKRTIGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMRHVDESH 
TcCLB.511633.79      YKRALPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEEEDVGPRHVDPDH 
                     *::     :        **   : :**::**:* **. *::     :        **    
 
LmjF.05.0380         YNTTTKDAYKPYDPDAYRREQPTDDGEGYEKVPVDPAMYNTTTKDAYKPYDPDAYRREQP 
Tb927.10.10360       FLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRT 
TcCLB.511633.79      FRSTTQDAYRPVDPSAYKRALPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALP 
                     : :**::**:* **. *::     :        **   : :**::**:* **. *::    
 
LmjF.05.0380         TDDGEGYERVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEGYEKVPVDPAMYNTTTK 
Tb927.10.10360       VGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTH 
TcCLB.511633.79      QEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEEEDVGPRHVDPDHFRSTTQ 
                       :        **   : :**::**:* **. *::     :        **   : :**: 
 
LmjF.05.0380         DAYKPYDPDAYRREQPTDDGEGYEKVPVDPAMYNTTTKDAYKPYDPDAYRREQPTDDGEG 
Tb927.10.10360       EAYKPIDPSEYRQKRTVGEEEATGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEV 
TcCLB.511633.79      DAYRPVDPSAYKRALPQEEEEDVGPRHVDPDHFRSTTQDAYRPVDPSAYKRALPQEEQED 
                     :**:* **. *::     : *      ***  :.:** ::* * ** **:*    :: *  
 
LmjF.05.0380         YEKVPVDPAMYNTTTKDAYKPYDPDAYRRVVDEVPSELPVLALSDRAFSTPAETHVGGLA 
Tb927.10.10360       TGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREE----VVKVSRRGG-----------D 
TcCLB.511633.79      VGPRHVDPDHFRSTTQDAYRPVDPSAYKRESPVVKD---VRAVNVRHA-----------Y 
                          ***  :.:** ::* * ** **:*          *  :. *               
 
LmjF.05.0380         EGTAEATPSHVDVEQKPNPRMRRAQADPAFYESIYAKDYKPAVPTAEAVPAPADVSEPAA 
Tb927.10.10360       DGHFRTT------------------A-KDSYCRYDSSCYKSSCRESSF----GDESVMSM 
TcCLB.511633.79      PDTLRSV------------------S-HESYKSVDSSAYKRESPV--V----KDLRAVNV 
                      .  .:.                  :    *    :. **             *       
 
LmjF.05.0380         EKPDPRRRRAQADPAFYESIYAKDYKPAVPTAEAVPAPADVSEPAAEKPDPRMRRAQADL 
Tb927.10.10360       RH---------SFTASSEADA-------------------IV------------------ 
TcCLB.511633.79      RH---------AYPDTLRSVSHESYKLLN-----VASTRDGL------------------ 
                     .:         :     .:                                          
(A) 




LmjF.05.0380         SSYQSTYAKDYGCSDGAPASVVGKPVVPPLRIPSEGKSNKKNGTARTSVRAPIAGRQKER 
Tb927.10.10360       -----VKKVVKGKSDGGVT-SKKVDVFTDMKCVASGESNGGAAAAV---AAT---T---- 
TcCLB.511633.79      -----SRAVCHRISDGKAA-QYGESSFSS--FVSNGDRNGTDGASSSCRGSA---R---- 
                                  ***  :       .      :.*. *   .::     :          
 
LmjF.05.0380         SSVPAAKAHAPVSPPASAEEAPTKKTLPVAPAKTGEPAEPRPRPKGSYETEYRKNYRAYS 
Tb927.10.10360       ECAAAA---------------------------VGD----------Q---PTGNGVRVSK 
TcCLB.511633.79      ACFGKS---------------------------SSE----------VFESNFQTPLKGTD 
                      .   :                            .:                 .  :  . 
 
LmjF.05.0380         NKHTPVETPRRTQACVHHVDPAFYTTTCSA------------------------------ 
Tb927.10.10360       ----WKKAPNVGYSCPCHVDADMYVSTAHRDFKAHGASKPYMPKAAPTVKQSSISMQGVS 
TcCLB.511633.79      ----DGHFSSKGYFCPCHTDPEMYRSTSHADYKAHHKDAYSRPYLKPLDRKFPLERRDFL 
                           .       *  *.*  :* :*.                                 
 
LmjF.05.0380         -----AYVAPAAAPARSAFTRPTVSVRHVDPSMYVSTSRAAYA------- 
Tb927.10.10360       SEYRNRFIRPEVQCPPRPIGKPAVQVRHVDPSMYVTTNRATFVNHSGRKV 
TcCLB.511633.79      SEYRKNFLRPEPQSLSRPVAASTVTVRHVDPSVYTTTNQAVFKDHWKKF- 






                                                             :                   
 
Tb927.10.10360      RTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTT 
Tb927.10.10280      ---G---------------TKGLEADYKWNDPQPYPQRDKERAEVYDCIDIKNKKKSLPH 
                       *                .  .  **  **. * *: .   **   :   ::.: *   
 
Tb927.10.10360      THEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEE 
Tb927.10.10280      NT-------ENLYMKQ--------QKANKQNYKEILSTMKESYAPIDPAAYKRDMLREEE 
                    .         . * ::         . .: : ..:*:* :*:* ****: *::.    ** 
 
Tb927.10.10360      VATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYK 
Tb927.10.10280      EVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDMLREEEEVTGPRHVDPSHFRSTTAESYA 
                     .*. **** *** :** *:* ****: *::.    ** .*. **** *** :** *:*  
 
Tb927.10.10360      PIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMR 
Tb927.10.10280      PIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPR 
                    ****: *::.    ** .*. **** *** :** *:* ****: *::.    ** .*. * 
 
Tb927.10.10360      HVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSE 
Tb927.10.10280      HVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAA 
                    *** *** :** *:* ****: *::.    ** .*. **** *** :** *:* ****:  
 
Tb927.10.10360      YRQKRTIGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMRHVDESH 
Tb927.10.10280      YKRDVLREEEEATGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEATGPRHVDPSH 
                    *::.    ** **. **** *** :** *:* ****: *::.    ** **. **** ** 
 
Tb927.10.10360      FLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRT 
Tb927.10.10280      FRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVL 
                    * :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.   
 
Tb927.10.10360      IGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTH 
Tb927.10.10280      REEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTA 
                      ** .*. **** *** :** *:* ****: *::.    ** .*. **** *** :**  
 
Tb927.10.10360      EAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVA 
Tb927.10.10280      ESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEV 
                    *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.    ** . 
 
Tb927.10.10360      TDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPI 
Tb927.10.10280      TGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPS------------- 
                    *. **** *** :** *:* ****: *::.    ** .*. **** *              
 
Tb927.10.10360      DPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHV 
Tb927.10.10280      -------------------------HFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHV 
                                             ** :** *:* ****: *::.    ** .*. *** 
 
Tb927.10.10360      DESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYR 
Tb927.10.10280      DPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYK 
                    * *** :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *: 
(B) 




Tb927.10.10360      QKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFL 
Tb927.10.10280      RDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFR 
                    :.    ** .*. **** *** :** *:* ****: *::.    ** .*. **** ***  
 
Tb927.10.10360      TTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVG 
Tb927.10.10280      STTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLRE 
                    :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.     
 
Tb927.10.10360      EEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEA 
Tb927.10.10280      EEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAES 
                    ** .*. **** *** :** *:* ****: *::.    ** .*. **** *** :** *: 
 
Tb927.10.10360      YKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATD 
Tb927.10.10280      YAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTG 
                    * ****: *::.    ** .*. **** *** :** *:* ****: *::.    ** .*. 
 
Tb927.10.10360      MRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDP 
Tb927.10.10280      PRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDP 
                     **** *** :** *:* ****: *::.    ** .*. **** *** :** *:* **** 
 
Tb927.10.10360      SEYRQKRTIGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDE 
Tb927.10.10280      AAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDP 
                    : *::.    ** .*. **** *** :** *:* ****: *::.    ** .*. ****  
 
Tb927.10.10360      SHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQK 
Tb927.10.10280      SHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRD 
                    *** :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *::. 
 
Tb927.10.10360      RTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTT 
Tb927.10.10280      VLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRST 
                        ** .*. **** *** :** *:* ****: *::.    ** .*. **** *** :* 
 
Tb927.10.10360      THEAYKPIDPSEYRQKRTIGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEE 
Tb927.10.10280      TAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLR--- 
                    * *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.       
 
Tb927.10.10360      VATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMRHVDESHFLTTTHEAYK 
Tb927.10.10280      -----------------------------------EEEEVTGPRHVDPSHFRSTTAESYA 
                                                        ** .*. **** *** :** *:*  
 
Tb927.10.10360      PIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMR 
Tb927.10.10280      PIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPR 
                    ****: *::.    ** .*. **** *** :** *:* ****: *::.    ** .*. * 
 
Tb927.10.10360      HVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSE 
Tb927.10.10280      HVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAA 
                    *** *** :** *:* ****: *::.    ** .*. **** *** :** *:* ****:  
 
Tb927.10.10360      YRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESH 
Tb927.10.10280      YKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSH 
                    *::.    ** .*. **** *** :** *:* ****: *::.    ** .*. **** ** 
 
Tb927.10.10360      FLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRT 
Tb927.10.10280      FRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVL 
                    * :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.   
 
Tb927.10.10360      VGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTH 
Tb927.10.10280      REEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTA 
                      ** .*. **** *** :** *:* ****: *::.    ** .*. **** *** :**  
 
Tb927.10.10360      EAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVA 
Tb927.10.10280      ESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEV 
                    *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.    ** . 
 
Tb927.10.10360      TDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHVDESHFLTTTHEAYKPI 
Tb927.10.10280      TGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPI 
                    *. **** *** :** *:* ****: *::.    ** .*. **** *** :** *:* ** 
 
Tb927.10.10360      DPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATDMRHV 
Tb927.10.10280      DPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEATGPRHV 
                    **: *::.    ** .*. **** *** :** *:* ****: *::.    ** **. *** 
 
Tb927.10.10360      DESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYR 
Tb927.10.10280      DPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYK 
                    * *** :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *: 
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Tb927.10.10360      QKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMRHVDESHFL 
Tb927.10.10280      RDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFR 
                    :.    ** .*. **** *** :** *:* ****: *::.    ** .*. **** ***  
 
Tb927.10.10360      TTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIG 
Tb927.10.10280      STTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLRE 
                    :** *:* ****: *::.    ** .*. **** *** :** *:* ****: *::.     
 
Tb927.10.10360      EEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTIGEEVATDMRHVDESHFLTTTHEA 
Tb927.10.10280      EEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAES 
                    ** .*. **** *** :** *:* ****: *::.    ** .*. **** *** :** *: 
 
Tb927.10.10360      YKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVATD 
Tb927.10.10280      HAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTG 
                    : ****: *::.    ** .*. **** *** :** *:* ****: *::.    ** .*. 
 
Tb927.10.10360      MRHVDESHFLTTTHEAYKPIDPSEYRQKRTVGEEVTTDMRHVDESHFLTTTHEAYKPIDP 
Tb927.10.10280      PRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDPSHFRSTTAESYAPIDP 
                     **** *** :** *:* ****: *::.    ** .*. **** *** :** *:* **** 
 
Tb927.10.10360      SEYRQKRTVGEEEATGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEVTGPRHVDP 
Tb927.10.10280      AAYKRDVLREEEEATGPRHVDPSHFRSTTAESYAPIDPAAYKRDVLREEEEATGPRHVDP 
                    : *::.    *****************************************.******** 
 
Tb927.10.10360      SHFRSTTAESYAPIDPAAYKRDVLREEVVKVSRRGGDDGHFRTTAKDSYCRYDSSCYKSS 
Tb927.10.10280      SHFRSTTAESYAPIDPAAYKRDVLREEVVKVSSRGGDDGHFRTTAKDSYCRYDSSCYKSS 
                    ******************************** *************************** 
 
Tb927.10.10360      CRESSFGDESVMSMRHSFTASSEADAIVVKKVVKGKSDGGVTSKKVDVFTDMKCVASGES 
Tb927.10.10280      CRESSFGDESVISKRHSFTASSVADAIVVKKVVKGKSDGGVTSKKVDVSTDMKCVASGES 
                    ***********:* ******** ************************* *********** 
 
Tb927.10.10360      NGGAAAAVAATTECAAAAVGDQPTGNGVRVSKWKKAPNVGYSCPCHVDADMYVSTAHRDF 
Tb927.10.10280      NGGAAAAVAATTECAAAAVGDQPTGNGVRVSKWKKAPNVGYSCPCHVDADMYVSTAHRDF 
                    ************************************************************ 
 
Tb927.10.10360      KAHGASKPYMPKAAPTVKQSSISMQGVSSEYRNRFIRPEVQCPPRPIGKPAVQVRHVDPS 
Tb927.10.10280      KAHGASKPYMPKAAPTVKQSSISMQGVSSEYRNRFIRPEVQCPPRPIGKPAVQVRHVDPS 
                    ************************************************************ 
 
Tb927.10.10360      MYVTTNRATFVNHSGRKV 
Tb927.10.10280      MYVTTNRATFVNHSGRKV 
                    ****************** 
 
Figure 9.6 (A) Sequence alignments of the microtubule-associated proteins in 
trypanosomatids. (B) Sequence alignment shows high similarity of two microtubule-












TbBBP590                    MPFAPQGPVMDLYNSDEGDLLAIRSEMWMCADSEKMFKVGAGRGSKNIVSIENGHFFVYS 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    TCGKQSRLIKDVPFHSVKRTASFVHDPKVSGASTVSGMQTAASSSSSSARSRDRRADVQV 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
(A) 
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TbBBP590                    PPYYYLVLEFVRDKTVAESTNLAKREHVVLCTDNVQDFQYWQQFVGRYKCQLNRTQRPDE 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    SVVGGRRSGKGCVKSASHKECDDSGSDETNLDISTLTMKLDELQEWKRIAVDLADAVASS 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    GAFPNCRRESLSNTEPNVEFSLKYVEKLLGELRKGVDCRLNTLNETQPPLPLVKDLKQQL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    ELWNSLYDRTFSDDRTSEARGLFTKERQQVRVQRMENIIARERTEGCTKLSPVVSRRELV 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    TSPEEWLQLPCLSTLSDADSAQNLVGGQREGGVLDGSAITLLSSSTVHADAPQEVWQRER 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    NLSSANEGDMFAELRAAHRNLGLRSAPQHEFHQLEREKKNTERLAREGLRAYTEATIVLL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    QACYSEYVTVVECVLSAISGGVDTRGERRLVTAYAHLQTVAALDEARRAATAKQTLLENL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    VNELKDLQKTRDEEINALRKTFFRAKDGWESDLAVLQTKLRTLQNTMTQTTVVVPSDTVS 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    FPPLERALCGGESSQELGRDSGEDKVSNTKIESVDKASYDECDEADSDESIRRWATRLTC 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    SHGEQRGHIIAFRLERFFHWTLENVVPLCSGADTNCLLELVMRALSNHITLLQAAGEVFG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    TQDVKVSVDDNGVRESRDLCSSIRDLHTQHSTLKHLVGKYIALTENEEDSPVLRCDELEK 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    QLQLHQFNTATLDHINSLLGTDNMTIKRRIQDMIQNEEQLLRIQEITGSKREICTVQHVR 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    QKHEELRQMSELINRLDQSRMHQEKDLTTQNYEAFTQMNTSVKKAEEIIENTTKKYNELQ 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    LRIDFDKIEFNERLQIVHEYYNEHPQHYHNNKINKQIEELNEIIEKQQNLIGHQDKKEKK 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    TERNSSTRAQCLQGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLKQELDEAMGRE 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    TALEEQLRNLSQATIALQGTLYGGEMPTGNDGSALDVGHAAMSALERMREDAAKASGVMT 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    AAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    QGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLRNLSQ 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    ATIALQGTLYGGEMPTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQEGEMSVPL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    LAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGT 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    TEAEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGTLYGG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    EMPTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQEGEMSVPLLAKCHHMAETTN 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
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TbBBP590                    ALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTEAEMPLASAIQ 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    RAAEEAKVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGTLYGGEMPTGNDGSALD 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    VGHAAMSALERMREDAAKASGVMTAAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRAL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    VGEDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDT 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    LKQELDEAMGRETALEEQLRNLSQATIALQGTVCEDGADVSCDISTFDLCSVAFLSLGVI 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    ESAFECSISREVSLKKQVEEAHKREVALRSRLKSLASAATAVQSTLDGNASPERVSPKES 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    SICSGDEVDGDDAFVDPFVAVQRAAEESKACRNALEEKLKEGAARIDAVEGRLLQLSRSI 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    ICLHSKLFDAEIGGNGEERAVELSELALVAADAIENAFECSISREVSLKKKVEEAHKREV 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    ALKTRLKCLVGAATAVQCTLEGGNYSCTADDPLSLSGCDMSASTNLDDSVLGSVAAIQRA 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    AEEAKVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGTLYGGEMPTGNDGSALDVG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    HAAMSALKRMREDAAKASGVMTAAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    EDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLK 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    QELDEAMGRETALEEQLRNLSQATIALQGTLYGGEMPTGNDGSALDVGHAAMSALERMRE 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    DAAKASGVMTAAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGT 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    DDSSTRAQCLQGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETA 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    LEEQLRNLSQATIALQGTLYGGEMPTGNDGSALDVGHAAMSALKRMREDAAKASGVMTAA 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    MQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    IESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLRNLSQAT 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    IALQGTLYGGEMPTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQEGEMSVPLLA 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    KCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTE 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    AEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGTLYGGEM 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    PTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQEGEMSVPLLAKCHHMAETTNAL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
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TbBBP590                    RDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTEAEMPLASAIQRA 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    AEEAKVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGTLYGGEMPTGNDGSALDVG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    HAAMSALERMREDAAKASGVMTAAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVG 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    EDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLR 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    QELDEAMGRETALEEQLRNLSQATIALQGTVCEDGADVSCDISTFDLCSVAFLSLGVIES 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    AFECSISREVSLKKQVEEAHKREVALRSRLKSLASAATAVQSTLDGNASPERVSPKESSI 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    CSGDEVDGDDAFVDPFVAVQRAAEESKACRNALEEKLKEGAARIDAVEGRLLQLSRSIIC 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    LHSKLFDAEIGGNGEERAVELSELALVAADAIENAFECSISREVSLKKKVEEAHKREVAL 
T.cruzi_TCDM_02199-t26      ------------------------------------------------------------ 
                                                                                         
 
TbBBP590                    KTRLKCLVGAATAVQCTLEGGNYSCTADDPLSLSGCDMSASTNLDDSVLGSVAAIQRAAE 
T.cruzi_TCDM_02199-t26      -------------------------------------------------------MRAAE 
                                                                                    **** 
 
TbBBP590                    EAKVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGTLYGGEMPTGNDGSALDVGHA 
T.cruzi_TCDM_02199-t26      EARAREEELHDRLDESAARGRALESKLSELTRTADSLQRALDGGVLAVGDEEDASAAGDR 
                            **:.**: *::.***: .*  ***.:* :*:::: :** :* ** : .*:: .*  .*.  
 
TbBBP590                    AMSALERMREDAAKASGVMTAAMQE---GEMSVPLLAKCHHMAETTNALNENDRELRMMS 
T.cruzi_TCDM_02199-t26      AVEALKRLCEDSVTVSAVMGGAMQRKLDDAEAEPLLQQCRKMASDMEALRRSERCSVVNL 
                            *:.**:*: **:...*.** .***.   .  : *** :*::**.  :**...:*   :   
 
TbBBP590                    RNLSFQLSVAMLFLEEAEERLTHVVRYGWVPAKVVSAALCGWLVLCCAGDLFHCSSGDTI 
T.cruzi_TCDM_02199-t26      FNQRALFLVSLLVSEELDERISLLSELSFFPSNLLKIFVSYFVSVSGICALLRCDAGSIV 
                             *    : *::*. ** :**:: : . .:.*::::.  :. :: :.    *::*.:*. : 
 
TbBBP590                    STLVDVRKELDDLRKLCGSQNAFDHGEVANVSRSECLLAIKRSVASLCADGAADPSLPLP 
T.cruzi_TCDM_02199-t26      HQVEELLESRDYYCRLVGGGDFILEADDDDVTRAECVHVIRRAVSLLAPAILDDATLRLP 
                              : :: :. *   :* *. : : ..:  :*:*:**: .*:*:*: *.     * :* ** 
 
TbBBP590                    TQLQKCVQSTVDEMYRLRDDADSALSENVRLKRDLQMVVGGCETSLEYLGSACGSS--LC 
T.cruzi_TCDM_02199-t26      EKLQGAVQGIMLDISRIRASLEEASDSAGRAEKDLQTIVSASERALLMLRGVDSSSEAVD 
                             :** .**. : :: *:* . :.* ..  * ::*** :*...* :*  * .. .**  :  
 
TbBBP590                    PALSPRSGVAAVSNLVVMTARIASEKLSSLRSVCEECNSVIERARRREERSHS--RESSP 
T.cruzi_TCDM_02199-t26      GVVVARPSVSFLSRSLLSQAGEITGRLRDLNDVCVECNAIVGQALKRECEQLQVGAEGSL 
                             .:  * .*: :*. ::  *   : :* .*..** ***::: :* :** .. .   *.*  
 
TbBBP590                    ASHRVEDGAEALLVERCKELVSELLVLRTDRRTSTAAIDQRLMESELMVTSVRNAIENLR 
T.cruzi_TCDM_02199-t26      SSTAPIEPDFLFLVDHCRELVAEVFTLREQRRSSLAAIERNVGEHEVLLGAVRGSVNALL 
                            :*    :    :**::*:***:*::.** :**:* ***::.: * *::: :**.::: *  
 
TbBBP590                    TSLDIDVPIGTPALDLVRTSGSCGEAVEGAISEKRQVSATGPSLAELDTSIRTQLELCVL 
T.cruzi_TCDM_02199-t26      FALDNAASVASQGEE------------------------DGDS-SDSVANLCDRLGSCTR 
                             :**  . :.: . :                         * * ::  :.:  :*  *.  
 
TbBBP590                    AVIRQLREKDRVISAAATLLGDALRSCSSAIRDEVTTDSLLAVASGTAHSLHSLFSELQS 
T.cruzi_TCDM_02199-t26      AVTRLLREKEHAASASVKLLQEALLPEE--DRRSSDNDGLFSLASDVVRALEARRVELDS 
                            ** * ****::. **:..** :**   .   * .  .*.*:::**...::*.:   **:* 
 
TbBBP590                    VRASLKQSQHHTEELRTRLEGGETTQLATLEAQTESVATAERLLNEALQRQVAASAQTAR 
T.cruzi_TCDM_02199-t26      MGKALEQSRHFAKEYRRRMDKNFAEQDAAMTAQVQTHAVMEGQLKEATERQVQATASAAK 
                            :  :*:**:*.::* * *:: . : * *:: **.:: *. *  *:** :*** *:*.:*: 
 
TbBBP590                    LQRTLMDFAGSIAASTLYADDAGDRVDKTGD---V----GASVSVVEERWLDGIVRHVAQ 
T.cruzi_TCDM_02199-t26      LLRDLSEFAGSVAAITLYDGDVKVDEGERSEDARVAHEKDVVTYEVSRERLEGILENCST 
                            * * * :****:** *** .*.    .: .:   *    .. .  *... *:**:.: :  
 
TbBBP590                    RMQESESLKGKLKLVTSELESVRIRMTATEVAAREAELNAQSVEVGNLTRIAEATARVEL 
T.cruzi_TCDM_02199-t26      VMRTLEAAKTKAKSLSSEAEDLRGRLRESENTSRELEYQSRHAETKAAARVAAMTEEMNF 
                             *:  *: * * * ::** *.:* *:  :* ::** * ::: .*.   :*:*  * .::: 
 
TbBBP590                    LRNALSERSVELQKMHQRVERHEKQVETLKAEISNDARSFDNERCSLLRAQSTLLAENTL 
T.cruzi_TCDM_02199-t26      LRNALQAKVTECERIQQQVQDTERRVDRLQAEMADNTRTFGNERDNLSKVQSLLLLENEE 
                            *****. : .* ::::*:*:  *::*: *:**:::::*:*.*** .* :.** ** **   
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TbBBP590                    KQQQLDELRQKLWEGEKSLHEFLHNSRVVSLVDATNKIRSLSANAVCGVLMLDEMERRSE 
T.cruzi_TCDM_02199-t26      MRRQLEELRT----EQKELQNFLRGCQVTSLDDAAKKMVAFAGDVLLNSLALEEAENRVQ 
                             ::**:***      :*.*::**:..:*.** **::*: :::.:.: . * *:* *.* : 
 
TbBBP590                    ILQSYILSFPTQESTLLSVCACIASTLSEREVQRLPDSVHRLNQRVQKYKHLLGNPTKVP 
T.cruzi_TCDM_02199-t26      LLQNWALSYGVHTAPLLGICTRVANAISASEFEDIPMRVAEMLKREQEFSRLLGVPAKTV 
                            :**.: **: .: : **.:*: :*.::*  *.: :*  * .: :* *::.:*** *:*.  
 
TbBBP590                    GPTRAVAVLALQKLAETVELAESVSSTSFVSNLIAAVADFRTRYLIANERIAKLEKEVNS 
T.cruzi_TCDM_02199-t26      GPTRAALLKMVTDWAERIGVEQQPDAGTFLTELDFALSDLHAGYASLKNKIAAIQNELYQ 
                            *****. :  : . ** : : :. .: :*:::*  *::*::: *   :::** :::*: . 
 
TbBBP590                    GGTLMEMCDRRVWEMVKLLRQANSVGGLHSGSQEGPRGECQTDVVDFSVAQLDALQSLAL 
T.cruzi_TCDM_02199-t26      ALSTLETGGKQAEQITALLRSAHPTEELTVTT--ATAGEM-----SPSAILQVALASLRL 
                            . : :*  .::. ::. ***.*: .  *   :  .  **      . *.    ** ** * 
 
TbBBP590                    ECGIAAKYIHRHTEANRKALETLRHVYDGESIFEACSHANEMMMKYRESEEDLRAQLLDV 
T.cruzi_TCDM_02199-t26      EVEWAVEKIVSNTEQTRRTLEVLEPVCSGRSVLEVCLHAAEELQERRSTEEVLRAELANA 
                            *   *.: *  :** .*::**.*. * .*.*::*.* ** * : : *.:** ***:* :. 
 
TbBBP590                    RSQLEACRHSIEESFSVFAETSTLNDAKKVEFLQQQCAAAAAELRRLKDEARVAQGLLAS 
T.cruzi_TCDM_02199-t26      QAKAESYRGCIEASMRCLPD--SLIHVKAGDDLQRRCASASAELRRRMEVLSSAQRIIAL 
                            ::: *: * .** *:  : :  :* ..*  : **::**:*:*****  :    ** ::*  
 
TbBBP590                    AGHDTHDGDICRNLAELLKEEEKQRECVNLLQSEKKCARKQLQELGNKLRATEEMRNAE- 
T.cruzi_TCDM_02199-t26      AGHDNRSGDLCMNVDDMLRKLRQLKEREKMLEATYESSQQRALRLEKTLRATEERLEETI 
                            ****.:.**:* *: ::*:: .: :*  ::*::  :.::::  .* :.******  :    
 
TbBBP590                    ----------LEEVQNRNDTLRTRLEEQSRQNNEWCQFVSTCAGVVGCPVENMQFEKSK- 
T.cruzi_TCDM_02199-t26      TLHEEKERNAIMQEKEKQNLLQAQLSESIHEREKLRTTLAACASAVGCSLEGGSGGNDAA 
                                      : : ::::: *:::*.*. ::.::    :::**..*** :*. .  :.   
 
TbBBP590                    ------------NKILQTLRNVASSQSVCAEAGILCTTAQEEQLQCHREGANAAVARLDM 
T.cruzi_TCDM_02199-t26      NHNNKNGDDKEVADVLRAVKALASAHDAS----VNELEELREQHALSRKALASA-NDI-R 
                                         .:*:::: :**::...    :      .**    *:.  :*   :   
 
TbBBP590                    PGSERYRCQLLEFVG-------------------------SVEEVLSELCPEKSESFL-- 
T.cruzi_TCDM_02199-t26      ALAQEEQCRLMEEVERLRAEIIAVTASNEEHRAALLHLTEQAEGVVLRISTAHSPSLFWA 
                              ::. :*:*:* *                          ..* *: .:.  :* *::   
 
TbBBP590                    ---TTKDAPLELRVCQAAGQLCSAKDTVQANIQKLEAEIASAKKKNKAQKREMEDARKAL 
T.cruzi_TCDM_02199-t26      SSTLTKRAPLVAQ-C--LLDAC---NVFEENRCALEDELSALKKLHEERQHEMKAVNEVL 
                                ** ***  : *    : *   :..: *   ** *::: ** :: :::**: ..:.* 
 
TbBBP590                    HKELEVGGPAVASCALSTLTEGIRKKLRETLDENRKLGTALEELRIDNAQLERTLRCVEQ 
T.cruzi_TCDM_02199-t26      CEALELTGETNPSD-TAQLGAIVKEKLSKALKEKNAIADVTGALQSENATLKASCTSTEA 
                             : **: * :  *   : *   :::** ::*.*:. :. .   *: :** *: :  ..*  
 
TbBBP590                    QLSETHTQLQCITESNGECRGQNATLQERVDPLTEPTEEASRKFRSPTQSPDIDADAAGL 
T.cruzi_TCDM_02199-t26      KLEETKTALEQVD-------RQKRALQEELRAFAAFAENVAETVGEPLPSGS-----TDL 
                            :*.**:* *: :         *: :***.:  ::  :*:.:... .*  * .     :.* 
 
TbBBP590                    AQVHEVCFGRGPSIQHRSEEPREFEDNLRGNCRSDAAAVMDVGVAPKEQRSLLERLQQVT 
T.cruzi_TCDM_02199-t26      EPLKVAFAANQASLQHHAEELTRVREELDVASSSSAVMRTKIDENAAERERLTEQLLGAE 
                              :: .  ..  *:**::**  ...::*   . *.*.   .:.    *:. * *:*  .  
 
TbBBP590                    KERDVLTLESEKLVERVQSVLYEHLNVQQELLSYCSNANENELGESDTTVGDIVQLCVER 
T.cruzi_TCDM_02199-t26      QEREALLKASEQLVERVQSILDDHVEVQRELTF--------AEGDDDVTVVDIVQACVEQ 
                            :**:.*   **:*******:* :*::**:**            *:.*.** **** ***: 
 
TbBBP590                    LEHYLSETKTLREDATSAKLESAR--------------MAEEVAALRGRIKHLQDDNHVA 
T.cruzi_TCDM_02199-t26      LDKNRIGAETSNEQLAALQRENAMLMKEIQRLQNSAAVKSGEVTELHEQLRILLESRQVA 
                            *::    ::* .*: :: : *.*                : **: *: ::: * :..:** 
 
TbBBP590                    ERDSLRQNAEFESLSRQLQAFFNDALHMAVNDLRLRLPPVTDTSAIGALYGLQSLFDCML 
T.cruzi_TCDM_02199-t26      QTDYSKLQAEHDSLSRQVQALFTDALRMVADEMRLQLPMFTDTTASGALQGLRSLFDYIA 
                            : *  : :**.:*****:**:*.***:*..:::**:** .***:* *** **:**** :  
 
TbBBP590                    SKCRDSIAFDEE------KLNCRLNELKGKHAKDLKSLHRVFCAHVTTYTDDPNDEDSAR 
T.cruzi_TCDM_02199-t26      EKFRSGALRSDDTEDKIESLKQLLQLQERQNAKENRILYRTFCDHVVVHTGTNYS---RR 
                            .* *..   .::      .*:  *:  : ::**: : *:*.** **..:*.   .    * 
 
TbBBP590                    SEGDGSSPVNLPTTDRLSGGLTPEHIVAAGDALHHVHSNVCHIVWA--CIRHAERAPPPS 
T.cruzi_TCDM_02199-t26      EDGDEDSSNG------KPHRLTTDFLVAVGETLHSVHTEFRHAGRLFRRLMGGPVELSSS 
                            .:** .*  .          ** :.:**.*::** **::. *       :  .      * 
 
TbBBP590                    LHTMGLPALTALLGEVVVASLERAELLQGAMVAGSRALGILPVDPSLNQQHMEEWLECFT 
T.cruzi_TCDM_02199-t26      LRGMTLPESAAWIGEAANETVERSELLHNAIRAVSQIVEILPIDLASSQEQVTEWVESFS 
                            *: * **  :* :**..  ::**:***:.*: * *: : ***:* : .*::: **:*.*: 
 
TbBBP590                    SEIQRVQRSGEGCELLLNHLEILLQDHGISVGELVSNSRSQSTLSNVGRLSQDNQL---- 
T.cruzi_TCDM_02199-t26      LWLERAQRGLDSFDRLLEALTSVVHSHGGTVEETLSTNTTITSFNNYNNNSSSNHHHLDI 
                              ::*.**. :. : **: *  :::.** :* * :*.. : :::.* .. *..*:      
 
TbBBP590                    -----GSPRGPS-SSVAVQDVMEFRSRALLGALRDLIAQFEHRYSTLTSEWQALTDQNNR 
T.cruzi_TCDM_02199-t26      VDTSLQDLNNSRTDMSFSRYITDPHHRAVFNAVRDLFSQLEGRGRVLTSEWQALMDQNNR 
                                  . ..   .    : : : : **::.*:***::*:* *  .******** ***** 
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TbBBP590                    LKTSQQANEEEFARVQEQMQELRHAVRKKVEDDRKVEQSLRDLDNHLDMQARELAMKYRA 
T.cruzi_TCDM_02199-t26      LIHERRQTEEEQARVEDHVQELRRVVQRKIEEDRRVEQSLKELDRHLDMQARELAMKYRS 
                            *  .:: .*** ***::::****:.*::*:*:**:*****::**.**************: 
 
TbBBP590                    DQEAISRQFAELRGSIRRVVIPTQEQLGTPSPKYDFVYPRE- 
T.cruzi_TCDM_02199-t26      DHDIIVRQFTELRGTIRRTIKPPRSHSTAAT-TFGSASHRTF 






TbBBP590          MPFAPQGPVMDLYNSDEGDLLAIRSEMWMCADSEKMFKVGAGRGSKNIVSIENGHFFVYS 
LmjF.36.5250      ---------MSFMEEMSDAPVSITGEMWMCADSAGPLKVGAGRGLKNLITIEKDRFCAYS 
                           *.: :. ..  ::* .********   :******* **:::**:.:* .** 
 
TbBBP590          TCGKQSRLIKDVPFHSVKRTASFVHDPKVSGASTVSGMQTAASSSSSSARSRDRRADVQV 
LmjF.36.5250      SRSEQCKQVKQIAFRSMKCVAWFAHHPKPPGREPAVST-------TAATLRRGARKDPLA 
                  : .:*.: :*:: *:*:* .* *.*.**  * . . .        ::::  *. * *  . 
 
TbBBP590          PPYYYLVLEFVRDKTVAESTNLAKREHVVLCTDNVQDFQYWQQFVGRYKCQLNRTQRPDE 
LmjF.36.5250      ATYYYLVLEFLRDNTIPGTVSLGKRERIVLCTDDQQDFSIWRKFAELYECPPVHEGFVEG 
                    ********:**:*:  :..*.***::*****: ***. *::*.  *:*   :    :  
 
TbBBP590          ---SVVGGRRSGKGCVKSASHKECDDSGSDETNLDISTLTMKLDELQEWKRIAVDLADAV 
LmjF.36.5250      RDKKALRAQAPAGGARDHDDTTSSDDEGYEGRGLDGGS-AVSRRPLDLWKNRCVALLNDF 
                     ..: .:  . *. .  . ...**.* :  .** .: ::.   *: **. .* * : . 
 
TbBBP590          ASSG----------AF---PNCRRESLSNTEPNVEFSLKYVEKLLGE--------LRKGV 
LmjF.36.5250      AHLSNPSLQVQSADVFDTPAGCGGLDW---DAHVESVLHAIEQDMRPSMKVVPAPSTRGA 
                  *  .          .*    .*   .    : :**  *: :*: :            :*. 
 
TbBBP590          DCRLNTLNETQ-------PP---------------LPLVKDLKQQLELWNSLYDR--TFS 
LmjF.36.5250      AAGPSSLLSSPSIAPSSIHPCAATKGTMETDFDEMQSLASNLQVELEQFQVVAAEVGALA 
                   .  .:* .:         *                 *..:*: :** :: :  .  ::: 
 
TbBBP590          DDRTSEARGLFTKERQQVRVQRMENIIARERTEGCTKLSPVVSRRELVT--------SPE 
LmjF.36.5250      EGRELKTTTILPD-ALHAYVERLRKMPTPA-----DPADSVAAQREDKTAANASAAAADL 
                  :.*  ::  :: .   :. *:*:.:: :          . *.::**  *        :   
 
TbBBP590          EWLQLPCLSTLSDADSAQNLVGGQREGGVLDGSAITLLSSSTVHADAPQEVWQRERNLSS 
LmjF.36.5250      AKLESACVNAVRSFT-----------------------DKVHTSALPLSQEWNREKAEQQ 
                    *:  *:.:: .                         ..  . *   .: *:**:  .. 
 
TbBBP590          A----------------------------------------------NEGDMFAELRA-- 
LmjF.36.5250      ERAALPQRVETIVAVLIDELTRAAADVSALKTSLATSMAPTTASPATNVPLELSELRRVL 
                                                                 *    ::***    
 
TbBBP590          AHRNLGLRSAPQHEFHQLEREKKNTERLAREGLRAYTEATIVLLQACYSEYVTVVECVLS 
LmjF.36.5250      NQKELEVETLQQRHFHASRHTKQ-LSRRLEELVFSYSDVAHDMLRSQYREYASLRNLFLR 
                   :::* :.:  *:.**  .: *:  .*  .* : :*::.:  :*:: * **.:: : .*  
 
TbBBP590          AISGGVD--------------------------------TRGERRLVTAYAHLQTVAALD 
LmjF.36.5250      ALRGEVPLDNSTAAEASLGESGSFGGTSEARCSGHLPGSFTGVQKLVISAAHLEAIQALE 
                  *: * *                                   * ::** : ***::: **: 
 
TbBBP590          EARRAATAKQTLLENLVNELKDLQKTRDEEINALRKTFFRAKDGWESDLAVLQTKLRTLQ 
LmjF.36.5250      QERIAARERQRELEKVMKELEVLRQERDEEIANLKCNFLAAGEAWEKDVAVLQAKLTALQ 
                  : * **  :*  **::::**: *:: *****  *: .*: * :.**.*:****:** :** 
 
TbBBP590          NTMTQTTVVVPSDTVSFPPLERALCGGESSQELGRDSGEDKV-SNTKIESVDKASYDECD 
LmjF.36.5250      SAIPRGALLLPASSLAAHTAVKA---GI-AQKLQSTQPHTPTAPADTRESTETV---TPM 
                  .:: : ::::*:.:::     :*   *  :*:*   . .  .    . **.:..       
 
TbBBP590          EADSDESIRRWATRLTC--SHGEQRGHIIAFRLERFFHWTLENVVPLCSGADTN-CLLEL 
LmjF.36.5250      LAESHKTLHKLTTLLATTPKETGVEAAVVTQRLQAFYDWVLEAVVPLSSTSVSDGSVLEI 
                   *:*.::::: :* *:   ..   .. ::: **: *:.*.** ****.* : :: .:**: 
 
TbBBP590          VMRALSNHITLLQAAGEVFGTQDVKVSVDDNGVRESRDLCSSIRDLHTQHSTLKHLVGKY 
LmjF.36.5250      ITHVVHAYHALFQQISTIYTATRS--GTDDTHV----DVLKLV---KNEHEKFEKLWGI- 
                  : :.:  : :*:*  . :: :     ..**. *    *: . :   :.:*..:::* *   
 
TbBBP590          IALTENEEDSPVLRCDELEKQLQLHQFNTATLDHINSLLGTDNMTIKRRIQDMIQNEEQL 
LmjF.36.5250      -----------------LEKHLLIHGE------------------------------DSS 
                                   ***:* :*                                :.  
 
(B) 
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TbBBP590          LRIQEITGSKREICTVQHVRQKHEELRQMSELINRLDQSRMHQEKDLTTQNYEAFTQMNT 
LmjF.36.5250      FHISGHQSSSERTALLFSSPPTMEELDQLPSFLETLW----------------------- 
                  ::*.   .*... . :     . *** *: .::: *                         
 
TbBBP590          SVKKAEEIIENTTKKYNELQLRIDFDKIEFNERLQIVHEYY--NEHPQHYHNNKINKQI- 
LmjF.36.5250      ----------TNATLYSQLKLRSGG--VPIATYLQDLEKKSAQLEQQQLQHTQREKRSLS 
                            ..:. *.:*:** .   : :   ** :.:     *: *  *.:: ::.:  
 
TbBBP590          ---EELNEIIEKQQNLIGHQDKKEKKTERNSSTRAQCLQGIESALAVLGTTEAE-MPLAS 
LmjF.36.5250      ALMATFQDDKHHTSSLIGHAN---------------------SALAALGVGAPASESAAE 
                       :::  .: ..**** :                     ****.**.        *. 
 
TbBBP590          AIQRAAEEAKVREDTLKQELDEAMGRET-----------ALEEQLRNL-------SQATI 
LmjF.36.5250      AIARAAADAAERERALRAEVAAMEERLEAANAQQQQLQADRDEQLRDADERLAETAAAHQ 
                  ** *** :*  ** :*: *:     *               :****:        : *   
 
TbBBP590          ALQGTLYGGEMPTGNDGSALDVGHAA----MSALERMREDAAKASGVMT---AAMQEGEM 
LmjF.36.5250      ELSGSVADAL-------AALGVGAPASESAAEAIARAAADAAERERALRAEVAAMEER-L 
                   *.*:: ..        :**.**  *     .*: *   ***: . .:    ***:*  : 
 
TbBBP590          SVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALA 
LmjF.36.5250      EAANAQQQQLQADRDEQLRDADERLAET----------------AAAHQELSGSVADALA 
                  ..    : :  *:  : ***::::                    :::: :   .: .*** 
 
TbBBP590          VLGTTEA-EMPLASAIQRAAEEAKVREDTLKQELDEAMGRET-----------ALEEQLR 
LmjF.36.5250      ALGVGAPASESAAEAIARAAADAAERERALRAEVAAMEERLEAANAQQQQLQADRDEQLR 
                  .**.    .   *.** *** :*  ** :*: *:     *               :**** 
 
TbBBP590          NL-------SQATIALQGTLYGGEMPTGNDGSALDVGHAA----MSALERMREDAAKASG 
LmjF.36.5250      DADERLAETAAAHQELSGSVADAL-------AALGVGAPASESAAEAIARAAADAAERER 
                  :        : *   *.*:: ..        :**.**  *     .*: *   ***: .  
 
TbBBP590          VMT---AAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSS 
LmjF.36.5250      ALRAEVAAMEER-LEAANAQQQQLQADRDEQLRDADERLAET----------------AA 
                  .:    ***:*  :..    : :  *:  : ***::::                    :: 
 
TbBBP590          TRAQCLQGIESALAVLGTTEA-EMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEE 
LmjF.36.5250      AHQELSGSVADALAALGVGAPASESAAEAIARAAADAAERERALRAEVAAM-------EE 
                  :: :   .: .***.**.    .   *.** *** :*  ** :*: *:          ** 
 
TbBBP590          QLRNLSQATIALQGTLYGGEMPTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQE 
LmjF.36.5250      RLEAANAQQQQLQ---------ADRDEQLLD-------ADERL----------------- 
                  :*.  .     **         :..* . **       * **:                  
 
TbBBP590          GEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIES 
LmjF.36.5250      --------------AETAAA------------------------------HQELSGSVAD 
                                ***: *                              : :   .: . 
 
TbBBP590          ALAVLGTTEA-EMPLASAIQRAAEEAKVREDTLKQELDEAMGR-----------ETALEE 
LmjF.36.5250      ALAALGVGAPASESAAEAIARAAADAAERERALRAEVAAMEERLEAANAQQQQLQADRDE 
                  ***.**.    .   *.** *** :*  ** :*: *:     *           ::  :* 
 
TbBBP590          QLRNLS-------QATIALQGTLYGGEMPTGNDGSALDVGHAA----MSALERMREDAAK 
LmjF.36.5250      QLRNADERLAETAAAHQELSGSVADAL-------AALGVGAPASESAAEAIARAAADAAE 
                  **** .        *   *.*:: ..        :**.**  *     .*: *   ***: 
 
TbBBP590          ASGVMTAAMQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSS 
LmjF.36.5250      RERA-------------LRAEVAAMEERLEAANAQQQQLQADRDEQLRNADE--RLAETA 
                   . .             * *:   * *  :* . .::: :*  .*:::: .      ::: 
 
TbBBP590          TRAQCL-QGIESALAVLGTTEA-EMPLASAIQRAAEEAKVREDTLKQELDEAMGR----- 
LmjF.36.5250      AAHQELSGSVADALAALGVGAPASESAAEAIARAAADAAERERALRAEVAAMEERLEAAN 
                  :  * *  .: .***.**.    .   *.** *** :*  ** :*: *:     *      
 
TbBBP590          ------ETALEEQLRNLSQATIALQGTVCEDGADVSCDISTFDLCSVAFLSLGVIESAFE 
LmjF.36.5250      AQQQQLQADRDEQLRDCVRERCAYVSQVCLRELEAKEAEARFDVVG------------AY 
                        ::  :****:  :   *  . **    :..   : **: .               
 
TbBBP590          CSISREVSLKK---------------QVEEAHKREVALRSRLKSLASAATAVQSTLD-GN 
LmjF.36.5250      CALSPYVSIASSIIGKLLDIRGMVGGDVDEIVGRVRALVAELNGLRAFASEAHEKVVWYE 
                  *::*  **: .               :*:*   *  ** :.*:.* : *: .:..:   : 
 
TbBBP590          ASPERVSPKES-----SICSGDEVDGDDAFVDPFVAVQRAAEESKACRNALEEKLKEGAA 
LmjF.36.5250      DVRVRVPLKKLSDFVRKRDGTDECEQREEFSVSFLA----------------ETLRSSFR 
                      **  *:      .  . ** :  : *   *:*                *.*:..   
 
TbBBP590          RIDAVEGRLLQLSRSIICLHSKLFDAEIGGNGEERAVELSELALVAADAIENAFECSISR 
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LmjF.36.5250      VLQCLDSEAMALQESIFSMTALLKE--CGTALNE-----------SVTNLQKALPCAASK 
                   ::.::.. : *..**:.: : * :   *   :*           :.  :::*: *: *: 
 
TbBBP590          EVSLKKKVEEAHKREVALKTRLKCLVGAATAVQCTLEGGNYSCTADDPLSLSGCDMSAST 
LmjF.36.5250      EDTSPSQSHST--LPVEWGLRVVC----------RRLGAT-------------------- 
                  * :  .: ..:    *    *: *             *..                     
 
TbBBP590          NLDDSVLGSVAAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLRNLSQATIAL----- 
LmjF.36.5250      ------------------------------VSEA----VHWQGELTNILKATYRILIATS 
                                                :.**    .  : :* *: :**  :      
 
TbBBP590          QGTL-YGGEMPTGNDGSALDVGHAAMSALKRMREDAAKASGVMTAAMQEGEMSVPLLAKC 
LmjF.36.5250      DGTRVHGAPVSDGDHPSF-----AEYSQLPRLAA-----------------------QAC 
                  :**  :*. :  *:. *      *  * * *:                           * 
 
TbBBP590          HHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALAVLGTTEA- 
LmjF.36.5250      SELLHSRR-FAAVEDELAA-VTQQ---RN-----DLTGTVGTCCGSLCSAISVATPGRVG 
                   .: .: . :   *..  * * ::    .     * :.* . *  .: **::*    ..  
 
TbBBP590          EMPLASAIQRAAEEA-------KVREDTLKQELDEAMGRETALEEQLRNLSQATIALQGT 
LmjF.36.5250      ALPATA-TSLTCDEAKSALRDITVLTSSILHDYAQSMEHTLAVLTPLASIAADTFAFSSS 
                   :* ::  . :.:**       .*  .:: ::  ::* :  *:   * .::  *:*:..: 
 
TbBBP590          LYGGEMPTGNDGSA--------LDVGHAAMSALERMREDAAKASGVMTAA---------- 
LmjF.36.5250      FEM--LAAATEAVRARIKRMERSQLQHLHMSQCD--EEGNAKARGAMQDQLFALSEDGEA 
                  :    : :..:.           :: *  **  :  .*. *** *.*              
 
TbBBP590          ------MQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTR 
LmjF.36.5250      GELARRNEQEEQAAPLAE-VTLQRQRWDAVAEVLGRFAEDVGATVRAKNGSESQSVGNT- 
                         :: * :.**        :  :*: :   ::   **  *: ..** . . ..*  
 
TbBBP590          AQCLQGIESALAVLGTTEAEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLR 
LmjF.36.5250      -EVLPLVRQAISLSASAK------------------------------------------ 
                   : *  :..*::: .:::                                           
 
TbBBP590          NLSQATIALQGTLYGGEMPTGNDGSALDVGHAAMSALKRMREDAAKASGVMTAAMQEGEM 
LmjF.36.5250      ----AQEELEGRL----------------------------------SGILDACKR-G-- 
                      *   *:* *                                  **:: *. : *   
 
TbBBP590          SVPLLAKCHHMAETTN---ALRDSEKHYRALVGEDVKKDSGSTGTDDSSTR-AQCL---Q 
LmjF.36.5250      -----AAEHHWAEATAARMALDPEELHASVTTGEHS--------PEKMQARANACQMPIA 
                       *  ** **:*    **  .* *  . .**.          :. .:*   *      
 
TbBBP590          GIESALAVLGTTEAEMPLASAIQRA-AEEAKVRE-------------------------- 
LmjF.36.5250      TMEAARAALGQSTTQMQLVAARAHEEALDVGVREWDASESGVRAPAGEGERLGEEMYLVQ 
                   :*:* *.** : ::* *.:*  :  * :. ***                           
 
TbBBP590          ---DTLKQ-----------------ELDEAMGRETALEEQLRNLSQATIALQGTLYGGEM 
LmjF.36.5250      SRMDAMQDRPNEAEERGSSQVMDAGVLLEAAGQVRSLEDVMRVVASYSLEYKTKS----- 
                     *::::                  * ** *:  :**: :* ::. ::  : .       
 
TbBBP590          PTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQEGEMSVPLLAKCHHMAETT--- 
LmjF.36.5250      --------LE------SKESRLRSEIVQDWA---------VMMVPLAVELRLLRAIAAGV 
                          *:      *  .*:*.: .:  .          * *** .: : :   :    
 
TbBBP590          ------NALRDSEKHYRALVGEDVKKDSGSTGTD-DSSTRAQCLQGIESALAVLGTTEAE 
LmjF.36.5250      DRPLPGTALADLPA-----HGSSVRRELTEAGRSLGAAASAPCTEEAT-REALLGAMDQA 
                        .** *         *..*:::  .:* . .::: * * :      *:**: :   
 
TbBBP590          MPLASAIQRAAEEAKVREDTLKQELDEAM--GRETALEEQLRNLSQATIALQGT-----L 
LmjF.36.5250      CQLLL----GAPPER--------VLDTAAPHGTASSAEE------CPAVTFAGAVSTTDV 
                    *      .*   :         ** *   *  :: **        :::: *:     : 
 
TbBBP590          YGGEMPTGND----------------GSALDVGHAAMSALERMREDAA---KASGVMTAA 
LmjF.36.5250      AGGTAPDKLADTVYAMIEERGDRAAANGTLCTGEAWYSAVARVTQTLCSALSSAGVAVSV 
                   **  *                    ..:* .*.*  **: *: :  .   .::** .:. 
 
TbBBP590          MQEGEMSVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDS---GSTGTDDSSTRAQC 
LmjF.36.5250      PADHGF-VVGHSSCVSPASQTSM-----LDFLASAAEHVLKYTTDTTRLFEDWRESLQDC 
                    :  : *   :.*   *. *.       .: * ..*.* * :        *  .:  :* 
 
TbBBP590          LQGIESALAVLGTTE--AEMPLASAIQRAAEEAKVREDTLKQELDEAMGRETALEEQLRN 
LmjF.36.5250      LSRTESSLPTLVAAVVEEVASLRAASQLAAEEQQHRDHEL----D-----------ALRT 
                  *.  **:* .* ::       * :* * **** : *:. *    *            **. 
 
TbBBP590          LSQATIALQGTLYGGEMPTGNDGSALDVGHAAMSALERMREDAAKASGVMTAAMQEGEM- 
LmjF.36.5250      LLQ-----------------------------------------EASAVFSDTSPFLSMQ 
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                  * *                                         :**.*:: :    .*  
 
TbBBP590          SVPLLAKCHHMAETTNALRDSEKHYRALVGEDVKKDSGSTGTDDSSTRAQCLQGIESALA 
LmjF.36.5250      SPNFVEKCMAYAKECARLTALESELSSVLGAASAQRSS----------------WEDASV 
                  *  :: **   *:    *   *..  :::*    : *.                 *.* . 
 
TbBBP590          VLGTTEAEMPLASAIQRAAEEAKVREDTLRQELDEAMGRETALEEQLRNLSQATIALQGT 
LmjF.36.5250      SLGDLAAEL------QRDRVE-------------------------LRE--VEVPKLQGL 
                   **   **:      **   *                         **:    .  ***  
 
TbBBP590          VCEDGADVSC---------------DISTFDLCSVAFLSLGVIESAFECSISREVSLKKQ 
LmjF.36.5250      VCTLSVEVLLAEERAARTMLVAEEATSRLHALCDPQLRELGFLVER---ALARAATAEAQ 
                  **  ..:*                     . **.  : .**.: .    :::* .: : * 
 
TbBBP590          VEEAHKREVALR---SRLKSLASAATAVQS-------TLDG----NASPERVSPKESSIC 
LmjF.36.5250      CAEKTAQHCSLLAAHESLVTMASGLVPVQEDCCRALVESEGDASCAAAPTRFTSEALRIL 
                    *   :. :*    . * ::**. . **.         :*     *:* *.: :   *  
 
TbBBP590          SGDEVDGDDAFVDPFVAV-----------QRA-AEESKACRNALEEKLKEGAARIDAV-- 
LmjF.36.5250      E-----QEAVLVPRLVQAHGRLTATCAALRSDLDAAKAACVQA----LADGEADLDIARS 
                  .      : .:*  :* .           :      . ** :*    * :* * :* .   
 
TbBBP590          -----EGRLLQLSRSIICLHSKLFDAEIGGNGEER----AVELSELALVAADAIENAFEC 
LmjF.36.5250      KSTELEAQLEHVLDAIEALGSLLFPHEEASLRDASCLPRLVEAA-GQLAHTAAADAAARC 
                       *.:* ::  :* .* * **  * ..  :       ** :   *. : * : * .* 
 
TbBBP590          SISREVSLKKKVEEAHKREVALKTRLKCLVGAATAVQCTLEGGNYSCTADDPLSLSGCDM 
LmjF.36.5250      RLERDVCDGAAAFA--------EQQRQCTAAESNAETLQETARRYECQEAEEIQTLTASA 
                   :.*:*.    .          : : :* .. :.*      . .*.*   : :.   ..  
 
TbBBP590          SASTNLDDSVLGSVAAIQRAAEEAKVREDTLKQELDEAMGRETA-LEEQLRNLSQATIAL 
LmjF.36.5250      KT---AAEAYAGIVTALCLSAESVP-----------SAASAAAAISEEQWAAV---VHAV 
                  .:     ::  * *:*:  :**..            .* .  :*  ***   :   . *: 
 
TbBBP590          QGTLYGGEMPTGNDGSALDVGHAAMSAL-ERMREDAAKASGVMTAAMQEGEMSVPLLAK- 
LmjF.36.5250      QAAVEEGGRQTS-DAAELRVE---MRILQSRMAE---LKAAVLESEAREGNLLQRLNALM 
                  *.::  *   *. *.: * *    *  * .** *     :.*: :  :**::   * *   
 
TbBBP590          --CHHMA-ETTNALNENDRELRMMSRNLSFQLSVAMLFLEEAEERLTHVVRYGW---VPA 
LmjF.36.5250      MSSEPLKAAVTAVVASRECNLESL-EDVALAMQAAVQLVERQQGNINQLIAGGGDLHSGV 
                    .. :   .* .: ..: :*. : .:::: :..*: ::*. : .:.:::  *      . 
 
TbBBP590          KVVSAALCGWLVLCCAGDLFHCSSGDTISTLVDVRKELDDLRKLCGSQNAFDHGEVANVS 
LmjF.36.5250      ESLNGRLCGVAKECDVTRPSLASLEETHGMLQ---RRMAQLE-------RHVH---DTIS 
                  : :.. ***    * .     .*  :* . *    :.: :*.        . *    .:* 
 
TbBBP590          RSECLLAIKRSVASLCADGAADPSLPLPTQLQKCVQSTVDEMYRLRDDADSALSENVRLK 
LmjF.36.5250      TVDCRA------------------------------VTVL--------------GAAELR 
                    :*                                 **                 ..*: 
 
TbBBP590          RDLQMVVGGCETSLEYLGS--ACGSSLCPALSPRSGVAAVSNLVVMTARIASEKLSSLRS 
LmjF.36.5250      RLDKSTPADCLDGIAYVADALACRAEEC-------------------------------- 
                  *  : . ..*  .: *:..  ** :. *                                 
 
TbBBP590          VCEECNSVIERARRREERSHSRESSPASHRVEDGAEALLVERCKELVSELLVLRTDRRTS 
LmjF.36.5250      -------------------------------------------DAAKAQLLAWRAEERIR 
                                                             .   ::**. *::.*   
 
TbBBP590          TAAIDQRLMESELMVTSVRNAIENLRTSLDIDVPIGTPALDLVRTSGSCGEAVEGAISE- 
LmjF.36.5250      EEASLR----TTTRLSTL---WQAFRTAL------LPLLVDEPADRGGCGEVAVFSADPV 
                    *  :    :   ::::    : :**:*          :*     *.***..  : .   
 
TbBBP590          -----------------------------------------------------------K 
LmjF.36.5250      EFLASEAEARQAAQMIVDTAERLRRTHNDLQAVYAALRGHFGGDAATGVREMTATPHAPA 
                                                                               
 
TbBBP590          RQVSATGPSLAELDTSIRTQLELCVLAVIRQLREKDRVISAAATLLGDALRSCSSAIRDE 
LmjF.36.5250      RVLHNSGVTSLRFDDTVTATLHLVSTVVNAKCTSVK---DFIDHVVSDVLRDTSGSARV- 
                  * :  :* :  .:* :: : *.*   .*  :  . .   .    ::.*.**. *.: *   
 
TbBBP590          VTTDSLLAVASG-TAHSLHSLFSELQSVRASLKQSQHHTEELRTRLEGGETTQLATLEAQ 
LmjF.36.5250      ----SFAALRPGAFAERLQGVLASLRALRESSDQHRDRA--------------------- 
                      *: *:  *  *. *:.:::.*:::* * .* :.::                      
 
TbBBP590          TESVATAERLLNEALQRQVAASAQTARLQRTLMDFAGSIAASTLYADDAGDRVDK----- 
LmjF.36.5250      -----------------------------RRLPAFMDALVET---IHSHGGRVDVASTDA 
                                               * *  * .::. :    .. *.***       




TbBBP590          TGDVGASVSVVE-----------------ERWLDGIVRHVAQRMQESESLKGKLKLVTSE 
LmjF.36.5250      TGALAIADATMPYRHSPATTLEDCQAREQRAIVHGLQALLNQQE-------ERVRALTAE 
                  ** :. : :.:                  .  :.*:   : *:         ::: :*:* 
 
TbBBP590          LESVRIRMTATEVAAREAELNAQSVEVGNLTRIAEATARVELLRNALSERSVELQKMHQR 
LmjF.36.5250      WQCVKMQYHQ--LSQE-------Q--------VAAEETVVELRRR-VQFKVQEDYKL--- 
                   :.*:::     :: .       .        :*   : *** *. :. :  *  *:    
 
TbBBP590          VERHEKQVETLKAEISNDARSFDNERCSLLRAQSTLLAENTLKQQQLDELRQKLWEGEKS 
LmjF.36.5250      ----EESLRELDSHLD----------------------------QQARELSMRYFADQDA 
                      *:.:. *.:.:.                            **  **  : : .:.: 
 
TbBBP590          LHEFLHNSRVVSLVDATNKIRSLSANAVCGVLMLDEMERRSEILQSYI---LSFPTQEST 
LmjF.36.5250      I------------------------------------VRRFTLLRNQIHAAMRLPTRR-- 
                  :                                     **  :*:. *   : :**:.   
 
TbBBP590          LLSVCACIASTLSEREVQRLPDSVHRLNQRVQKYKHLLGNPTKVPGPTRAVAVLALQKLA 
LmjF.36.5250      -----------------------------------SASAMPPRTPGRDTSTPRS------ 
                                                        . * :.**   :.          
 
TbBBP590          ETVELAESVSSTSFVSNLIAAVADFRTRYLIANERIAKLEKEVNSGGTLMEMCDRRVWEM 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          VKLLRQANSVGGLHSGSQEGPRGECQTDVVDFSVAQLDALQSLALECGIAAKYIHRHTEA 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          NRKALETLRHVYDGESIFEACSHANEMMMKYRESEEDLRAQLLDVRSQLEACRHSIEESF 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          SVFAETSTLNDAKKVEFLQQQCAAAAAELRRLKDEARVAQGLLASAGHDTHDGDICRNLA 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          ELLKEEEKQRECVNLLQSEKKCARKQLQELGNKLRATEEMRNAELEEVQNRNDTLRTRLE 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          EQSRQNNEWCQFVSTCAGVVGCPVENMQFEKSKNKILQTLRNVASSQSVCAEAGILCTTA 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          QEEQLQCHREGANAAVARLDMPGSERYRCQLLEFVGSVEEVLSELCPEKSESFLTTKDAP 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          LELRVCQAAGQLCSAKDTVQANIQKLEAEIASAKKKNKAQKREMEDARKALHKELEVGGP 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          AVASCALSTLTEGIRKKLRETLDENRKLGTALEELRIDNAQLERTLRCVEQQLSETHTQL 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          QCITESNGECRGQNATLQERVDPLTEPTEEASRKFRSPTQSPDIDADAAGLAQVHEVCFG 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          RGPSIQHRSEEPREFEDNLRGNCRSDAAAVMDVGVAPKEQRSLLERLQQVTKERDVLTLE 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          SEKLVERVQSVLYEHLNVQQELLSYCSNANENELGESDTTVGDIVQLCVERLEHYLSETK 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          TLREDATSAKLESARMAEEVAALRGRIKHLQDDNHVAERDSLRQNAEFESLSRQLQAFFN 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          DALHMAVNDLRLRLPPVTDTSAIGALYGLQSLFDCMLSKCRDSIAFDEEKLNCRLNELKG 
LmjF.36.5250      ------------------------------------------------------------ 
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TbBBP590          KHAKDLKSLHRVFCAHVTTYTDDPNDEDSARSEGDGSSPVNLPTTDRLSGGLTPEHIVAA 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          GDALHHVHSNVCHIVWACIRHAERAPPPSLHTMGLPALTALLGEVVVASLERAELLQGAM 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          VAGSRALGILPVDPSLNQQHMEEWLECFTSEIQRVQRSGEGCELLLNHLEILLQDHGISV 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          GELVSNSRSQSTLSNVGRLSQDNQLGSPRGPSSSVAVQDVMEFRSRALLGALRDLIAQFE 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          HRYSTLTSEWQALTDQNNRLKTSQQANEEEFARVQEQMQELRHAVRKKVEDDRKVEQSLR 
LmjF.36.5250      ------------------------------------------------------------ 
                                                                               
 
TbBBP590          DLDNHLDMQARELAMKYRADQEAISRQFAELRGSIRRVVIPTQEQLGTPSPKYDFVYPRE 
LmjF.36.5250      ------------------------------------------------------------ 





Figure 9.7 (A) Sequence alignments of TbBBP590 against BLAST search top hit in T. cruzi, 




P.falciparum        -----------------MNIAIDEYGQPFVILREE-EKKRIKGIEAHKSNILAAKVVADI 
G.lamblia           -------MAQRINGAQLLGVSQDENGNPVYLMREGTEKKRARGLEAHKSNITIARALANT 
S.cerevisiae        MAARPQQPPMEMPDLSNAIVAQDEMGRPFIIVKDQGNKKRQHGLEAKKSHILAARSVASI 
L.major             -----------------MSLAFDEYGRPFLLVKEQQQKERVSGVEAQRANILAALGVANV 
T.brucei            -----------------MSLAFDEYGRPFLLVKEQANKERVTGVEAQKANILAAISVSNV 
T.cruzi             -----------------MSLAFDEYGRPFLLVKEQAQKERLTGVEAQKSNILAAISVSNV 
P.tetraurelia       -----------------MSLAFDDYGRPYIILRDQGQKKRMKGLEAYKSNILAAKAVANT 
D.discoideum        -----------------MSLVFDEYGNPFIVIRDQQAKERLRGIEAHRSHILAAKTISNI 
Ch.reinhardtii      -----------------MSLAFDEFGRPFIILREQERKSRVKGIEAVKASIMAAKTVART 
C.elegans           ------------MAQSSAQLLFDESGQPFIVMREQENQKRITGVEAVKSHILAARAVANT 
H.sapiens           -------------MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANT 
C.owczarzaki        -----------------MSLAFDEYGRPFIILREQDTRQRMTGSDAIKQHILAAKAIAHT 
                                       :  *: *.*  ::::   :.*  * :* :  *  *  ::   
 
P.falciparum        LKSSIGPRGMDKIIVSEDNNVTVTNDGATILEKIDVQHECAKLLVELSKSQDNEIGDGTT 
G.lamblia           LRTSLGPRGMDKILVSGDRELTITNDGATILERMEVDNHIARLLVDLSKCQDNEIGDGTT 
S.cerevisiae        IKTSLGPRGLDKILISPDGEITITNDGATILSQMDLDNEIAKLLVQLSKSQDDEIGDGTT 
L.major             LKSSLGPRGMDKILTTPDNEVVVTNDGATILDLMDIDNEVGQLMVELSKSQDSEIGDGTT 
T.brucei            LKTSLGPRGMDKILVTQDNEVVVTNDGATIMDLMDIDNEIGQLMVELSKSQDSEIGDGTT 
T.cruzi             LKTSLGPRGMDKILVTQDNDVVVTNDGATIVDLMDIDNEIGQLMVELSKSQDSEIGDGTT 
P.tetraurelia       LQSSLGPKGMDKMLVSPDGDVSVTNDGATIVEKMEIQHPTAKLLVELSQSQDAEIGDGTT 
D.discoideum        MKSSLGPKGMDKMMVSQDGEVLVTNDGATILENMQVDNQIAKLMVQLSKSQDDEIGDGTT 
Ch.reinhardtii      LRSSLGPKGMDKMLQSPDGDVTITNDGATILEMMEVENQIGKLMVELSKSQDHEIGDGTT 
C.elegans           LRTSLGPRGLDKMLVSPDGDVTITNDGATIMEKMDVQHHVAKLMVELSKSQDHEIGDGTT 
H.sapiens           MRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTT 
C.owczarzaki        LKTSLGPKGLDKMMVSPDGAVTITNDGATILSQMDVQHPIAKLLVELSQSQDSEIGDGTT 
                    :::*:**.*:**::   *  : :*******:. :::::  .:*:*:**:.** ******* 
 
P.falciparum        GVVIIAGVLLEEAYALIDKGIHPLRIADGFENACNIALKVIEDIALTVDIEEND--HKIL 
G.lamblia           GVVVLAGSLLEHAETLLDKGIHPIRISDGYDMACDVAIKHLENIATTYSFSADN--KEPL 
S.cerevisiae        GVVVLASALLDQALELIQKGIHPIKIANGFDEAAKLAISKLEETCDDISASNDELFRDFL 
L.major             GVVCFAGALLEQATALLDKGIHSSRISEGYEKACEMACKRLEEVAESISLEK----KEVL 
T.brucei            GVVCLAGALLEQASGLLDKGIHSSRISEGFEKACEIACKRLEEIADTVPVSREE--YSYL 
T.cruzi             GVVCFAGALLEQANGLLDKGIHSSRISEGFEKGCEVACKRIEEISETVPVSREE--YNYL 
P.tetraurelia       GVVVLAGKLLEQALTLLDKGIHPLKISDGFDRACDVAIKHLETISEEIDIQANE--HEAL 
D.discoideum        GVVVLAGSLLEQAEQLIEKGIHPCRIYEGYETACKIATEHLKTISDSIEFSKDN--IEPL 
Ch.reinhardtii      GVVVLAGALLEHAEALLDMGMHPLRIAEGYEMACKVATENLDNIKTRFDFSKEN--IEPL 
C.elegans           GVVVLAGALLEEAEKLIDRGIHPIKIADGFDLACKKALETLDSISDKFPVE--N--RERL 
H.sapiens           GVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIEHLDKISDSVLVDIKD--TEPL 
C.owczarzaki        GVVVLAGSLLEQAEHLIDRGIHPIRIADGFEMACAVAVKQLEAVSDIIPVGKDE--KESL 
                    *** :*. **:.*  *:: *:*  :* :*:: ..  * . :.               . * 





P.falciparum        KKVAKTSLSSKIVSSKKDLLSNIVVDAVLSVADMKRKDVRFDLIKIEGKTGGLLEESTLI 
G.lamblia           IKAAMTSLGSKVINRYHRTMAEVAVDAVLRVADLQRNDVDFELIKVRSKIGGKLEDIKII 
S.cerevisiae        LRAAKTSLGSKIVSKDHDRFAEMAVEAVINVMDKDRKDVDFDLIKMQGRVGGSISDSKLI 
L.major             LQTARSTLNSKVVNRDRDRLAQICVDAVLAVADMERRDVNMDLIKVEGKVGGRLEETCLV 
T.brucei            LQTARSTLNSKVVNRDRDRLAKICVDAVLSVADMERRDVNLDLIKMEGKVGGCLEETCLV 
T.cruzi             LQTARSTLNSKVVNRERDRLAKICVDAVLSVADMERRDVNLDLIKVEGKVGGCLEDTCLV 
P.tetraurelia       IQAACTALGSKVVSKRKRELGKIAVTAVLDVADLARKDVNLDLIKIQTKTGGSVEDTRLI 
D.discoideum        IKTAMTCLGSKIVNRFHRQMSEIAVKAVISVADLERKDVNLENIKLEGKEGGKLEDTQLV 
Ch.reinhardtii      VKTCMTTLSSKVVGRLKRPMAEICVKAVLAVADLERRDVNLDLIKVEGKVGGKMEDTRLV 
C.elegans           VETAQTSLGSKIVNRSLRQFAEIAVDAVLSVADIESKDVNFEMIKMEGKVGGRLEDTILV 
H.sapiens           IQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLI 
C.owczarzaki        VQTAMTTLGSKIINKCHRQMAEIAVDAVLAVADLETRDVNFELIKMEGKVGGQLQDTQLV 
                     ... : *.**::.     :.:: * **: * *   .** :: **:. : ** :.:  :: 
 
P.falciparum        KGIVLNKELSHSQMIKEV------RNAKIAILTCPFEPPKPKIKHKLNITNVDAYRDLQA 
G.lamblia           NGFLIDQEMSHPGMRKSI------NHAKIAVLTCPFEPPKPKTTYKIDVDSVEKYNTLYK 
S.cerevisiae        NGVILDKDFSHPQMPKCVLPKEGSDGVKLAILTCPFEPPKPKTKHKLDISSVEEYQKLQT 
L.major             DGIVLDKDFSHPQMPKEL------TNPKMAILTCAFEPPKPKTKHTLQINSAEHMRELHE 
T.brucei            NGIVIDKDFSHPQMPKVL------KNPKIAILTCPFEPPKPKTKHTVHISSAEHMKEIHE 
T.cruzi             NGIVLDKDFSHPQMPKQL------KNPKIAILTCPFEPPKPKTKHTVQIANAEQMSEIHA 
P.tetraurelia       SGILIDKDMSHPQMPKEV------KEAKICLLTCPFEPPKPKTKHNINISSAEDYKKLYQ 
D.discoideum        KGIIIDKGISHPQMPKII------KDAKICLLTCPFEPPKPKTKNSIEITKAEDFKVLGE 
Ch.reinhardtii      EGIVIDKEFSHPQMPKEL------KDVKVAILTCPFEPPKPKTKHKVDIDTVEKFEALRD 
C.elegans           KGIVIDKTMSHPQMPKEL------KNAKVAILTCPFEPPKPKTKHKLDITSTEDFKALRD 
H.sapiens           KGVIVDKDFSHPQMPKKV------EDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQK 
C.owczarzaki        RGVVIDKDFSHPQMPKEL------RDAKIAILTCPFEPPKPKTKHKLDIASVEDYKSLQS 
                     *.:::: :**  * * :         *:.:*** ******* . .:.: ..:    :   
 
P.falciparum        IEKKYFYDMVASLKKAGANFVICQWGFDDEANYLLLKENIPAIRWVGGVEMELIAIATGG 
G.lamblia           EEQQFFINMIEHLKGAGANFVACQWGFDDEANHLLMQNDINAVRWVKGEDIEAIALATGA 
S.cerevisiae        YEQDKFKEMIDDVKKAGADVVICQWGFDDEANHLLLQNDLPAVRWVGGQELEHIAISTNG 
L.major             QEQEYFRSEVQRCKDAGADLVICQWGFDDEANYLLYRNQLPAVRWVGGVELEMIAIATAG 
T.brucei            QEQEYFRNQVKLCKQAGADLVICQWGFDDEANYLLYRNDLPAVRWVGGVELEMIAIATGG 
T.cruzi             QEQEYFRKQVQLCKDAGAELVICQWGFDDEANYLLFRNDLPAVRWVGGVELEMVAIATGG 
P.tetraurelia       QEQQYFVDMVKLVKDSGANIALCQWGFDDEANHLLLQNELPAVRWVSGTDVELIAMATGA 
D.discoideum        IEQKYFTDMVEKVKATGANLVICQWGFDDEANHLLLQNNLPAVRWVGGLDLEKIAMATGG 
Ch.reinhardtii      AEKSYFTDMVQRCKDSGAELVICQWGFDDEANHLLMHKNLPAVRWVGGVEIELLAMATGA 
C.elegans           YERETFETMIRQVKESGATLAICQWGFDDEANHLLQANDLPAVRWVGGPEIELLAIATNA 
H.sapiens           YEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGG 
C.owczarzaki        YEHKIFVEMIERVKQSGANFVVCQWGFDDEANHLLLQNSLPAVRWVGGPEIELVAIATNG 
                     *:. *   :   * :** .. **********:**  :.: *:*** * ::* :*::* . 
 
P.falciparum        KIIPRFEDIDESKLGKADLIREISHGTVNNPMVYIEGCSNT---------KAITILLRGG 
G.lamblia           RIIPRFEDISSDKLGYAEVVREVSLGTSSDKVMVFEGLQPQQTTADSVPHMISTVFIRGG 
S.cerevisiae        RIVPRFQDLSKDKLGTCSRIYEQEFGTTKDRMLIIEQSKET---------KTVTCFVRGS 
L.major             RIVPRFEDLTAEKLGTCGRVREVGFGTTKDRMIFVENCPNS---------KAVTVFIRGG 
T.brucei            RIIPRFEDLQSAKLGTCGTVREVGFGTTKDRMIFIEECPSS---------KAVTIFIRGG 
T.cruzi             RIIPRFEDISGSKLGTCGTVREVGFGTTKDRMIFIEDCPNS---------RAVTILIRGG 
P.tetraurelia       RIIPRFQEITPEKLGKAGSVKEVQFGTSNERMLVIENCQCT---------KAVTILIRGG 
D.discoideum        RIVARFEDVSADKLGRAGLVREVGFGTTQDRYLSIEDCPNT---------NAVTIFVRGG 
Ch.reinhardtii      RIVPRFQELSADKLGHAGSVKEVGFGTTKDKMLVIEGCPHL---------KAVTIFVRGG 
C.elegans           RIVPRFSELSKEKLGTAGLVREITFGAAKDRMLSIEQCPNN---------KAVTIFVRGG 
H.sapiens           RIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNS---------RAVTIFIRGG 
C.owczarzaki        RIVPRFEELSPEKLGHAGVVREISFGTTKDRMLFIEDCKNT---------RAVTVFVRGG 
                    :*: **.::   *** .  : *   *: .:  : .*                 * ::**. 
 
 
P.falciparum        NQMMIEECERSVHDALCSVRNLIRDNRILPGGGSTEIYAALEIEKVADKCKGIEQYAIRA 
G.lamblia           NNMIIEEARRSLHDAMCVVRNLIRDPRVIYGGGSAEISCSLAVAEAAEHVGTVEQYALRA 
S.cerevisiae        NKMIVDEAERALHDSLCVVRNLVKDSRVVYGGGAAEVTMSLAVSEEADKQRGIDQYAFRG 
L.major             NKMMIEEAKRSLHDAICMVRNLIRDNRIVYGGGSAELAASSAVLAHADAVSTVDQYAIRA 
T.brucei            NKMMIEEAKRSLHDAVCMVRNLIRDNRIVYGGGSAEIAASMAVLNYADTVSTVDQYAIRR 
T.cruzi             NKMMVEEAKRSLHDALCMVRNLIRDNRVVYGGGSAEIAASLAVLNYADSISTVDQYAIRR 
P.tetraurelia       SQMIVDEAKRSIHDAICVIRNLIKDNRIVYGGGSAELACSIQVLQYADEVSSVEQYAIRS 
D.discoideum        NKMIVEEAKRSIHDALCVTRNLIRDNRVIYGGGSSEISCGLKISAMADDIASIEQYAVRA 
Ch.reinhardtii      NRMVLDEIKRSLHDAICVARNLVRDNAIVYGGGAAEISCALAVEEAADKVTGVEHYAMRT 
C.elegans           NKMIIDEAKRALHDALCVIRNLVRDSRIVYGGGSAELAAAIQVAKEADRIDGIEQYAFRA 
H.sapiens           NKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRA 
C.owczarzaki        NQMIIEEAKRSLHDAICVVRNLVKDNRVVYGGGAPEITCSLAVYEAADKVATLEQYAMRA 
                    ..*:::* .*::**::*  ***::*  :: ***: *:  .  :   *:    :::**.*  
 
P.falciparum        FGNALLSIPINLCNNMGLNSIDIISEIKTKIIQDKTKNLGIDCLNYKVGDMIERGIFETF 
G.lamblia           FSEALDIIPLTLARNSSIQPIETLAMVKAAQKKTGTHHLGIDCMRRNTIDMKEQNVFETL 
S.cerevisiae        FAQALDTIPMTLAENSGLDPIGTLSTLKSKQLKEKISNIGVDCLGYGSNDMKELFVVDPF 
L.major             FADALESIPINLALNSGLDPIRALSDARKAQIQGNNPYAGIDCMDRGTIDMKQQEVFETL 
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T.brucei            FADALESIPINLALNSGLEPIKCLSRARIEQVEGKNPYAGVDCMDSGTLDMKKQQVFETL 
T.cruzi             FADALESIPINLALNSGLDPIKALSLARIVQVEGKNPYAGVDCMDCGTIDMKQQQVFETL 
P.tetraurelia       FADALEGIPCCLADNCGLNPITSVAQAKARQLQESNPRIGIDCMELGTTDMKEQRIYETL 
D.discoideum        FADALDAIPLALAENSGLPSIESLSTVKAMQIKEKNPRLGIDCNHRDTNDMKAQHVFDTL 
Ch.reinhardtii      FADALQAVPLALAENSGLPPIESLTAVKKRQLEEKNPYLGIDCNDTGTNDMREQNVFETV 
C.elegans           FADALESIPMALAENSGLAPIDALSDLKAKQIETGKSSLGIDAVFAGTNDMKEQKVIETL 
H.sapiens           FADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETL 
C.owczarzaki        FGDALEATPIALAENSGLPPIETLAAVKSRQVKEKNPRLGIDCNMTGNADMRDQHVVETL 
                    *.:**   *  *. * .:  *  ::  :    :      *:*.      **    : : . 
 
P.falciparum        NSKYNQFSLATQVVKMILKIDDVIAPNDFN---- 
G.lamblia           SSKVQQLLLATQVVRMILKIDEVITDEV------ 
S.cerevisiae        IGKKQQILLATQLCRMILKIDNVIISGKDEY--- 
L.major             SGKCSQLRLATQVVKMILKIDDVIVTKPDEEQQQ 
T.brucei            QGKCSQLRLATQVVKMILKVDDVIVTKPEEEE-- 
T.cruzi             QGKCSQLRLATQVVKMILKVDDVILTHVEEEQ-- 
P.tetraurelia       SSKKQQIQLATQVVKMILKIDDVIAPDDY----- 
D.discoideum        PGKTQQFLLANQVVKMILKIDDIIKMGPGADE-- 
Ch.reinhardtii      MGKKQQLFLATQVCKMILKIDDVIKPSDYE---- 
C.elegans           LSKREQISLATQVVRMILKIDDVRVPDDERMGY- 
H.sapiens           IGKKQQISLATQMVRMILKIDDIRKPGESEE--- 
C.owczarzaki        VGKKQQFQLATQLVKMILKIDDIVTPGGAQ---- 
                     .* .*: **.*: :****:*::            
 
Figure 9.8 Sequence alignments of the TCP-1- protein in different organisms. GroEL-like 
equatorial domains that locate at both C and N terminus are in red bracket; (2) GroEL-like 
apical domain is located at the central of the sequences in orange braket; (3) TCP-1-like 
chaperonin intermediate domain, which can be found between the GroEL-like equatorial and 
















The RNAi constructs of all eleven selected putative TbRP2-interacting /nearby 
neighbour proteins analysed by Sanger Sequencing. In all the sequences analyses 
restriction sites BamHI (GGATCC) and XhoI (CTCGAG) (SalI; GTCGAC for TbKMP11) are 
highlighted in different colours, RNAi targeted region is highlighted in bold.  
 












➢ Translated protein sequence:   
ggatcctgagccgcgtgtactgatagtgggccttgacaatgctggaaagactaccgtactg 
  D  P  E  P  R  V  L  I  V  G  L  D  N  A  G  K  T  T  V  L  
aatgcattgggagaagacgaggtgcctgtggagggaaaagtttcccacgccgcacctgag 
 N  A  L  G  E  D  E  V  P  V  E  G  K  V  S  H  A  A  P  E  
ggaccaacgcaagggtttaatatcaaaacactcacacgtgggaataaacgggctaagtta 
 G  P  T  Q  G  F  N  I  K  T  L  T  R  G  N  K  R  A  K  L  
tgtgatctcggtggccagcgggcgctgcgagactattggcaggattactacagcaacacg 
 C  D  L  G  G  Q  R  A  L  R  D  Y  W  Q  D  Y  Y  S  N  T  
gactgcattatgtacgtggtggattcttctgaccaccgccgactcgaagaatctcacgct 
 D  C  I  M  Y  V  V  D  S  S  D  H  R  R  L  E  E  S  H  A  
gcatttgtggatgttctaaagggcattgaaggtgctccggttttggtgtttgcgaataaa 
 A  F  V  D  V  L  K  G  I  E  G  A  P  V  L  V  F  A  N  K  
caagatcttgcaaccgcaaaagatgctcaggcgatcgcagaatgccttcatttgcatgac 
 Q  D  L  A  T  A  K  D  A  Q  A  I  A  E  C  L  H  L  H  D  
ttccgagaccgcaagtggcacatccaaggctgtagcgccaaaacgggagcaggactggag 
 F  R  D  R  K  W  H  I  Q  G  C  S  A  K  T  G  A  G  L  E  
gaaggcgtgacatggatacttagcacttgtgccccgtaatgggaagctgatgtctgtaag 
 E  G  V  T  W  I  L  S  T  C  A  P  -  W  E  A  D  V  C  K  
gcgctgaaagcaaataactcgag 
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➢ TritrpDB BLAST alignments:   
> Tb927.6.3650:mRNA-p1 | transcript=Tb927.6.3650:mRNA | gene=Tb927.6.3650  
| organism=Trypanosoma_brucei_brucei_TREU927 | gene_product=ADP-ribosylation  
factor, putative | transcript_product=ADP-ribosylation  
factor, putative | location=Tb927_06_v5.1:1087819-1088370(-)  




 Score = 353 bits (906), Expect = 3e-125, Method: Compositional matrix 
adjust. 
 Identities = 169/170 (99%), Positives = 169/170 (99%), Gaps = 0/170 (0%) 
 
Query  1    EPRVLIVGLDNAGKTTVLNALGEDEVPVEGKVSHAAPEGPTQGFNIKTLTRGNKRAKLCD  60 
            EPRVLIVGLDNAGKTTVLNALGEDEVPVEGKVSHAAPEGPTQGFNIKTLTRGNKRAKLCD 
Sbjct  14   EPRVLIVGLDNAGKTTVLNALGEDEVPVEGKVSHAAPEGPTQGFNIKTLTRGNKRAKLCD  73 
 
Query  61   LGGQRALRDYWQDYYSNTDCIMYVVDSSDHRRLEESHAAFVDVLKGIEGAPVLVFANKQD 120 
            LGGQRALRDYWQDYYSNTDCIMYVVDSSDHRRLEESHAAFVDVLKGIEGAPVLVFANKQD 
Sbjct  74   LGGQRALRDYWQDYYSNTDCIMYVVDSSDHRRLEESHAAFVDVLKGIEGAPVLVFANKQD 133 
 
Query  121  LATAKDAQAIAECLHLHDFRDRKWHIQGCSAKTGAGLEEGVTWILSTCAP  170 
            LATAKDAQAIAECLHLHDFRDRKWHIQGCSAKTGAGLEEGV WILSTCAP 
Sbjct  134  LATAKDAQAIAECLHLHDFRDRKWHIQGCSAKTGAGLEEGVAWILSTCAP  183 
 
 















➢ Translated protein sequence:   
ggatccggaagaaaccgaggagcagattattattcggctgcagaaggagctgagggaattc 
  D  P  E  E  T  E  E  Q  I  I  I  R  L  Q  K  E  L  R  E  F  
gaagcatatgaggaggagatgcagccaaacctgaacatgtacgaagaggtcatcgaactc 
 E  A  Y  E  E  E  M  Q  P  N  L  N  M  Y  E  E  V  I  E  L  
cgacgagaagctgagcaactggaggatgacaggaagcgcgcattgcttcagattgatctt 
 R  R  E  A  E  Q  L  E  D  D  R  K  R  A  L  L  Q  I  D  L  
ggtgatatatcctcttactacgacggtgatgtggaacgggaggtggaggagctggaggca 
 G  D  I  S  S  Y  Y  D  G  D  V  E  R  E  V  E  E  L  E  A  
gcagtggagaattcatatttacaagcctgctggacgaaagagcgccaacgatacatcgca 
 A  V  E  N  S  Y  L  Q  A  C  W  T  K  E  R  Q  R  Y  I  A  




 R  N  E  T  D  L  P  E  W  W  R  V  D  I  M  K  L  G  F  R  
ttgagggaggccaaaaggtcatttgattcaagtaatcgtgttgcccaagacttatatcgt 
 L  R  E  A  K  R  S  F  D  S  S  N  R  V  A  Q  D  L  Y  R  
gcccacgaggtgaaggtgaacgctaccaccgactctcgtgacaaggcaaaagctgaactg 
 A  H  E  V  K  V  N  A  T  T  D  S  R  D  K  A  K  A  E  L  
cggcaagagatcgctgcggagttgaacgagctgcgtcagcggcgggaacgtctgttggtt 
 R  Q  E  I  A  A  E  L  N  E  L  R  Q  R  R  E  R  L  L  V  
atagacaaggaacaacgtttccatttacgccgtggtactcacgtgaaggctcgag 
 I  D  K  E  Q  R  F  H  L  R  R  G  T  H  V  K  A  R       
 
 
➢ TritrpDB BLAST alignments:   
> Tb927.7.2650:mRNA-p1 | transcript=Tb927.7.2650:mRNA | gene=Tb927.7.2650  
| organism=Trypanosoma_brucei_brucei_TREU927 | gene_product=hypothetical  
protein, conserved | transcript_product=hypothetical  
protein, conserved | location=Tb927_07_v5.1:680735-682348(-)  




 Score = 362 bits (930),  Expect = 1e-123, Method: Compositional matrix 
adjust. 
 Identities = 187/189 (99%), Positives = 189/189 (100%), Gaps = 0/189 (0%) 
 
Query  8    QIIIRLQKELREFEAYEEEMQPNLNMYEEVIELRREAEQLEDDRKRALLQIDLGDISSYY  67 
            QIIIRL++ELREFEAYEEEMQPNLNMYEEVIELRREAEQLEDDRKRALLQIDLGDISSYY 
Sbjct  235  QIIIRLREELREFEAYEEEMQPNLNMYEEVIELRREAEQLEDDRKRALLQIDLGDISSYY  294 
 
Query  68   DGDVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVDIMKLGFRLREAKRS  127 
            DGDVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVDIMKLGFRLREAKRS 
Sbjct  295  DGDVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVDIMKLGFRLREAKRS  354 
 
Query  128  FDSSNRVAQDLYRAHEVKVNATTDSRDKAKAELRQEIAAELNELRQRRERLLVIDKEQRF  187 
            FDSSNRVAQDLYRAHEVKVNATTDSRDKAKAELRQEIAAELNELRQRRERLLVIDKEQRF 
Sbjct  355  FDSSNRVAQDLYRAHEVKVNATTDSRDKAKAELRQEIAAELNELRQRRERLLVIDKEQRF  414 
 
Query  188  HLRRGTHVK  196 
            HLRRGTHVK 
Sbjct  415  HLRRGTHVK  423 
 
 
> Tb927.7.2640:mRNA-p1 | transcript=Tb927.7.2640:mRNA | gene=Tb927.7.2640  
| organism=Trypanosoma_brucei_brucei_TREU927 | gene_product=cytoskeleton  
associated protein, putative | transcript_product=cytoskeleton  
associated protein, putative | location=Tb927_07_v5.1:676956-678317(-)  
| protein_length=453 |  
sequence_SO=chromosome | SO=protein_coding 
Length=453 
 
 Score = 299 bits (766),  Expect = 4e-100, Method: Compositional matrix 
adjust. 
 Identities = 156/189 (83%), Positives = 171/189 (90%), Gaps = 0/189 (0%) 
 
Query  8    QIIIRLQKELREFEAYEEEMQPNLNMYEEVIELRREAEQLEDDRKRALLQIDLGDISSYY  67 
            QIIIRLQKELREFEAYE+EMQPNLN+YE++IELRREAEQLEDDRKRALLQIDLGDISSYY 
Sbjct  151  QIIIRLQKELREFEAYEKEMQPNLNIYEDIIELRREAEQLEDDRKRALLQIDLGDISSYY  210 
 
Query  68   DGDVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVDIMKLGFRLREAKRS  127 
            DGDVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRV++  L  RL++A+ S 
Sbjct  211  DGDVEREVEELEAAVENSYLQACWTKERQRYIARNETDLPEWWRVNVKDLPSRLKDARAS  270 
 
Query  128  FDSSNRVAQDLYRAHEVKVNATTDSRDKAKAELRQEIAAELNELRQRRERLLVIDKEQRF  187 
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            FDSSNRVAQDLYRAHEVKVNATTDSRDKAKAE+   + AE+   +  RERL  + K+Q F 
Sbjct  271  FDSSNRVAQDLYRAHEVKVNATTDSRDKAKAEIFNGMKAEIEATKGERERLRQLQKDQLF  330 
 
Query  188  HLRRGTHVK  196 
            HLRRGTHVK 
Sbjct  331  HLRRGTHVK  339 
 
 













➢ Translated protein sequence:   
ggcgattgggcccgacgtcgcatgctcccggccgccatggcggccgcgggaattcgattgga 
   R  L  G  P  T  S  H  A  P  G  R  H  G  G  R  G  N  S  I  G  
tccggccactttaggacaactgcaaaggattcgtattgtcgctatgattcttcttgttat 
 S  G  H  F  R  T  T  A  K  D  S  Y  C  R  Y  D  S  S  C  Y  
aagagttcgtgtagggagtcttcctttggtgatgaatctgttatatctaagaggcatagc 
 K  S  S  C  R  E  S  S  F  G  D  E  S  V  I  S  K  R  H  S  
tttactgcttcatctgtagctgatgctattgttgttaagaaggtcgtgaaaggtaaaagt 
 F  T  A  S  S  V  A  D  A  I  V  V  K  K  V  V  K  G  K  S  
gatggtggtgtgacatcaaagaaggttgatgtctccactgatatgaagtgtgtcgcaagt 
 D  G  G  V  T  S  K  K  V  D  V  S  T  D  M  K  C  V  A  S  
ggggagagtaatggaggtgctgctgcggttgttgcagctactactgagtgtgctgctgcg 
 G  E  S  N  G  G  A  A  A  V  V  A  A  T  T  E  C  A  A  A  
gctgtgggcgatcaaccaactggtaacggagtacgtgtgtcaaagtggaaaaaggcccct 
 A  V  G  D  Q  P  T  G  N  G  V  R  V  S  K  W  K  K  A  P  
aatgttggttattcctgcccttgtcatgtagatgctgatatgtacgtgagtaccgcgcat 
 N  V  G  Y  S  C  P  C  H  V  D  A  D  M  Y  V  S  T  A  H  
agagatttcaaggcacacggtgccagcaaaccttatatgccaaaggctgctccgactgtt 
 R  D  F  K  A  H  G  A  S  K  P  Y  M  P  K  A  A  P  T  V  
aaacagtcaagcatttctatgcaaggtgtaagcagcgctcgagaatcactagtgaattcg 
 K  Q  S  S  I  S  M  Q  G  V  S  S  A  R  E  S  L  V  N  S  
 
 
➢ TritrpDB BLAST alignments:   
> Tb927.10.10360:mRNA-p1 | transcript=Tb927.10.10360:mRNA | gene=Tb927.10.10360  
| organism=Trypanosoma_brucei_brucei_TREU927  
| gene_product=Microtubule-associated repetitive protein |  
transcript_product=Microtubule-associated repetitive protein  
| location=Tb927_10_v5.1:2548906-2558502(-) | protein_length=3198  
| sequence_SO=chromosome | SO=protein_coding 





 Score =  300 bits (769),  Expect = 9e-94, Method: Compositional matrix adjust. 
 Identities = 166/171 (97%), Positives = 167/171 (98%), Gaps = 0/171 (0%) 
 
Query  1     GHFRTTAKDSYCRYDSSCYKSSCRESSFGDESVISKRHSFTASSEADAIVVKKVVKGKSD  60 
             GHFRTTAKDSYCRYDSSCYKSSCRESSFGDESV+S RHSFTASSEADAIVVKKVVKGKSD 
Sbjct  2979  GHFRTTAKDSYCRYDSSCYKSSCRESSFGDESVMSMRHSFTASSEADAIVVKKVVKGKSD  3038 
 
Query  61    GGVTSKKVDVSTDMKCVASGESNGGAAAVVAATTECAAAAVGDQPTGNGVRVSKWKNAPN  120 
             GGVTSKKVDV TDMKCVASGESNGGAAA VAATTECAAAAVGDQPTGNGVRVSKWK APN 
Sbjct  3039  GGVTSKKVDVFTDMKCVASGESNGGAAAAVAATTECAAAAVGDQPTGNGVRVSKWKKAPN  3098 
 
Query  121   VGYSCPCHVDADMYVSTAHRDFKAHGASKPYMPKAAPTVKQSSISMQGVSS  171 
             VGYSCPCHVDADMYVSTAHRDFKAHGASKPYMPKAAPTVKQSSISMQGVSS 

















➢ Translated protein sequence:   
gcgaattcactagtgattgcgggatccagatcgtgctttcaagagtaaactaaactttaa 
 A  N  S  L  V  I  A  G  S  R  S  C  F  Q  E  -  T  K  L  -  
gatactttttcaagaaacatggccaccacatacgaagaatttgctgcgaagctcgaccgc 
 D  T  F  S  R  N  M  A  T  T  Y  E  E  F  A  A  K  L  D  R  
ctcgatgccgaattcgccaagaagatggaggagcagaacaagcgattcttcgctgacaag 
 L  D  A  E  F  A  K  K  M  E  E  Q  N  K  R  F  F  A  D  K  
cctgatgaggctacgctgtcccctgagatgaaagagcactatgaaaagttcgaaaaaatg 
 P  D  E  A  T  L  S  P  E  M  K  E  H  Y  E  K  F  E  K  M  
atccaggagcacacggacaagttcaacaagaagatgcgcgagcactcagagcacttcaag 
 I  Q  E  H  T  D  K  F  N  K  K  M  R  E  H  S  E  H  F  K  
gccaagtttgcggaactcctcgagcagcagaagaatgcccagttccccggaaaatgattg 
 A  K  F  A  E  L  L  E  Q  Q  K  N  A  Q  F  P  G  K  -  L  
caaatttactacacctctcattttctttcctatgttagagtccctagggataatactata 
 Q  I  Y  Y  T  S  H  F  L  S  Y  V  R  V  P  R  D  N  T  I  
aaaatcttttaaaagatgtaaataccacttttctagcgcaatgcgtcgaccgcaatcgaa 
 K  I  F  -  K  M  -  I  P  L  F  -  R  N  A  S  T  A  I  E  
 
 
➢ TritrpDB BLAST alignments:   
> Tb927.9.13820:mRNA-p1 | transcript=Tb927.9.13820:mRNA | gene=Tb927.9.13820  
| organism=Trypanosoma_brucei_brucei_TREU927 |  
gene_product=kinetoplastid membrane protein 11-3 | 
transcript_product=kinetoplastid  
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membrane protein 11-3 | location=Tb927_09_v5.1:2179681-2179959(-)  




 Score =  184 bits (468),  Expect = 1e-60, Method: Compositional matrix adjust. 
 Identities = 92/92 (100%), Positives = 92/92 (100%), Gaps = 0/92 (0%) 
 
Query  25   MATTYEEFAAKLDRLDAEFAKKMEEQNKRFFADKPDEATLSPEMKEHYEKFEKMIQEHTD  84 
            MATTYEEFAAKLDRLDAEFAKKMEEQNKRFFADKPDEATLSPEMKEHYEKFEKMIQEHTD 
Sbjct  1    MATTYEEFAAKLDRLDAEFAKKMEEQNKRFFADKPDEATLSPEMKEHYEKFEKMIQEHTD  60 
 
Query  85   KFNKKMREHSEHFKAKFAELLEQQKNAQFPGK  116 
            KFNKKMREHSEHFKAKFAELLEQQKNAQFPGK 



















➢ Translated protein sequence:   
gattgggcccgacgtcgcatgctcccggccgccatggcggccgcgggaattcgatttatgga 
   L  G  P  T  S  H  A  P  G  R  H  G  G  R  G  N  S  I  Y  G  
tccatcgagatcgatgcactcttcgaaaacattgacttccaggcgaccattacccgtgct 
 S  I  E  I  D  A  L  F  E  N  I  D  F  Q  A  T  I  T  R  A  
cgtttcgaggaactgtgcggtgacctgttccgtggtacattgcaacccgtagagcgtgtg 
 R  F  E  E  L  C  G  D  L  F  R  G  T  L  Q  P  V  E  R  V  
ctgcaggatgccaagatggacaaacgcgccgtgcacgatgtggtcctggttggtggttcc 
 L  Q  D  A  K  M  D  K  R  A  V  H  D  V  V  L  V  G  G  S  
acccgtatccccaaggtgatgcagcttgtgtctgactttttcggtggcaaggagcttaac 
 T  R  I  P  K  V  M  Q  L  V  S  D  F  F  G  G  K  E  L  N  
aagagcatcaaccccgacgaggcagtggcctacggcgctgctgtacaagctttcatcttg 
 K  S  I  N  P  D  E  A  V  A  Y  G  A  A  V  Q  A  F  I  L  
accggtggtaagagcaagcaaacggaaggtctcctccttctggatgtcgccccgcttacg 
 T  G  G  K  S  K  Q  T  E  G  L  L  L  L  D  V  A  P  L  T  
ctcggcatcgagacggcaggtggcgtgatgacggcactgatcaagcgcaacacgacgatc 
 L  G  I  E  T  A  G  G  V  M  T  A  L  I  K  R  N  T  T  I  
cccaccaaaaagagccaaatcttctccacatactcagacaatcagcccggtgtgcacatt 
 P  T  K  K  S  Q  I  F  S  T  Y  S  D  N  Q  P  G  V  H  I  
caggtctttgagggtgagcgtaccatgacgaaggactgccatctcttgggcaccttcgat 
 Q  V  F  E  G  E  R  T  M  T  K  D  C  H  L  L  G  T  F  D  
ctctctggaatccccccggcaccccgcggcgtgccacagatagaagtgaccttcgaccta 
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➢ TritrpDB BLAST alignments:   
> Tb927.11.11330:mRNA-p1 | transcript=Tb927.11.11330:mRNA | gene=Tb927.11.11330  
| organism=Trypanosoma_brucei_brucei_TREU927  
| gene_product=heat shock protein 70 | transcript_product=heat  
shock protein 70 | location=Tb927_11_v5.1:3028681-3030666(+)  
| protein_length=661 | sequence_SO=chromosome | SO=protein_coding 
Length=661 
 
 Score = 422 bits (1084), Expect = 6e-144, Method: Compositional matrix adjust. 
 Identities = 205/205 (100%), Positives = 205/205 (100%), Gaps = 0/205 (0%) 
 
Query  1    IEIDALFENIDFQATITRARFEELCGDLFRGTLQPVERVLQDAKMDKRAVHDVVLVGGST  60 
            IEIDALFENIDFQATITRARFEELCGDLFRGTLQPVERVLQDAKMDKRAVHDVVLVGGST 
Sbjct  285  IEIDALFENIDFQATITRARFEELCGDLFRGTLQPVERVLQDAKMDKRAVHDVVLVGGST  344 
 
Query  61   RIPKVMQLVSDFFGGKELNKSINPDEAVAYGAAVQAFILTGGKSKQTEGLLLLDVAPLTL  120 
            RIPKVMQLVSDFFGGKELNKSINPDEAVAYGAAVQAFILTGGKSKQTEGLLLLDVAPLTL 
Sbjct  345  RIPKVMQLVSDFFGGKELNKSINPDEAVAYGAAVQAFILTGGKSKQTEGLLLLDVAPLTL  404 
 
Query  121  GIETAGGVMTALIKRNTTIPTKKSQIFSTYSDNQPGVHIQVFEGERTMTKDCHLLGTFDL  180 
            GIETAGGVMTALIKRNTTIPTKKSQIFSTYSDNQPGVHIQVFEGERTMTKDCHLLGTFDL 
Sbjct  405  GIETAGGVMTALIKRNTTIPTKKSQIFSTYSDNQPGVHIQVFEGERTMTKDCHLLGTFDL  464 
 
Query  181  SGIPPAPRGVPQIEVTFDLDANGIL  205 
            SGIPPAPRGVPQIEVTFDLDANGIL 
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➢ Translated protein sequence:   
ggatccaaattgtcgagtctgcgatccgtgtgtgaggaatgtaactctgttattgagcgt 
 G  S  K  L  S  S  L  R  S  V  C  E  E  C  N  S  V  I  E  R  
gcccgtaggagagaagagcggtctcactcgcgggagtcttcgccagcgtcacatcgtgta 
 A  R  R  R  E  E  R  S  H  S  R  E  S  S  P  A  S  H  R  V  
gaggatggcgcagaggctttacttgtggagcgttgcaaagagctggtgtcggagctgctc 
 E  D  G  A  E  A  L  L  V  E  R  C  K  E  L  V  S  E  L  L  
gtgttgcgtaccgatcgacggactagcacggctgcaatagaccagaggcttatggagagt 
 V  L  R  T  D  R  R  T  S  T  A  A  I  D  Q  R  L  M  E  S  
gagttgatggtgacatccgtacgaaatgccatagagagcctacgaacttcccttgatatc 
 E  L  M  V  T  S  V  R  N  A  I  E  S  L  R  T  S  L  D  I  
gatgtacctatcggcacacctgccctggatttagtaaggacttctggtagttgtggagaa 
 D  V  P  I  G  T  P  A  L  D  L  V  R  T  S  G  S  C  G  E  
gcagttgaaggtgctatcagtgagaaaaggcaagtttccgccaccggaccgagtttagcg 
 A  V  E  G  A  I  S  E  K  R  Q  V  S  A  T  G  P  S  L  A  
gaactggacacctctatccgtacccagctcgaactctgcgtgcttgcagtgatcagacaa 
 E  L  D  T  S  I  R  T  Q  L  E  L  C  V  L  A  V  I  R  Q  
ttacgtgaaaaggaccgggtaatttccgctgcggcaactttgttgggagatgcgctgcgt 
 L  R  E  K  D  R  V  I  S  A  A  A  T  L  L  G  D  A  L  R  
tcatgctccagtgccattaaagacgaagttactactgattcgcttttagcggttgcaagc 
 S  C  S  S  A  I  K  D  E  V  T  T  D  S  L  L  A  V  A  S  
ggtactgctcacagtctgcactccctattctcagagttacagagtgttcgtgcgtcgctt 
 G  T  A  H  S  L  H  S  L  F  S  E  L  Q  S  V  R  A  S  L  
aaacaatcgcagcaccacacggaagagctgcgtacgcggttggaggggggagaaacaacg 
 K  Q  S  Q  H  H  T  E  E  L  R  T  R  L  E  G  G  E  T  T  
cagctggcaactctggaggcgcagacggagtcagttgccacagcggaacggctacttaat 
 Q  L  A  T  L  E  A  Q  T  E  S  V  A  T  A  E  R  L  L  N  
gaggcactacaacgacaagttgcggcatcagcgcaaacagcaagactacagcggacgctc 
 E  A  L  Q  R  Q  V  A  A  S  A  Q  T  A  R  L  Q  R  T  L  
atggacttcgcaggaagcatagcagcttcaacgctttatgctgacgctcgagcgcaatca 
 M  D  F  A  G  S  I  A  A  S  T  L  Y  A  D  A  R  A  Q  S  
 
➢ TritrpDB BLAST alignments:   
> Tb927.11.10660:mRNA-p1 | transcript=Tb927.11.10660:mRNA | gene=Tb927.11.10660  
| organism=Trypanosoma_brucei_brucei_TREU927  
| gene_product=Basal body protein | transcript_product=Basal  
body protein | location=Tb927_11_v5.1:2840342-2856547(+)  
| protein_length=5401 | sequence_SO=chromosome | SO=protein_coding 
Length=5401 
 
 Score = 566 bits (1458), Expect = 0.0, Method: Compositional matrix adjust. 
 Identities = 291/293 (99%), Positives = 293/293 (100%), Gaps = 0/293 (0%) 
 
Query  1     KLSSLRSVCEECNSVIERARRREERSHSRESSPASHRVEDGAEALLVERCKELVSELLVL  60 
             KLSSLRSVCEECNSVIERARRREERSHSRESSPASHRVEDGAEALLVERCKELVSELLVL 
Sbjct  3621  KLSSLRSVCEECNSVIERARRREERSHSRESSPASHRVEDGAEALLVERCKELVSELLVL  3680 
 
Query  61    RTDRRTSTAAIDQRLMESELMVTSVRNAIESLRTSLDIDVPIGTPALDLVRTSGSCGEAV  120 
             RTDRRTSTAAIDQRLMESELMVTSVRNAIE+LRTSLDIDVPIGTPALDLVRTSGSCGEAV 
Sbjct  3681  RTDRRTSTAAIDQRLMESELMVTSVRNAIENLRTSLDIDVPIGTPALDLVRTSGSCGEAV  3740 
 
Query  121   EGAISEKRQVSATGPSLAELDTSIRTQLELCVLAVIRQLREKDRVISAAATLLGDALRSC  180 
             EGAISEKRQVSATGPSLAELDTSIRTQLELCVLAVIRQLREKDRVISAAATLLGDALRSC 
Sbjct  3741  EGAISEKRQVSATGPSLAELDTSIRTQLELCVLAVIRQLREKDRVISAAATLLGDALRSC  3800 
 
Query  181   SSAIKDEVTTDSLLAVASGTAHSLHSLFSELQSVRASLKQSQHHTEELRTRLEGGETTQL  240 
             SSAI+DEVTTDSLLAVASGTAHSLHSLFSELQSVRASLKQSQHHTEELRTRLEGGETTQL 
Sbjct  3801  SSAIRDEVTTDSLLAVASGTAHSLHSLFSELQSVRASLKQSQHHTEELRTRLEGGETTQL  3860 
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Query  241   ATLEAQTESVATAERLLNEALQRQVAASAQTARLQRTLMDFAGSIAASTLYAD  293 
             ATLEAQTESVATAERLLNEALQRQVAASAQTARLQRTLMDFAGSIAASTLYAD 

















➢ Translated protein sequence:   
gaattcgattatggatccttctgcttctcgcagactgagcggcccgagggatgggaaccg 
 E  F  D  Y  G  S  F  C  F  S  Q  T  E  R  P  E  G  W  E  P  
caggacgtgaaggtaattggccgcccagttccagccaaagttctcccggagaggctgcga 
 Q  D  V  K  V  I  G  R  P  V  P  A  K  V  L  P  E  R  L  R  
aatactggccagtccgacgacccggctgctgcagcgcgtgacaacagggacgaagcggct 
 N  T  G  Q  S  D  D  P  A  A  A  A  R  D  N  R  D  E  A  A  
gccagctccgtcaagagctgcacagcggcacaggagtctggagataatgatcaaatggtt 
 A  S  S  V  K  S  C  T  A  A  Q  E  S  G  D  N  D  Q  M  V  
ctcaaggcagtaactgcactgagttcagataccgcttccacagatcccgaggtgctagcc 
 L  K  A  V  T  A  L  S  S  D  T  A  S  T  D  P  E  V  L  A  
taccgtgaaaagctcattcgtgaacaggaggaggcatggcaagtggcagaaagcgcacac 
 Y  R  E  K  L  I  R  E  Q  E  E  A  W  Q  V  A  E  S  A  H  
aaaaagcgggataaggaagacaaggatgggacgacctctggaccggcagatgttgattca 
 K  K  R  D  K  E  D  K  D  G  T  T  S  G  P  A  D  V  D  S  
ttgtttggtccaactgaaaagaaggaagctgtaaaggaaaacaaggcatctgctattgac 
 L  F  G  P  T  E  K  K  E  A  V  K  E  N  K  A  S  A  I  D  
gacttatttggtggcatggagacacaaccatcacagcctcaaaaaccaacaacggatgac 
 D  L  F  G  G  M  E  T  Q  P  S  Q  P  Q  K  P  T  T  D  D  
ctctttctcgagccaatcactagtgaattcgcggccgcctgcaggtcgaccatatgggag 
 L  F  L  E  P  I  T  S  E  F  A  A  A  C  R  S  T  I  W  E  
 
➢ TritrpDB BLAST alignments:   
> Tb927.9.6560:mRNA-p1 | transcript=Tb927.9.6560:mRNA | gene=Tb927.9.6560  
| organism=Trypanosoma_brucei_brucei_TREU927 | gene_product=NAK  
family pseudokinase, putative | transcript_product=NAK  
family pseudokinase, putative | location=Tb927_09_v5.1:1077469-1079649(+)  




 Score =  348 bits (893),  Expect = 9e-114, Method: Compositional matrix adjust. 
 Identities = 173/178 (97%), Positives = 174/178 (98%), Gaps = 0/178 (0%) 




Query  22   GSFCFSQTERPEGWEPQDVKVIGRPVPAKVLPERLRNTGQSDDPAAAARDNRDEAAASSV  81 
            G FCFSQTERPEGWEPQDVKVIGRPVPAKVLPERLRNTGQSDDPAAAARDNRDEAAA+SV 
Sbjct  339  GPFCFSQTERPEGWEPQDVKVIGRPVPAKVLPERLRNTGQSDDPAAAARDNRDEAAATSV  398 
 
Query  82   KSCTAAQESGDNDQMVLKAVTALSSDTASTDPEVLAYREKLIREQEEAWQVAESAHKKRD  141 
            KS TAAQESGDNDQMVLKAVTALSSDTASTDPEVLAYREKLIREQEEAWQVAESAHKKRD 
Sbjct  399  KSRTAAQESGDNDQMVLKAVTALSSDTASTDPEVLAYREKLIREQEEAWQVAESAHKKRD  458 
 
Query  142  KEDKDGTTSGPADVDSLFGPTEKKEAVKENKASAIDDLFGGMETQPSQPQKPTTDDLF  199 
            KEDKDG TSGPADVDSLFGPTEKKEAVKENKASAIDDLFGGMETQPSQ QKPTTDDLF 















➢ Translated protein sequence:   
ttgggagctctcccatatggtcgacctgcaggcggccgcgaattcactagtgattgcggg 
 L  G  A  L  P  Y  G  R  P  A  G  G  R  E  F  T  S  D  C  G  
atcctggaagctgtcttctacgcatttgcatccttcggcacggcgcccacgaaggagatg 
 I  L  E  A  V  F  Y  A  F  A  S  F  G  T  A  P  T  K  E  M  
gacagtgcccatttctccaaaatgttaaaggaggctaaaatcattggcaaaaccttcacc 
 D  S  A  H  F  S  K  M  L  K  E  A  K  I  I  G  K  T  F  T  
tctacagatgccgacctcctcttcaacaagatcaaggcgaagggcgcccgtaaaatcacc 
 S  T  D  A  D  L  L  F  N  K  I  K  A  K  G  A  R  K  I  T  
ttcacggagtttaacacaagagccctccctgatattgccaccaagttgaagatgacaccc 
 F  T  E  F  N  T  R  A  L  P  D  I  A  T  K  L  K  M  T  P  
gagcaggtggctgaaattctcacgaaggcatcacccgcctccaattccacaaaagcagaa 
 E  Q  V  A  E  I  L  T  K  A  S  P  A  S  N  S  T  K  A  E  
gctgttaagttccatgacgacaaaaatctctacacgggcgtctacaaggcgggaggcccc 
 A  V  K  F  H  D  D  K  N  L  Y  T  G  V  Y  K  A  G  G  P  
acaaatgtggatcgtaacgccggatccctttcaggggttgtcgaccgccgtgtggatcag 
 T  N  V  D  R  N  A  G  S  L  S  G  V  V  D  R  R  V  D  Q  
gtcgatgtgctcgagcgcaatcgaattcccgcggccgccatggcggccgggagcatgcga 






➢ TritrpDB BLAST alignments:   
 
> Tb927.4.2740:mRNA-p1 | transcript=Tb927.4.2740:mRNA | gene=Tb927.4.2740  
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| organism=Trypanosoma_brucei_brucei_TREU927 | gene_product=p25-alpha,  
putative | transcript_product=p25-alpha,  
putative | location=Tb927_04_v5.1:723054-723506(+) | protein_length=150  
| sequence_SO=chromosome | SO=protein_coding 
Length=150 
 
 Score =  286 bits (732),  Expect = 1e-99, Method: Compositional matrix 
adjust. 
 Identities = 140/141 (99%), Positives = 141/141 (100%), Gaps = 0/141 (0%) 
 
Query  1    EAVFYAFASFGTAPTKEMDSAHFSKMLKEAKIIGKTFTSTDADLLFNKIKAKGARKITFT  60 
            EAVFYAFASFGTAPTKEMD+AHFSKMLKEAKIIGKTFTSTDADLLFNKIKAKGARKITFT 
Sbjct  2    EAVFYAFASFGTAPTKEMDNAHFSKMLKEAKIIGKTFTSTDADLLFNKIKAKGARKITFT  61 
 
Query  61   EFNTRALPDIATKLKMTPEQVAEILTKASPASNSTKAEAVKFHDDKNLYTGVYKAGGPTN 120 
            EFNTRALPDIATKLKMTPEQVAEILTKASPASNSTKAEAVKFHDDKNLYTGVYKAGGPTN 
Sbjct  62   EFNTRALPDIATKLKMTPEQVAEILTKASPASNSTKAEAVKFHDDKNLYTGVYKAGGPTN 121 
 
Query  121  VDRNAGSLSGVVDRRVDQVDV  141 
            VDRNAGSLSGVVDRRVDQVDV 















➢ Translated protein sequence:   
tgcaggcggccgcgaattcactagtgattgcgggatcctttacagttcacgcattcgcca 
 C  R  R  P  R  I  H  -  -  L  R  D  P  L  Q  F  T  H  S  P  
atgtggcgtacccccgttgacaacttcattgacgagaggtgtgccctctccacggacgat 
 M  W  R  T  P  V  D  N  F  I  D  E  R  C  A  L  S  T  D  D  
gaagagatgaaggtcgagcagacagaggtacacatgcaatttcgaaaaattaccgatgac 
 E  E  M  K  V  E  Q  T  E  V  H  M  Q  F  R  K  I  T  D  D  
attctttctaaatacgtgaaggagctaggcataacgctagaggacgcgctgaatgctgtg 
 I  L  S  K  Y  V  K  E  L  G  I  T  L  E  D  A  L  N  A  V  
gtgaactccatggacaccgcgagccagacgaacaggcttggcaagaagttcatgcaggaa 
 V  N  S  M  D  T  A  S  Q  T  N  R  L  G  K  K  F  M  Q  E  
atcttctatatcgaggatttccccaccttccacaagatgatggtgcgacgcaacatcgag 
 I  F  Y  I  E  D  F  P  T  F  H  K  M  M  V  R  R  N  I  E  
ctcgacatccttgctcagtgtgaaatcagtcaaaaacgtgagaacagtggtgcaaaaact 
 L  D  I  L  A  Q  C  E  I  S  Q  K  R  E  N  S  G  A  K  T  
gcaaatgatgaggaggaggcgatgaggctcgctatcgaggcttctcttaacgatgaggag 
 A  N  D  E  E  E  A  M  R  L  A  I  E  A  S  L  N  D  E  E  
aagacccgccgtctaatggagttggaggatctgcagctacaggctcgagcgcaatcgaat 
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 K  T  R  R  L  M  E  L  E  D  L  Q  L  Q  A  R  A  Q  S  N  
 
➢ TritrpDB BLAST alignments:   
> Tb927.10.5810:mRNA-p1 | transcript=Tb927.10.5810:mRNA | 
gene=Tb927.10.5810  
| organism=Trypanosoma_brucei_brucei_TREU927 |  
gene_product=The ARF-like 2 binding protein BART, putative  
| transcript_product=The ARF-like 2 binding protein BART, putative  
| location=Tb927_10_v5.1:1441554-1442855(-) | protein_length=433  
| sequence_SO=chromosome | SO=protein_coding 
Length=433 
 
 Score =  338 bits (867),  Expect = 9e-116, Method: Compositional 
matrix adjust. 
 Identities = 160/161 (99%), Positives = 160/161 (99%), Gaps = 0/161 
(0%) 
 
Query  1    LQFTHSPMWRTPVDNFIDERCALSTDDEEMKVEQTEVHMQFRKITDDILSKYVKELGITL  60 
            LQFTHSPMWRTPVDNFIDERCAL TDDEEMKVEQTEVHMQFRKITDDILSKYVKELGITL 
Sbjct  11   LQFTHSPMWRTPVDNFIDERCALFTDDEEMKVEQTEVHMQFRKITDDILSKYVKELGITL  70 
 
Query  61   EDALNAVVNSMDTASQTNRLGKKFMQEIFYIEDFPTFHKMMVRRNIELDILAQCEISQKR  120 
            EDALNAVVNSMDTASQTNRLGKKFMQEIFYIEDFPTFHKMMVRRNIELDILAQCEISQKR 
Sbjct  71   EDALNAVVNSMDTASQTNRLGKKFMQEIFYIEDFPTFHKMMVRRNIELDILAQCEISQKR  130 
 
Query  121  ENSGAKTANDEEEAMRLAIEASLNDEEKTRRLMELEDLQLQ  161 
            ENSGAKTANDEEEAMRLAIEASLNDEEKTRRLMELEDLQLQ 
Sbjct  131  ENSGAKTANDEEEAMRLAIEASLNDEEKTRRLMELEDLQLQ  171 
 
 












➢ Translated protein sequence:   
gtcgacctgcaggcggccgcgaattcactagtgattgcgggatcctctcgcatctctgag 
 V  D  L  Q  A  A  A  N  S  L  V  I  A  G  S  S  R  I  S  E  
gggtttgagaaggcctgtgaaattgcctgtaagcggttggaggagatcgcagacaccgtg 
 G  F  E  K  A  C  E  I  A  C  K  R  L  E  E  I  A  D  T  V  
cccgtcagccgtgaggaatacagttatttgctgcaaaccgcgcgctcaacactcaactcg 
 P  V  S  R  E  E  Y  S  Y  L  L  Q  T  A  R  S  T  L  N  S  
aaggtggtaaaccgtgaccgtgatcggttggcaaagatatgtgttgatgcggttctttcg 
 K  V  V  N  R  D  R  D  R  L  A  K  I  C  V  D  A  V  L  S  
gtcgcagacatggaacgccgtgacgtcaatctcgatctaattaagatggagggtaaagtc 
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 V  A  D  M  E  R  R  D  V  N  L  D  L  I  K  M  E  G  K  V  
ggtggatgccttgaggaaacatgcttagtgaacggcatcgtcattgacaaggacttctcc 
 G  G  C  L  E  E  T  C  L  V  N  G  I  V  I  D  K  D  F  S  
catcctcaaatgcccaaggtgctgaagaatccaaagattgccatcctcacatgcccattt 
 H  P  Q  M  P  K  V  L  K  N  P  K  I  A  I  L  T  C  P  F  
gagcccccgaaacccaaaactaaacacaccgtgcacatttcgagtgccgagcacatgaaa 
 E  P  P  K  P  K  T  K  H  T  V  H  I  S  S  A  E  H  M  K  
gaaattcacgagcaagagcaggagtacttccgcactcgagcgcaatcgaattcccgcggc 
 E  I  H  E  Q  E  Q  E  Y  F  R  T  R  A  Q  S  N  S  R  G  
 
 
➢ TritrpDB BLAST alignments:   
> Tb927.11.14250:mRNA-p1 | transcript=Tb927.11.14250:mRNA | 
gene=Tb927.11.14250  
| organism=Trypanosoma_brucei_brucei_TREU927  
| gene_product=T-complex protein 1, epsilon subunit, putative  
| transcript_product=T-complex protein 1, epsilon subunit,  
putative | location=Tb927_11_v5.1:3793465-3795081(+) | 
protein_length=538  
| sequence_SO=chromosome | SO=protein_coding 
Length=538 
 
 Score =  327 bits (839),  Expect = 1e-110, Method: Compositional 
matrix adjust. 
 Identities = 156/156 (100%), Positives = 156/156 (100%), Gaps = 
0/156 (0%) 
 
Query  1    SRISEGFEKACEIACKRLEEIADTVPVSREEYSYLLQTARSTLNSKVVNRDRDRLAKICV  60 
            SRISEGFEKACEIACKRLEEIADTVPVSREEYSYLLQTARSTLNSKVVNRDRDRLAKICV 
Sbjct  127  SRISEGFEKACEIACKRLEEIADTVPVSREEYSYLLQTARSTLNSKVVNRDRDRLAKICV  186 
 
Query  61   DAVLSVADMERRDVNLDLIKMEGKVGGCLEETCLVNGIVIDKDFSHPQMPKVLKNPKIAI  120 
            DAVLSVADMERRDVNLDLIKMEGKVGGCLEETCLVNGIVIDKDFSHPQMPKVLKNPKIAI 
Sbjct  187  DAVLSVADMERRDVNLDLIKMEGKVGGCLEETCLVNGIVIDKDFSHPQMPKVLKNPKIAI  246 
 
Query  121  LTCPFEPPKPKTKHTVHISSAEHMKEIHEQEQEYFR  156 
            LTCPFEPPKPKTKHTVHISSAEHMKEIHEQEQEYFR 
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➢ Translated protein sequence:   
cgggatcctattgtgctggagtcgcttgtcaaaaattgtaacacgaagttgcacacggaa 
 R  D  P  I  V  L  E  S  L  V  K  N  C  N  T  K  L  H  T  E  
gtcgctgcgcagaaaggcattgtgaaggaactgtacaacattgccacccgcagcgctacc 
 V  A  A  Q  K  G  I  V  K  E  L  Y  N  I  A  T  R  S  A  T  
agtgagaaggagtgcttagcgaaggaagcagctttggcgctcattcttaatttctctgtt 
 S  E  K  E  C  L  A  K  E  A  A  L  A  L  I  L  N  F  S  V  
tggtttgcagggcatcccaacagccggttaaagttcttgacgtcagtcgctgaggctgtt 
 W  F  A  G  H  P  N  S  R  L  K  F  L  T  S  V  A  E  A  V  
cgacgggctgtagggcccaatgcatttgatggaatccagcccgacattgatacgcgactc 
 R  R  A  V  G  P  N  A  F  D  G  I  Q  P  D  I  D  T  R  L  
tccatggcagtaggcccaacgggccagcgcacccgtcccccggcgaagcaaccgaacaaa 
 S  M  A  V  G  P  T  G  Q  R  T  R  P  P  A  K  Q  P  N  K  
tcaatacaccacccaccagaaactggactcccgccgggagcacacgtggtagacgcaatt 
 S  I  H  H  P  P  E  T  G  L  P  P  G  A  H  V  V  D  A  I  
ggcatcgttttaccaacggacgaggactcgagcgcaatcgaattcccgcggccgccatgg 
 G  I  V  L  P  T  D  E  D  S  S  A  I  E  F  P  R  P  P  W  
 
➢ TritrpDB BLAST alignments:   
> Tb927.11.10770:mRNA-p1 | transcript=Tb927.11.10770:mRNA | gene=Tb927.11.10770  
| organism=Trypanosoma_brucei_brucei_TREU927  
| gene_product=VHS domain containing protein, putative | transcript_product=VHS  
domain containing protein, putative |  
location=Tb927_11_v5.1:2883543-2884919(+) | protein_length=458  
| sequence_SO=chromosome | SO=protein_coding 
Length=458 
 
 Score =  303 bits (777),  Expect = 1e-102, Method: Compositional matrix adjust. 
 Identities = 145/145 (100%), Positives = 145/145 (100%), Gaps = 0/145 (0%) 
 
Query  1    IVLESLVKNCNTKLHTEVAAQKGIVKELYNIATRSATSEKECLAKEAALALILNFSVWFA  60 
            IVLESLVKNCNTKLHTEVAAQKGIVKELYNIATRSATSEKECLAKEAALALILNFSVWFA 
Sbjct  80   IVLESLVKNCNTKLHTEVAAQKGIVKELYNIATRSATSEKECLAKEAALALILNFSVWFA  139 
 
Query  61   GHPNSRLKFLTSVAEAVRRAVGPNAFDGIQPDIDTRLSMAVGPTGQRTRPPAKQPNKSIH  120 
            GHPNSRLKFLTSVAEAVRRAVGPNAFDGIQPDIDTRLSMAVGPTGQRTRPPAKQPNKSIH 
Sbjct  140  GHPNSRLKFLTSVAEAVRRAVGPNAFDGIQPDIDTRLSMAVGPTGQRTRPPAKQPNKSIH  199 
 
Query  121  HPPETGLPPGAHVVDAIGIVLPTDE  145 
            HPPETGLPPGAHVVDAIGIVLPTDE 
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